0001213900-15-008716.txt : 20151116 0001213900-15-008716.hdr.sgml : 20151116 20151116160557 ACCESSION NUMBER: 0001213900-15-008716 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20150930 FILED AS OF DATE: 20151116 DATE AS OF CHANGE: 20151116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OxySure Systems Inc CENTRAL INDEX KEY: 0001413797 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 710960725 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-54137 FILM NUMBER: 151234357 BUSINESS ADDRESS: STREET 1: 10880 JOHN W. ELLIOTT ROAD STREET 2: SUITE 600 CITY: Frisco STATE: TX ZIP: 75034 BUSINESS PHONE: (972) 294-6450 MAIL ADDRESS: STREET 1: 10880 JOHN W. ELLIOTT ROAD STREET 2: SUITE 600 CITY: Frisco STATE: TX ZIP: 75034 10-Q 1 f10q0915_oxysure.htm QUARTERLY REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2015

 

  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 000-54137

 

 

 

OXYSURE SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   71-0960725
(State or other jurisdiction of   (IRS Employer
incorporation or organization)   Identification No.)

 

10880 John W. Elliott Drive, Suite 600, Frisco, TX 75033

(Address of principal executive offices)

 

(972) 294-6450

(Registrant’s telephone number)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒   No ☐

  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
(Do not check if a smaller reporting company)    

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes    No 

 

Our common stock is traded in the over-the-counter market and quoted on the OTCQB under the symbol “OXYS.”

 

The number of shares outstanding of the registrant’s class of $0.0004 par value common stock as of November 13, 2015 was 36,220,761.

 

 

 

 

 

 

INDEX

 

    Page
    Number
PART I - FINANCIAL INFORMATION  
     
Item 1. Condensed Financial Statements F-1
  Condensed Balance Sheets – September 30, 2015 (unaudited) and December 31, 2014 F-1
  Condensed Statements of Operations – For the three and nine months ended September 30, 2015 and 2014 (unaudited) F-2
  Condensed Statements of Cash Flows – For nine months ended September 30, 2015 and 2014 (unaudited) F-3
  Condensed Notes to Financial Statements F-4 – F-13
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 2
Item 3. Quantitative and Qualitative Disclosures about Market Risk 8
Item 4. Controls and Procedures 8
     
PART II - OTHER INFORMATION  
     
Item 1. Legal Proceedings 9
Item 1A. Risk Factors 10
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 10
Item 3. Defaults upon Senior Securities 10
Item 4. Mine Safety Disclosures 10
Item 5. Other Information 10
Item 6. Exhibits 10
   
SIGNATURES 11

 

 

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1. CONDENSED FINANCIAL STATEMENTS

 

OXYSURE SYSTEMS INC.
CONDENSED BALANCE SHEETS

 

   September 30,   December 31, 
   2015   2014 
   Unaudited     
         
ASSETS        
Current assets        
Cash and cash equivalents  $6,312   $647,093 
Restricted cash  $2,000,000   $- 
Accounts receivable, net   830,596    369,575 
Inventories   390,028    277,346 
License fee receivable   403,478    463,308 
Prepaid expenses and other current assets   91,747    53,588 
Total current assets   3,722,161    1,810,910 
           
Property and equipment, net   89,544    91,537 
Intangible assets, net   340,142    362,764 
Other assets   276,692    246,237 
           
TOTAL ASSETS  $4,428,538   $2,511,448 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities          
Accounts payable and accrued expenses  $768,674   $558,338 
Related party payable   222,417    154,850 
Capital leases - current   -    149 
Notes payable - current, net of discount   47,103    40,897 
Convertible notes payable, net of discount   1,132,808    606,932 
Derivative liability   76,618    31,010 
Total current liabilities   2,247,620    1,392,176 
           
Long-term liabilities          
Notes payable   -    44,484 
Total long-term liabilities   -    44,484 
           
TOTAL LIABILITIES   2,247,620    1,436,660 
           
COMMITMENTS AND CONTINGENCY          
           
STOCKHOLDERS’ EQUITY          
Preferred stock, par value $0.0005 per share; 25,000,000 shares authorized;          
518,750 Series A convertible preferred shares issued and outstanding as of September 30, 2015 and 593,750 shares issued and outstanding as of December 31, 2014.   258    296 
750 Series B convertible preferred shares issued and outstanding as of September 30, 2015 and 1,145 shares issued and outstanding as of December 31, 2014.   1    1 
770,000 Series C convertible preferred shares issued and outstanding as of September 30, 2015 and 0 shares issued and outstanding as of December 31, 2014.   385    - 
1,050,000 Series D convertible preferred shares issued and outstanding as of September 30, 2015 and 0 shares issued and outstanding as of December 31, 2014.   525    - 
531,666 Series E convertible preferred shares issued and outstanding as of September 30, 2015 and 0 shares issued and outstanding as of December 31, 2014.   266    - 
Common stock, par value $0.0004 per share; 100,000,000 shares authorized;          
33,488,420 shares of voting common stock issued and outstanding as of September 30, 2015 and 28,436,930 shares issued and outstanding as of December 31, 2014   13,398    11,377 
Other stockholder equity   (1,231,666)   - 
Additional Paid-in Capital   25,418,546.00    19,104,322 
Accumulated deficit   (22,020,795)   (18,041,208)
           
TOTAL STOCKHOLDERS’ EQUITY   2,180,918    1,074,788 
           
TOTAL LIABILITIES  AND STOCKHOLDERS’ EQUITY  $4,428,538   $2,511,448 

 

See accompanying notes to financial statements

 

 F-1 

 

 

OXYSURE SYSTEMS INC.

STATEMENTS OF OPERATIONS

(Unaudited)

 

   For the three months
ended
September 30,
   For the nine months
ended
September 30,
 
   2015   2014   2015   2014 
   Unaudited   Unaudited   Unaudited   Unaudited 
                 
Revenues, net  $1,138,380   $818,456   $2,809,553   $1,852,796 
Cost of goods sold   580,126   $321,932    1,325,165   $792,378 
Gross profit   558,254    496,524    1,484,388    1,060,418 
                     
Operating expenses                    
Research and development  $362,599   $155,869   $873,450   $433,384 
Sales and marketing   437,442    202,825    1,231,581    444,818 
Other general and administrative   686,828    527,289    1,930,425    1,132,276 
Total operating expenses   1,486,869    885,983    4,035,456    2,010,478 
                     
Loss from operations   (928,615)   (389,459)   (2,551,067)   (950,060)
                     
Other income (expenses)                    
Interest expense   (626,127)   (169,051)   (1,519,071)   (362,638)
Change in value of derivative liabilities   219,673    -    342,257    - 
Derivative expense   (47,091)   -    (251,363)   - 
Other income (expense)   1,407    96,161    (342)   154,521 
Total other income (expenses   (452,138)   (72,890)   (1,428,519)   (208,117)
                     
Net loss  $(1,380,753)  $(462,349)  $(3,979,587)  $(1,158,177)
                     
Basic net loss per common share  $(0.04)  $(0.02)  $(0.13)  $(0.04)
                     
Weighted average common shares outstanding:                    
Basic and Diluted   32,425,195    26,120,974    30,543,678    26,042,971 

 

See accompanying notes to financial statements

 

 F-2 

 

 

OXYSURE SYSTEMS INC.

STATEMENTS OF CASH FLOWS

(Unaudited)

 

   For the nine months ended 
   September 30, 
   2015   2014 
         
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss  $(3,979,587)  $(1,158,177)
Adjustments to reconcile net loss to net cash from operating activities:          
Depreciation and amortization expense   33,239    35,462 
Amortization of debt discount and beneficial conversion features   1,315,271    254,944 
Gain on forgiveness of debt   (44,954)   - 
Excess derivative over proceeds   251,363    - 
Derivative liability fair value adjustment   (342,257)   - 
Expenses paid by related parties   137,150    4,374 
Warrants issued for services   11,025    - 
Stock based compensation   119,083    62,137 
Common stock issued for services   147,363    - 
Gain on extinguishment of debt   -    (123,667)
Changes in operating assets and liabilities:          
Accounts receivable   (461,020)   (444,915)
Inventories   (112,682)   (11,618)
License fees receivable   59,830    36,692 
Prepaid expenses and other current assets   (38,159)   87,070 
Other assets   (30,455)   - 
Accounts payable and accrued liabilities   266,363    476,772 
Deferred revenue   -    (2,976)
           
NET CASH USED IN OPERATING ACTIVITIES   (2,668,427)   (783,900)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
    Purchase of property and equipment   (8,624)   (70,651)
Purchase of intangible assets   -    (198)
           
NET CASH USED IN INVESTING ACTIVITIES   (8,624)   (70,849)
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Common stock subscribed and issued for cash   80,001    29,672 
Preferred stock issued for cash and warrants   2,650,001    - 
Cash received from related parties   43,917    9,800 
Payments made to related parties   (113,500)   (115,300)
Cash received from convertible notes payable   1,551,000    475,000 
Payments made on convertible notes payable   (175,000)   (192,000)
Payments on capital leases   (149)   (1,440)
           
NET CASH PRODUCED BY FINANCING ACTIVITIES   4,036,270    205,732 
           
Net change in cash and cash equivalents   1,359,219    (649,019)
           
Cash and cash equivalents, at beginning of period   647,093    657,673 
           
Cash and cash equivalents, at end of period  $2,006,312   $8,654 
           
Supplemental disclosure of cash flow information:          
Cash paid during the period for:          
Interest  $-   $12,996 
Income taxes  $-   $- 
           
Supplemental non-cash investing and financing activities:          
Conversion of preferred stock to common stock  $371   $- 
Common stock issued for prepaid services   -    25,000 
Conversion of convertible notes payable   1,234,730    188,358 
Beneficial conversion feature   843,515    - 
Initial value of the derivative   165,200    - 

 

See accompanying notes to financial statements

 

 F-3 

 

 

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2015

(Unaudited)

 

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

A summary of significant accounting policies of OxySure® Systems, Inc. (“OxySure” or the “Company”) is presented to assist in understanding the Company’s financial statements. The accounting policies presented in these footnotes conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the accompanying financial statements. These financial statements and notes are representations of the Company’s management who are responsible for their integrity and objectivity.

 

Basis of Presentation - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The interim financial statements include all adjustments which, in the opinion of management, are necessary in order to make the financial statements not misleading.

 

The accompanying Condensed Financial Statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (“SEC”) and therefore do not contain all of the information and footnotes required by GAAP and the SEC for annual financial statements. The Company's Condensed Financial Statements reflect all adjustments that management believes are necessary for the fair presentation of their financial position, results of operations, comprehensive loss and cash flows for the periods presented. The information at December 31, 2014 in the Company's Condensed Balance Sheet included in this quarterly report was derived from the audited Balance Sheet included in the Company's Annual Report on Form 10-K for the year ended December 31, 2014 filed with the SEC on March 31, 2015. Where applicable, the Company's 2014 Annual Report on Form 10-K is referred to in this quarterly report as the “2014 Annual Report.” This quarterly report should be read in conjunction with the 2014 Annual Report.

 

Deferred Revenue and Income - We defer revenue and income when we invoice a customer or a customer makes a payment and the requirements of revenue recognition have not been met (i.e. persuasive evidence of an arrangement exists, shipment from a company warehouse has occurred, the price is fixed or determinable and collectability is reasonably assured). Deferred Revenue was $0 for each of the periods ended September 30, 2015 and December 31, 2014, respectively.

 

Inventory – Our inventory consists of raw material and components for our portable oxygen systems as well as completed products and accessories.   Inventories are computed using the lower of cost or market, which approximates actual cost on a first-in first-out basis. Inventory components are parts, work-in-process and finished goods. Finished goods are reported as inventories until the point of title transfer to the customer.

 

Inventories as at September 30, 2015 and December 31, 2014 consisted of the following:

 

   September 30,   December 31, 
   2015   2014 
         
Parts inventory  $207,605   $133,477 
Work in process   45,120    41,114 
Finished goods   137,303    102,755 
Total inventories  $390,028   $277,346 

 

 F-4 

 

 

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2015

(Unaudited)

 

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

Cash and Cash Equivalents - We invest our cash in deposits and money market funds with major financial institutions.  We place our cash investments in instruments that meet high credit quality standards, as specified in our investment policy guidelines. These guidelines also limit the amount of credit exposure to any one issue, issuer or type of instrument.

 

Fair Value of Financial Instruments - Our financial instruments consist principally of cash and cash equivalents, accounts receivable and accounts payable.  We believe that the recorded values of all of our other financial instruments approximate their fair values because of their nature and respective maturity dates or durations. The fair value of our long-term debt is determined by using estimated market prices. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:

 

Level 1:  Inputs are based on quoted market prices for identical assets or liabilities in active markets at the measurement date.

 

Level 2:  Inputs include quoted prices for similar assets or liabilities in active markets and/or quoted prices for identical or similar assets or liabilities in markets that are not active near the measurement date.

 

Level 3: Inputs include management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument’s valuation.

 

The fair value of the majority of our cash equivalents was determined based on “Level 1” inputs. We do not have any marketable securities in the “Level 2” and “Level 3” category. We believe that the recorded values of all our other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations.

 

Property and Equipment – Property and equipment are recorded at cost with depreciation and amortization provided over the shorter of the remaining lease term or the estimated useful life of the improvement ranging from three to seven years. Renewals and betterments that materially extend the life of an asset are capitalized. Expenditures for maintenance and repairs are charged to expense when incurred. Furniture and fixtures are depreciated over five years. Machinery and equipments are depreciated over five to seven years. Software is depreciated over three years.  Leasehold improvements are computed using the shorter of the estimated useful lives of the assets or the lease terms.  Depreciation expense was $3,797 and $3,052 for the three month periods ended September 30, 2015 and 2014, respectively. Depreciation expense was $10,617 and $12,838 for the nine month periods ended September 30, 2015 and 2014, respectively.

 

Other Long-Lived Assets – We have two types of intangible assets – patents and trademarks. Intangible assets are carried at cost, net of accumulated amortization. Amortization expense for patents and trademarks was $7,508 and $7,557 for the three month periods ended September 30, 2015 and 2014, respectively. Amortization expense for patents and trademarks was $22,616 and $22,623 for the nine month periods ended September 30, 2015 and 2014, respectively.

 

Intangible assets with definite useful lives and other long-lived assets are tested for impairment if certain impairment indicators are identified.   Management evaluates the recoverability of its identifiable intangible assets in accordance with applicable accounting guidance, which requires the assessment of these assets for recoverability when events or circumstances indicate a potential impairment exists. If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. Impairment charges for patents were $0 for each of the three month periods ended September 30, 2015 and 2014.

 

5-Year amortization expense for patents and trademarks is as follows:

 

2015   $ 30,232  
2016     30,232  
2017     30,232  
2018     30,232  
Thereafter     188,982  
    $ 340,142  

 

 F-5 

 

 

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2015

(Unaudited)

 

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

Other Assets– We record Other Assets net of accumulated amortization. Amortization expense for Other Assets was $9,654 and $9,654 for the three month periods ended September 30, 2015 and 2014, respectively. Amortization expense for Other Assets was $28,962 and $47,216 for the nine month periods ended September 30, 2015 and 2014, respectively.

 

Capitalization of software: The Company accounts for internal-use software and website development costs, including the development of its partner marketplaces in accordance with ASC 350-50 (Intangibles – Website cost). The Company capitalizes internal costs consisting of payroll and direct payroll-related costs of employees who devote time to the development of internal-use software, as well as any external direct costs. It amortizes these costs over their estimated useful lives, which typically range between three to five years. The Company’s judgment is required in determining the point at which various projects enter the stages at which costs may be capitalized, in assessing the ongoing value of the capitalized costs, and in determining the estimated useful lives over which the costs are amortized. The estimated life is based on management’s judgment as to the product life cycle.

 

Amortization expense for websites and URLs was $9,654 and $9,654 for the three month periods ended September 30, 2015 and 2014, respectively. Amortization expense for websites and URLs was $28,962 and $28,962 for the nine month periods ended September 30, 2015 and 2014, respectively.

 

Research and Development Costs – Costs associated with the development of our products are charged to expense as incurred.  Research and development expense was $362,599 and $155,869 for the three month periods ended September 30, 2015 and 2014, respectively. Research and development expense was $873,450 and $433,384 for the nine month periods ended September 30, 2015 and 2014, respectively.

 

Equity Warrants - We issued warrants to purchase shares of our common stock in connection with convertible notes. In accordance with ASC 470-20, Debt with conversions and other options, the proceeds from the notes were allocated based on the relative fair values of the notes without the warrants issued in conjunction with the notes and of the warrants themselves at the time of issuance. We record the fair value of the warrants at the time of issuance as additional paid in capital and as a debt discount to the notes.  We amortize this debt discount as interest expense over the life of the note.  Additionally, as a result of issuing the warrants with the convertible notes, a beneficial conversion option is recorded as a debt discount reflecting the incremental conversion option intrinsic value of the conversion option provided to the holders of the notes. We also amortize this debt discount as interest expense over the life of the notes.  The intrinsic value of each conversion option was calculated as the difference between the effective conversion price and the fair value of the common stock, multiplied by the number of shares into which the note is convertible.

 

Stock-Based Compensation – We account for share-based payments, including grants of stock options to employees, consultants and non-employees; moreover, we issue warrants to the consultants and related parties.  We are required to estimate the fair value of share-based awards and warrants on the date of grant. The value of the award is principally recognized as expense ratably over the requisite service periods. We have estimated the fair value of stock options and warrants as of the date of grant or assumption using the Black-Scholes option pricing model.

 

 F-6 

 

 

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2015

(Unaudited)

 

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

For the three month periods ended September 30, 2015 and 2014, stock based compensation expense was approximately $25,740 and $42,437, respectively, which consisted primarily of stock-based compensation expense related to stock options issued to the employees and recognized under GAAP. For the nine month periods ended September 30, 2015 and 2014, stock based compensation expense was approximately $132,651 and $60,025, respectively.

 

Shipping and Handling Costs - Shipping and handling charges to customers are included in net revenues, and the associated costs incurred are recorded in cost of revenues.

 

Advertising Costs - Advertising costs are charged to operations when incurred.  We incurred $437,442 and $202,825 in advertising and promotion costs during the three month periods ended September 30, 2015 and 2014, respectively. Advertising and promotion costs during the nine month periods ended September 30, 2015 and 2014 were $1,231,581 and $444,818, respectively.

 

Net Income (Loss) Per Share - Basic earnings (loss) per share is computed based on the weighted average number of common shares outstanding. However, basic loss per share excludes anti-dilutive securities. Diluted earnings per share is computed based on the weighted average number of common shares outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive common shares been issued, and reduced by the number of shares the Company could have repurchased from the proceeds from issuance of the potentially dilutive shares. Potentially dilutive shares of common stock include stock options and other stock-based awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan. As of September 30, 2015 there were 21,865,386 potentially dilutive shares.

  

Recent Accounting Pronouncements

 

We have reviewed recent accounting pronouncements and concluded that they are either not applicable to our business or that no material effect is expected on the financial statements as a result of future adoption.

 

 F-7 

 

 

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2015

(Unaudited)

 

NOTE 2 – NOTES PAYABLE

 

We have issued warrants for the purchase of shares of our restricted common stock in connection with raising equity and debt financing and for other professional services.  The fair value of warrants issued is determined in accordance with Codification topic 470-20.

 

Frisco Promissory Note. On March 22, 2011 we entered into an Amended and Restated Performance Agreement with the Frisco Economic Development Corporation (“FEDC”) pursuant to an economic incentive package. In terms of the Amended and Restated Performance Agreement, the FEDC provided us with economic assistance in the form of the renewal and extension a forgivable loan of $213,000 (the “Frisco Note”) together with performance credits over 5 years, commencing on March 22, 2011 and ending on the earlier to occur of: (i) the full payment of the economic incentives; or (ii) March 31, 2016.

 

The Frisco Note requires varying annual principal payments through December 2015. The Frisco Note is non-interest bearing; however, interest has been imputed at 12.34% per annum. The unamortized discount at September 30, 2015 was $4,897 and the net amount of the Frisco Note as at September 30, 2015 was $47,103.

 

Future principal payments of the Frisco Note payable are as follows:

 

2015   52,000 
Total  $52,000 

 

During the nine months ended September 30, 2015 we issued ten convertible notes with a total principal value of $1,683,500 for $1,461,500 in cash. The notes contained original issuance discounts for a total of $222,500, and interest rates ranging between 8% and 12%. The maturity dates of the notes range from January 7, 2016 to May 4, 2017. The creditors have the option at any time to convert the principal and any accrued interest into common stock of the Company at an aggregate discount rate of approximately 7% off the market price of the Company’s common stock. During the nine months ended September 30, 2014 we repaid two notes with principal values totaling $175,000 for $237,298 in cash and the two notes were extinguished in their entirety pursuant to these transactions.

 

During the nine months ended September 30, 2014 we issued eight convertible notes with a total principal value of $475,000 for $412,500 in cash. The notes contained original issuance discounts for a total of $62,500, and interest rates of 12%. The maturity dates of the notes range from January 28, 2015 to September 10, 2015. The creditors have the option at any time to convert the principal and any accrued interest into common stock of the Company at a an aggregate discount rate of approximately thirty eight percent off the market price of the Company’s common stock. During the nine months ended September 30, 2014 we repaid two notes with principal values totaling $167,500 for $207,000 in cash and the two notes were extinguished in their entirety pursuant to these transactions. During the nine months ended September 30, 2014 we exchanged a lease with an outstanding amount of $307,662 for a convertible note with a principal value of $150,000 and 75,000 shares of our common stock. The lease was extinguished in its entirety pursuant to the exchange transaction.

 

During the nine months ended September 30, 2015, we issued warrants associated with notes. In accordance with ASC 470-20, Debt with conversions and other options, the proceeds from the notes were allocated based on the relative fair values of the notes without the warrants issued in conjunction with the notes and of the warrants themselves at the time of issuance. We recorded the relative fair value of the warrants issued with the notes in the amount of $251,363 as debt discounts upon issuance, and amortized these debt discounts as interest expense over the life of the notes. Additionally, as a result of issuing the warrants with the subordinated convertible promissory notes, a beneficial conversion option for each note was recorded as a debt discount reflecting the incremental conversion option intrinsic value benefit totaling $133,637 at the time of issuance provided to the holders of the notes, which was also amortized as interest expense over the life of the notes. We recorded interest expense in the amounts of $270,361 and $0 for the three months ended September 30, 2015 and 2014, respectively in connection with the notes (issued with warrants) that contained beneficial conversion features. We recorded interest expense in the amounts of $355,101 and $0 for the nine months ended September 30, 2015 and 2014, respectively in connection with all the notes (issued with warrants) that contained beneficial conversion features.

 

 F-8 

 

 

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2015

(Unaudited)

 

NOTE 3 - SHAREHOLDERS’ EQUITY

 

Preferred Shares Rights

 

We have 25,000,000 shares of preferred stock authorized, par value $0.0005 per share.

 

Series A Convertible Preferred Stock: As of September 30, 2015, the Company had authorized the issuance of 3,143,237 shares of preferred stock designated as Series A Convertible Preferred Stock (“Series A Preferred”). The original issue price of the Series A Preferred is $1.00 per share. There were 518,750 and 593,750 Series A Preferred shares issued and outstanding as of September 30, 2015 and December 31, 2014, respectively.

 

During the three months ended September 30, 2015 the Company did not issue any shares of the Series A Preferred, and no shares of the Series A Preferred have been converted into common stock.

 

Series B Convertible Preferred Stock: As of September 30, 2015, we had 3,500 shares of preferred stock designated as Series B Convertible Preferred Stock (“Series B Preferred”). The original issue price of the Series B Preferred is $1,000 per share. There were 750 and 1,145 Series B Preferred shares issued and outstanding as of September 30, 2015 and December 31, 2014, respectively.

 

During the three months ended September 30, 2015 the Company did not issue any shares of the Series B Preferred and 150 shares of Series B Preferred were converted into 313,296 shares of our common stock.

 

Series C Convertible Preferred Stock: As of September 30, 2015, we had 770,000 shares of preferred stock designated as Series C Convertible Preferred Stock (“Series C Preferred”). The original issue price of the Series C Preferred is $2.00 per share. There were 770,000 and 0 Series C Preferred shares issued and outstanding as of September 30, 2015 and December 31, 2014, respectively.

 

During the three months ended September 30, 2015 the Company issued no shares of the Series C Preferred and no shares of Series C Preferred were converted into common stock.

 

Series D Convertible Preferred Stock: As of September 30, 2015, we had 1,050,000 shares of preferred stock designated as Series D Convertible Preferred Stock (“Series D Preferred”). The original issue price of the Series D Preferred is $2.00 per share. There were 1,050,000 and 0 shares of the Series D Preferred issued and outstanding as of September 30, 2015 and December 31, 2014, respectively.

 

During the three months ended September 30, 2015 the Company issued no shares of the Series D Preferred and no shares of Series D Preferred were converted into common stock.

 

Series E Convertible Preferred Stock: As of September 30, 2015, we had 531,666 shares of preferred stock designated as Series E Convertible Preferred Stock (“Series E Preferred”). The original issue price of the Series E Preferred is $1.00 per share. There were 531,666 and 0 shares of the Series E Preferred issued and outstanding as of September 30, 2015 and December 31, 2014, respectively.

 

During the three months ended September 30, 2015 the Company issued no shares of the Series E Preferred and no shares of Series E Preferred were converted into common stock.

 

Common Stock

 

The Company has authorized 100,000,000 shares of $0.0004 par value common stock.

 

During the three months ended September 30, 2015:

 

  (1) We issued 313,296 shares of common stock pursuant to the cashless conversion of 150 shares of Series B Preferred;
  (2) We issued 1,767,650 shares of common stock pursuant to the conversion of convertible notes;
  (3) We issued 90,000 shares of common stock for services;
  (4) We issued 93,474 shares of common stock for compensation;
  (5) We recorded $2,380 in expenses in connection warrants issued for services;
  (6) We recorded $219,673 in connection with derivative revaluation;
  (7) We recorded $26,740 for the computed fair value of options issued to employees, non-employee directors, and consultants, net of cancellations and forfeitures; and
  (8) We recorded $434,983 in connection with beneficial conversion features.

 

During the nine months ended September 30, 2015:

 

  1. We issued 133,333 shares of common stock for $80,001 in cash;
  2. We issued 91,500 shares of common stock pursuant to the cashless conversion of 75,000 shares of Series A Preferred;
  3. We issued 835,833 shares of common stock pursuant to the cashless conversion of 395 shares of Series B Preferred;

 

 F-9 

 

 

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2015

(Unaudited)

 

  4. We issued 770,000 shares of the Series C Preferred for which we received $700,000 in cash and recorded a stock subscription receivable for the remaining $700,000;
  5. We issued 1,050,000 shares of the Series D Preferred for $2,000,000 in cash held in escrow, to be released upon our uplisting to a national exchange;
  6. We issued 3,719,350 shares of common stock pursuant to the conversion of convertible notes;
  7. We issued 178,000 shares of common stock for services;
  8. We issued 93,474 shares of common stock for compensation;
  9. We recorded $11,025 in expenses in connection warrants issued for services;
  10. We recorded $342,257 in connection with derivative revaluation;
  11. We recorded $132,651 for the computed fair value of options issued to employees, non-employee directors, and consultants, net of cancellations and forfeitures; and
  12. We recorded $1,315,271 in connection with beneficial conversion features.

 

During the three months ended September 30, 2014:

 

  (1) We issued 26,580 shares of common stock for $19,000 in cash; and
  (2) We issued 360,781 shares of common stock pursuant to cashless conversions of convertible notes payable and accrued interest, valued at $150,858.

 

During the nine months ended September 30, 2014:

 

  (1) We issued 41,580 shares of common stock for $29,700 in cash;
  (2) We issued 444,072 shares of common stock pursuant to cashless conversions of convertible notes payable and accrued interest, valued at $188,358; and
  (3) We issued 122,000 shares of common stock pursuant to the cashless conversion of 100,000 shares of Series A Preferred.

  

As of September 30, 2015 we had approximately 33,488,420 shares of common stock issued and outstanding.

 

NOTE 4 - STOCK OPTIONS AND WARRANTS

 

Equity Incentive Plans

 

In April 2004, our Board of Directors and the stockholders at that time approved the adoption of a Voting Stock Option Plan (“the Plan”), which provides for the issuance of stock options to eligible employees, consultants, Board members and Advisory Board members of the Company to acquire up to a maximum of 5,000,000 shares of common stock.

 

Our Board of Directors, which determines the number of options that will be granted, the effective dates of the grants, the option process and the vesting schedules, administers the Plan. In the absence of an established market for the common stock of the Company, the Board of Directors determines the fair market value of our common stock. Options generally expire between five and ten years from the date of grant and automatically terminate 90 days after such optionee ceases to be an eligible individual under the Plan other than by reason of death or disability.

 

The portion of options granted that is not exercisable on the date the optionee ceases to be an eligible individual under the Plan by reason other than death, shall terminate and be forfeited to the Company on the date of such cessation. An optionee has no right as a stockholder with respect to any shares covered by the options granted to him until a certificate representing such shares is issued to them.

 

Stock Options

 

The following table summarizes information about the number and weighted average of the options that were forfeited or expired under the Plan as at September 30, 2015:

 

   Employee   Non-Employee     
       Weighted       Weighted     
   Number   Average   Number   Average   Combined 
   Of   Exercise   Of   Exercise   Total 
Outstanding at June 30, 2015   2,513,838   $0.41    -   $-    2,513,838 
Granted   -   $-    -   $-    - 
Exercised   -   $-    -   $-    - 
Forfeited/Cancelled   (62,500)  $-    -   $-    - 
Outstanding at September 30, 2015   2,451,338   $0.39    -   $-    2,451,338 

 

The number of stock options exercisable at September 30, 2015 was 1,886,721.

 

 F-10 

 

 

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2015

(Unaudited)

 

NOTE 4 - STOCK OPTIONS AND WARRANTS (CONTINUED)

 

We used the following assumptions to estimate the fair value of options granted under the Plan for the three and nine months ended September 30, 2015 and 2014:

 

   Equity Incentive Plans   Equity Incentive Plans 
   for the Three Months Ended September 30,   for the Nine Months Ended September 30, 
   2015   2014   2015   2014 
                 
Expected terms (in years)   5-10    5-10    5-10    5-10 
Volatility (weighted ave.)   83.79%   40.45%   83.79%   40.45%
Risk-free interest rate   .85% - 1.74%   1.50% - 1.80%   .85% - 1.74%   1.44% - 1.80%
Expected dividend rate   0%   0%   0%   0%

  

The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding. The expected term is based on the observed and expected time to exercise and post-vesting cancellations of options by optionees.  We use historical volatility in deriving our expected volatility assumption because it believes that future volatility over the expected term of the stock options is not likely to differ from the past.

 

The expected dividend assumption is based on our history and expectation of dividend payouts.  The fair value of the shares of common stock underlying the stock options has historically been determined by the board of directors. On or before February 2012, when our common stock commenced trading on the over the counter bulletin board (OTCQB), there has been no public market for our common stock. Consequently, the board of directors has historically determined the fair value of the common stock at the time of grant of the option by considering a number of objective and subjective factors including valuation of comparable companies, operating and financial performance, the lack of liquidity of capital stock and general and industry specific economic outlook, amongst other factors.  

 

FASB ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company only records stock-based compensation expense for awards that are expected to vest. While we generally consider historical forfeitures in its estimates, judgment is also required in estimating the amount of stock-based awards that are expected to be forfeited. The Company’s estimates for forfeitures may differ from actual forfeitures. If actual results differ significantly from these estimates, stock-based compensation expense and its results of operations could be materially impacted when the Company records a true-up for the difference in the period that the awards vest. We adjust stock-based compensation expense based on our actual forfeitures on an annual basis, if necessary.

 

Stock compensation cost, using the graded vesting attribute method in accordance with Codification topic 718, is recognized over the requisite service period, generally 5 years, during which each tranche of shares is earned (zero, one, two, three, and four years).  The value of each tranche is generally amortized on a straight-line basis.  For the three months ended September 30, 2015 and 2014, stock based compensation expense was approximately $26,736 and $42,437 respectively, which consisted primarily of stock-based compensation expense related to stock options recognized under GAAP issued to employees.  For each of the three months ended September 30, 2015 and 2014, the number of options exercised was 0.

 

Compensation expense is recognized only for the portion of stock options that are expected to vest, assuming an expected forfeiture rate in determining stock-based compensation expense, which could affect the stock-based compensation expense recorded if there is a significant difference between actual and estimated forfeiture rates. As of September 30, 2015, total unrecognized compensation cost related to stock-based awards granted to employees and non-employee directors was $323,715.

 

 F-11 

 

 

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2015

(Unaudited)

 

NOTE 4 - STOCK OPTIONS AND WARRANTS (CONTINUED)

 

Warrants.

 

The following table summarizes our warrant activities for the three months ended September 30, 2015:

 

       Weighted 
   Number   Average 
   Of   Exercise 
   Warrants   Price 
Outstanding at June 30, 2015   4,863,956   $1.22 
Granted   15,000   $1.23 
Exercised   -   $- 
Forfeited/Cancelled   -   $- 
Outstanding at September 30, 2015   4,878,956   $1.23 

 

The number of warrants exercisable at September 30, 2015 was 4,878,956.

 

NOTE 5 – RELATED PARTY TRANSACTIONS

 

A summary of the related party financings and notes as at September 30, 2015 is as follows:

 

Related party  Julian Ross (1) 
Amount  $222,417 
Stated interest rate   0%
Maturity   n/a 

 

(1) Our CEO, Mr. Ross provides us shareholder cash advances and other consideration from time to time to fund working capital.

 

 

NOTE 6 – OFF BALANCE SHEET ARRANGEMENTS AND CONTRACTUAL OBLIGATIONS

 

We have not entered into any transactions with unconsolidated entities whereby we have financial guarantees, subordinated retained interests, or other contingent arrangements that expose us to material continuing risks, contingent liabilities, or any other obligation under a variable interest in an unconsolidated entity that provides financing, liquidity, market risk or credit risk support to us.

 

NOTE 7 – FAIR VALUE MEASUREMENTS

 

Changes related to derivatives for the nine months ended September 30, 2015 are as follows:

 

Balance as of December 31, 2014  $31,010 
Additions related to embedded derivative of convertible notes issued   416,563 
Gain on decrease in value of derivative liabilities   (342,257)
Conversions   (28,698)
Balance as of September 30, 2015  $76,618 

 

During the nine month period the Company recorded derivatives related to convertible notes of $416,563 of which $251,363 exceed the proceeds of the convertible notes and was recorded as a derivative expense. The Company also converted $28,698 and recorded gains on the change in the fair values of the derivatives of $342,257.

 

 F-12 

 

  

OXYSURE® SYSTEMS, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2015

(Unaudited)

 

Assets Measured at Fair Value on a Recurring Basis

 

       Fair value measurements at
reporting date using:
 
   Total   Level 1   Level 2   Level 3 
                 
Cash (1)  $2,006,312   $2,006,312    -    - 
Derivatives   (76,618)   -    (76,618)   - 
Total assets at fair value as of September 30, 2015  $1,929,694   $2,006,312   $(76,618)  $- 

 

(1) Included in Cash and cash equivalents on the Company's Balance Sheet.

 

   Total   Level 1   Level 2   Level 3 
                 
Cash (1)  $647,093   $647,093    -    - 
Total assets at fair value as of December 31, 2014  $647,093   $647,093    -    - 

 

(1) Included in Cash and cash equivalents on the Company's Balance Sheet.

 

NOTE 8 – SEGMENT INFORMATION

 

We are organized as, and operate in, one reportable segment: the development, distribution and sale of specialty respiratory products and related medical products, accessories, and services. Our chief operating decision-maker is our Chief Executive Officer. Our Chief Executive Officer reviews financial information presented for purposes of evaluating financial performance and allocating resources, accompanied by information about revenue by geographic regions. Our assets are primarily located in the United States of America and not allocated to any specific region and we do not measure the performance of our geographic regions based upon asset-based metrics. Therefore, geographic information is presented only for revenue. Revenue by geographic region is based on the ship to address on our customer orders.

 

The following presents total revenue by geographic region for the three month periods ended September 30, 2015 and 2014:

 

   Three Months Ended
September 30,
 
   2015   2014 
         
United States - product sales  $1,138,380   $814,619 
ROW - product sales   -    3,837 
           
Totals  $1,138,380   $818,456 

 

The following presents total revenue by geographic region for the nine month periods ended September 30, 2015 and 2014:

 

    Nine Months Ended September 30,
    2015   2014
         
United States - product sales   $ 2,807,600     $ 1,793,729  
ROW - product sales     1,953       41,567  
ROW - license fees/service revenue     -       17,500  
                 
Totals   $ 2,809,553     $ 1,852,796  

 

NOTE 9 – GOING CONCERN

 

Our financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. Historically we have been suffering from recurring loss from operations. We have an accumulated deficit of $22,020,795 and $18,041,208 at September 30, 2015 and December 31, 2014, respectively, and stockholders’ equity of $2,180,918 and $1,074,787 as of September 30, 2015 and December 31, 2014, respectively. We require substantial additional funds to manufacture and commercialize our products. Our management is actively seeking additional sources of equity and/or debt financing; however, there is no assurance that any additional funding will be available.

 

In view of the matters described above, recoverability of a major portion of the recorded asset amounts shown in the accompanying September 30, 2015 balance sheet is dependent upon continued operations of the Company, which in turn is dependent upon the Company’s ability to meet its financing requirements on a continuing basis, to maintain present financing, and to generate cash from future operations. These factors, among others, raise substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should we be unable to continue in existence.

 

 F-13 

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis summarizes the significant factors affecting our results of operations, financial conditions and liquidity position for the three months ended September 30, 2015 and 2014, and should be read in conjunction with our financial statements, including the notes thereto, appearing elsewhere in this report.

 

Forward-Looking Statements

 

Statements and information included in this Quarterly Report on Form 10-Q that are not purely historical, including, without limitation, statements that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development, are forward-looking statements within the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. When used in this report, words such as “believe,” “expect,” “intend,” “goal,” “plan,” “pursue,” “likely,” “believe,” “project,” “anticipate,” “intend,” “estimate,” “evaluate,” “opinion,” “may,” “could,” “future,” “potential,” “probable,” “if,” “will” and similar expressions generally identify forward-looking statements. These statements are subject to risks and uncertainties.

 

Forward-looking statements in this Quarterly Report on Form 10-Q represent our beliefs, projections and predictions about future events. These statements are necessarily subjective and involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any future results, performance or achievement described in or implied by such statements. Actual results may differ materially from the expected results described in our forward-looking statements, including with respect to the correct measurement and identification of factors affecting our business or the extent of their likely impact, the accuracy and completeness of publicly available information relating to the factors upon which our business strategy is based, or the success of our business. The factors or uncertainties that could cause actual results, performance or achievement to differ materially from forward-looking statements contained in this report can be found in our filings with the Securities and Exchange Commission, including our filings on Form 10-K.

 

Highlights

 

Financial highlights:

 

Total revenue increased 39% to $1,138,380 for the three months ended September 30, 2015 as compared to $818,456 for the prior period;
   
Total revenue increased 52% to $2,809,553 for the nine months ended September 30, 2015 as compared to $1,852,796 for the prior period;
   
Gross profit increased 12% to $558,254 for the three months ended September 30, 2015 as compared to $496,524 for the prior period;
   
Gross profit increased 40% to $1,484,388 for the nine months ended September 30, 2015 as compared to $1,060,418 for the prior period;
   
Total cash equivalents increased 210% to $2,006,312 at September 30, 2015 from $647,093 at December 31, 2014;
   
Working capital surplus increased 252% to $1,474,540 at September 30, 2015 from $418,734 at December 31, 2014;
   
Total assets increased 110% to $4,428,538  at September 30, 2015 from $2,511,448 at December 31, 2014; and
   
Stockholder equity increased 103% to $2,180,918 at September 30, 2015 from $1,074,788 at December 31, 2014.

 

 2 

 

 

Non-financial highlights and milestones:

 

We appointed Dr. Joseph M. Chalil, MD, MBA, FACHE, a Physician and Executive at Boehringer Ingelheim to our Strategic Advisory Board;
   
Our business and industry received support from an opinion paper published in the Journal of Emergency Medical Services (JEMS) that appears to pave the way for “public/first aid oxygen” usage, prior to the arrival of professional first responders;
   
Our stockholders voted to approve two proposals designed to support an uplisting of the Company to a national exchange such as Nasdaq and an amendment of the Company’s capital structure to facilitate significant future growth;
   
We conducted an investor day, at our headquarters where a tour of the Company’s production plant and operations was provided;

 

We announced the appointment of two new Territory Sales Managers in Indiana and Colorado;
   
We placed fourth on the Fast Tech Award listing honoring the fastest growing technology Companies in North Texas – our Company grew at an average of 801.45% for the two-year period under review;
   
We received commercial drone approval from the Federal Aviation Administration (FAA) - The Company’s petition for exemption for commercial drone usage was granted by the FAA, a division of the United States Department of Transportation (DOT);
   
We presented at 2015 Sidoti Emerging Growth Conference;
   
We retained Donohoe Advisory Associates LLC of Rockville, Maryland to advise and assist us in our efforts to obtain a listing on a national securities exchange;
   
Our OxySure Model 615 portable emergency oxygen device was used eighteen times during the Special Olympics World Games which took place July 25 - August 2, 2015 in Los Angeles;
   
We teamed up with Cardiac Science Corporation (Cardiac Science), a market-leading manufacturer and marketer of automated external defibrillators (AEDs) and related services with a partnership covering various joint strategic initiatives; and 
   
We closed a $3 million institutional financing transaction.

 

 3 

 

 

Overview

 

OxySure Systems, Inc. was formed on January 15, 2004 as a Delaware “C” Corporation for the purpose of developing products with the capability of generating medical grade oxygen “on demand,” without the necessity of storing oxygen in compressed tanks.  Our technology, process and methodologies involve the creation of medically pure (USP) oxygen from two dry, inert powders.  We believe that other available chemical oxygen generating technologies contain hazards that make them commercially unviable for broad-based emergency use by lay rescuers or the general public.  Our launch product is the OxySure Model 615 portable emergency oxygen system.  We believe that the OxySure Model 615 is currently the only product on the market that can be safely pre-positioned in public and private venues for emergency administration of medical oxygen by lay persons, without the need for training.

 

To date, we have been issued 7 patents and we have other patents pending on this process and technology that we believe is revolutionizing the emergency/short duration oxygen supply marketplace. We believe that OxySure makes the delivery devices lighter, safer, more affordable and easier to use. We believe our products can improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other “Immediately Dangerous to Life or Health” (IDLH) environments.

 

The OxySure Model 615 emergency oxygen device was cleared by the Food and Drug Administration (“FDA”) (510k, Class II) for over-the-counter purchase in December 2005. We believe it bridges the gap between the onset of a medical emergency and the time first responders arrive on the scene. We believe it allows a lay rescuer – a bystander or loved one – to administer medical oxygen during those first, critical minutes after an emergency occurs, improving medical outcomes and saving lives in the process. In March 2014 we also received CE Marking approval for Model 615, allowing us to begin commercializing it in the European Union.

 

We have since diversified our product portfolio to provide include solutions focused on the emergency medical preparedness and respiratory needs of our education, commercial and government customers. Our solutions include Automated External Defibrillators (AEDs) and accessories, resuscitation equipment, and respiratory and monitoring equipment and supplies.

 

 4 

 

 

The OxySure Strategy

 

The following summarizes the principal elements of our strategy:

 

We launched the OxySure Model 615 into the K-12 education market in the United States, and we subsequently diversified into other institutional markets, such as colleges, churches and places of worship, manufacturing facilities and other commercial and municipal buildings. We plan to continue to pursue institutional customers in these and other vertical markets, both in the United States and internationally.

 

We believe that Model 615 is a natural complement and companion product to an Automated External Defibrillator (AED). We plan to continue to market Model 615 as a companion product to AEDs, and our goal in the foreseeable future is to pursue the placement of the OxySure Model 615 next to as many AEDs as possible, in the United States as well as internationally. According to Frost & Sullivan, there are approximately We believe in the long term, however, Model 615 has the potential to become a standard issue item for public and private settings, just like a fire extinguisher.

 

We plan to continue to leverage our core competencies in oxygen, breathing technologies, research and manufacturing to pursue revenue opportunities in new vertical markets, including the military.

 

We plan to continue to build our sales force by recruiting dedicated sales professionals focusing on business to business sales, former first responders, paramedics and firefighters as well individuals from other medical, first aid and safety sales areas to market our products and craft solutions for our customers.
   
Our channel strategy includes leveraging distribution partnerships to enhance market penetration, and we plan to increase our efforts to partner with distributors, including distributors of AEDs, safety products and medical devices.  We plan to invest resources in training and tools for our distribution partners’ sales, systems and support organizations, in order to improve the overall efficiency and effectiveness of these partnerships.

 

We plan to continue our increasing efforts to promote market awareness and education of our products and their critical need, and our efforts may include partnerships with industry, medical thought leaders, and community and advocacy organizations.

 

We plan to market to “at risk” markets – people with conditions such as asthma and other respiratory and medical conditions where supplemental or emergency oxygen is either required or desired – by way of direct to consumer campaigns utilizing television, print and online media to increase sales, awareness and brand recognition.

 

We plan to pursue market catalysts such as a legislative agenda for state and federal mandates, medical reimbursement for at risk markets, and insurance underwriting benefits and discounts for product users.

 

We plan to continue to diversify our product offerings through the addition of complimentary or additive products and solutions that enhance our core product usability, feasibility, appeal or application, or that enhances our ability to access or add value to existing and new customers. In addition, we plan to continue our development efforts focused on developing new products incorporating our core “oxygen from powder” technology for other vertical markets, such as aviation, mining, and sports and recreation as applicable.

 

We plan to pursue strategic alliances where applicable to accelerate our growth and access to new customers, sales channels, markets and products.

 

 5 

 

 

Results of Operations

 

You should read the selected financial data set forth below along with our discussion and our financial statements and the related notes. We have derived the financial data from our unaudited financial statements. We believe the financial data shown in the table below include all adjustments consisting only of normal recurring adjustments, that we consider necessary for a fair presentation of such information. Operating results for the period are not necessarily indicative of the results that may be expected in the future.

 

Results for the Three Months Ended September 30, 2015 Compared to the Three Months Ended September 30, 2014 (unaudited)

 

   Three Months Ended 
   September 30, 
   2015   2014 
         
Net loss  $(1,380,753)  $(462,349)
Shares used in computing basic and diluted loss per share amounts (weighted ave.)   32,425,195    26,120,974 
Net loss per share:          
Basic and diluted  $(0.04)  $(0.02)

 

Revenues

 

We had $1,380,753 in revenues from operations for the three months ended September 30, 2015 as compared to revenues of $818,456 for the three months ended September 30, 2014.  The increase in revenues is primarily attributable to an increase in US product sales and military products.

 

Expenses

 

Total expenses for the three months ended September 30, 2015 were $2,740,213, which amount includes $1,486,870 of operating expenses, $580,126 in cost of goods sold, $626,127 in interest expense and $47,091 in derivative expense, as compared to total expenses for the three months ended September 30, 2014 of $1,376,966, which amount includes $885,983 of operating expenses, $321,932 in cost of goods sold, and $169,051 in interest expense. The increase in total selling, general and administrative expenses is primarily attributable to an increase in advertising and promotional expense, an increase in other general and administrative expense, and an increase in research and development expense. The increase in interest expense is primarily attributable to an increase in interest expense related to convertible notes. The in other general and administrative expense is primarily attributable to an increase in salaries and wages, stock compensation expense, professional fees and insurance expense.

 

Research and Development

 

Research and development expenses of $362,599 and $155,869 were incurred in the three months periods ended September 30, 2015 and 2014, respectively.  The increase in research and development expense is primarily attributable to an increase in research and development expense associated with products for military markets.

 

Net Income (Loss)

 

Net loss for the three months ended September 30, 2015 was $1,380,753 and basic and diluted net loss per share was $(0.04) as compared to a net loss for the three months ended September 30, 2014 of $462,349 and basic and diluted net loss per share of $(0.02). The increase in net loss during the three months ended September 30, 2015 as compared to the three months ended September 30, 2014 is primarily due to the combined effect of an increase in research and development expense, an increase in interest expense, an increase in sales and marketing expense and an increase in other general and administrative expenses, offset by an increase in revenues and gross profit.

 

 6 

 

 

Results for the Nine Months Ended September 30, 2015 Compared to the Nine Months Ended September 30, 2014 (unaudited)

 

   Nine Months Ended 
   September 30, 
   2015   2014 
         
Net loss  $(3,979,587)  $(1,158,177)
Shares used in computing basic and diluted loss per share amounts (weighted ave.)   30,543,678    26,042,971 
Net loss per share:          
Basic and diluted  $(0.13)  $(0.04)

 

Revenues

 

We had $2,809,553 in revenues from operations for the nine months ended September 30, 2015 as compared to revenues of $1,852,796 for the nine months ended September 30, 2014.  The increase in revenues is primarily attributable to an increase in US product sales and military products.

 

Expenses

 

Total expenses for the nine months ended September 30, 2015 were $7,131,396, which amount includes $4,035,456 of operating expenses, $1,325,165 in cost of goods sold, $1,519,071 in interest expense, and $251,363 in derivative expense, and $342 net in other expenses as compared to total expenses for the nine months ended September 30, 2014 of $3,165,494, which amount includes $2,010,479 of operating expenses, $792,378 in cost of goods sold, and $362,638 in interest expense. The increase in total selling, general and administrative expenses is primarily attributable to an increase in advertising and promotional expense, an increase in other general and administrative expense, and an increase in research and development expense. The increase in interest expense is primarily attributable to an increase in interest expense related to convertible notes.

 

Research and Development

 

Research and development expenses of $873,450 and $433,384 were incurred in the nine months periods ended September 30, 2015 and 2014, respectively.  The increase in research and development expense is primarily attributable to an increase in research and development expense associated with products for military markets.

 

Net Income (Loss)

 

Net loss for the nine months ended September 30, 2015 was $3,979,587 and basic and diluted net loss per share was $(0.13) as compared to a net loss for the nine months ended September 30, 2014 of $1,158,177 and basic and diluted net loss per share of $(0.04). The increase in net loss during the nine months ended September 30, 2015 as compared to the nine months ended September 30, 2014 is primarily due to the combined effect of an increase in research and development expense, an increase in interest expense, an increase in derivative expense, an increase in sales and marketing expense and an increase in other general and administrative expenses, offset by an increase in revenues and gross profit.

 

Liquidity and Capital Resources

 

We had a cash balance of approximately $2,006,312 as of September 30, 2015, as compared to $647,093 as of December 31, 2014.  Of this amount, $2,000,000 is held in a U.S. based third party escrow account, and is to be released upon an uplisting of our Company to a national stock exchange. The remainder of our funds is kept in financial institutions located in the United States of America.

 

We had a working capital surplus of $1,479,075 as of September 30, 2015 as compared to a working capital surplus of $418,734 as of December 31, 2014.

 

We had total notes payable of $1,177,869 and $692,313 as of September 30, 2015 and December 31, 2014, respectively. The increase in Notes Payable was primarily due to an increase in new convertible notes payable offset by note repayments in cash, partial note conversions into common stock and note forgiveness related to an economic incentive received from the City of Frisco.

 

We generally provide our customers with terms of up to 30 days on our accounts receivable.  In some cases we require prepayment, depending on history or credit review.  Further, we generally require pre-payment on orders shipped to international destinations.  Our accounts receivable, net of allowances, were $830,596 and $369,575 as at September 30, 2015 and December 31, 2014, respectively.

 

Since inception, we have been engaged primarily in product research and development, obtaining certain regulatory approvals, investigating markets for our products, developing manufacturing and supply chain partners, developing our production capability, and developing distribution, licensing and other channel relationships. In the course of funding research and development activities, we have sustained operating losses since inception and have an accumulated deficit of $22,020,795 at September 30, 2015.

 

 7 

 

 

We completed product development of our launch product, the OxySure Model 615 and launched sales thereof in 2008.  We have and will continue to use significant capital to manufacture and commercialize our products.  These factors raise doubt about our ability to continue as a going concern.  In this regard, management is proposing to raise any necessary additional funds not provided by operations through loans or through additional sales of our common stock.

 

During the remainder of 2015 and 2016, we will need additional capital to market and sell our products, and to further develop and enhance our current product offerings, introduce new products and address unanticipated competitive threats, technical problems, economic conditions or other requirements.  We estimate that we will require approximately $3.5 million over the next 12 months to remain viable.  There is no assurance that we will be successful in raising this additional capital or in achieving profitable operations.  The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might result from this uncertainty.  However, there can be no assurance that any additional financing will be available to us.  Additional equity financing may involve substantial dilution to our then existing stockholders.  In the event we are unable to raise additional capital, we may be required to substantially reduce or curtail our activities.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide information under this item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our President and Chief Financial Officer has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934) as of the end of period covered by this report.  Based upon such evaluation,  the President and Chief Financial Officer concluded that our disclosure controls and procedures were not effective to ensure that the information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our President and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 8 

 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

The Company is subject to litigation in the normal course of business, none of which management believes will have a material adverse effect on the Company’s financial statements.

 

On or about December 13 of 2013, Wall Street Buy Sell Hold, Inc., (“WSBSH”) filed a lawsuit against the Company in the New York Supreme Court, Nassau County. The suit seeks damages in the form of money, stock and warrants for breach of a marketing agreement entered into on October 22, 2012 and another entered into on March 11, 2013. We have answered the complaint and filed a counterclaim against WSBSH seeking the return of all moneys and shares we paid or transferred to WSBSH, as well as punitive damages for fraud.

 

On May 8, 2015, we filed a lawsuit against Wall Street Buy Sell Hold, Inc., and its principals Christopher and Jerry Castaldo in federal court in the Eastern District of Texas. The suit arises out of certain agreements made between the defendants and us. These and/or similar agreements are also the subject of parallel breach of contract actions between us and WSBSH in the 2013 suit in New York state.

 

The core of the Texas federal suit is that WSBSH attempted to contract to provide broker/dealer services despite the fact that, unbeknownst to us, its principal was a disgraced former broker who was not licensed to provide such services under state and federal law. Irrespective of the defendants' failed performance, the Texas suit seeks the return of the compensation and shares we paid and rescission of their illegal contracts, which are voidable at the option of the innocent party, as well as our attorney's fees.

 

On September 30, 2015, we issued $2.7 million in convertible preferred stock (“Series C, Series D and Series E Preferred Stock”) and $.3 million in 2 convertible notes (“Convertible Notes”). On July 14, 2015, a lawsuit was filed by Alpha Capital Anstalt (“Alpha”) against us and Adar Bays LLC, Union Capital LLC, JSJ Investments LLC, Group 10 Holdings LLC, and Macallan Partners LLC (the “Noteholders”) in the United States District Court for the Southern District of New York (the “Court”). Alpha is one of the holders of our Series B convertible preferred stock (“Series B Preferred”). In its complaint, Alpha claims that the issuance of the Series C, D and E Preferred Stock and of the Convertible Notes without allowing the Alpha the opportunity to invest constitutes, and that future conversions of the Series, C, D and E Preferred Stock and of the Convertible Notes into our common stock could constitute, a breach of contract under the terms of the Series B Preferred Stock and the terms of the stock purchase agreements pursuant to which the Alpha acquired its Series B Preferred Stock. Alpha asked for preliminary and permanent injunctive relief and monetary damages. On July 16, 2015, the Court, upon hearing oral arguments from us and Plaintiff and ruling from the bench, denied Alpha preliminary injunctive relief. The case has entered the discovery phase. We believe this lawsuit to be an attempt by Alpha to extract more favorable terms from us and that it has no merit, and we intend to vigorously contest any remaining claims that might remain.

 

 9 

 

 

On November 3, 2015, we issued a press release announcing that we have filed a lawsuit in the Texas District Court in Collin County, Texas, against TEGNA Inc., WFAA T.V. Channel 8, Jobin Panicker, a reporter for WFAA T.V., The Redwine Law Firm PLLC (the “Redwine Law Firm”), and Symone Redwine, an attorney at the Redwine Law Firm (“Redwine,” and together with the Redwine Law Firm, the “Redwine Defendants”). We filed the lawsuit seeking declaratory relief against the defendants for publicly making false statements about the OxySure Model 615 in which they falsely and fraudulently attempted to fabricate a link between the product and the December 2013 passing of Meaghan Levy (“Ms. Levy”). The lawsuit further alleges tortious interference against the Redwine Defendants and seeks damages in excess of $1 million. In a separate case, the Redwine Defendants represent Jolandi Nicole Kennedy and Marvin Levy, individually and as representatives of the estate of Ms. Levy, in a lawsuit filed against the Company in the District Court in Collin County, Texas, on October 19, 2015. The lawsuit seeks an unspecified amount of damages for the injuries suffered by Ms. Levy prior to her death and for the alleged wrongful death of Ms. Levy. The plaintiffs in this case allege that the OxySure Model 615 contributed to Ms. Levy’s death in December 2013. The allegation is contrary to the conclusion of the Collin County Medical Examiner’s autopsy report, which stated that Ms. Levy “died as a result of asphyxia resulting from an obstruction of her airway by a push pin.” The allegation also contradicts the findings of two separate investigations conducted by the Frisco Police Department and the school district in which Ms. Levy’s school was located, both concluding that the passing of Ms. Levy was an accident. We believe this lawsuit is misguided, baseless, is contrary to all available factual, medical or scientific evidence and has no merit, and we intend to vigorously defend the Company’s good name and reputation.

 

ITEM 1A. RISK FACTORS

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide information under this item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None. 

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

The following Exhibits are filed herein:

 

No.   Title
     
31.1   Certification of President Pursuant to the Securities Exchange Act of 1934, Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
31.2   Certification of Chief Financial Officer Pursuant to the Securities Exchange Act of 1934, Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32   Certifications Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 10 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

OXYSURE SYSTEMS, INC.
   
DATED: November 16, 2015 /s/ Julian T. Ross
  BY: Julian T. Ross
  ITS: President and Chief Financial Officer
  (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)

 

 

11

 

 

 

 

EX-31.1 2 f10q0915ex31i_oxysure.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION OF PRESIDENT

PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934,

RULES 13a-14(a) AND 15d-14(a)

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Julian T. Ross, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q for the period ended September 30, 2015 of OxySure Systems, Inc.
   
2. Based upon my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
   
3. Based upon my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure control and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrants’ board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weakness in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 16, 2015

 

/s/ Julian T. Ross  
Julian T. Ross,  
President  

EX-31.2 3 f10q0915ex31ii_oxysure.htm CERTIFICATION

Exhibit 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934,

RULES 13a-14(a) AND 15d-14(a)

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Julian T. Ross, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q for the period ended September 30, 2015 of OxySure Systems, Inc.
   
2. Based upon my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
   
3. Based upon my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure control and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrants’ board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weakness in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 16, 2015

 

/s/ Julian T. Ross  
Julian T. Ross,  
Chief Financial Officer  

 

EX-32 4 f10q0915ex32_oxysure.htm CERTIFICATION

Exhibit 32

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of OxySure Systems, Inc. (the “Company”) on Form 10-Q for the period ending September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Julian T. Ross, President and Chief Financial Officer of the Company, respectively, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

  1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
     
  2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: November 16, 2015

 

/s/ Julian T. Ross  
Julian T. Ross,  
President and Chief Financial Officer  

 

 

 

GRAPHIC 5 img_001.jpg GRAPHIC begin 644 img_001.jpg M_]C_X 02D9)1@ ! 0 0 ! #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" !7 44# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^_BB@X[X_ M&N?\0>(-$\,:-JFN>(-0M=+T?2K-KR^OKUXX[*UB13\Q=MI/.. ,DE0-I8"H MJ5(4H3J5)PITX1E*=2/\ MQ>%'_%->#H_[7DC=1MC_ +4U-!)#%C((RS/T5H_7P'5OB7\6_P!M#7+_ ,+? M"W4M3^%W[/>E7AL=>^(,:M%XH\;LH"S:1X;4LQA@Y.Z55.OQC5C[TW?V<_\ 5JC)+VK7+)>TJQ=^5VT9\T\TQV:Z9(U'E(;>W4Y=YO 6EW^F MJ!\Q!D@(D08SD@@@#./ES7[4"[GFX69%'HJ@ 8[8 &/7\![5.US"P.^6)E(. M[>@92N#NW!L@KC.<]LGWKP,7X;<58Q77B=QBJEFTOW:AS-72<5RZ7T:6FKTL M>1B\@S#&:QXSJPJIW7*HJ*ET7*DMFK::71^._@#_ (*@?$"QN8+?XC^!-*\1 M:>0 VH>%9'L]349Y;[+,7CR!D[%5&<_*#SFOU*^#'[1/PJ^/6D#4/ NOP7%[ M""+_ ,.ZFRZ;XCTS ^[=Z/(QF08R 0"HP Q)S7YA_M_?L^^'?#45A\:?!%A: MZ2;J].F>,]/L^-,N[C665M(U[8@ #9(SM"@[U7;D$G\XO"/BSQ+X#\2:;XL\ M(:Q/H?B73+MKJ+4K=0T%W&QS)#<*1M:.51LE5LC:3SD U^.1\6?$/PHXN?#W M&#_UBR"_*JT>55HTY.SFI?%?D;DU)-\=5?]APN*PF-PD<;@I1G"I%-236[L[2LW9K6,E]EIKS=FBB@D#J M0/K7NG2%%%&1ZB@ HHHH **** "BBBBZ[H I#@@YZ8YSS02#D X/3KR.W\_U MK#UG6M*\/Z5J.LZOJ%CI>E:9:75WJ.HZA-';P006L+SW%Q/-*\<2111J\DCN MVT*K= *<(3JR5.E"=6I.2A"G23E4G.348P@HJ3$OV>/" M(^(=[IDCV-YXWUR[;3?"K3J"L<^@6L9$_B"W1\/Y]O)%&Z#"AQM8_G!KG_!6 M[]MW4[R2>T\<>$?#EMM)6PTKPAI4X . S:VTDY4X.0K%R.%(.#7[YPQ]&?Q M6XDRZ./>3T<@I."JJ'$]9X:O4BXJ7+"GR5)\\E:,>91?-.*4;WM_(W&?TU_! M#@_'SRF.;XCB6=%N]7A.FJ^'4H-OE]M*5.F_>C:\9:3I"^(]9E%Q'KWA?[&MQ]B2*'5HE064T[C=%:,@< M_,"79=U>5QAX >)' N7+.\]R>-/)7"ZQ-&K3J0ANW4E":A6C'9/EA4?-)6T3 MM])X5K0A*= M/5I[6/UA!_&OQ<_IK_*_R[^GGMYBT444 %%)D>H_.EH M**3(]1^=+2NNZ^]?Y@%%%)D8SD8]H_,4 +1110!3=B%9V<(H3)9CC&.6.<<849.>,5^2'Q MC\3ZO^UU\:V^"WA._NK3X,?#J[2[^)&M66"OB#4XSE+*-UP#"AW #H[EG[J! M]F_M;?$YOA;\$_$FKV%Q]GU[6(D\,Z%GG&J:V#&C]P=JER&XPPSWKYR_9?\ M!]M\.?A/H8:W U_Q?G7_ !!?X.XNW.B L>3QV)Z]:_#>.<75XAS_ ";@F$JE M+)J+Y^V]Z=*C/FH\-WIN+C*K-*K4C?50BFK:/Y7/<9]9QD/,HSF MXMQNG9I76MGR[72=E>Z/JKP[8Z)X5T?2_#GAC3K72M!TBQ%A865D IT_: -S M8 R3CELYYX/KN_;^WZ4?;_ &_3 M_P"M7!_;/?\ \=JTU\ K,UUM158NQ*X55!9B3GLH)_"NMX_V:YY2M&'O-N36 MD?>>K:6T7U)^MJ.KY5;7MMKV\CYL_;LUF"'X :GIT[!;K5O$OA>QLDZD[=2W MYYQ\H"$<'C(''%?B=Y+#GL.2!C&!^.,?I7V[^UE\8(/BEXKT_P -Z'.;GP;X M.7RX+PY(U+5@!N;Y2,X[' YY'7CY)^P$^GZ5_"_C!FN#XEXYECL!=J"<>O+[ MKEV;6]]S\=XKQ?\ ;.>:62BN6Z5MK]5OOW7H>\?L@_$R?X4_'#PI-)C13QR+C.#U48[=\@&OZ!OB_K?Q8N/V?;7QA\)- M6M-/\;Z5X5TCQ5Y.H:2NK0:Y;'2DFU/3?+9E*S DRQ2("PEC53P2:_:/HW<1 MXG!\,<89=B%.=+AJI[5).[4>67/RI\VEH.6FETUN]/J\MGEF'/ R1T]<=?R!^II'=<#= MSR!D'KDX&?Q_'/49%?SD#_@H!^U"^&/B_06&.,^$--'!]<,",]#W&>F:_1[] MAG]JW6/C=8^(/!OQ%O=/G^(?ARX%[#<6MHNGQ:_H5RQ,5_;VQ7;_ ,2F5A93 MA1O+$/M/)K]7X1\>>".,\]>0Y;5J*NFX-U8J"]HM.1W:][FNN5I2OTNT?0Y3 MQUD6SQ[XM<) M_'3'TS]>.V.O%)E0 2>.PQUSZGC'ZXZXZU^4/['?Q/\ VM_CQK@\2>)O%FFZ M9\)]$NI4N[@^$=,BN?&<_(^QZ1-AF@LH2,/=!2V" NYC4'[G>&?$OA6\U&VL[OP]8ZG)'J&DW*6UP%ED99-C)<)($SC(QS@US5 M_%O(\-P5#CNMD_%$,BERR4IX51JQA*7*JLH2FI*E=61+/ MI1FJ,N5.\+2LVU?E=G;1I>\E<_6<%> S+D<8!S]!D=,'_#IBE.2K9/4X^F/3 MGZ?E7X1? #]N3XX>(_C'\/O#?Q$\3:'=^$_$>O\ ]@:ELT+3M*D9KRT:XTYE M=6,B%I?+7Y6&<@=\5^ZHE_=*^,EER1VR.WK[<<]<<&O9X!\01?&GXH:3\(OAQ MXI\?:[&/;D#!)/%?A)/_P4 _:?NI)) MH/%OA_3A>3R-:Q-X:TQSI\2H28W!8F5EP1@DDX ))R:\OC_Q:X2\-J^78+/J MLW5JTO:1A1493A&,6HW3=[R<=&URO2S9Q9_Q9EW#TX4\P;YJC22@E)KGFHWE MJM'=VM?9W:5C^C!P DCO@ +DG=@;0,L3Z# )SVP/:OYO/^"SO[56MWWB71?V M6O!E_=6&C66B0>*_BA<69.-2DNWSH/A&1\#"74:_VC+C"M&@5L@$5^IG[#_Q M#^.'Q<\)ZY\1/BMKEM/X70<11N M6 0Y0;1S_-O_ ,%/%U6Q_;F^-$NKAC/=+X4.G!1R=%&D%=%_$1BX&>02<<5_ M8GT,(Y'Q[QWDV?XC*IU,HPV75>*<+AJ_*GB75A!4ZGLIZRE&=:,K*+Y934TD MDFOY.^FOQ[CLF\"<17R1U8T.+\=0X=K2BJE*<%?A?X M;>X\0^+]66WL);D9M-.MK>-%U._NE4AC M;6L.^:5."Z*54[FQ7]!OA;_@A_\ ".P\/1_\)M\4_']]XJO+:WCU"^T232[3 M2;6Y=1OCTBSU&TNGBT_>3\C2,S1@C",P%?C7^PS^T'X=_9L_:>\#_$OQ-;QR M^#UAU7PAKEW;(&N-'TGQ(+6W?5+M3PMO975OY]PZ_,L".W;%?VE^%O%'A_QS MX;T;Q3X1U>PU[PUK=E;ZGINK:;6MP!(K)-%E3E&# %@P!PT8-?T']) M[Q%\4.%N),JPF3O$<-<.5,-&6&E0^"O44JB=&=?V5:%.<(JBXTYK]Y3J2J7M M"2A_.'T)?![P9\0N$>)LQXTRW#\2\4+'H-XA\5:;=1K)J'AFS3-MIGAM[A5+?Z(BF]N$W^6;R[G/+*37ZD1QPK&5^ M8ISPP^Z-.%Z'"_$6 M-6(PU"O2JNIR1A4K*D[PIUITI*G42E:H[4Z.JW M'G"V33HUJU&M1I495)UZ6%>(]R4\*JBE*G*TG&*BTHMW7*V^:JZ;T;R6 N6 M#N"Q5L7"W&$61CNP0N-P'./3'4'/O7X%_\ !0__ (*1 M_&S]FS]H5OA3\*E\%KH.B^%-&UO7O[>TR:^N!K&NM<75L(WAGA*E[!,[2Z$D M_,REB1Q_[$G_ 47_:Y_:0_:5\"_"G7X? ;^%;E]1U?QK?:=X7FCN(] T:R9 MI[>WGDUV;[//+J%S9(DHBD";MP5EW*VT/ WCR?!2\19T\-#AJ6&J8RG4JXCD MG[*-.52,G2]C=P<8+D3DH-N,8RE^<>_.2!W)_JVL9-4N'B%F\4LCJI_=KYJ)_ K* M3Q^8\-\/9EQ1G>7\.Y-253.LW4G"#FH*]K/\W\/_ *0?AUXH MX'B7-.&QPV&Q.)GR1FK5'.CA*KIQ37/[J6CN?0K M/@_,N[WV@8'X#I[]?RI1DE2'V@')78/F SP.2?\ ZX]LU_(!%_P6)_;9N#"P M\3^!!F61Y1_PB=@!]E< VP#%@ >?F8GG.2>3CM=-_P""T'[4UGX+O=!O;3P1 MJOC"[NW-KXVOM*EM8+"TD;Y8+;PYIR-#--&I/DWTQ:V5V$EQ'(@Q7Z'B/HI> M+%/E]WA:7OPC)O':0A*5I3;JT8Q2IQO-_:=K03E9'XU2^GOX%^VK1OQ?>,*L ME'_5NSDX1DU%G'H:BD,054## M$A(5!D^8W92^<#/'.>!SZ5_%=JO_ 4K_;;UC4)M2/QTU/3MTP*6.G:-H=OH M\>U@P CDT0*\9( =7E0.N0TB#YJ_=?\ X)B_M%?M8_M"^&-4\2_&30O#ES\, M+3-MX:^(4D$N@^*O%.IVC;)#'H5COT]],@E#!KY?)CD4.V) K >5XA?1WXK\ M/.':&?YIG'"6(IUG"V&PV,E*O.[2=.E"<(^WJ2UC%4O>3U459V^E\*_I<^'_ M (L\:8?@C(,FXJI5<7AJN,^M8S#Q6%HPHPE5D\5*,E*A1Y8WG*I)0<>:[>S_ M %X"CR0C1ACGB-&; SW+;B3^??/'=5)0*@0IDCA06QT^\23[YY'&>G;\LOVO M_P#@J/\ "3]FZ_U'P!X0T^?XK?%BUA5Y=!TN[$.@:#+)DK_;VM1>8J20L%DE MTJ$MEO(S6N@^!]*AL[FVM2>5 MFUK52]S*53(W0_O1C*8;&>'@?Z/'B7QY@X9IAJ%+A_))I2HXC,).C[6.C4J- M%4YXFK!Z>_R48-?"Y+5]WB?]+[P=\-,=/(JF:8GB[/Z4_95\@X3A'$K"2^U[ M6NY*@G!*4I0C4J-*#ZM']D9#$=8VQS@G!_#'T)[]O8U#D+(@)B0EL!3G)^G7 M'<=?IS7\1^C_ +?7[:&GW$5W9_M"^,KH0RQ2+:ZDB:JDQC=6\F0%<.LF K#' MS*=N>37ZQ_L:?\%?]7\6^+/#/PP_:7TS0K"^UVYMM,T7XF:('M=/O=0N;J*T MM[+7M"82R6$SR.HDOXW2TB&YFC0;I!]'Q1]&/Q*X7RVMF=.CA^(,'AZ-6OB9 MY?[3VE&C1ISJU*GLZD5[11IPG-QA[[4'RQD]'\GX?_3@\(>.L]H\/U8\3<.X MS$UZ6&PBQ]*G]7JXBM6IT*5*I4IS;IQE5J0C)SM&*D^=I*3C_0_16='/'.J3 M03!DFABG6: JUO/%*I,4L+,S!E9!U4\C;R1@T5_.+:3:;2:=FFTFFMTTVFFN MJ:378_M):I-:II--:IIJZ::NFFFFFFTTTTVG<_-#]OVXEUC4OA7X,4#[-:O?'&046--+C^7_ &6G<^V?:NVM[^VL(+2UM_\ CUL]/CL,>X5<>@./?/:J MW[:&BSR^)?AKXA4D06+ZC8/]76-@?J>=OOQVX\Y_MW@8YX '.,X'U]J_F;-L M5+ \<\88QWU4(J^B:Y81T3LGIM:_=GY[C';/7>,/CSX;\'3G3E^U^(M=ZFTL?N:=@YQN!88R,9QP.0>*X[Q9XH MN8M--II]R;74[W@WO7^SQ@AEP>?F!QUQS]17S[_PC7))Y/.2>3ZG))S[\FOG M.(.+,PPL7@LNO>2TDF]&U=:K3=]^AQXK-L=M@?)?=O\ KZL]E_X:PU/MX!4' ML3K7 /8GVSC/M7D/Q ^,WQ ^(-INX:WQN'/W1U M (YRWZ_X5^?8O-N*\;@OJ..SF2O>]FT[/>-U9VL^7 M?]3Y_%XO'XS?F6O=KUV_K[SQ[^P@.G'X?_6H_L+_ #C_ %>P_\ ".#V_7_" M@>' 3@XP>#R1QWYQ7RG^KUW=QN^KM=ON[[Z[[]3REA'=/FUOJ[:[ZZV_4\7. M@>8?+P3YEU;1G@_QSQ+C 'OT')S7](WA"P6Q\(>'-,90PL?#^F6+HPRKK%IL M$10@KR& (Z8.#7XX?!GX;CQC\3?!VD2*39QZJ^OZB."3IV@L%MUX& 7?:!D MG.<>U?MF3M0@#[H50!CGU X'O[@?2OZ;\ >'UE^&SK'3C:->:I.\?=G&TG)- M-6DE&^C4E=[='^B<$8%X6EF^+:=JU6,%=7326MN]N9+1-.^KMH_YQOVUO@3+ M\&/B[J5YH\(A\%_$$:EXBTAEP%M]1>7=K.AJ1A542E)80#PC@)1XDU#3-"F\/6X\0Z%XCU((!HVI:<-RE68HW^DA6M-JEBQF!"L5 M4'^;D?, 2'0D9^3_ %B%NNP\_..WJP%?S5XR\-+PXX^EC>'7&"SJI+C&2IM0 M=-RJVG"T'%Q49IJ*:A%JW*FE<_+^-?V@_C]XN_:"\:3^)->+&,T=U8_#31I(_\ A+-? *?:KI74_P#".^'7PVR\ M&/*U*0@J(BXSDUYS\"OA6WQI^)_AGX?/K5MX?M-5,K7.J2X\VZM;;YIH+ \? M\5'+"'2Y.>-S'/'/],'P]\ >%_A9X2T/P;X2TV/2=$T6W%M;6\ BV$!!NO;^ M10C2W,[ N\A;+R$9P0 OT'A'X?XWQ3SG.>,N,INKDBK1E1A*;DY58.-2,;.< MW&*<8N6D;*T5OIZ7!_#V,XNQ_P#K%Q ^>TTU3;^*<7&27*V^564>:R6EHQM? M3HO"OAK0_!F@:5X7\.:?:Z7HNB:?%86&G6B*L=M;PH%2-5&3A1R226;))S7Y MJ_\ !4/P>U_\./ 'CF&V3S_"GBU+&[D3'.G^(X7LU'/)Q=I;/QT.>!D5^I,A M8$-WQCIQ[9QV.?ZU\L?ME>$/^$W_ &=?B7IRX%SI^B-KU@0"6:[T*1;\ <;L M#RF&<# .[CO_ %UXDY LY\/>)L@PT8PI_P"J]2-*"24;4*7-&,(I12DZ="=K M13WZZ/\ 6^(L%'&\/YMA(Q6E.;A%15DZ2C4ARI)+>FEITZ/5/^;73=5NO#VJ MZ%K< S=:!J6FZO;9[P07L$[G)/4QQMQUZ@8[_P!9/A36H->\,>&/$$2@PZYH MFGZL%^\NS4+&&8COP1)T.1@U_)/&OVVTQU\V-E /HZ$*#RO4-@\G@G/-?M1\ M,_VG8/A[^P;I?C:XO+6[\4^'K6_^'OARW$F#?>(8)7T[3H%7[[FRBE69\' 2 M CJW/\G_ $<.,,%PUC>*_P"T:BHY'#A2CCH-M*TN&;X2<8Q;C^\J*5HZ*4I- M.T['Y;X99O' RS]8Z2CR<]1+F45>E&>MFTF]E%*UWI<\ _X*-?'?_A-/'5A\ M'M"O&?PSX#$>H>)7LR&6Z\5S'_0-*D(&-ME;,TSH<@-NX#=/A_X3?#?5/B]\ M1/"?P[T.#=<^(M0DEOKO./[!TB"56O\ 41QC-[:>:BYQEI >>>"U'4+B]O+ M_5M4G-_J>I7DWB#5[X'YM0UFY!-U#LSX*SZC&. M4RC:A.T5]6KQIR6'KPVE72O'_A8-8:LA'^KCO5C!74K;<1YINE= MO+W!9(U&!_*9^TY^S/\ $/\ 9:^)%Y\.O'T!F6>.YU#PKXDL/^01XET= QMY M-,!4%-7 _M&,C68 MVQ'A-V268\K@DOG(X YQT/0X/%?Y_P!X#^(6O?"+QEX6^)/@K4+G1_%?@K6+ M35+&\LO^/FZME5+C4=)O4X#V]];QR6LZGY=DK# QBO[G?"GQ+TOQ5\$]-^*= MN%M["_\ AQ!XU,*C'E0IH#ZQ@8&T7QQ-X?C8G+8\.V<&C\$DX&^U8@9 YXZU^F/\ P0S\!KJ? MCOXT?%.[L #I&BZ!X1TB^)P%GU2-]0UE5SCF2&'3AGC&WCK7X7^,/$#>*/&O MBSQ1<'#^*/%FNZX_(.-.N]6NY+7/.0?+90-O'7B76+LY *II]VNF6F#V&RQ3 /T YQ7].^/M=\)^ -#*X/D>/RS@KA MB-.+:2^H8"E5JVBM+RCAW&;Y5?F?-*Y_#_T6,%_K[]+'&<2U6Y0P&:\;\6N4 M]G+%X[%JGJVT[3Q"E#5I*.D4E<_7MHVVD=28M@'8MC@XY')P,\X]*_G._P"" MZ_B9&U']GKP=#+NN8+CQ1XB:$<$H+:"Q#9 X"O"X'!SR1D]/Z,C+GR_1D+8X MP0 ?M;M96\ > M+LKNW!!$4VK2W&LQN3R M-P6\ (.#T!K^5/HSY1+-O%GAZHUIA<)C<3+1WCR82LHNZ7NRO*25VOM+5Z'] MV?3ASV.3^ F?8-2BIY]CL%2IWE9M?685I6CS)SC:G&Z5U:2?37X0_9A\&_\ M"Q?VA_@/X)E4RVVI_$CPO%J4>2=]CI-[%JUZI^\ &MX'!)]?K7]3W_!5;QC! MX!_8@^*UM"1#/XGE\.^"M+C'3=?ZS8O(N,8P=/T^X7CW)]*_"O\ X)&>!Y/% M7[:OAC4Y+=9;#P)X9\7^())FQMCN%C328W[@G==L5.!@C(SR:_2#_@N;XVET M_P"$/PA^'\+ACXQ^(-_K%VO]RW\+:=+-"6R>-SZF ,9R1BOWSQ?G/BSZ2'A? MPQ2;DLLP>7XJK'GO&,L/5JYDN:*3Y)X81/,; M9&#P!YC_ ,* _>;G:.<<&OW/_P""=_\ P3)\)?&GP1I/QY^/ O[WPUXEN6U' MP-\/H+J?2!>Z5&?L_P!J\3W5J\5Q?6L]PC36443HP@=)B6RJO^(^BZ1=:_JF M@^'+/F\\0ZUIFBV@Y.;G5;Z&Q@X&?#?P/X(M"OV M7PUX6T'1(4V ,D.FZ;#; G;@!_,B.0.A/)) KZ?Z57B#GW!.39)E'#^+G@\V MXBHRQ&.Q-&3A7IX2$8*I[*JDW1NY^]4BHU%"$E2DISYX?#_09\&^'_$GBCB/ MB3B_(H<093PZZ5/!PQ+D\-/'3E*=-5H.2C4BE"$N22DFI6DN5-2^#OB1_P $ MGOV/OB+IFFV6C>!;CX<3V%]:23:CX2GN[6;4[.WN(VN]+O5O'G^U6]]"KP27 M7EK,BR-*DH917E?_ 45_:?TG]B[X&^%?@?\#;73M$\9^*M'DT#PU!9K]G_X M0GP98V@L[W65MD=FDU.5S)'8WI V7X:>7>R!C^QP3R$(5OW:-OD+YGGTOPKK47PY\/6P(V1:=X7C\JYD!.=H M?69=4O,C./[2!Y Q7\[>!F5YUXJ\8Y;A>,,TQW$G#_!-*>?^PQE:K5IRG7K4 MH4:,U5E5E*-:NXU/9RJ5X\E.RA&$YQ?]=_2?S+A;P%\.\QSCP\X4X4X8XM\1 M:L>&<9B,-2IX:NL%3HU5BZF'G2C35*I3H2G:I2=)0E*-2;,M*T7P_'?^)/&WC;Q';6>F-/ GA&PO/CGI=U\7/B#>V=M=ZY>ZA>ZM8Z#I%U<1K(= M.T'2-)N([:X2SE8Q3W;N\DR@2,$W%5_F0^'?Q/\ %GPF\<^'?B)X+N=.L?%W MAB^N]0T*XU#3(M16V6]MVLYIV6?$#M;Y,@$F%.W#84DU]W)_P5R_;<@6.&?X MC>$;A 5)/_"$>&]H ( +F%MY3 Y (;'W6 MT\)+VU*GCZF!QCJ1FN6,9T**:H*E%-J-2G*527++W%:7\*_1LX[\"N!JF>Y[ MXM\/8GB?C.>(B^':DLO?%-&.&Y6Y2<9U'3G6YKK]XI.<5+9RL?J7^V/_ ,$K M?@E)\*/%?C_X!Z'-\,_''A71+_7;/2-,U34;SP_K]EH]I+?7=A/I>HM,UO>Z MC#"UM%<0N##(ZY+!@5_F'>.80'S@;>YA0VZ1CEK:YM;O_3) 00=T;JS @@C' M!K].]2_X*V_MAZKI6HZ3J?BOP'J.GZE97.GWJ1>#[*RGDL[B)X9D2>-M\3&- MVVRKDH<,.5%?F'/)?".4Y]E7B'F]#/J4*D8TIRQ\L96C3]G4CB76JXA4Y.*=G3BY5O<4N::5DO MG_I(\9>#O&?$>3<0>"^35^'JM2C.7%%*GPY/AN+S'FBZ/LZ5)R2E*HVIJFJ: MQ!)5'_@GEX;D\)_L9_ '2Y@3)/X#TW66P,<^(#)KG3@C_D(>GYT5 M_EEQW_8T.->+(TN94EQ%G'L53BW35+^T<6Z2AROEY5!I)1T5K+0_W%\,,?FE M3PXX#J5ZDHUI\(<.RJJ$/J.AW2ZS8D Y,D0D+>N=RELCG&S\!^9NK7%UI4UK;W7!S_H/;)SR.<=Q MW'TK]7*M7:R;T75,OB'*GC+8 M_!?%:TM&F[)J[6^B]=M#PFRL#JT-MJ/&,X)[9Y!]>>/YU9_X1W_9KTCP-X!\ M1^%[NZ\)>(=.^UV]R?M^A:W9G_B5:FI&<@],@$G /7!.>*]8_P"$'_Z=J_(< M+PWF&+P7O1=T];QE?1V>\4[:/T/G\)@WU3\]&K_>OGKN?+__ CO^S1_PCO^ MS7U!_P (/_T[?K1_P@QQG[,<=C_@:Z5PD]/<=]/L-ZZ>7<[/[)?\KZ_9_P" M?+__ CO^S2_\(Z1C"%B>B_WSTVCUW'C SUQ7TG<>#TM;:YO+IDL["TS]OOK M\@!NN< X!X!S@$=?K4WP\;PI>:P;NW7^U8;4C^SF<#^RP 1M9,CJI (R.PP< MYKU\H\.\=C<>N:+47:Z::]WKNNS?F+"9/>Z:T=T].[L]UIN>O_L[?"C_ (0G M2[CQ)JL*C7?$-O'(MM@9T_3!AH;901D$[E9\8R, YYKZ!U?6-+\/:??:SK-U M;6&F6%K+?7=[=NJ+:1QKO9W+ !4!.,Y+ 9R :>F:K%'927E[=QI''&\CM( MP2.-(T+L[,<*B(H+'./E';&:_"G]L_\ :VO/B]K6H_#KP-?-!\-=%O1%J.J6 MKD_\);JD?(:4Y/\ Q3L3$/&RD&:10QX"*/ON,.+%5%14JJ@XTJ*?OU* MTHM1YTGS6=1Q3=M%+EC=[>MF^<8#@[)+W3:5J<%K*=1]96N^52LW+KI!:ZKB M?VP?VKK[]H'Q./#GAV:ZL_A?X>O_ "]%M,LL?BK48SC^V_$*C&-#=W1?V-/AMX? M^ .N_!>&V2\O_%.GR7&O>)_LT2ZGJGB=DS;>()G9R!)97"Q(@5L*@QRQ<5_& M>1\#\<^->:\0<3YG4E&E2IUJ\)SYDJL*<*E2/"\%+E48T8Q3O&T8V5[N5G^. MY7E&>\>8K.\RJ2]G&\O9\UXJ4E%RIPC%V25H*-UI!6;O?7^>S0/$&K>%-;T7 MQ1X>N;O3M7\/WPU'3+BS^Y!J*2+)-9L/[MQ@PDX&%?)Y.3_3_P# #XL:-\:O MA?X:\?:5M4ZA:)#JEEGG3-:@5(]8LV&>MO=F1%)^\FT@5_,/XD\/ZIX0\0Z[ MX0\00BUUGPWKDN@W[((I-4'.[A2KJ3IT^92:44JEH27NW3_NFW ?$$LGSN>4YAS*,Y>S5[Q49\ MSA%WDK*S?*W=:/7X=/Z%NPSZ GV__56%X@TV+5- UO2Y%5X]2TS4;4*_1FN[ M2:$ ]>\@Q]>_(K=# CJ.F3@BFOAD< @_*<\_X5_H7B81JX7$4]'&KAJ]-[-. M-2A6A;JGI4V?W']"RBIPE![3C*+])1E%[^4GN?R%:UI,_AW7O$/AZ2'['*GUI22!QX@L(KD@'H M<-D''<=,8->";@#DYX^9MO7 (SC'<]%]\?2O\D<]PU3*,^SWAZFVIK$SIQ5W M&\_;2M"R<=Y\K<&GJ]8O2_\ (^:8:>!QV=X!.2<:[75-VJ/>S6]MDWOU3/OC'7=-^R^.OB++#J>J)<&-I=/TMN=(TQ,;G6K7PWX@T7 M79?"VN-H^M0:5>QS3:+K5C$'GT_4@CEDN4\X,T1&.>#UKX1_X*+?MD:=^RM\ M);NUT&2*X^*WC^TGT3P3832QQS6(DCDAO/%D12?Z*^U5:[^SIW85_ M+-\'_P!ICXX_!3QMJ'Q ^&7CS5=,\3^([Z35O&8OXCK.D^*[V4[I;G7O#I>, M7MQ.?D>^C>-XPS,D@90R_P![>%_T>>*/$OA;..(:-:.25H2=+AB-6F^3&J#< M<2ISBI*E!13I0JJ$X^W?T)Z\6XVA.2 M?"\IN*P].*E%1KU=?:3@I:4E&,7[2;2_O 9R8V=5)8@HJYRE11!?MR:5:Z7%;ZI)G!(A9YHDD/W M21\O3-?+Z?\ !:W]J.+0_P"SW^'OPQFU?R7C.MQ0ZQ$ID9"JRQZ.VN2%75B" MJ.SQDJ%9&!(/Y>?%[XQ?$OXY>.[[XC?%CQ+?>)_$-["MF"S+:6^GV3R9@TG0 M-#3"6\-N[9+*I9B-SYX-?K'@[]'KCWAGCO+^(L]I4,'2R%UDG3Q<*L\7.I1K M4(*7LU3IPI*59U*CG*4G91Y5[S/YW^DE]+KPPX[\+,TX)X.C6X@S?B%TX5/: M8:<:>$BIQG4E&,XRG*LE%1I*DHMRO9N[/,%M+G5;E=/M /MFK3)IUH H MRK9VX &%'BEQ[B\LG1QW&W!6*R;AFE.,J=7ZAA,LS&K4K.G*,*L%4E=TY2A"4W&Z< MDTG_ U6Z;K!')S<2QHY(&<$(/Z]Q^>37]B?_!*EK6#]B'X2S6R[Q(VM07* MX*NVLZ@)V(Y(8.3@X&3V.:_CPA>XB46DD%UY]G,]C/:7+>7-:W]L!]MLA)UC MD)!C#8!1B&/*U^HG[%G_ 4R\6?LF> [OX7:OX'3XA^$X;RXU+P^+/6H='O] M(FO9/-ETVZO[F.:*[59&PK; ^[<,[3@_MOTB. ^(O$3@+*\MX6I?6LZP6-H8 MBI2IU*L?UD^*/$FD>$_#6N>*-8N5 MT_1/#^D:A?7UQ/QLM-/M);J[ER2,A((I7X&21M &<5_"3\>?B;<_&/XT?$WX MH7,HG7Q;XJU+4+$K\JKIIE>'0]JG.%^P6L9*G/WB..E?:?[5W_!3GXW?M-^' M+OP';:98_#3P)J,S'6M/T6[DN]<\06L>&BL+G5&(B-HI51>Q6T:)/&&5@5VK M7YJQ,B*V2%50&(X&%4CH,=%&0 ,]AR>OA_1O\&,Z\/,-G6?\5*G#B"K[##4\ M/&4)2P]%3K4J.4E3O"$*<(N4KMKZ[Z8OTB^'?%ZOD.0<%.K4X=X? MK.4JTH3A'$5WR4T[:IPA&*C!2;>KV9^^W_!";P4LWB/XX^/BH>UL['PWX2LF M)&-_V>>^OSD#()+H!@\KGCA:\[_X+D>,VU?X_P#PN\"6TA:R\*_#Q]0F4G'E MZUX@UB_D95QG)_LVULF]>2!P:^^_^")G@JV\/?LJ:QXG2 +?>.OB'XEOC)CF M6WT%H]#BR?X=PLR$ZCYB:_$W_@J-XN_X3']MOXQNMTM[!X6DT3P?9*I!%C>: M3H=A)?0Y'#'=<'.Z3PV4X7 VCHU M95*E9))JTE*VJ9]_QY!<'_0-X R;DE&IQ[Q-@\TJ6BXM*>:YEFK]HFHM1E2P M%!7>C5EK>)YS^PCX1D\?_M;_ +/GAZ. 3B#QY:>+;B5L;4A\*VS:HS$8/ -K MP"#EB!@DU_@]*_DG_P""-_@C_A)?VOFU\$?9 M/ 7PZUS5^>OVO7;F+3P.F P#$J.O!ST(K^M>&1F6,'/S*Q.1_=( ]/?MTK\P M^EYG$W%?WUSOM24 M-NV[PA* YPP92P^5N0,\889&".U?R#_\%4/V9=:^"/[0'B;XG:/H]ROPV^*6 MICQ);ZCI]H$T[P]XEN+^6-L=QJFI&VU:VE_U8,A"D%75>GZ(F?8#* M..\?E&,JPI//\&E1J5*D*455P\JU;E#L]RBG*I2X=S_'?7(QA.K[.E7PTX*M4A"G4DZ<72DJC<6N5VNKJ_K'_!(? MX>_ 7XK^(/BQ\//C7\/O!_C7Q/#9Z1XF\/R>(-/AU":*QM9&TK6;=990VT+? MRVQ!3!.[!/V"/V.W3S&_9V^&D;+\RB/P_:LKX!8 ':=O/?/'.!7\87 MPO\ B9XW^"?CS0/B/\.]>71O%'AV1#8W:1M<0:A9SSQRWVFZS$IS<6-R@,5V MF'[>W^(/P$O-8UZSMO+>_\+^*X8++49@F#,FD MS1/+ DK_ #;)I)=H)50%X/Z!XV^%?C%B^)\5Q%P1G.+Q>#Q]2@HT._P!'[*.#\-PIXI@8^4.O P6Z8QSFG?\ #!G['EPK*?V>?AHH8;0%\.V[*X.>#\F< M$=2I!Q^O\UW[3W_!4+]H/X_+'8:&;3X4^!=.U33]8.C>'+TW.NZ_>Z7=17NF MKK?B'Y433H)X8O[0TBWC1+R-#%(6P"/Z?OV5/C)#\>_@1\,/BE:JYE\4^'+" M;5"$$*6VL6*M8ZY"(BH(7^V;>ZC5A]]-K9 Q^#^(G!OB[X<9)EV=<1YYC%' M-JKP\J%+BS$XB=)NFJDXXCV>,EI.E*I&*G&<)U$Z3J)R3E_5_A-X@_1[\7^( ML^X;X/X+X4?]ES6)A7EPAA,.ZKI5$U7ISG@^53ISC"<)\[DFHS4;)'O^DZ-I MFAZ;8Z-I5E%I^EZ9:P6.G6%C!]FM+*SMHUAM[:WAC"I'%#$BQHB#:JJH'N>HK]" M+G ^WW>CKI7B72M_?# ABN>@4#/&"2>.[\5?LRZ;?9_T;@\_Y/'OT]\5XCJO M[(-M,/\ CU'H!VX]NG/\OK7-]3R_:T5?LHKOY=V8&5L1X!U8G.#@8;Y>N!R2O'S<=C[-WQW_S^/X=*ZG2 M?V2;:W(_T; !!/H.<_A^OX]3R+)\O3O[NC3^&/1W[?UY#T[+[E_D?+[_ !=^ M.?QMUNVO/'.N.]@2&L?#.DVATSPMI@##"J!@MVVA@>>#SS7Z*_ _2M2A@M%N M"5!PN0=NT] V>-N."#VQGC%7O"G[.NG6 ^S]""!P.^0/3\,D8[>GU9X.\!6 M^E_9?]&/3U[XSGZ#Z?48KTTE&S24;6U22LEUT2V2O\@MY)OM9:^6W7;YFYXC M^'&E_$WP-J/@OQ1<:HFB:I;Q6MX-&U633]2O_+<%BVKQ,DDBL ZHPRIP1@@#][C . .<'')K[=TRS$$ 7< 01QC\N1G MIP1SQ6K@]V5NG5>?P)'!]Z^2SS@OA?B/%?7<[RJAGDW\#Q$'*$;;.,'*,='M MV:31QXC+,OQ^F/RBG)+^9*;5M;WO*UGK:WZG@/P@_9R^%OP0BU5?A_H<>E7. MMSBZU*\GF:^U">3C:KSRDOY8)SM0@=,Y Q7OI7*D8R "!GZ=,\'\ <^G-/ 3 M/W<$]NWL!@9_SWI& Z$GZ#/'H,Y!^IQWSUKTL#E> R7!QP.49;3P]!-_N81A M2@^96FY;N5TVI73;5]SKPF%P>$CR82G&G%)^Y!)16MVE&"2N^K;;\]%;Y*^) M/['/P'^+/BB7QGXM\+7LGB6>T6REN[36-0TY;J*/IOCAD4%P!@$ Y7 .22:X MB+_@G;^S1!+#/%X;UJ.:":*>&5?$.KAHIH766*13YW#1R(K*3GD#.17W84Z9 MP??L/Q/ S^M)G )[8.?R.?\ /;M7S-?P_P""<5CUC\7PCPQ*OS*4:SP\7653 MF34HM0IQ4N=)II1?-KOJ<6(R'(\5/VDLJHNHY*3ER)2YN9-RO=2O?WN[?:X6SM8K6&\NI6NKV18U5"T\C)\[G +.#@]\ 5?>:..-S)*@" MJS,Q884*"22<] .3R./;!KYI_:P^(?BOX7_ OQKXU\%7-K8^(]%M+>33KN\M M%U"%5ENX879HG*HQV.Q4R_NP1\V!DU^#WCO]JSX^?$;39M&\2_$?58M+E1DO M=/\ #T6F^'I-1C;(=))M&9F,<@R&5G*;237Q_B!XRY'X7<.6PE2,Y3]GS144G96DDG)W=THVL MDVM+7=V[W[7?B_0/'/[17Q$\1^'+FVU'0C=Z?H_]HV9#9N?#Z-;:L2<898[L M!%_";X2^./C%XDMO"_P /?#TVK-))$]UJ,\31>'M)MC(@G;6- M9P?M5U'$6<1J6,KKMYW ']V/#_P\3]E7X+:#X*^'SV]]XX\7^)]%\-MXEU*$ M/#<>)/$5T]LVO:C#N4RV&C6BRI9699580PP%U\QR/Y7\/>#VJXBM"=*A"$E!SO*<.:"5HQ;NE<_,.&LEJ<0Y]5XCS** MCDDINI14HM*=9/GIQLTFTI\CE?11T;]X^U85A18E2*.)81B*)2H"CH"%!P, M\ <+R.,BK;#(*MC# @@8PP^G0]>X[U\@>)/!/Q7^'.BZMXWTGXO>*/&&KZ!9 M/KFL>&O%%EH$?A+Q%86<;76I65A#%I5I=>'9WMXIOL?DZY.MO)L,X=,+YNP'^VJW&.!RE*.;Y74R9M*-*E>G/GE4]RC3I^R5DZM3DHP5 MDN>I33=I)G[2\>L,N7$-1<;*+3C:-WRT_@;LG448)**2DX+:46>R_M!_LM_! M3]I3P^FB_%7PCI^M"UBE32M=,8@\0Z&S\;M'UR)/M-A\Q#"W1S$[!=\; 8/Y M%^//^"&?AN^NKF[^%7QO\0:!; 6^D>+=!CU_9CC:=6M[S0IY$)SG,+\$C). M!7Z5W?B?XE_L\11>+?B=KNH_$GP1K8^V^-Y-.TTF[^&OB&\ %O<:%IT8_P!, M\"-,%TB;+M/IE^T-\VY;QU3.F\0?&77-8T"";6H_!^M?&&ZO[G0=,-M!J*?# MOX>>&[:+4;T)8, FM^*M;CNK6=R^4T2>7*B2.W=9/T?A3Z0_'7 ]!9?D&><6 M9-SM2_U3E"%2C&4Y1BI24W5PT8U9.,9*-6$=:CDH\DY/\DX_\'O"GQ'J>UXR MX*IY[GCC>I7HIT\0F_)(&A>-O%EQ]@\/1SQR+(DL?A[2BEJ@#HK&-B\;@% M&4H2*^C+C5=4^&WC&TL-'_:!@\5:C_:MMI7BCP-\1/%&@3:A<+?0%X+CPLZ6 M\5S8ZM;;A.^G)#.MX$$/V?>T:MYSX!\4:#XHTS3K[Q7^T)\9+/Q7J>K7BWNF MZ18-%I=K<0:K/I^GV2R?\((ABB,/E(Q:6,!F9RZ; P[>)/I:^*6-=%\0ZIH_Q2U8ZSX2\4_$7Q5X6\#^) M[H%9-(U[2+]K2'PCKDA*0B'5+>W-WX;N I::9;FW=ED""O>_@IXFUOQ'I'CZ M37[QKRYL_BCXYTFT4JJ"QTW3]11+*UPO550<$_PDJ, FOSS+.+\)F]ZJE+VD MU.:)=8\?^ ]=OOA+XNUR62\U! M-#LDU'PO?:S*Y>;5I]"W6ZP7]])M74;B"6,M&SD!'^>OBV#_ ((4?$%[V-K[ MX_\ A6.S$L9EGL_!&J/=-#O4RF&-]=DB,VS<8A(K1L^T.&!8']/HO&5GJ_BO MXDP^+_CK\5?"5]IGQ(\2:!9:)X:L=NC6NFZ?>VUM:+ Q\-:XBQL;M0\GVF/& M=[% I9<+2/&GA2*3QS!\0/VJO'7A?6O#GC'Q3I\.FS:MHMI<6>B:#?K8Z9?3 MP_\ "/-&Z7"HD[E\Q2;RK@#?C]"ROZ7WB9PCET.'\)G6)>1T4XT*DI9#B*\' M#F44JE6,JZE>*]FI59RNHV?NI'\R<7_1K\ >*<\GQ!FW!5%9O4J<^)IQXEEP MY2G[.?--U\)#EI/F49MTDE[2'/&RYV>=?"?_ (([_LR^!O#>J:?X]EU_XH^( M/$%B+.ZU[5;EM,DTU/, +^%],@=!I,P#A[B=6=@,,N",#HO^'-G[%D.UX_#W MCW@+,PG^+VJ_$[X+Z%?:2OQ)UOQ#H_C71/%&C^&]:UNVLH_%G@[QE;6)U#1+ ML:EI,,$&H:9Y<4[W"SVZN%@QE4=L\<_I,^(..I5\^GQ)QU:I&=6I;$RA91@[ MI4D^6"44HVITXQU4K2UF_L\'X)^"."R6#POAAP?/)J<>>DEAJSJ2JULY+[6;R"]N6@2/3D\N-9+=%B'FEHU!4OD@K]5^ ?CG*OP1OO M'?C:&.T\6^!K9M'\7Z1(Z>:/&-O;V]K;Z;&P!./$=]=:=-9LF[<+^++<-BY^ MR_XA\?\ B;X:W]S\3;U+OQ9;>,O&&E:C$R[C:K:ZS=IIVDY4,=UCIXAA9ASN M4G.:\WA[Q@SK YY1S3AS.^)L+G7$N%K8ZOBX3=*JX^SJ5IO%UW3!]>T7XA^,;&T\,:=KV@V]GINF:?K$B:="+'6/#[/=QHB*&@ M5R)(CY 8[JZSX9^+_BS\8$7PG_PFUWX1L/">AVEUKOBB'0=)C\8>+I==NKB; MPQJ$6FWD%QI7ANTDT&UM]0E:"&GPOA.'.%\OH9!PUE%+(,CI1F\+AZ M,8Q@I\SO%TXM^Q=24.;]Y)MJ[U>_Z AEVL-PW8S@$@]\9(Z _P">>G!>/?A_ MX.^(_AK6?"?COP_I?B?PUK5K);:CI&LZ?#J%M+&49)&1)$8K+L9O+=2'1B=K M+N(/R3XWA^+7PYNK?P;H_P 0M7\7S^+=-UG5? VH>(8K%/$D/B+P;<0>)IO" MFIW^F:7!;:SH?B;2Y;O28$G2VDL$D<;FVJ]=.WQVL4\?? C6H=?*^#/C7HE] MHJ:!,BI]E\110IJ>E:I*!GR/,FNKO0]40D8U%M+C+%R0*PO&>%P=>A]8Q$^' MJ\*]#V4I3C"I"I*M3C3<:L7#DM4E3M--*-^9I13/9QN(RO%PGA=-QFI0DIJMR/1MJHF^5:K\[/C#_P $3/A/XDU2YU;X-_$3 MQ!\-SJ+23'0[ZS'B?PY&['/E68FGM[C2( ,#[/;RYVY"%#AAX7I/_!"?Q_\ M;@FM?M">'8M*:6,%]'\$WQU%(F8!V(O-<>U=PF2HECDA8X$J,A93^J7Q6\;> M,O$OCZXTWPMXNUOPKX/TCQ]X*^%3:EH30&2]\0ZO<7^H^+O*2:.412Z+;IIF ME0R-!+%]HEN%*R*KI7;^,M,\>?!:31O$=I\1O%'C/P?J.LV&@>*-!\7S:=J% M_92ZWL>&[ZTTF"6-++4+B*>_TZ1F66,#RV5TP/UW#_ $M_%C+,OS+# MX?/)9KDN058X6GC:O^K=>K3A=0]LJE>"J/V#O-UI;9GC/#54G&O&I-0J5*%"HXR;XY^&%S::QXN@U[XPZ];M [S>,KYXM#5X760/;^'; QV(7>HS!,)HI 2C@H3 MG]0]%T?2?#EA8:)H-A8Z+I&FP16ECIUC;QVMI:V\0V)!#!$H1%5 H4*H4>H) M)K\]?ASXBTCQ)H_A>X\0?M%_&2'Q1J=[!I]_I=AIB-HBZLU]/''8F27P-J$4 M$$D.V*21]2B0Q#C_$/P<=$UW5/'?[4?C7PQXKTS7?$T-[I+W^DQ M0:5'HVNZK%I,3:?'X?5KF.XAMX=]O'('N4;[.A1\5^4\3>/&<<68B&8Y_F>( MXBE4::J5.*,CK4Z2DTG*&&O&E!Q4KJ-*BIR2<5+FLC]6X/X7X!\/,!&CP1PI MPMPW2J)*:PRI4\1-/ENIUG"56<^RE6=Y;[-GZFJR$<,3^8_0>M%>)? _Q%XC M\1_"WP7KOB7:=^GD@:WFO?]8MMJ$L2D^6U_:""[,9QL:9@ =JE:4 M.(<)B:-*O",N6M"-2-X2;M)75VNI^F4<5[:E3JJG.U2$9K1+224EHY)K1ZZ+ M\CVN> 3 G&*S+C2K:;_ !QS_+^7]***^A.LR[CPW;3'^O\ GT_S[Y<_@^V^ MGY=>GKSC^OM110!6_P"$,@_YYVW_ 'RW^%68/!]M]?RZ]/7C/]/>BB@#>M_# MEM#G_/TZ>@_6M2&Q@M^!U[?YQ]?THHH T" >H!^M)@>@_(444 +28!Z@'\** M* %I#T/T/7I^-%%*R[+[E_D!YI\2_AKX6^+?@_5/ GC*RN+SP[K,<<6HP6MT M]F[^1,LRA9(F610)$4Y!/3IFOG31_P!A7]F'P],)4\ VU_+N4A]8O=3U3)W9 M"E9[DJRDXR&4@@D-N!Q117SN+X-X9XAQKQF=Y1A,SQ%-I4YXNG&JHLX*\93IQE)6O):R4EH^EFCZG\*>$/#?A'3$ MTGPQH>DZ!I<(/E6FCV,%A"A]1'"B@L,<%@?[N2*Y'XJ?#U/B'X:_L2+4;C0- M4M-2LM?\-^(K':]QH>O:'(+K2=1:W5#<%%=]3+\)# M+)X>G1A3I1I-1A",8)*,9.*2C"*M%QBTN6R:32NKG)[*G[!4>2*I:+DC&,4D MW9I*,4DK=E=;W/'M3\$_'WQGIK>#?&/BKP-I/AZ]@2V\4:[X5M=:_P"$FUS2 MPZJ\>F6U\?[)T"34X]]M?[!=F.*:0VY#!6JQIW[.6EZO%XJN/B,;;5;SQ#I< M/A;P_9V"O%8^!O!FB'.B:?X=9I#)::W&\4.IWNLQ@27-W#&C$QKY9**^>RK( MZ;ES: M*3BKIJUTIR:=KJ4G+XG=;UU\+O'6O_!;7?ASXG\16>K>(;RV?2-,\2;78WFD M6VJ6=SIESJT)+?PAKGAWQ##X;\8^! MKR:[\+ZM-9&_TZ:YO+*/3K[3+^P&QX])O8X3%^Y?S;8-YT0\Q%!**[:N7X6. M5QC[._L^1QDY-SO&49QO/XWRN,;/FNN5+O?=X+#KF?*[I*"?,[V34H^\K2O% MVY7>ZLM=[^>W_P (_B/\0-Z]K!@FT^WM+D)(RVR/<7$:>5YP4\6?!O@?X_>!_#VG>&[$_"34=-TA;N"W MN[P>*#J4\,U[/=#S"P>,3D3E2S2,FX DXY)17FRR/+HUZN;JB_K]:%2G4K\R M;E"4+-]VSH MO"'P*C@^%_BKP'X_DL-:'BCQ+XH\3WTEG&Z165YKVJ_VS:36+.OF1W.C72PS MVDPY6>W1@2N0=;X&?#/Q!\+O"%_H7B3Q&WC+5;[Q9XBUY==N 8[F_MM>!+WP7'XMBU. M\M=17Q-X_P#$?BFT$< LX=?NOM?V9BZY;8RG(!(YX(SQ1^'GPSM_".F^)H- M6BTG5IO$/C7Q;XF25M/A8I;>(]1DOOL;-*C,0JL48'Y><'(XHHKT9Y7@6G%T M(-)2LGYD[Z.FUU?0F=.F]X1ERIVYHQE\5K_%"5T[[/\CQ?0?V?_'W@>'2 M=:\%>)/#_P#PEVF6^N:1J6E:E:7,7A;7O#NJ^);_ ,0:9:W36JB]M;S13?NM MMW7C_7_" UFP\/:UH_A+0O#FGZA_8.E:MKTT M5O>^)[^]U0M?7=T;&T:R2W2/8JR2LJ@R[P45X<>&\J?LZ?L9\DJD8RA[67(] M8J_+M?6[7PMI-Q=CGG@,,J+IJ#5.4I1<$[0TC9/E22OK>WP\R4N5M(V-4_9[ MDU'XE>&/$QUZ!/"<,6C7GCKPJUL9!XM\8>$M/AM? ^JR2F,)%!IL(GGNXR09 MIK333AC$P'L7PM\!:EX$TKQ)8ZCJ4=\VN>-?%?B>W,",BVT7B+5[G5?LY)P6 M,9G*MV&2!D="BN_#Y#EF!S'$U,+0=*7LZFJG)V4Z4TTK[*T591LM6]6[EY?@ M\/!*486DW=RYI7;G&S5VV[6BK)-*[D[-R;=+X=_#.+PA!XE36$TO5;C6O'GB MKQ1:7 L(#+!'XBU*YU98"\B,VZ+S64',1XX3XB?#36-"L? M$-UHEGH/BCP[XCMKJ;PWKEG93F?3+MI;(+=VM]IQ=EMYH0V(_E*MR&**WJ99 M@XY71A&BHI.$E*-HSOS7NYQBI/KO)Z-KJ=JP6'^#V:2N[6T::YFFG:]US-7= M]&T0>'?AKXQU/QS:>./B;K6A7VK>'K.YL_"7AKPM;7L&AZ'%?HD&IZE->:EN MN[_4;M!Y>2D211 (@(P%\Z7]EAS<_%9I-?41>)I9KCX3A;=,?#>XFNX_%<]] M!G+22OX\<:DZH"QMH(H0P1F"E%>:^'I*5IR?O-N[=H-N_\ =4;:)1<8N*3BC6O?@7XPM_A7X&\- M:!J^@7/Q"\+>+-&^(6LZUXBMYY=+UWQ2UWJ-[XBN9Q9J;F-=2U#4+N17C4R1 M0MM0[]IK9O\ X8?$WQQJVF3_ !+\2>'+'0M!NVU+2/"G@ZWU0Q:QK5K$&L=4 MU[5]1F2[6#2KLK[WOL.6"P_LI+EERN*BXJ349*":CS+=VNWJ]7J[F;X(\$?'WP;X=T7 MPM8M\([O3M$LH-.M;ZX3Q.VH300R2H)90ZF)[@1.@7>Q4N#N.T\>I_#3X9?\ M(EX'F\,>(TT75]6O=4\5ZQ?7%OI\:V9/BG7=4UB6"%94\P1Q_;WBRWIT(Y)1 M75@\CRV%-16'BXN"A:4:;M&2Y6E^Z5M-%O\ ?J:83#TH4TE'F2IN*4U&2BG% MW23AV25W=Z+4O?"CX?:AX"^'OAOP??ZHE]=:)#>0/>11MLEBGO[FZMHU#D$" MV@F2W'8[..,$E%%?2T,HP%*C2IPH6C"G"$5S/11BDMK+\#-48))6>B26K6B5 (EHK+9+9'_]D! end EX-101.INS 6 oxys-20150930.xml XBRL INSTANCE FILE 0001413797 2004-04-30 0001413797 2004-04-01 2004-04-30 0001413797 oxys:FriscoPromissoryNoteMember 2011-03-22 0001413797 oxys:FriscoPromissoryNoteMember 2011-03-20 2011-03-22 0001413797 2013-12-31 0001413797 2014-07-01 2014-09-30 0001413797 us-gaap:MinimumMember 2014-07-01 2014-09-30 0001413797 us-gaap:MaximumMember 2014-07-01 2014-09-30 0001413797 country:US 2014-07-01 2014-09-30 0001413797 oxys:RowProductSalesMember 2014-07-01 2014-09-30 0001413797 us-gaap:ComputerSoftwareIntangibleAssetMember 2014-07-01 2014-09-30 0001413797 us-gaap:ConvertibleNotesPayableMember 2014-07-01 2014-09-30 0001413797 2014-01-01 2014-09-30 0001413797 us-gaap:MinimumMember 2014-01-01 2014-09-30 0001413797 us-gaap:MaximumMember 2014-01-01 2014-09-30 0001413797 country:US 2014-01-01 2014-09-30 0001413797 oxys:RowProductSalesMember 2014-01-01 2014-09-30 0001413797 us-gaap:ComputerSoftwareIntangibleAssetMember 2014-01-01 2014-09-30 0001413797 us-gaap:ConvertibleNotesPayableMember 2014-01-01 2014-09-30 0001413797 us-gaap:SeriesAPreferredStockMember 2014-01-01 2014-09-30 0001413797 oxys:ConvertibleNotesPayableTwoMember 2014-01-01 2014-09-30 0001413797 oxys:ConvertibleNotesPayableOneMember oxys:RepaymentOfNotesOneMember 2014-01-01 2014-09-30 0001413797 oxys:ConvertibleNotesPayableOneMember oxys:RepaymentOfNotesTwoMember 2014-01-01 2014-09-30 0001413797 oxys:ConvertibleNotesPayableTwoMember oxys:RepaymentOfNotesOneMember 2014-01-01 2014-09-30 0001413797 oxys:ConvertibleNotesPayableTwoMember oxys:RepaymentOfNotesTwoMember 2014-01-01 2014-09-30 0001413797 oxys:RowMember 2014-01-01 2014-09-30 0001413797 2014-09-30 0001413797 oxys:ConvertibleNotesPayableTwoMember 2014-09-30 0001413797 2014-12-31 0001413797 us-gaap:SeriesAPreferredStockMember 2014-12-31 0001413797 us-gaap:WarrantMember 2014-12-31 0001413797 us-gaap:EmployeeStockOptionMember 2014-12-31 0001413797 us-gaap:SeriesBPreferredStockMember 2014-12-31 0001413797 us-gaap:SeriesCPreferredStockMember 2014-12-31 0001413797 us-gaap:SeriesDPreferredStockMember 2014-12-31 0001413797 us-gaap:SeriesEPreferredStockMember 2014-12-31 0001413797 oxys:EmployeeMember us-gaap:EmployeeStockOptionMember 2014-12-31 0001413797 oxys:NonEmployeeStockOptionMember us-gaap:EmployeeStockOptionMember 2014-12-31 0001413797 us-gaap:FairValueInputsLevel1Member 2014-12-31 0001413797 us-gaap:FairValueInputsLevel2Member 2014-12-31 0001413797 us-gaap:FairValueInputsLevel3Member 2014-12-31 0001413797 2015-07-01 2015-09-30 0001413797 us-gaap:MinimumMember 2015-07-01 2015-09-30 0001413797 us-gaap:MaximumMember 2015-07-01 2015-09-30 0001413797 country:US 2015-07-01 2015-09-30 0001413797 oxys:RowProductSalesMember 2015-07-01 2015-09-30 0001413797 us-gaap:ComputerSoftwareIntangibleAssetMember 2015-07-01 2015-09-30 0001413797 us-gaap:ConvertibleNotesPayableMember 2015-07-01 2015-09-30 0001413797 us-gaap:SeriesBPreferredStockMember 2015-07-01 2015-09-30 0001413797 us-gaap:SeriesCPreferredStockMember 2015-07-01 2015-09-30 0001413797 us-gaap:SeriesDPreferredStockMember 2015-07-01 2015-09-30 0001413797 us-gaap:SeriesEPreferredStockMember 2015-07-01 2015-09-30 0001413797 us-gaap:WarrantMember 2015-07-01 2015-09-30 0001413797 2015-01-01 2015-09-30 0001413797 us-gaap:MinimumMember 2015-01-01 2015-09-30 0001413797 us-gaap:MaximumMember 2015-01-01 2015-09-30 0001413797 country:US 2015-01-01 2015-09-30 0001413797 oxys:RowProductSalesMember 2015-01-01 2015-09-30 0001413797 us-gaap:ComputerSoftwareIntangibleAssetMember 2015-01-01 2015-09-30 0001413797 us-gaap:ConvertibleNotesPayableMember 2015-01-01 2015-09-30 0001413797 us-gaap:SeriesAPreferredStockMember 2015-01-01 2015-09-30 0001413797 us-gaap:WarrantMember 2015-01-01 2015-09-30 0001413797 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-09-30 0001413797 us-gaap:SeriesBPreferredStockMember 2015-01-01 2015-09-30 0001413797 us-gaap:SeriesCPreferredStockMember 2015-01-01 2015-09-30 0001413797 us-gaap:SeriesDPreferredStockMember 2015-01-01 2015-09-30 0001413797 oxys:EmployeeMember us-gaap:EmployeeStockOptionMember 2015-01-01 2015-09-30 0001413797 oxys:NonEmployeeStockOptionMember us-gaap:EmployeeStockOptionMember 2015-01-01 2015-09-30 0001413797 us-gaap:WarrantMember 2015-01-01 2015-09-30 0001413797 us-gaap:NotesPayableOtherPayablesMember 2015-01-01 2015-09-30 0001413797 us-gaap:LeaseholdImprovementsMember us-gaap:MinimumMember 2015-01-01 2015-09-30 0001413797 us-gaap:LeaseholdImprovementsMember us-gaap:MaximumMember 2015-01-01 2015-09-30 0001413797 us-gaap:FurnitureAndFixturesMember 2015-01-01 2015-09-30 0001413797 us-gaap:MachineryAndEquipmentMember us-gaap:MinimumMember 2015-01-01 2015-09-30 0001413797 us-gaap:MachineryAndEquipmentMember us-gaap:MaximumMember 2015-01-01 2015-09-30 0001413797 us-gaap:ComputerSoftwareIntangibleAssetMember us-gaap:MinimumMember 2015-01-01 2015-09-30 0001413797 us-gaap:ComputerSoftwareIntangibleAssetMember us-gaap:MaximumMember 2015-01-01 2015-09-30 0001413797 oxys:ConvertibleNotesPayableOneMember 2015-01-01 2015-09-30 0001413797 oxys:RowMember 2015-01-01 2015-09-30 0001413797 2015-09-30 0001413797 oxys:FriscoPromissoryNoteMember 2015-09-30 0001413797 us-gaap:SeriesAPreferredStockMember 2015-09-30 0001413797 us-gaap:WarrantMember 2015-09-30 0001413797 us-gaap:EmployeeStockOptionMember 2015-09-30 0001413797 us-gaap:SeriesBPreferredStockMember 2015-09-30 0001413797 us-gaap:SeriesCPreferredStockMember 2015-09-30 0001413797 us-gaap:SeriesDPreferredStockMember 2015-09-30 0001413797 us-gaap:SeriesEPreferredStockMember 2015-09-30 0001413797 oxys:EmployeeMember us-gaap:EmployeeStockOptionMember 2015-09-30 0001413797 oxys:NonEmployeeStockOptionMember us-gaap:EmployeeStockOptionMember 2015-09-30 0001413797 us-gaap:FairValueInputsLevel1Member 2015-09-30 0001413797 us-gaap:FairValueInputsLevel2Member 2015-09-30 0001413797 us-gaap:FairValueInputsLevel3Member 2015-09-30 0001413797 us-gaap:NotesPayableOtherPayablesMember 2015-09-30 0001413797 oxys:ConvertibleNotesPayableOneMember 2015-09-30 0001413797 us-gaap:ChiefExecutiveOfficerMember 2015-09-30 0001413797 us-gaap:CommonStockMember us-gaap:SeriesAPreferredStockMember 2015-09-30 0001413797 us-gaap:CommonStockMember us-gaap:SeriesBPreferredStockMember 2015-09-30 0001413797 oxys:ConvertibleNotesPayableOneMember us-gaap:MaximumMember 2015-09-30 0001413797 oxys:ConvertibleNotesPayableOneMember us-gaap:MinimumMember 2015-09-30 0001413797 2015-11-13 xbrli:shares iso4217:USD iso4217:USDxbrli:shares oxys:ConvertibleNotes xbrli:pure OxySure Systems Inc 0001413797 false --12-31 10-Q 2015-09-30 Q3 2015 Smaller Reporting Company 36220761 647093 6312 2000000 369575 830596 277346 390028 463308 403478 53588 91747 1810910 3722161 91537 89544 362764 340142 246237 276692 2511448 4428538 558338 768674 154850 222417 149 40897 47103 606932 1132808 416563 76618 1392176 2247620 44484 44484 1436660 2247620 296 1 258 1 385 525 266 11377 13398 -1231666 19104322 25418546 -18041208 -22020795 1074788 2180918 2511448 4428538 0.0005 0.0005 1.00 1000 25000000 25000000 3143237 593750 1145 0 0 0 518750 750 770000 1050000 531666 593750 1145 0 0 0 518750 750 770000 1050000 531666 0.0004 0.0004 100000000 100000000 28436930 33488420 28436930 33488420 818456 1852796 1138380 2809553 321932 792378 580126 1325165 496524 1060418 558254 1484388 155869 433384 362599 873450 202825 444818 437442 1231581 527289 1132276 686828 1930425 885983 2010478 1486869 4035456 -389459 -950060 -928615 -2551067 169051 0 362638 0 626127 270361 1519071 355101 219673 342257 47091 251363 96161 154521 1407 -342 -72890 -208117 -452138 -1428519 -462349 -1158177 -1380753 -3979587 -0.02 -0.04 -0.04 -0.13 26120974 26042971 32425195 30543678 35462 33239 254944 1315271 -44954 -251363 342257 4374 137150 11025 42437 62137 26736 119083 -147363 -123667 444915 461020 11618 112682 -36692 -59830 -87070 38159 30455 476772 266363 -2976 -783900 -2668427 70651 8624 198 -70849 -8624 29672 80001 -2650001 -9800 -43917 115300 113500 475000 1551000 192000 175000 237298 167500 207000 175000 1440 149 205732 4036270 -649019 1359219 657673 8654 647093 2006312 12996 371 25000 188358 1234730 843515 165200 <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">A summary of significant accounting policies of OxySure&#174; Systems, Inc. (&#8220;OxySure&#8221; or the &#8220;Company&#8221;) is presented to assist in understanding the Company&#8217;s financial statements. The accounting policies presented in these footnotes conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the accompanying financial statements. These financial statements and notes are representations of the Company&#8217;s management who are responsible for their integrity and objectivity.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Basis of Presentation&#160;</b>- The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The interim financial statements include all adjustments which,&#160;in the opinion of management, are necessary in order to make the financial statements not misleading.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The accompanying Condensed Financial Statements have been prepared in accordance with United States generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information and in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not contain all of the information and footnotes required by GAAP and the SEC for annual financial statements. The Company's Condensed Financial Statements reflect all adjustments that management believes are necessary for the fair presentation of their financial position, results of operations, comprehensive loss and cash flows for the periods presented. The information at December 31, 2014 in the Company's Condensed Balance Sheet included in this quarterly report was derived from the audited Balance Sheet included in the Company's Annual Report on Form 10-K for the year ended December 31, 2014 filed with the SEC on March 31, 2015. Where applicable, the Company's 2014 Annual Report on Form 10-K is referred to in this quarterly report as the &#8220;2014 Annual Report.&#8221; This quarterly report should be read in conjunction with the 2014 Annual Report.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Deferred Revenue and Income -&#160;</b>We defer revenue and income when we invoice a customer or a customer makes a payment and the requirements of revenue recognition have not been met (i.e. persuasive evidence of an arrangement exists, shipment from a company warehouse has occurred, the price is fixed or determinable and collectability is reasonably assured). Deferred Revenue was $0 for each of the periods ended September 30, 2015 and December 31, 2014, respectively.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Inventory&#160;</b>&#8211; Our inventory consists of raw material and components for our portable oxygen systems as well as completed products and accessories.&#160;&#160;&#160;Inventories are computed using the lower of cost or market, which approximates actual cost on a first-in first-out basis. Inventory components are parts, work-in-process and finished goods. Finished goods are reported as inventories until the point of title transfer to the customer.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Inventories as at September 30, 2015 and December 31, 2014 consisted of the following:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">September&#160;30,</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">December&#160;31,</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2015</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: right;" colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;" colspan="2">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1191px; text-align: left; font-family: 'times new roman', times, serif;">Parts inventory</td><td style="width: 16px; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif;">$</td><td style="width: 142px; text-align: right; font-family: 'times new roman', times, serif;">207,605</td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif;">$</td><td style="width: 141px; text-align: right; font-family: 'times new roman', times, serif;">133,477</td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; font-family: 'times new roman', times, serif;">Work in process</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">45,120</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">41,114</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">Finished goods</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">137,303</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">102,755</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">Total inventories</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">390,028</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">277,346</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Cash and Cash Equivalents -</b>&#160;We invest our cash in deposits and money market funds with major financial institutions.&#160;&#160;We place our cash investments in instruments that meet high credit quality standards, as specified in our investment policy guidelines. These guidelines also limit the amount of credit exposure to any one issue, issuer or type of instrument.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Fair Value of Financial Instruments -&#160;</b>Our financial instruments consist principally of cash and cash equivalents, accounts receivable and accounts payable.&#160;&#160;We believe that the recorded values of all of our other financial instruments approximate their fair values because of their nature and respective maturity dates or durations. The fair value of our long-term debt is determined by using estimated market prices. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><i>Level 1</i>:&#160; Inputs are based on quoted market prices for identical assets or liabilities in active markets at the measurement date.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><i>Level 2</i>:&#160; Inputs include quoted prices for similar assets or liabilities in active markets and/or quoted prices for identical or similar assets or liabilities in markets that are not active near the measurement date.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><i>Level 3</i>: Inputs include management&#8217;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument&#8217;s valuation.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The fair value of the majority of our cash equivalents was determined based on &#8220;Level 1&#8221; inputs. We do not have any marketable securities in the &#8220;Level 2&#8221; and &#8220;Level 3&#8221; category. We believe that the recorded values of all our other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Property and Equipment&#160;</b>&#8211; Property and equipment are recorded at cost with depreciation and amortization provided over the shorter of the remaining lease term or the estimated useful life of the improvement ranging from three to seven years. Renewals and betterments that materially extend the life of an asset are capitalized. Expenditures for maintenance and repairs are charged to expense when incurred. Furniture and fixtures are depreciated over five years. Machinery and equipments are depreciated over five to seven years. Software is depreciated over three years.&#160;&#160;Leasehold improvements are computed using the shorter of the estimated useful lives of the assets or the lease terms.&#160;&#160;Depreciation expense was $3,797 and $3,052 for the three month periods ended September 30, 2015 and 2014, respectively. Depreciation expense was $10,617 and $12,838 for the nine month periods ended September 30, 2015 and 2014, respectively.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Other Long-Lived Assets</b>&#160;&#8211; We have two types of intangible assets &#8211; patents and trademarks. Intangible assets are carried at cost, net of accumulated amortization. Amortization expense for patents and trademarks was $7,508 and $7,557 for the three month periods ended September 30, 2015 and 2014, respectively. Amortization expense for patents and trademarks was $22,616 and $22,623 for the nine month periods ended September 30, 2015 and 2014, respectively.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Intangible assets with definite useful lives and other long-lived assets are tested for impairment if certain impairment indicators are identified<i>.&#160;&#160;&#160;</i>Management evaluates the recoverability of its identifiable intangible assets in accordance with applicable accounting guidance, which requires the assessment of these assets for recoverability when events or circumstances indicate a potential impairment exists.&#160;If impairment is indicated based on a comparison of the assets&#8217; carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. Impairment charges for patents were $0 for each of the three month periods ended September 30, 2015 and 2014.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">5-Year amortization expense for patents and trademarks is as follows:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1365.67px; line-height: 14.26px; padding-left: 10pt; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">2015</font></td><td style="width: 16px; line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="width: 16px; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">$</font></td><td style="width: 141px; text-align: right; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">30,232</font></td><td style="width: 15px; line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="line-height: 14.26px; padding-left: 10pt; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">2016</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="text-align: right; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">30,232</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="line-height: 14.26px; padding-left: 10pt; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">2017</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="text-align: right; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">30,232</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="line-height: 14.26px; padding-left: 10pt; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">2018</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="text-align: right; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">30,232</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">Thereafter</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; line-height: 14.26px; font-family: calibri, sans-serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">188,982</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif; border-bottom-color: black; border-bottom-width: 4.5pt; border-bottom-style: double;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">$</font></td><td style="text-align: right; line-height: 14.26px; font-family: calibri, sans-serif; border-bottom-color: black; border-bottom-width: 4.5pt; border-bottom-style: double;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">340,142</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Other Assets</b>&#8211; We record Other Assets net of accumulated amortization. Amortization expense for Other Assets was $9,654 and $9,654 for the three month periods ended September 30, 2015 and 2014, respectively. Amortization expense for Other Assets was $28,962 and $47,216 for the nine month periods ended September 30, 2015 and 2014, respectively.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><i>Capitalization of software</i>: The Company accounts for internal-use software and website development costs, including the development of its partner marketplaces in accordance with ASC 350-50 (Intangibles &#8211; Website cost). The Company capitalizes internal costs consisting of payroll and direct payroll-related costs of employees who devote time to the development of internal-use software, as well as any external direct costs. It amortizes these costs over their estimated useful lives, which typically range between three to five years. The Company&#8217;s judgment is required in determining the point at which various projects enter the stages at which costs may be capitalized, in assessing the ongoing value of the capitalized costs, and in determining the estimated useful lives over which the costs are amortized. The estimated life is based on management&#8217;s judgment as to the product life cycle.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Amortization expense for websites and URLs was $9,654 and $9,654 for the three month periods ended September 30, 2015 and 2014, respectively. Amortization expense for websites and URLs was $28,962 and $28,962 for the nine month periods ended September 30, 2015 and 2014, respectively.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Research and Development Costs&#160;&#8211;</b>&#160;Costs associated with the development of our products are charged to expense as incurred.&#160;&#160;Research and development expense was $362,599 and $155,869 for the three month periods ended September 30, 2015 and 2014, respectively. Research and development expense was $873,450 and $433,384 for the nine month periods ended September 30, 2015 and 2014, respectively.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Equity Warrants&#160;-</b>&#160;We issued warrants to purchase shares of our common stock in connection with convertible notes. In accordance with ASC 470-20, Debt with conversions and other options, the proceeds from the notes were allocated based on the relative fair values of the notes without the warrants issued in conjunction with the notes and of the warrants themselves at the time of issuance. We record the fair value of the warrants at the time of issuance as additional paid in capital and as a debt discount to the notes.&#160;&#160;We amortize this debt discount as interest expense over the life of the note.&#160;&#160;Additionally, as a result of issuing the warrants with the convertible notes, a beneficial conversion option is recorded as a debt discount reflecting the incremental conversion option intrinsic value of the conversion option provided to the holders of the notes. We also amortize this debt discount as interest expense over the life of the notes.&#160;&#160;The intrinsic value of each conversion option was calculated as the difference between the effective conversion price and the fair value of the common stock, multiplied by the number of shares into which the note is convertible.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Stock-Based Compensation &#8211;&#160;</b>We account for share-based payments, including grants of stock options to employees, consultants and non-employees; moreover, we issue warrants to the consultants and related parties.&#160;&#160;We are required to estimate the fair value of share-based awards and warrants on the date of grant. The value of the award is principally recognized as expense ratably over the requisite service periods. We have estimated the fair value of stock options and warrants as of the date of grant or assumption using the Black-Scholes option pricing model.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">For the three month periods ended September 30, 2015 and 2014, stock based compensation expense was approximately $25,740 and $42,437, respectively, which consisted primarily of stock-based compensation expense related to stock options issued to the employees and recognized under GAAP. For the nine month periods ended September 30, 2015 and 2014, stock based compensation expense was approximately $132,651 and $60,025, respectively.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Shipping and Handling Costs&#160;</b>- Shipping and handling charges to customers are included in net revenues, and the associated costs incurred are recorded in cost of revenues.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Advertising Costs -&#160;</b>Advertising costs are charged to operations when incurred.&#160;&#160;We incurred $437,442 and $202,825 in advertising and promotion costs during the three month periods ended September 30, 2015 and 2014, respectively. Advertising and promotion costs during the nine month periods ended September 30, 2015 and 2014 were $1,231,581 and $444,818, respectively.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Net Income (Loss) Per Share -&#160;</b>Basic earnings (loss) per share is computed based on the weighted average number of common shares outstanding. However, basic loss per share excludes anti-dilutive securities. Diluted earnings per share is computed based on the weighted average number of common shares outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive common shares been issued, and reduced by the number of shares the Company could have repurchased from the proceeds from issuance of the potentially dilutive shares. Potentially dilutive shares of common stock include stock options and other stock-based awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan. As of September 30, 2015 there were 21,865,386 potentially dilutive shares.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b><i>Recent Accounting Pronouncements</i></b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">We have reviewed recent accounting pronouncements and concluded that they are either not applicable to our business or that no material effect is expected on the financial statements as a result of future adoption.</p></div> <div> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>NOTE 2 &#8211; NOTES PAYABLE</b></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">We have issued warrants for the purchase of shares of our restricted common stock in connection with raising equity and debt financing and for other professional services.&#160;&#160;The fair value of warrants issued is determined in accordance with Codification topic 470-20.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b><u>Frisco Promissory Note.</u></b>&#160;On March 22, 2011 we entered into an Amended and Restated Performance Agreement with the Frisco Economic Development Corporation (&#8220;FEDC&#8221;) pursuant to an economic incentive package. In terms of the Amended and Restated Performance Agreement, the FEDC provided us with economic assistance in the form of the renewal and extension a forgivable loan of $213,000 (the &#8220;Frisco Note&#8221;) together with performance credits over 5 years, commencing on March 22, 2011 and ending on the earlier to occur of: (i) the full payment of the economic incentives; or (ii) March 31, 2016.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Frisco Note requires varying annual principal payments through December 2015. The Frisco Note is non-interest bearing; however, interest has been imputed at 12.34% per annum. The unamortized discount at September 30, 2015 was $4,897 and the net amount of the Frisco Note as at September 30, 2015&#160;was $47,103.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Future principal payments of the Frisco Note payable are as follows:</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1379px; text-align: left; padding-bottom: 1.5pt;">2015</td> <td style="width: 16px; padding-bottom: 1.5pt;">&#160;</td> <td style="width: 16px; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td> <td style="width: 141px; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">52,000</td> <td style="width: 15px; text-align: left; padding-bottom: 1.5pt;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; padding-bottom: 4pt;">Total</td> <td style="padding-bottom: 4pt;">&#160;</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">52,000</td> <td style="text-align: left; padding-bottom: 4pt;">&#160;</td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">During the nine months ended September 30, 2015 we issued ten convertible notes with a total principal value of $1,683,500 for $1,461,500 in cash. The notes contained original issuance discounts for a total of $222,500, and interest rates ranging between 8% and 12%. The maturity dates of the notes range from January 7, 2016 to May 4, 2017. The creditors have the option at any time to convert the principal and any accrued interest into common stock of the Company at an aggregate discount rate of approximately 7% off the market price of the Company&#8217;s common stock. During the nine months ended September 30, 2014 we repaid two notes with principal values totaling $175,000 for $237,298 in cash and the two notes were extinguished in their entirety pursuant to these transactions.</p> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p> <p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">During the nine months ended September 30, 2014 we issued eight convertible notes with a total principal value of $475,000 for $412,500 in cash. The notes contained original issuance discounts for a total of $62,500, and interest rates of 12%. The maturity dates of the notes range from January 28, 2015 to September 10, 2015. The creditors have the option at any time to convert the principal and any accrued interest into common stock of the Company at a an aggregate discount rate of approximately thirty eight percent off the market price of the Company&#8217;s common stock. During the nine months ended September 30, 2014 we repaid two notes with principal values totaling $167,500 for $207,000 in cash and the two notes were extinguished in their entirety pursuant to these transactions. During the nine months ended September 30, 2014 we exchanged a lease with an outstanding amount of $307,662 for a convertible note with a principal value of $150,000 and 75,000 shares of our common stock. The lease was extinguished in its entirety pursuant to the exchange transaction.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">During the nine months ended September 30, 2015, we issued warrants associated with notes. In accordance with ASC 470-20, Debt with conversions and other options, the proceeds from the notes were allocated based on the relative fair values of the notes without the warrants issued in conjunction with the notes and of the warrants themselves at the time of issuance. We recorded the relative fair value of the warrants issued with the notes in the amount of $251,363 as debt discounts upon issuance, and amortized these debt discounts as interest expense over the life of the notes. Additionally, as a result of issuing the warrants with the subordinated convertible promissory notes, a beneficial conversion option for each note was recorded as a debt discount reflecting the incremental conversion option intrinsic value benefit totaling $133,637 at the time of issuance provided to the holders of the notes, which was also amortized as interest expense over the life of the notes. We recorded interest expense in the amounts of $270,361 and $0 for the three months ended September 30, 2015 and 2014, respectively in connection with the notes (issued with warrants) that contained beneficial conversion features. We recorded interest expense in the amounts of $355,101 and $0 for the nine months ended September 30, 2015 and 2014, respectively in connection with all the notes (issued with warrants) that contained beneficial conversion features.</p> </div> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>NOTE 3 - SHAREHOLDERS&#8217; EQUITY</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b><i>Preferred Shares Rights</i></b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">We have 25,000,000 shares of preferred stock authorized, par value $0.0005 per share.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">Series A Convertible Preferred Stock:&#160;As of September 30, 2015, the Company had authorized the issuance of 3,143,237&#160;shares of preferred stock designated as Series A Convertible Preferred Stock (&#8220;Series A Preferred&#8221;). The original issue price of the Series A Preferred is $1.00 per share.&#160;There were 518,750 and 593,750 Series A Preferred shares issued and outstanding as of September 30, 2015 and December 31, 2014, respectively.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">During the three months ended September 30, 2015 the Company did not issue any shares of the Series A Preferred, and no shares of the Series A Preferred have been converted into common stock.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">Series B Convertible Preferred Stock:&#160;As of September 30, 2015, we had 3,500 shares of preferred stock designated as Series B Convertible Preferred Stock (&#8220;Series B Preferred&#8221;). The original issue price of the Series B Preferred is $1,000 per share.&#160;There were 750 and 1,145 Series B Preferred shares issued and outstanding as of September 30, 2015 and December 31, 2014, respectively.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">During the three months ended September 30, 2015 the Company did not issue any shares of the Series B Preferred and 150 shares of Series B Preferred were converted into 313,296 shares of our common stock.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">Series C Convertible Preferred Stock:&#160;As of September 30, 2015, we had 770,000 shares of preferred stock designated as Series C Convertible Preferred Stock (&#8220;Series C Preferred&#8221;). The original issue price of the Series C Preferred is $2.00 per share.&#160;There were 770,000 and 0 Series C Preferred shares issued and outstanding as of September 30, 2015 and December 31, 2014, respectively.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">During the three months ended September 30, 2015 the Company issued no shares of the Series C Preferred and no shares of Series C Preferred were converted into common stock.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">Series D Convertible Preferred Stock:&#160;As of September 30, 2015, we had 1,050,000 shares of preferred stock designated as Series D Convertible Preferred Stock (&#8220;Series D Preferred&#8221;). The original issue price of the Series D Preferred is $2.00 per share.&#160;There were 1,050,000 and 0 shares of the Series D Preferred issued and outstanding as of September 30, 2015 and December 31, 2014, respectively.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">During the three months ended September 30, 2015 the Company issued no shares of the Series D Preferred and no shares of Series D Preferred were converted into common stock.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">Series E Convertible Preferred Stock:&#160;As of September 30, 2015, we had 531,666 shares of preferred stock designated as Series E Convertible Preferred Stock (&#8220;Series E Preferred&#8221;). The original issue price of the Series E Preferred is $1.00 per share.&#160;There were 531,666 and 0 shares of the Series E Preferred issued and outstanding as of September 30, 2015 and December 31, 2014, respectively.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">During the three months ended September 30, 2015 the Company issued no shares of the Series E Preferred and no shares of Series E Preferred were converted into common stock.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b><i>Common Stock</i></b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company has authorized 100,000,000 shares of $0.0004 par value common stock.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">During the three months ended September 30, 2015:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 24px; line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="width: 24px; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">(1)</font></td><td style="text-align: justify; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">We issued 313,296 shares of common stock pursuant to the cashless conversion of 150 shares of Series B Preferred;</font></td></tr><tr style="vertical-align: top;"><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">(2)</font></td><td style="text-align: justify; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">We issued 1,767,650 shares of common stock pursuant to the conversion of convertible notes;</font></td></tr><tr style="vertical-align: top;"><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">(3)</font></td><td style="text-align: justify; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">We issued 90,000 shares of common stock for services;</font></td></tr><tr style="vertical-align: top;"><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">(4)</font></td><td style="text-align: justify; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">We issued 93,474 shares of common stock for compensation;</font></td></tr><tr style="vertical-align: top;"><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">(5)</font></td><td style="text-align: justify; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">We recorded $2,380 in expenses in connection warrants issued for services;</font></td></tr><tr style="vertical-align: top;"><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">(6)</font></td><td style="text-align: justify; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">We recorded $219,673 in connection with derivative revaluation;</font></td></tr><tr style="vertical-align: top;"><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">(7)</font></td><td style="text-align: justify; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">We recorded $26,740 for the computed fair value of options issued to employees, non-employee directors, and consultants, net of cancellations and forfeitures; and</font></td></tr><tr style="vertical-align: top;"><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">(8)</font></td><td style="text-align: justify; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">We recorded $434,983 in connection with beneficial conversion features.</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">During the nine months ended September 30, 2015:</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; width: 24px; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; width: 24px; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">1.</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-align: justify; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">We issued 133,333 shares of common stock for $80,001 in cash;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">2.</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-align: justify; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">We issued 91,500 shares of common stock pursuant to the cashless conversion of 75,000 shares of Series A Preferred;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">3.</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-align: justify; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">We issued 835,833 shares of common stock pursuant to the cashless conversion of 395 shares of Series B Preferred;</font></td></tr></table><p style="font: 13.33px/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>&#160;</b></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; width: 24px; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; width: 24px; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">4.</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-align: justify; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">We issued 770,000 shares of the Series C Preferred for which we received $700,000 in cash and recorded a stock subscription receivable for the remaining $700,000;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; width: 24px; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; width: 24px; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">5.</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-align: justify; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">We issued 1,050,000 shares of the Series D Preferred for $2,000,000 in cash held in escrow, to be released upon our uplisting to a national exchange;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; width: 24px; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; width: 24px; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">6.</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-align: justify; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">We issued 3,719,350 shares of common stock pursuant to the conversion of convertible notes;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">7.</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-align: justify; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">We issued 178,000 shares of common stock for services;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">8.</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-align: justify; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">We issued 93,474 shares of common stock for compensation;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">9.</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-align: justify; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">We recorded $11,025 in expenses in connection warrants issued for services;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">10.</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-align: justify; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">We recorded $342,257 in connection with derivative revaluation;</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">11.</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-align: justify; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">We recorded $132,651 for the computed fair value of options issued to employees, non-employee directors, and consultants, net of cancellations and forfeitures; and</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">12.</font></td><td style="font: 10pt/normal 'times new roman', times, serif; padding: 0pt; text-align: justify; text-indent: 0pt; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">We recorded $1,315,271 in connection with beneficial conversion features.</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">During the three months ended September 30, 2014:</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; width: 24px; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; width: 24px; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">(1)</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">We issued 26,580 shares of common stock for $19,000 in cash; and</font></td></tr><tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-size-adjust: none; font-stretch: normal;"><td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></td><td style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">(2)</font></td><td style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; font-size-adjust: none; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">We issued 360,781 shares of common stock pursuant to cashless conversions of convertible notes payable and accrued interest, valued at $150,858.</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">During the nine months ended September 30, 2014:</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 24px; line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="width: 24px; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">(1)</font></td><td style="text-align: justify; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">We issued 41,580 shares of common stock for $29,700 in cash;</font></td></tr><tr style="vertical-align: top;"><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">(2)</font></td><td style="text-align: justify; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">We issued 444,072 shares of common stock pursuant to cashless conversions of convertible notes payable and accrued interest, valued at $188,358; and</font></td></tr><tr style="vertical-align: top;"><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">(3)</font></td><td style="text-align: justify; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/15.33px 'times new roman', serif; font-size-adjust: none; font-stretch: normal;">We issued 122,000 shares of common stock pursuant to the cashless conversion of 100,000 shares of Series A Preferred.</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">&#160;</font>&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">As of September 30, 2015 we had approximately 33,488,420 shares of common stock issued and outstanding.</p> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>NOTE 4 - STOCK OPTIONS AND WARRANTS</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b><i>Equity Incentive Plans</i></b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In April 2004, our Board of Directors and the stockholders at that time approved the adoption of a Voting Stock Option Plan (&#8220;the Plan&#8221;), which provides for the issuance of stock options to eligible employees, consultants, Board members and Advisory Board members of the Company to acquire up to a maximum of 5,000,000 shares of common stock.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Our Board of Directors, which determines the number of options that will be granted, the effective dates of the grants, the option process and the vesting schedules, administers the Plan. In the absence of an established market for the common stock of the Company, the Board of Directors determines the fair market value of our common stock. Options generally expire between five and ten years from the date of grant and automatically terminate 90 days after such optionee ceases to be an eligible individual under the Plan other than by reason of death or disability.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The portion of options granted that is not exercisable on the date the optionee ceases to be an eligible individual under the Plan by reason other than death, shall terminate and be forfeited to the Company on the date of such cessation. An optionee has no right as a stockholder with respect to any shares covered by the options granted to him until a certificate representing such shares is issued to them.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b><i>Stock Options</i></b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The following table summarizes information about the number and weighted average of the options that were forfeited or expired under the Plan as at September 30, 2015:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6">Employee</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6">Non-Employee</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Weighted</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Weighted</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Number</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Average</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Number</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Average</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Combined</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Of</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Exercise</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Of</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Exercise</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Total</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 627px; padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">Outstanding at June 30, 2015</td><td style="width: 16px; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="width: 142px; text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,513,838</td><td style="width: 16px; text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="width: 142px; text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">0.41</td><td style="width: 16px; text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="width: 141px; text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="width: 15px; text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="width: 141px; text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="width: 15px; text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="width: 141px; text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,513,838</td><td style="width: 15px; text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-family: 'times new roman', times, serif;">Granted</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-family: 'times new roman', times, serif;">Exercised</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">Forfeited/Cancelled</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(62,500</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">)</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">Outstanding at September 30, 2015</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,451,338</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">0.39</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,451,338</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The number of stock options exercisable at September 30, 2015 was 1,886,721.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">We used the following assumptions to estimate the fair value of options granted under the Plan for the three and nine months ended September 30, 2015 and 2014:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="6"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>Equity Incentive Plans</b></font></td><td style="font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="6"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>Equity Incentive Plans</b></font></td><td style="font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td></tr><tr style="vertical-align: bottom;"><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>for the Three Months Ended September 30,</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>for the Nine Months Ended September 30,</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td></tr><tr style="vertical-align: bottom;"><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>2015</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>2014</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>2015</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>2014</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td></tr><tr style="vertical-align: bottom;"><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Expected terms (in years)</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">5-10</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">5-10</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">5-10</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">5-10</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 815px; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Volatility (weighted ave.)</font></td><td style="width: 16px; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="width: 142px; text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">83.79</font></td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td><td style="width: 16px; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="width: 142px; text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">40.45</font></td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td><td style="width: 15px; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="width: 141px; text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">83.79</font></td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td><td style="width: 15px; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="width: 141px; text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">40.45</font></td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Risk-free interest rate</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">.85%&#160;-&#160;1.74</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">1.50%&#160;-&#160;1.80</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">.85%&#160;-&#160;1.74</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">1.44%&#160;-&#160;1.80</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Expected dividend rate</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding. The expected term is based on the observed and expected time to exercise and post-vesting cancellations of options by optionees.&#160;&#160;We use historical volatility in deriving our expected volatility assumption because it believes that future volatility over the expected&#160;term of the stock options is not likely to differ from the past.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The expected dividend assumption is based on our history and expectation of dividend payouts.&#160;&#160;The fair value of the shares of common stock underlying the stock options has historically been determined by the board of directors. On or before February 2012, when our common stock commenced trading on the over the counter bulletin board (OTCQB), there has been no public market for our common stock. Consequently, the board of directors has historically determined the fair value of the common stock at the time of grant of the option by considering a number of objective and subjective factors including valuation of comparable companies, operating and financial performance, the lack of liquidity of capital stock and general and industry specific economic outlook, amongst other factors.&#160;&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">FASB ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company only records stock-based compensation expense for awards that are expected to vest. While we generally consider historical forfeitures in its estimates, judgment is also required in estimating the amount of stock-based awards that are expected to be forfeited. The Company&#8217;s estimates for forfeitures may differ from actual forfeitures. If actual results differ significantly from these estimates, stock-based compensation expense and its results of operations could be materially impacted when the Company records a true-up for the difference in the period that the awards vest. We adjust stock-based compensation expense based on our actual forfeitures on an annual basis, if necessary.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Stock compensation cost, using the graded vesting attribute method in accordance with Codification topic 718, is recognized over the requisite service period, generally 5 years, during which each tranche of shares is earned (zero, one, two, three, and four years).&#160;&#160;The value of each tranche is generally amortized on a straight-line basis.&#160;&#160;For the three months ended September 30, 2015 and 2014, stock based compensation expense was approximately $26,736 and $42,437 respectively, which consisted primarily of stock-based compensation expense related to stock options recognized under GAAP issued to employees.&#160;&#160;For each of the three months ended September 30, 2015 and 2014, the number of options exercised was 0.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Compensation expense is recognized only for the portion of stock options that are expected to vest, assuming an expected forfeiture rate in determining stock-based compensation expense, which could affect the stock-based compensation expense recorded if there is a significant difference between actual and estimated forfeiture rates. As of September 30, 2015, total unrecognized compensation cost related to stock-based awards granted to employees and non-employee directors was $323,715.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b><i>Warrants.</i></b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>&#160;</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The following table summarizes our warrant activities for the three months ended September 30, 2015:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Weighted</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Number</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Average</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Of</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Exercise</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Warrants</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Price</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1191px; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">Outstanding at June 30, 2015</td><td style="width: 16px; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="width: 142px; text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">4,863,956</td><td style="width: 16px; text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">$</td><td style="width: 141px; text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">1.22</td><td style="width: 15px; text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-family: 'times new roman', times, serif;">Granted</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">15,000</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif;">1.23</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-family: 'times new roman', times, serif;">Exercised</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">Forfeited/Cancelled</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">Outstanding at September 30, 2015</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">4,878,956</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">1.23</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The number of warrants exercisable at September 30, 2015 was 4,878,956.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>NOTE 5 &#8211; RELATED PARTY TRANSACTIONS</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">A summary of the related party financings and notes as at September 30, 2015 is as follows:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">Related party</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Julian Ross&#160;(1)</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1379px;">Amount</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">$</td><td style="width: 141px; text-align: right;">222,417</td><td style="width: 15px; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left;">Stated interest rate</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">0</td><td style="text-align: left;">%</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td>Maturity</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">n/a</font></td><td style="text-align: left;">&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">(1) Our CEO, Mr. Ross provides us shareholder cash advances and other consideration from time to time to fund working capital.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>NOTE&#160;6 &#8211; OFF BALANCE SHEET ARRANGEMENTS AND CONTRACTUAL OBLIGATIONS</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">We have not entered into any transactions with unconsolidated entities whereby we have financial guarantees, subordinated retained interests, or other contingent arrangements that expose us to material continuing risks, contingent liabilities, or any other obligation under a variable interest in an unconsolidated entity that provides financing, liquidity, market risk or credit risk support to us.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>NOTE 7 &#8211; FAIR VALUE MEASUREMENTS</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Changes related to derivatives for the nine months ended September 30, 2015 are as follows:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1379px;">Balance as of December 31, 2014</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">$</td><td style="width: 141px; text-align: right;">31,010</td><td style="width: 15px; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left;">Additions related to embedded derivative of convertible notes issued</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">416,563</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left;">Gain on decrease in value of derivative liabilities</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(342,257</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 1.5pt;">Conversions</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(28,698</td><td style="text-align: left; padding-bottom: 1.5pt;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding-bottom: 4pt;">Balance as of September 30, 2015</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">76,618</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">During the nine month period the Company recorded derivatives related to convertible notes of $416,563 of which $251,363 exceed the proceeds of the convertible notes and was recorded as a derivative expense. The Company also converted $28,698 and recorded gains on the change in the fair values of the derivatives of $342,257.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b><i>Assets Measured at Fair Value on a Recurring Basis</i></b></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b><i>&#160;</i></b></p><table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">Fair value measurements at&#160;<br />reporting date using:</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Total</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 815px; text-indent: 0pt; padding-left: 0pt; font-family: 'times new roman', serif;"><font style="font: 10pt/14.13px 'times new roman', serif; font-stretch: normal;">Cash&#160;<sup>(1)</sup></font></td><td style="width: 16px; font-family: 'times new roman', serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', serif;">$</td><td style="width: 142px; text-align: right; font-family: 'times new roman', serif;">2,006,312</td><td style="width: 16px; text-align: left; font-family: 'times new roman', serif;">&#160;</td><td style="width: 16px; font-family: 'times new roman', serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', serif;">$</td><td style="width: 142px; text-align: right; font-family: 'times new roman', serif;">2,006,312</td><td style="width: 16px; text-align: left; font-family: 'times new roman', serif;">&#160;</td><td style="width: 15px; font-family: 'times new roman', serif;">&#160;</td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif;">&#160;</td><td style="width: 141px; text-align: right; font-family: 'times new roman', serif;">-</td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif;">&#160;</td><td style="width: 15px; font-family: 'times new roman', serif;">&#160;</td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif;">&#160;</td><td style="width: 141px; text-align: right; font-family: 'times new roman', serif;">-</td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-family: 'times new roman', serif;">Derivatives</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(76,618</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">)</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(76,618</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">)</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-family: 'times new roman', serif;">Total assets at fair value as of September 30, 2015</td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">1,929,694</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,006,312</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">(76,618</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;">)</td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td></tr></table><p style="font: 10pt/14.26px calibri, sans-serif; margin: 0pt; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/14.26px calibri, sans-serif; margin: 0pt; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman', serif;">(1) Included in Cash and cash equivalents on the Company's Balance Sheet.</font></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0pt; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Total</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 815px; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-family: 'times new roman', serif;"><font style="font: 10pt/14.13px 'times new roman', serif; font-stretch: normal;">Cash&#160;<sup>(1)</sup></font></td><td style="width: 16px; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">$</td><td style="width: 142px; text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">647,093</td><td style="width: 16px; text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="width: 16px; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">$</td><td style="width: 142px; text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">647,093</td><td style="width: 16px; text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="width: 15px; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="width: 141px; text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="width: 15px; text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="width: 15px; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="width: 141px; text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="width: 15px; text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-family: 'times new roman', serif;">Total assets at fair value as of December 31, 2014</td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">647,093</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">647,093</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td></tr></table><p style="font: 10pt/14.13px calibri, sans-serif; margin: 0pt; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/14.13px calibri, sans-serif; margin: 0pt; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman', serif;">(1) Included in Cash and cash equivalents on the Company's Balance Sheet.</font></p></div> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><b>NOTE&#160;8 &#8211; SEGMENT INFORMATION</b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">We are organized as, and operate in, one reportable segment: the development, distribution and sale of specialty respiratory products and related medical products, accessories, and services. Our chief operating decision-maker is our Chief Executive Officer. Our Chief Executive Officer reviews financial information presented for purposes of evaluating financial performance and allocating resources, accompanied by information about revenue by geographic regions. Our assets are primarily located in the United States of America and not allocated to any specific region and we do not measure the performance of our geographic regions based upon asset-based metrics. Therefore, geographic information is presented only for revenue. Revenue by geographic region is based on the ship to address on our customer orders.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">The following presents total revenue by geographic region for the three month periods ended September 30, 2015 and 2014:</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p> <table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td>&#160;</td> <td style="font-family: 'times new roman', serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-family: 'times new roman', serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6">Three Months Ended<br />September 30,</td> <td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td>&#160;</td> <td style="font-family: 'times new roman', serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-family: 'times new roman', serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2015</td> <td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td> <td style="font-family: 'times new roman', serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-family: 'times new roman', serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2014</td> <td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1191px; font-family: 'times new roman', serif; text-align: left;">United States - product sales</td> <td style="width: 16px; font-family: 'times new roman', serif;">&#160;</td> <td style="width: 16px; font-family: 'times new roman', serif; text-align: left;">$</td> <td style="width: 142px; font-family: 'times new roman', serif; text-align: right;">1,138,380</td> <td style="width: 16px; font-family: 'times new roman', serif; text-align: left;">&#160;</td> <td style="width: 15px; font-family: 'times new roman', serif;">&#160;</td> <td style="width: 15px; font-family: 'times new roman', serif; text-align: left;">$</td> <td style="width: 141px; font-family: 'times new roman', serif; text-align: right;">814,619</td> <td style="width: 15px; font-family: 'times new roman', serif; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-family: 'times new roman', serif; text-align: left;">ROW - product sales</td> <td style="font-family: 'times new roman', serif;">&#160;</td> <td style="font-family: 'times new roman', serif; text-align: left;">&#160;</td> <td style="font-family: 'times new roman', serif; text-align: right;">-</td> <td style="font-family: 'times new roman', serif; text-align: left;">&#160;</td> <td style="font-family: 'times new roman', serif;">&#160;</td> <td style="font-family: 'times new roman', serif; text-align: left;">&#160;</td> <td style="font-family: 'times new roman', serif; text-align: right;">3,837</td> <td style="font-family: 'times new roman', serif; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-bottom: 1.5pt;">&#160;</td> <td style="padding-bottom: 1.5pt;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: left;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: right;">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left;">&#160;</td> <td style="padding-bottom: 1.5pt;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: left;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: right;">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-family: 'times new roman', serif; padding-bottom: 4pt;">Totals</td> <td style="font-family: 'times new roman', serif; padding-bottom: 4pt;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-family: 'times new roman', serif; text-align: left;">$</td> <td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-family: 'times new roman', serif; text-align: right;">1,138,380</td> <td style="padding-bottom: 4pt; font-family: 'times new roman', serif; text-align: left;">&#160;</td> <td style="font-family: 'times new roman', serif; padding-bottom: 4pt;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-family: 'times new roman', serif; text-align: left;">$</td> <td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-family: 'times new roman', serif; text-align: right;">818,456</td> <td style="padding-bottom: 4pt; font-family: 'times new roman', serif; text-align: left;">&#160;</td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">T<font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">he following presents total revenue by geographic region for the nine month periods ended September 30, 2015 and 2014:</font></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p> <table style="font: 11pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center; line-height: 15.6933px;" colspan="7"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">Nine Months Ended September 30,</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center; line-height: 15.6933px;" colspan="3"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">2015</font></td> <td style="line-height: 15.6933px;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center; line-height: 15.6933px;" colspan="3"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">2014</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;" colspan="3">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;" colspan="3">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1215.81px; padding-left: 5.4pt; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">United States - product sales</font></td> <td style="width: 16px; line-height: 15.6933px;">&#160;</td> <td style="width: 16px; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">$</font></td> <td style="width: 126px; text-align: right; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">2,807,600</font></td> <td style="width: 16px; line-height: 15.6933px;">&#160;</td> <td style="width: 15px; line-height: 15.6933px;">&#160;</td> <td style="width: 15px; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">$</font></td> <td style="width: 125px; text-align: right; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">1,793,729</font></td> <td style="width: 15px; line-height: 15.6933px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="padding-left: 5.4pt; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">ROW - product sales</font></td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="text-align: right; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">1,953</font></td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="text-align: right; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">41,567</font></td> <td style="line-height: 15.6933px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-left: 5.4pt; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">ROW - license fees/service revenue</font></td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="text-align: right; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">-</font></td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="text-align: right; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">17,500</font></td> <td style="line-height: 15.6933px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="padding-left: 5.4pt; line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; line-height: 15.6933px;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: right; line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; line-height: 15.6933px;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: right; line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-left: 5.4pt; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">Totals</font></td> <td style="line-height: 15.6933px;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 4.5pt; border-bottom-style: double; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">$</font></td> <td style="border-bottom-color: black; border-bottom-width: 4.5pt; border-bottom-style: double; text-align: right; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">2,809,553</font></td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 4.5pt; border-bottom-style: double; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">$</font></td> <td style="border-bottom-color: black; border-bottom-width: 4.5pt; border-bottom-style: double; text-align: right; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">1,852,796</font></td> <td style="line-height: 15.6933px;">&#160;</td> </tr> </table> <div>&#160;</div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>NOTE 9 &#8211; GOING CONCERN</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Our financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. Historically we have been suffering from recurring loss from operations. We have an accumulated deficit of $22,020,795 and $18,041,208 at September 30, 2015 and December 31, 2014, respectively, and stockholders&#8217; equity of $2,180,918 and $1,074,787 as of September 30, 2015 and December 31, 2014, respectively. We require substantial additional funds to manufacture and commercialize our products. Our management is actively seeking additional sources of equity and/or debt financing; however, there is no assurance that any additional funding will be available.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In view of the matters described above, recoverability of a major portion of the recorded asset amounts shown in the accompanying September 30, 2015 balance sheet is dependent upon continued operations of the Company, which in turn is dependent upon the Company&#8217;s ability to meet its financing requirements on a continuing basis, to maintain present financing, and to generate cash from future operations. These factors, among others, raise substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should we be unable to continue in existence.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Basis of Presentation&#160;</b>- The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The interim financial statements include all adjustments which,&#160;in the opinion of management, are necessary in order to make the financial statements not misleading.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The accompanying Condensed Financial Statements have been prepared in accordance with United States generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information and in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not contain all of the information and footnotes required by GAAP and the SEC for annual financial statements. The Company's Condensed Financial Statements reflect all adjustments that management believes are necessary for the fair presentation of their financial position, results of operations, comprehensive loss and cash flows for the periods presented. The information at December 31, 2014 in the Company's Condensed Balance Sheet included in this quarterly report was derived from the audited Balance Sheet included in the Company's Annual Report on Form 10-K for the year ended December 31, 2014 filed with the SEC on March 31, 2015. Where applicable, the Company's 2014 Annual Report on Form 10-K is referred to in this quarterly report as the &#8220;2014 Annual Report.&#8221; This quarterly report should be read in conjunction with the 2014 Annual Report.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Deferred Revenue and Income -&#160;</b>We defer revenue and income when we invoice a customer or a customer makes a payment and the requirements of revenue recognition have not been met (i.e. persuasive evidence of an arrangement exists, shipment from a company warehouse has occurred, the price is fixed or determinable and collectability is reasonably assured). Deferred Revenue was $0 for each of the periods ended September 30, 2015 and December 31, 2014, respectively.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Inventory&#160;</b>&#8211; Our inventory consists of raw material and components for our portable oxygen systems as well as completed products and accessories.&#160;&#160;&#160;Inventories are computed using the lower of cost or market, which approximates actual cost on a first-in first-out basis. Inventory components are parts, work-in-process and finished goods. Finished goods are reported as inventories until the point of title transfer to the customer.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Inventories as at September 30, 2015 and December 31, 2014 consisted of the following:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">September&#160;30,</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">December&#160;31,</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2015</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: right;" colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;" colspan="2">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1191px; text-align: left; font-family: 'times new roman', times, serif;">Parts inventory</td><td style="width: 16px; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif;">$</td><td style="width: 142px; text-align: right; font-family: 'times new roman', times, serif;">207,605</td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif;">$</td><td style="width: 141px; text-align: right; font-family: 'times new roman', times, serif;">133,477</td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; font-family: 'times new roman', times, serif;">Work in process</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">45,120</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">41,114</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">Finished goods</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">137,303</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">102,755</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">Total inventories</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">390,028</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">277,346</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;"></td></tr></table></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Cash and Cash Equivalents -</b>&#160;We invest our cash in deposits and money market funds with major financial institutions.&#160;&#160;We place our cash investments in instruments that meet high credit quality standards, as specified in our investment policy guidelines. These guidelines also limit the amount of credit exposure to any one issue, issuer or type of instrument.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Fair Value of Financial Instruments -&#160;</b>Our financial instruments consist principally of cash and cash equivalents, accounts receivable and accounts payable.&#160;&#160;We believe that the recorded values of all of our other financial instruments approximate their fair values because of their nature and respective maturity dates or durations. The fair value of our long-term debt is determined by using estimated market prices. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><i>Level 1</i>:&#160; Inputs are based on quoted market prices for identical assets or liabilities in active markets at the measurement date.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><i>Level 2</i>:&#160; Inputs include quoted prices for similar assets or liabilities in active markets and/or quoted prices for identical or similar assets or liabilities in markets that are not active near the measurement date.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><i>Level 3</i>: Inputs include management&#8217;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument&#8217;s valuation.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The fair value of the majority of our cash equivalents was determined based on &#8220;Level 1&#8221; inputs. We do not have any marketable securities in the &#8220;Level 2&#8221; and &#8220;Level 3&#8221; category. We believe that the recorded values of all our other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Property and Equipment&#160;</b>&#8211; Property and equipment are recorded at cost with depreciation and amortization provided over the shorter of the remaining lease term or the estimated useful life of the improvement ranging from three to seven years. Renewals and betterments that materially extend the life of an asset are capitalized. Expenditures for maintenance and repairs are charged to expense when incurred. Furniture and fixtures are depreciated over five years. Machinery and equipments are depreciated over five to seven years. Software is depreciated over three years.&#160;&#160;Leasehold improvements are computed using the shorter of the estimated useful lives of the assets or the lease terms.&#160;&#160;Depreciation expense was $3,797 and $3,052 for the three month periods ended September 30, 2015 and 2014, respectively. Depreciation expense was $10,617 and $12,838 for the nine month periods ended September 30, 2015 and 2014, respectively.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Other Long-Lived Assets</b>&#160;&#8211; We have two types of intangible assets &#8211; patents and trademarks. Intangible assets are carried at cost, net of accumulated amortization. Amortization expense for patents and trademarks was $7,508 and $7,557 for the three month periods ended September 30, 2015 and 2014, respectively. Amortization expense for patents and trademarks was $22,616 and $22,623 for the nine month periods ended September 30, 2015 and 2014, respectively.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Intangible assets with definite useful lives and other long-lived assets are tested for impairment if certain impairment indicators are identified<i>.&#160;&#160;&#160;</i>Management evaluates the recoverability of its identifiable intangible assets in accordance with applicable accounting guidance, which requires the assessment of these assets for recoverability when events or circumstances indicate a potential impairment exists.&#160;If impairment is indicated based on a comparison of the assets&#8217; carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. Impairment charges for patents were $0 for each of the three month periods ended September 30, 2015 and 2014.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">5-Year amortization expense for patents and trademarks is as follows:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1365.67px; line-height: 14.26px; padding-left: 10pt; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">2015</font></td><td style="width: 16px; line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="width: 16px; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">$</font></td><td style="width: 141px; text-align: right; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">30,232</font></td><td style="width: 15px; line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="line-height: 14.26px; padding-left: 10pt; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">2016</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="text-align: right; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">30,232</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="line-height: 14.26px; padding-left: 10pt; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">2017</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="text-align: right; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">30,232</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="line-height: 14.26px; padding-left: 10pt; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">2018</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="text-align: right; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">30,232</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">Thereafter</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; line-height: 14.26px; font-family: calibri, sans-serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">188,982</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif; border-bottom-color: black; border-bottom-width: 4.5pt; border-bottom-style: double;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">$</font></td><td style="text-align: right; line-height: 14.26px; font-family: calibri, sans-serif; border-bottom-color: black; border-bottom-width: 4.5pt; border-bottom-style: double;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">340,142</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;"></td></tr></table></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Other Assets</b>&#8211; We record Other Assets net of accumulated amortization. Amortization expense for Other Assets was $9,654 and $9,654 for the three month periods ended September 30, 2015 and 2014, respectively. Amortization expense for Other Assets was $28,962 and $47,216 for the nine month periods ended September 30, 2015 and 2014, respectively.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><i>Capitalization of software</i>: The Company accounts for internal-use software and website development costs, including the development of its partner marketplaces in accordance with ASC 350-50 (Intangibles &#8211; Website cost). The Company capitalizes internal costs consisting of payroll and direct payroll-related costs of employees who devote time to the development of internal-use software, as well as any external direct costs. It amortizes these costs over their estimated useful lives, which typically range between three to five years. The Company&#8217;s judgment is required in determining the point at which various projects enter the stages at which costs may be capitalized, in assessing the ongoing value of the capitalized costs, and in determining the estimated useful lives over which the costs are amortized. The estimated life is based on management&#8217;s judgment as to the product life cycle.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Amortization expense for websites and URLs was $9,654 and $9,654 for the three month periods ended September 30, 2015 and 2014, respectively. Amortization expense for websites and URLs was $28,962 and $28,962 for the nine month periods ended September 30, 2015 and 2014, respectively.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Research and Development Costs&#160;&#8211;</b>&#160;Costs associated with the development of our products are charged to expense as incurred.&#160;&#160;Research and development expense was $362,599 and $155,869 for the three month periods ended September 30, 2015 and 2014, respectively. Research and development expense was $873,450 and $433,384 for the nine month periods ended September 30, 2015 and 2014, respectively.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Equity Warrants&#160;-</b>&#160;We issued warrants to purchase shares of our common stock in connection with convertible notes. In accordance with ASC 470-20, Debt with conversions and other options, the proceeds from the notes were allocated based on the relative fair values of the notes without the warrants issued in conjunction with the notes and of the warrants themselves at the time of issuance. We record the fair value of the warrants at the time of issuance as additional paid in capital and as a debt discount to the notes.&#160;&#160;We amortize this debt discount as interest expense over the life of the note.&#160;&#160;Additionally, as a result of issuing the warrants with the convertible notes, a beneficial conversion option is recorded as a debt discount reflecting the incremental conversion option intrinsic value of the conversion option provided to the holders of the notes. We also amortize this debt discount as interest expense over the life of the notes.&#160;&#160;The intrinsic value of each conversion option was calculated as the difference between the effective conversion price and the fair value of the common stock, multiplied by the number of shares into which the note is convertible.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Stock-Based Compensation &#8211;&#160;</b>We account for share-based payments, including grants of stock options to employees, consultants and non-employees; moreover, we issue warrants to the consultants and related parties.&#160;&#160;We are required to estimate the fair value of share-based awards and warrants on the date of grant. The value of the award is principally recognized as expense ratably over the requisite service periods. We have estimated the fair value of stock options and warrants as of the date of grant or assumption using the Black-Scholes option pricing model.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">For the three month periods ended September 30, 2015 and 2014, stock based compensation expense was approximately $25,740 and $42,437, respectively, which consisted primarily of stock-based compensation expense related to stock options issued to the employees and recognized under GAAP. For the nine month periods ended September 30, 2015 and 2014, stock based compensation expense was approximately $132,651 and $60,025, respectively.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Shipping and Handling Costs&#160;</b>- Shipping and handling charges to customers are included in net revenues, and the associated costs incurred are recorded in cost of revenues.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Advertising Costs -&#160;</b>Advertising costs are charged to operations when incurred.&#160;&#160;We incurred $437,442 and $202,825 in advertising and promotion costs during the three month periods ended September 30, 2015 and 2014, respectively. Advertising and promotion costs during the nine month periods ended September 30, 2015 and 2014 were $1,231,581 and $444,818, respectively.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>Net Income (Loss) Per Share -&#160;</b>Basic earnings (loss) per share is computed based on the weighted average number of common shares outstanding. However, basic loss per share excludes anti-dilutive securities. Diluted earnings per share is computed based on the weighted average number of common shares outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive common shares been issued, and reduced by the number of shares the Company could have repurchased from the proceeds from issuance of the potentially dilutive shares. Potentially dilutive shares of common stock include stock options and other stock-based awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan. As of September 30, 2015 there were 21,865,386 potentially dilutive shares.</p></div> <div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b><i>Recent Accounting Pronouncements</i></b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">We have reviewed recent accounting pronouncements and concluded that they are either not applicable to our business or that no material effect is expected on the financial statements as a result of future adoption.</p></div> <div><table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">September&#160;30,</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">December&#160;31,</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2015</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td style="text-align: right;" colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;" colspan="2">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1191px; text-align: left; font-family: 'times new roman', times, serif;">Parts inventory</td><td style="width: 16px; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif;">$</td><td style="width: 142px; text-align: right; font-family: 'times new roman', times, serif;">207,605</td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif;">$</td><td style="width: 141px; text-align: right; font-family: 'times new roman', times, serif;">133,477</td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; font-family: 'times new roman', times, serif;">Work in process</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">45,120</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">41,114</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">Finished goods</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">137,303</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">102,755</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">Total inventories</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">390,028</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">277,346</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr></table></div> <div><table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1365.67px; line-height: 14.26px; padding-left: 10pt; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">2015</font></td><td style="width: 16px; line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="width: 16px; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">$</font></td><td style="width: 141px; text-align: right; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">30,232</font></td><td style="width: 15px; line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="line-height: 14.26px; padding-left: 10pt; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">2016</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="text-align: right; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">30,232</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="line-height: 14.26px; padding-left: 10pt; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">2017</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="text-align: right; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">30,232</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="line-height: 14.26px; padding-left: 10pt; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">2018</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="text-align: right; line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">30,232</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="line-height: 14.26px; font-family: calibri, sans-serif;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">Thereafter</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; line-height: 14.26px; font-family: calibri, sans-serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">188,982</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td><td style="line-height: 14.26px; font-family: calibri, sans-serif; border-bottom-color: black; border-bottom-width: 4.5pt; border-bottom-style: double;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">$</font></td><td style="text-align: right; line-height: 14.26px; font-family: calibri, sans-serif; border-bottom-color: black; border-bottom-width: 4.5pt; border-bottom-style: double;"><font style="font: 10pt/normal 'times new roman', serif; font-stretch: normal;">340,142</font></td><td style="line-height: 14.26px; font-family: calibri, sans-serif;">&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p></div> <div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1379px; text-align: left; padding-bottom: 1.5pt;">2015</td><td style="width: 16px; padding-bottom: 1.5pt;">&#160;</td><td style="width: 16px; text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="width: 141px; text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">52,000</td><td style="width: 15px; text-align: left; padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-bottom: 4pt;">Total</td><td style="padding-bottom: 4pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">52,000</td><td style="text-align: left; padding-bottom: 4pt;">&#160;</td></tr></table></div> <div><table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6">Employee</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6">Non-Employee</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Weighted</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Weighted</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Number</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Average</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Number</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Average</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Combined</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Of</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Exercise</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Of</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Exercise</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Total</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 627px; padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">Outstanding at June 30, 2015</td><td style="width: 16px; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="width: 142px; text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,513,838</td><td style="width: 16px; text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="width: 142px; text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">0.41</td><td style="width: 16px; text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="width: 141px; text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="width: 15px; text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="width: 141px; text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="width: 15px; text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="width: 141px; text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,513,838</td><td style="width: 15px; text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-family: 'times new roman', times, serif;">Granted</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-family: 'times new roman', times, serif;">Exercised</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">Forfeited/Cancelled</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(62,500</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">)</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">Outstanding at September 30, 2015</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,451,338</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">0.39</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,451,338</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif;">&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p></div> <div><table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="6"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>Equity Incentive Plans</b></font></td><td style="font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="6"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>Equity Incentive Plans</b></font></td><td style="font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td></tr><tr style="vertical-align: bottom;"><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>for the Three Months Ended September 30,</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>for the Nine Months Ended September 30,</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td></tr><tr style="vertical-align: bottom;"><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>2015</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>2014</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>2015</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>2014</b></font></td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>&#160;</b></font></td></tr><tr style="vertical-align: bottom;"><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td colspan="2"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Expected terms (in years)</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">5-10</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">5-10</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">5-10</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">5-10</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 815px; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Volatility (weighted ave.)</font></td><td style="width: 16px; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="width: 142px; text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">83.79</font></td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td><td style="width: 16px; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="width: 142px; text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">40.45</font></td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td><td style="width: 15px; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="width: 141px; text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">83.79</font></td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td><td style="width: 15px; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="width: 141px; text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">40.45</font></td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Risk-free interest rate</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">.85%&#160;-&#160;1.74</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">1.50%&#160;-&#160;1.80</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">.85%&#160;-&#160;1.74</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">1.44%&#160;-&#160;1.80</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Expected dividend rate</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td><td style="font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></td><td style="text-align: right; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">0</font></td><td style="text-align: left; font-family: 'times new roman', times, serif;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">%</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p></div> <div><table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Weighted</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Number</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Average</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Of</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold;" colspan="2">Exercise</td><td style="font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Warrants</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Price</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1191px; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif; font-weight: bold;">Outstanding at June 30, 2015</td><td style="width: 16px; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="width: 142px; text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">4,963,956</td><td style="width: 16px; text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="width: 15px; text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">$</td><td style="width: 141px; text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">1.22</td><td style="width: 15px; text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-family: 'times new roman', times, serif;">Granted</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">15,000</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif;">1.20</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-family: 'times new roman', times, serif;">Exercised</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td><td style="font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif;">-</td><td style="text-align: left; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">Forfeited/Cancelled</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', times, serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">Outstanding at September 30, 2015</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">4,963,956</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td><td style="text-align: left; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', times, serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">1.22</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p></div> <div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">Related party</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td><td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Julian Ross&#160;(1)</td><td style="padding-bottom: 1.5pt; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1379px;">Amount</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">$</td><td style="width: 141px; text-align: right;">222,417</td><td style="width: 15px; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left;">Stated interest rate</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">0</td><td style="text-align: left;">%</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 13.33px/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">Maturity</td><td style="font: 13.33px/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</td><td style="font: 13.33px/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</td><td style="font: 13.33px/normal 'times new roman', times, serif; text-align: right; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-size-adjust: none; font-stretch: normal;">n/a</font></td></tr></table></div> <div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1379px;">Balance as of December 31, 2014</td><td style="width: 16px;">&#160;</td><td style="width: 16px; text-align: left;">$</td><td style="width: 141px; text-align: right;">31,010</td><td style="width: 15px; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left;">Additions related to embedded derivative of convertible notes issued</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">416,563</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left;">Gain on decrease in value of derivative liabilities</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">(342,257</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 1.5pt;">Conversions</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(28,698</td><td style="text-align: left; padding-bottom: 1.5pt;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font: 13.33px/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; padding-bottom: 4pt; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">Balance as of September 30, 2015</td><td style="font: 13.33px/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; padding-bottom: 4pt; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</td><td style="font: 13.33px/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">$</td><td style="font: 13.33px/normal 'times new roman', times, serif; text-align: right; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">76,618</td></tr></table></div> <table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="10">Fair value measurements at&#160;<br />reporting date using:</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Total</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 815px; text-indent: 0pt; padding-left: 0pt; font-family: 'times new roman', serif;"><font style="font: 10pt/14.13px 'times new roman', serif; font-stretch: normal;">Cash&#160;<sup>(1)</sup></font></td><td style="width: 16px; font-family: 'times new roman', serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', serif;">$</td><td style="width: 142px; text-align: right; font-family: 'times new roman', serif;">2,006,312</td><td style="width: 16px; text-align: left; font-family: 'times new roman', serif;">&#160;</td><td style="width: 16px; font-family: 'times new roman', serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', serif;">$</td><td style="width: 142px; text-align: right; font-family: 'times new roman', serif;">2,006,312</td><td style="width: 16px; text-align: left; font-family: 'times new roman', serif;">&#160;</td><td style="width: 15px; font-family: 'times new roman', serif;">&#160;</td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif;">&#160;</td><td style="width: 141px; text-align: right; font-family: 'times new roman', serif;">-</td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif;">&#160;</td><td style="width: 15px; font-family: 'times new roman', serif;">&#160;</td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif;">&#160;</td><td style="width: 141px; text-align: right; font-family: 'times new roman', serif;">-</td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-family: 'times new roman', serif;">Derivatives</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(76,618</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">)</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(76,618</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">)</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-family: 'times new roman', serif;">Total assets at fair value as of September 30, 2015</td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">1,929,694</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2,006,312</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">(76,618</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;">)</td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td></tr></table><p style="font: 10pt/14.26px calibri, sans-serif; margin: 0pt; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/14.26px calibri, sans-serif; margin: 0pt; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman', serif;">(1) Included in Cash and cash equivalents on the Company's Balance Sheet.</font></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0pt; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td>&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Total</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 1</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 2</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td><td style="text-align: center; font-family: 'times new roman', serif; font-weight: bold; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Level 3</td><td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif; font-weight: bold;">&#160;</td></tr><tr style="vertical-align: bottom;"><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td><td colspan="2">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 815px; text-indent: 0pt; padding-bottom: 1.5pt; padding-left: 0pt; font-family: 'times new roman', serif;"><font style="font: 10pt/14.13px 'times new roman', serif; font-stretch: normal;">Cash&#160;<sup>(1)</sup></font></td><td style="width: 16px; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">$</td><td style="width: 142px; text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">647,093</td><td style="width: 16px; text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="width: 16px; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="width: 16px; text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">$</td><td style="width: 142px; text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">647,093</td><td style="width: 16px; text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="width: 15px; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="width: 141px; text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="width: 15px; text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="width: 15px; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td><td style="width: 15px; text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="width: 141px; text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">-</td><td style="width: 15px; text-align: left; padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-indent: 0pt; padding-bottom: 4pt; padding-left: 0pt; font-family: 'times new roman', serif;">Total assets at fair value as of December 31, 2014</td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">647,093</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">647,093</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td><td style="text-align: left; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; font-family: 'times new roman', serif; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt; font-family: 'times new roman', serif;">&#160;</td></tr></table><p style="font: 10pt/14.13px calibri, sans-serif; margin: 0pt; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/14.13px calibri, sans-serif; margin: 0pt; color: #000000; text-transform: none; text-indent: 0pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman', serif;">(1) Included in Cash and cash equivalents on the Company's Balance Sheet.</font></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p> <table style="font: 10pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td>&#160;</td> <td style="font-family: 'times new roman', serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-family: 'times new roman', serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6">Three Months Ended<br />September 30,</td> <td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td>&#160;</td> <td style="font-family: 'times new roman', serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-family: 'times new roman', serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2015</td> <td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td> <td style="font-family: 'times new roman', serif; padding-bottom: 1.5pt;">&#160;</td> <td style="font-family: 'times new roman', serif; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2014</td> <td style="padding-bottom: 1.5pt; font-family: 'times new roman', serif;">&#160;</td> </tr> <tr style="vertical-align: bottom;"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1191px; font-family: 'times new roman', serif; text-align: left;">United States - product sales</td> <td style="width: 16px; font-family: 'times new roman', serif;">&#160;</td> <td style="width: 16px; font-family: 'times new roman', serif; text-align: left;">$</td> <td style="width: 142px; font-family: 'times new roman', serif; text-align: right;">1,138,380</td> <td style="width: 16px; font-family: 'times new roman', serif; text-align: left;">&#160;</td> <td style="width: 15px; font-family: 'times new roman', serif;">&#160;</td> <td style="width: 15px; font-family: 'times new roman', serif; text-align: left;">$</td> <td style="width: 141px; font-family: 'times new roman', serif; text-align: right;">814,619</td> <td style="width: 15px; font-family: 'times new roman', serif; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-family: 'times new roman', serif; text-align: left;">ROW - product sales</td> <td style="font-family: 'times new roman', serif;">&#160;</td> <td style="font-family: 'times new roman', serif; text-align: left;">&#160;</td> <td style="font-family: 'times new roman', serif; text-align: right;">-</td> <td style="font-family: 'times new roman', serif; text-align: left;">&#160;</td> <td style="font-family: 'times new roman', serif;">&#160;</td> <td style="font-family: 'times new roman', serif; text-align: left;">&#160;</td> <td style="font-family: 'times new roman', serif; text-align: right;">3,837</td> <td style="font-family: 'times new roman', serif; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-bottom: 1.5pt;">&#160;</td> <td style="padding-bottom: 1.5pt;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: left;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: right;">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left;">&#160;</td> <td style="padding-bottom: 1.5pt;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: left;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: right;">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-family: 'times new roman', serif; padding-bottom: 4pt;">Totals</td> <td style="font-family: 'times new roman', serif; padding-bottom: 4pt;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-family: 'times new roman', serif; text-align: left;">$</td> <td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-family: 'times new roman', serif; text-align: right;">1,138,380</td> <td style="padding-bottom: 4pt; font-family: 'times new roman', serif; text-align: left;">&#160;</td> <td style="font-family: 'times new roman', serif; padding-bottom: 4pt;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-family: 'times new roman', serif; text-align: left;">$</td> <td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-family: 'times new roman', serif; text-align: right;">818,456</td> <td style="padding-bottom: 4pt; font-family: 'times new roman', serif; text-align: left;">&#160;</td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">&#160;</font></p> <table style="font: 11pt/normal calibri, helvetica, sans-serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center; line-height: 15.6933px;" colspan="7"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">Nine Months Ended September 30,</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center; line-height: 15.6933px;" colspan="3"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">2015</font></td> <td style="line-height: 15.6933px;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center; line-height: 15.6933px;" colspan="3"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">2014</font></td> </tr> <tr style="vertical-align: bottom;"> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;" colspan="3">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;" colspan="3">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 1215.81px; padding-left: 5.4pt; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">United States - product sales</font></td> <td style="width: 16px; line-height: 15.6933px;">&#160;</td> <td style="width: 16px; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">$</font></td> <td style="width: 126px; text-align: right; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">2,807,600</font></td> <td style="width: 16px; line-height: 15.6933px;">&#160;</td> <td style="width: 15px; line-height: 15.6933px;">&#160;</td> <td style="width: 15px; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">$</font></td> <td style="width: 125px; text-align: right; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">1,793,729</font></td> <td style="width: 15px; line-height: 15.6933px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="padding-left: 5.4pt; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">ROW - product sales</font></td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="text-align: right; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">1,953</font></td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="text-align: right; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">41,567</font></td> <td style="line-height: 15.6933px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-left: 5.4pt; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">ROW - license fees/service revenue</font></td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="text-align: right; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">-</font></td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="text-align: right; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">17,500</font></td> <td style="line-height: 15.6933px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="padding-left: 5.4pt; line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; line-height: 15.6933px;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: right; line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; line-height: 15.6933px;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: right; line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-left: 5.4pt; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">Totals</font></td> <td style="line-height: 15.6933px;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 4.5pt; border-bottom-style: double; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">$</font></td> <td style="border-bottom-color: black; border-bottom-width: 4.5pt; border-bottom-style: double; text-align: right; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">2,809,553</font></td> <td style="line-height: 15.6933px;">&#160;</td> <td style="line-height: 15.6933px;">&#160;</td> <td style="border-bottom-color: black; border-bottom-width: 4.5pt; border-bottom-style: double; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">$</font></td> <td style="border-bottom-color: black; border-bottom-width: 4.5pt; border-bottom-style: double; text-align: right; line-height: 15.6933px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">1,852,796</font></td> <td style="line-height: 15.6933px;">&#160;</td> </tr> </table> <div>&#160;</div> 133477 207605 41114 45120 102755 137303 30232 30232 30232 30232 188982 340142 0 0 3052 12838 3797 10617 0 0 7557 9654 22623 28962 7508 9654 22616 28962 9654 47216 9654 28962 42437 60025 25740 132651 202825 444818 437442 1231581 21865386 P3Y P3Y P7Y P5Y P5Y P7Y P3Y P5Y 52000 52000 2 2 213000 (i) the full payment of the economic incentives; or (ii) March 31, 2016. P5Y 62500 4897 222500 475000 47103 1683500 412500 1461500 0.1234 0.12 0.00 0.12 0.08 Maturity dates of the notes range from January 28, 2015 to September 10, 2015. Maturity dates of the notes range from January 7, 2016 to May 4, 2017. 0.38 0.07 307662 150000 75000 251363 133637 100000 150 91500 835833 3500 122000 313296 75000 395 19000 29700 80001 700000 26580 41580 133333 770000 1050000 434983 1315271 360781 444072 1767650 3719350 26740 132651 700000 2380 11025 90000 178000 93474 93474 150858 188358 2000000 4863956 2513838 2513838 4878956 2451338 2451338 1.22 0.41 1.23 0.39 15000 1.23 -62500 P5Y P10Y P5Y P10Y P5Y P10Y P5Y P10Y 0.4045 0.4045 0.8379 0.8379 0.0150 0.0180 0.0144 0.0180 0.0085 0.0174 0.0085 0.0174 0.00 0.00 0.00 0.00 5000000 P10Y P5Y P90D P5Y 323715 1886721 4878956 222417 416563 -342257 -28698 647093 647093 2006312 2006312 -76618 -76618 647093 647093 1929694 2006312 -76618 818456 814619 3837 1852796 1793729 41567 17500 1138380 1138380 2809553 2807600 1953 (1) Our CEO, Mr. Ross provides us shareholder cash advances and other consideration from time to time to fund working capital. Included in Cash and cash equivalents on the Company's Balance Sheet. EX-101.SCH 7 oxys-20150930.xsd XBRL SCHEMA FILE 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Notes Payable link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Shareholders' Equity link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Stock Options and Warrants link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Off Balance Sheet Arrangements and Contractual Obligations link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Segment Information link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Going Concern link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Notes Payable (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Stock Options and Warrants (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Related Party Transactions (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Segment Information (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Summary of Significant Accounting Policies (Details 1) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Summary of Significant Accounting Policies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Notes Payable (Details) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Notes Payable (Details Textual) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Shareholders' Equity (Details) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Stock Options and Warrants (Details) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Stock Options and Warrants (Details 1) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Stock Options and Warrants (Details 2) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Stock Options and Warrants (Details Textual) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Related Party Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Fair Value Measurements (Details 1) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Fair Value Measurements (Details Textual) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Segment Information (Details) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Going Concern (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 oxys-20150930_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 oxys-20150930_def.xml XBRL DEFINITION FILE EX-101.LAB 10 oxys-20150930_lab.xml XBRL LABEL FILE EX-101.PRE 11 oxys-20150930_pre.xml XBRL PRESENTATION FILE EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`-J!<$>)6B0\O`$``"88```3````6T-O;G1E;G1?5'EP97-= M+GAM;,V9S4[#,!"$7Z7*%36N;?Y%>P&N@`0O8))M8S6.+=N4\O;8*2"H"FJ! M2G/)3V>],\DZWZ47#R^.PF!IVBZ,BR9&=\Y8J!HR*I3649>4J?5&Q73K9\RI M:JYFQ,1H=,PJVT7JXC#F'L7DXG9!WNN:!I%\JY5EO=1W: MZ5175-OJR:0E94S6=)#T8G"G?+Q1)K5@RY;UPNK(RZRS_S$,SI.J0T,435N& M^-)2V.2_4MZ=KVBJGMJXD_';NRL]M7U-:+1[L[I>IBXA_38NDAJV]89>DXKND!I9:_\G[?:=4UM-6AKEPCQ]%HSS5]]&G^6[^-CX7 M["]'GFM__=W0>S&P_K1'2.R40X#DD"`Y#D%R'('D.`;)<0*2XQ0DQQE(#CY" M"8)"5(Z"5(["5(X"58Y"58Z"58["58X"5HY"5H%"5H%"5H%"5H%"5H%"5H%" M5H%"5H%"5H%"5H%"5HE"5HE"5HE"5HE"5HE"5HE"5HE"5OE!5M;_/3!Y!5!+ M`P04````"`#:@7!'2'4%[L4````K`@``"P```%]R96QS+RYR96QSK9++;L)` M#$5_)9I]<4HE%A%AQ88=0OR`.^,\E,QXY#$B_?N.V(#"0ZW$TJ][CZZ\#JFL M#C2B]AQ2U\=43'X,JQW8OG*\M"_V/Z'D4X$G1H>)%]2-F`Q+M*;V"^GH`A3&^.R6: ME((C-Z."N[_8_`)02P,$%`````@`VH%P1\3+)$.4`0``/!<``!H```!X;"]? M&?/ODKC;671NJN@^S]^;: MANWP?Y]5,?9;8T)1N<:&AZYW[;!Z[GQCX_#I2]/;XF)+9SC/E\9/YV2'W<_9 ML^-IG_GCB;+9B_6EB_OLK?.74#D7@QE?]#!L,"S?>O>?[;OSN2[<8U>\-JZ- M?U28KPTRDP[B=!!#@B0=))"@>3IH#@E:I(,6D*!E.F@)"5JE@U:0H'4Z:`T) MVJ2#-I`@RA49C-&;%;T9HSC-&;U;T M9HS>K.C-&+U9T9LQ>K.B-V/T%D5OP>@MBMZ"T5L4O05T5Z)=EF#T%D5OP>@M MBMZ"T5L4O06CMRAZ"T9OF>@=*NO=Z3GZNBW#O6N^#5>+)GB'>+NZ^Z>,4]7[ MR(G6<=C)F?%Y=Q3'J9\AYM=%^>$#4$L#!!0````(`-J!<$?I/*UYHP(``&\* M```0````9&]C4')O<',O87!P+GAM;+U6P5+;,!#]%8TOI8?BD%"89H)G:("V M,Z5DF@#G15['&F3)E>0,X>N[LDEJ@YV0')I+Y/5[N]KW5K9'RO:&$Z-S-$Z@ M94^95'9(P;,@=2X?AJ'E*69@#PFBZ&ZB30:.+LT\U$DB.%YH7F2H7-CO]4Y" M?'*H8HP_Y>ND033R5<[S7`H.3F@570MNM-6)8Y=/'.4H?`TH&91YBKPPPBVC M7H6IATK,E(/$,=6*$I`6*]2_8(D9ZRP'M0RKJY]"/=K;?*8OP&&=U;Q194_! M8$Q%&]G7P1+S?4E]2L\=IZ#F&->Q;V^NM+A#8WVG1_W#'OW6$JSB56Z$6*CY M!(2QT6CAA@OD3IL7FQ9N7Y=BS;WI]FY&^[,!>P"+?GD6+,`(4"Y@5CS393^H MRE;179+U:JSI7"B+,?L* M$A1'-GVCWU8P.R`!L+W`U-'<^EU9IA-V0X-7;H8XMPJ*>$N=)GL,-F57LKU. MD65@EAXV%7,E2%-RD9USK@N2HI7S2SMZNDQ@"0\2V[/Z4Y5J&=/\?V"7?PK2 MM*--S1^IO:HW;\`]&$,[:%?R-TIJ+&9^<)9L1D`+O.2VPF^2I"DY._?)YR_2 MM'*N:$S9'<@"V36"+4P%;M\]SLO!V38MWS3-/R-[.)H.NS?93"W0@9$M3X!``!I M`P``$0```&1O8U!R;W!S+V-O&ULS9--3\,P#(;_"NJ]R[*-241=#X`X M,0F)(1"WD'A;6/.AQ%/7?T^6=2T#+KUQJVN_CU_'22$<$];#D[<./"H(5P== MF<"$6V1;1,<("6(+FH=1K#`QN;9>5PDF!8$*-!@,A(XHR^?'E*&9&WE(:BNJJ[K43U-=7%@2MZ6C\_I M;')E`G(C(*J"8M@X6&3GSJ_3N_O50U9.QO0ZIS2G\Q6=,SICLYOWXV07_GK# MNAWBWSH^&TS;1845#-QMTLBTW/290!*"\,JALF80+F&^B1,L[#\^0>!P4"M, MEVT'36V]#&6Z7WUT?#EQ91OKFU/J1W3QJLHO4$L#!!0````(`-J!<$>97)PC M$`8``)PG```3````>&PO=&AE;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V M;0O&-H&VM!-S:7;;M)F$[4X?A1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[ MSD5'Y^@X>?/N+F+HAHB4\GA@V2_;UKNW+][@5S(D$4$P&:>O\,`*I4Q>M5II M`,,X?+&A`T%11 M6F]?(+3E'S/X%/F7/Z3H=,H%N,!M8('_. M;Z?D3EJ(X53"Q,!J9S]6:\?1TDB`@LE]E`6Z2?:CTQ4(,@T[.IU8SG9\]L3M MGXS*VG0T;1K@X_%X.+;+THMP'`3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ- M4T_3]WW?ZYMHG`J-6T_3:W?=TXZ)QJW0>`V^\4^'PZZ)QJO0=.MI)B?]KFND MZ19H0D;CZWH2%;7E0-,@`%AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;% M!-9ITAF6-$9RG9`%#@`WQ-%,4'RO0;:*X,*2TER0UL\IM5`:")K(@?5'@B'% MW*_]]9>[R:0S>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+`GQ^R-; M88C'(CN]WV6'WV M3T=N(]>IP+,BUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0'`*D"3&6H8;XM,:L M$>`3?;>^",C?C8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SCFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6 MQKQ0KH)[`?_1VC?"J_B"P#E_+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+ MRO`JQ`GH9%LE"0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q? MY[3-"S-#MW)+ZK:4OK4F.$KTL@'37[]EUVY".E,%.7 M0[@:0KX#;;J=W#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&P MH^\\EAW'B/*B(>ZAAIC/PT.'>7M?F&>5QE`T%&ULK"0L1K=@N-?Q+!3@9&`M MH`>#KU$"\E)58#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG" M:9@39ZO*WF6QP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3 MON>;G*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QY MQ1$!=$4"(Y4U#VT%SU&\Z.9X!ZSAW.;>KC" M1:S_6-8>^3+?.7#;.MX#7N83+$.D?L%]BHJ`$:MBOKJO3_DEG#NT>_&!()O\ MUMND]MW@#'S4JUJE9"L1/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA M9CC?AT6:&C/5BZPYC0IO0=5`Y3_;U`UH]@TT')$%7C&9MC:CY$X*/-S^[PVP MPL2.X>V+OP%02P,$%`````@`VH%P1R++84I;`@``V`H```T```!X;"]S='EL M97,N>&ULS59=;YLP%/TKECM-K30%R-:T6P%IBA1ITE95:A[V5ADP8,D?S)B, M]-?/'P1(M"QMEE;EQ=?'U^<>7U^XA+5:4WQ?8JQ`RRBO(U@J57WQO#HM,4/U M1%28ZY5<2(:4GLK"JRN)45:;38QZ4]^?>0P1#N.0-VS!5`U2T7`5P4\]!-S^ MNQE MMJL[]+-GTO^+?(?ZZ@#U'-7EGHR,EOZ:E&M#[779C\-<\.$2IM`!<5@_@A6B MVC\P[JF@0@*E;UEKL`A'##N/.:(DD<2`.6*$KAT\-8`MC,Z/$2ZDC>TB[,:9 M^$,D6201]+OGZ>&2@=T.YGB$TNWC:2`.*Z04EGRA)Z"SE^M*'XX+CIU(ZW?` MNY!H'4PO1QOLH.,F0F98]I$#N('BD.)LIOH7D`,` M`,H,```/````>&PO=V]R:V)O;VLN>&ULE99;<],Z$(#_BL8OI[R06$Y2FB', M0"_0F0/MD%">55N.-94E(\FTY=>?E=VMWYY;]W=K;5W M[*'6QB_=*JE":):3B<\K60O_VC;2P+/2NEH$N'3;B2U+EU-&'"I]/% MQ$DM@K+&5ZKQR1/-_PW--TZ*PE=2AEKWL%HHD[Q[ZY>ETO)&.@]@)IKFBZCE M*GG0"=/"A_-"!5FLDAE%[&&;2OGO M3P\25LA2M#IL8+*[[ZZ2E,\X7_2,^-J-DO<>`^,-)O*@?LJ-N%TETX2)-M@+ MI8-T9R+(C\ZVC3);8"6L5,Z'=5QN]V:MC*K5KSAON/*5O?]DG?IE31!ZG3NK M=3#N/T:,[%*%E,`_E1>W2JMPN,JZX!478KQ/4-Z\L)?0EAJ$!Q["XGW!W- M&N<8-:BYE,.CJ`RCL,^<*KNCJ!E&8<,Y8?AO+IW)()0>Q@B;S0FS:03;R(?0 M"CU`8;,Y8395/>E)81`(``(X'```8````>&PO=V]R:W-H965T&UL M?57;CILP$/T5Q`%NPNVZ8CKSP0=THQ_W,D+1OV(0B?&V_-K99Z M(RJ+:.9=&DHZT;`NX.2Z#P]@=P)(0PSB9T,&L9@'VODS8^]Z\?VR#V/M`VE) M);4)K(8'.9&VU9:4\N_)Z*>F)B[G3^M?3;C*_3,6Y,3:7\U%ULK;.`PNY(KO MK7QCPS` M)@*:"2`QD8Z>F;B^8(G+@K,AX.-E]%C?.=@A=7*5WM0'I6(2ZI]&E,6CC(OH MH2L;K\3&Y5N/Y>B!K+R6K5=BZ_(32\(#2?T2ND#XX[(,%Z.WAG6;ZH4'+4]/^Z'9EV<]^UM6ANY_O^OYXMUATC[NR+KJO MS;$\#-\\-6U=],-N^[SHCFU9;,]!=;5`Y\*B+O:'^6IY/O:M72V;E[[:'\IO M[:Q[J>NB_7==5LWI?@[SMP/?]\^[?CRP6"T7U[CMOBX/W;XYS-KRZ7[^"]QM M.!LE9\5?^_+4W6S/1O,/3?-CW/EC>S]WHX>R*A_[<8AB^'@M-V55C2,-9_[G M,NC_YQP#;[??1O_M/-W!_D/1E9NF^GN_[7>#6S>?;GW\O+'/PX MX&-3=>?_L\>7KF_JMY#YK"Y^3I_[P_GS-'V3N4N8'8"7`+P&`'\80)<`$@&+ MR=EY7K\6?;%:MLUIUDX7XUB,UQSN:,C;N)YBO=B$I/D<);$LR00 MR'D8(HXN3\R%32^LO03AA6].XR>)._\).\90T;;B32M>QV?"BE=6,G(^%XXW M7B6&0NZCM]T$TTW0;G+A)B@WE#LG36^T#&,D#K:;:+J)R@V)]*^C.@T[XBC= M&+)`Y#+;36:ZR;0;$&XR=9H<(D=A1JL\^2SA)3>]Y-J+)$*NKU-$A"`\;[0. M,G`Y.-O/R%L+44X[(LDHIQ=R[IDEJ+0L!T^)JH($,D'[8>D'=(K8`2MR&KJ` M,23P!S8_`;4C"<"+YGW5A)`K1X:.`R9S9!,9-)))8A!(5PYCYDE6F"%$#\"< M6-=@DQEN>4J799L8P08J:*)*LVO02(TA"U$M1:WS/B-*SY/.='ZH(U#U#AD MB4-#HXH"+61REKA;H,U!U'VE["/6AD:;T7WL1V9LI*)&*DNDHFX_$]=;"X$I MA)!`&-I010U5EE`U-#I!'VK>.[%ABE&MO!2.T68@:@9ZR4#4#`2B7!6X(0.* MJ1G9#$3-0"\9B!IM7P`)A@LI+>G14ADF&X"D`>@E`$F3#3U#YF4-;]XI+RD: MVETF3&"9;`J2IJ"7%"0-MR^(#EW,O;1E2"%S#)AZ3"&;A*0;3:^>M(T&ERAQ,._YJ:7;*7/MIJ&\,-6DVS$DL:G3ZU+FXOD/UWY9%., M-'V\)"L9C])2M+%$>>(.2C;'2#=\/M'+DDV\9-\9`R7385P:V:XV-GD&E M0S<#J&[/QD`J'8N;-]7'XKG\LVB?]X=N]M#T?5.?7UL_-4U?#N.YKT-Z=V6Q MO>Y4Y5,_;L9ANYU>ST\[?7-\^[7A^I/'ZC]02P,$%`````@`VH%P1QWRI5/> M`@``'0T``!@```!X;"]W;W)K<9I5)5V8CGUNM.=,&4FO^%V*P;^5N>_8]+//4W@='S)_KTO5^._\DZL9?6GW*J#IB6^MQ4[?JK4 MBSS_$&,-L4FXD577_WN;4Z=D?0GQO9I_#->RZ:_GX4X"@X)OW/XKE#.".*4*(($B464807;K5Q_:5L1A.C-#&D M22V:&)1-"4$;=(]RQI2@3`EDRBRF!.P4AE&612P2%MXDRE"@#1'&*QR_0^`6(3RW0U0*`QC1+8[L>1+8(I[(9C;%AS+D( MY*&V=9'[@##=+2*'EU+8X84C`VZ$%#HAZ#%E@!4I"(HHC1PV2'$?I-`(88.A MP2$P4'0#!K=`BGB@Z^G@MD6A;\'>0CM*4\2U$)T+!O^5[\ MXNV^;#KO52I])NY/M3LIE=#IR(-^*P_Z6^4ZJ<1.F6&JQ^UP>A\F2AXO'R/7 M+Z+B/U!+`P04````"`#:@7!'"1YW'W0$``!P$P``&````'AL+W=OJU?LN94QV+;&Y6'3`IAL[+8'Z>+>3_VK5[,J]?V ML#_&;_6D>2W+HOYW&0_5^6$*T_>![_N77=L-9(MY=K7;[LMX;/;5<5+'YX?I M(\QR*3M(C_AK'\_-S?.DF_Q35?WH7O[8/DQ%-X=XB)NVXBH=#YRE% M_N?B]"-F9WC[_.[]MYYNFOY3T<15=?A[OVUW:;9B.MG&Y^+UT'ZOSK_'"P?3 M.=Q4AZ;_G&Q>F[8JWTVFD[+X.7SOC_WW>?A%NXL9;R`O!O)J<(W#&ZB+@?HP MT%\:Z(N!_K\1S,7`H`C9P+W/W+IHB\6\KLZ3>ECN4]%5%?;6^;E`EK<0.4#49\B:0N"*R%+\ZR0D-XFE).9H#BN*\W:ZQM[/=A;E.L! M&^1N36'2BV`,6K^<">N-=,'R]`Q+SU!Z#M$S-W%,#S%>@$337E&8DA`46L\U MA8&2!JQ!["C.!:F+QZ#2[M;:)R)G`.F+2[=R+D$(QH'E*/"'('; M;Y94WHH!>F\"=KAF<%HH0\[HG`%*`4*/G4_`:N@C2$I28Y*2A+H+TELPF"0# M5#YH0Y:2`4ICTA'D,$TNMDG]JABAR6LP4!'V(R(,O`H#E6&/91@TG:R5%J3# MB:+*>0MAD@Q2"@\PMH1\NP"T7\!5MX3`G!JIR7>X M,5]Q2&VETN0@9H`JN&#PIL_9X%U[X4:(2KYSD+1S"+ASD+<"'H98XE[@EG@$ MAOM]'@9X&_XRZ&=V?,\@;WN&06>"&O'`"[*D@ARP($LJBDJF/@@"5F0&V>F1 M"/1_,.-3&*TL_L.2LSY3&Q8N7_B*GF6RJUV,[I.KTL>NSO MBM#X$F8K8,;7,,N'JZ`/]XOYJ7B)?Q;UR_[83)ZJMJW*_AKCN:K:F`B(^Z0E MNUALKR^'^-QVCRX]U\.%T/#25J?W^ZWK)=OB/U!+`P04````"`#:@7!'@I`& M\6X%``#;&P``&````'AL+W=OR8224EVD0:89+'8/2PPF,/NV=.Z;3!)W(W=Z>R_7W^DF91\-9A+/AR2 M>DG+CZAH]=JCOW\[<+GW>/3]UP8;E>+2]^][M#?6QWS7%VJA]NYQ_]S5;*P62T^'M7 MO[97GV>#^"]-\W7X\N?][=P-&NI]?=<-(:K^[5N]K??[(5(_\K_GH#_&'!RO M/[]%_WU,MY?_I6KK;;/_9W??/?5JW7QV7S]4+_ON<_/Z1WW.(0P![YI].[[. M[E[:KCF\N9V=IIOQ7`WWW-]P7[F[X>)0J#ZGMO]ML%BOOJW+L%I^&^*<33;7 M)C2:^(O%L@]^&8'0"!LR[O1^@*VU2()'8)@#7_GSE$/$_@+]Y3-)HLN$QE*)+*!1AZ'PJ?$E84H*)@,\KX1^@?;4:%RBA>"0VC"3-QJ=(! M5D$B82T):DE6BQIED\PHGGV@I.["-IGB4I!2,I.E@'(*(\<[I_041L]"I`RB MY-A0E+E+)912`BEZXI5&"@7/D944&RHG98`:XH`#8DB3P-G"L!`%_12`:%D] M&2YYH(>U'@\F3O+!:3G>3!SA'&,\Q-A'3T"0:$%D!?5E#%J/C94M#T:>9Z#& M@)N!FM(5>O*\LYO*$ZDO9$81AJBW%/4N:D46CUZ2G@C64!9LJ6;/^UI>9!9`P6\G2 MD#7G":&U\$$OR._LIOM;))=<1A"&*UFXLH8'6;8NV$G0+`.Q#8&1H0=9!"^H3)GVE#!:":#5Z[600.?9 M5Z@0JTFLIE1PZ7*3"!.6;)/J?69-)0Q%LGVJ]V8B1IM8$4DW8V1;U45R,>3V M*IBQ!!CK]2H&C&R1`5Y]F0$98;82Z%6]7L.H^+7R`+0F5TB948312B6XYYFD M&,.00:/I]8K!EH:%<[HYWK*%(94Q]ZPSABE.OEANV-*08D*1?QR%C'#+` M(6D><,[MKP$+2+&3`N9Y106^MMM@P<%841B(#)))& M(EO0^1#Z[9X190TE!9?5A('(H.74S^&&`\C__5AG3VDIP>#%@&@"4-6+;P%,>1DBF2-207$N<(@#G+@+,:Z!NV`.WG=TF: M75M@N(A2.I]!+6/4,NAB2?^)P[8]C9)A MG^)/=75_^;*O'[KA8^H_GZ:SI^E+USR_':5=SO/6_P-02P,$%`````@`VH%P M1UM[K1BC`0``L0,``!@```!X;"]W;W)K357JT0FNX-D@.TK)S/L)A)Z..,?7Q`OO>A<2I"K)PFNX!&6Y M5LA`>\3W^>%4!$0$_.4PV=4:!>]GK5]#\*;(91`RT;A7O1TV^86]@'P5H+&T=4 MC]9I>:5@)-E;FKF*\Y1V]L5,VR;0F4`7PH\L&D^%HLU?S+&J-'I")AWMP,(- MY@?J#Z(.R="WMVC]7D!4Y:7*=S]+<@E",^:TQM"$61#$JR\EZ%:)$_U&I]OT MW:;#W8J^2]6+;%N@V!0H5@+%+)!_:7$+\]4E69VI!-/%IV-1K4?ETN$MV>5U MWM-X)Y_PJAQ8!T_,=%Q9=-;.WVR\FU9K!]Y*=K/'J/?_9PD$M"XL[_S:I">5 M`J>'ZP=9?FGU`5!+`P04````"`#:@7!'?5G!::(!``"Q`P``&````'AL+W=O M0/"![&DT0CCZ5,HM7N8:4H MA]TS8[=M%*`=P./D[P/X$2OQ!>BFJKJ:1SZ@>;4M@"/O2FI[2EKGNB.EMFQ! M<7N#'6B_4Z-1W/G0--1V!G@524I2EJ:W5'&ADR*/N6=3Y-@[*30\&V)[I;CY M.(/$X93LDCGQ(IK6A00M,X"(@+^"1CL:DV"]POB M:PC^5*XO6[P5$D5^+7;;/Z34( M39CS&L-&S(*@7GTIP;9*G-D/.MNF[S<=[E?T_>0PVQ;(-@6RE4`V"1R^M;B% MN?U6A*[.5(%IXM.QI,1>N_'PENSR.A]8O),O>)%WO(&_W#1"6W)!YV\VWDV- MZ,!;26\."6G]_UD"";4+RSN_-N.3&@.'W?Q!EE]:?`)02P,$%`````@`VH%P M1^L\44*D`0``L0,``!@```!X;"]W;W)K=\?&7-5!UJX.^S!A)T&K18^A+9EKK<@ZD32BO$L M^\*TD(:61=/9]IVP0^$_A">,B2\:E0LOE->%$6%D=BIZ/M1;S! MW9&'@ZAB,O8=++JP%Q%E<2UW^7W!KE%HQIS7&#YA%@0+ZDL)OE7BS#_1^39] MO^EPOZ+O9XSN0$D7_L\2*&A\7-Z'M9V> MU!1X[&\?9/FEY7]02P,$%`````@`VH%P1\T;-C6B`0``L0,``!@```!X;"]W M;W)KP!'WI74]D1[YX8C8[;N M07%[AP-HO].B4=SYT'3,#@9X$TE*LBQ)OC#%A:95&7//IBIQ=%)H>#;$CDIQ M\^<,$J<33>DM\2*ZWH4$JTJV\AJA0%N!FAAH3_0A/9Z+@(B`7P(FNUF3X/V" M^!J"'\V))L$"2*A=4.!^NL(C2!F$?.&W1?.C9"!NUS?U;[%;[_["+3RB_"T: MUWNS"24-M'R4[@6G[["T<`B"-4H;1U*/UJ&Z42A1_'V>A8[S-._D]PMMGY`M MA&PEW"?1^%PHVGSBCE>EP8F8^6@''FXP/6;^(.J0#'U[B];O!4157JOTD);L M&H06S'F+R6;,BF!>?2V1[94X9__0LWUZONLPW]#SQ>%_!(I=@6(C4"P"^:<6 M]S#%IR)L?CB4UCMK-A[=FU]?YD,4[^8!7Y<`[^,E-)[0E%W3^9N/= MM(@.O)7D[D!)[__/&DAH75A^]6LS/ZDY<#C\K0P%I`$``+$#```9````>&PO=V]R:W-H965TVRC`N,"CKM_OX`=UVK]`LQP MSIDS7/(![9MK`3SYT,JX$VV][XZ,N;(%+=P==F#"3HU6"Q]"VS#761!5(FG% M>);=,RVDH46>-Y%1`+\D3"XQ9I$[Q?$MQC\JDXTBQ9`0>FC@@C3%9Y`J2@4 M"K]/FI\E(W&YOJG_2-T&]Q?AX`G57UGY-IC-**F@%KWRKSC\A*F%?10L4;DT MDK)W'O6-0HD6'^,L39J'<6=[F&CK!#X1^$PX9,GX6"C9?!9>%+G%@=CQ:#L1 M;W!SY.$@RIB,?0>++NQ%1)%?B\U^G[-K%)HPYR6&CY@9P8+Z7(*OE3CS;W2^ M3M^N.MPNZ-O)X?VZP&Y58+<0V$T"#U]:7,,Y)UHX+>PC32.7-"'FTUW4R-Z"%:RNSTE;?@_=\? M&7-5!UJX.^S!A)T&K18^A+9EKK<@ZD32BO$LNV=:2$/+(N6>;5G@X)4T\&R) M&[06]M\9%(XGFM-;XD6VG8\)5A9LX=52@W$2#;'0G.AC?CSO(R(!?DL8W6I- MHO<+XFL,?M8GFD4+H*#R44&$Z0I/H%04"H7_SIKO)2-QO;ZI?T_=!O<7X>`) MU1]9^RZ8S2BIH1&#\B\X_H"YA4,4K%"Y-))JB[J?I]MBVPWQ38KP3V MLT#^H<4MS$>7;'6F&FR;GHXC%0[&3X>W9)?7^@I`O_9PD4-#XN'\+:3D]J"CSVMP^R_-+R/U!+`P04```` M"`#:@7!'&;)&?Z(!``"Q`P``&0```'AL+W=O+V`7O0?J=!H[CSH6F9[0WP M.I*49&F2G)CB0M.RB+EG4Q8X."DT/!MB!Z6X^7<%B>.%'NB2>!%MYT*"E05; M>;50H*U`30PT%_IX.%_S@(B`WP)&NUF3X/V&^!J"G_6%)L$"2*A<4.!^NL,3 M2!F$?.&_L^9[R4#&PO=V]R:W-H965T#@E33P M8HD;M!;V[QD4CB>:TUOB5;:=CPE6%FSAU5*#<1(-L=":10N@H/)1083I"L^@5!0*A?_,FA\E(W&]OJE_2]T&]Q?A MX!G5;UG[+IC-**FA$8/RKSA^A[F%^RA8H7)I)-7@/.H;A1(MWJ=9FC2/T\XN MGVG;!#X3^$)XS)+QJ5"R^55X41861V*GH^U%O,'\R,-!5#$9^PX67=B+B+*X MEOG#H6#7*#1CSFL,GS`+@@7UI03?*G'F_]'Y-GVWZ7"WHN]FAX_;`OM-@?U* M8#\+?/G4X@;FD'TJPE9GJL&VZ>DX4N%@_'1X2W9YG4\\W;[J9!]!"L9'?WE'3A_RR!@L;'Y2&L[?2DIL!C?_L@RR\M_P%02P,$ M%`````@`VH%P1R0I"'>A`0``L0,``!D```!X;"]W;W)K&UL=5/;;MP@$/T5Y`\(-NMVRC`N(#7Z=\' M\"56ZKX`,YQSY@R78D3S9CL`1]Z5U/:4=,[U1TIMU8'B]@9[T'ZG0:.X\Z%I MJ>T-\#J2E*0L3>^HXD(G91%S+Z8L<'!2:'@QQ`Y*U+_';KW["[?PA/*WJ%WGS:8)J:'A@W2O./Z` MN87;(%BAM'$DU6`=JH62$,7?IUGH.(_3#EMH^P0V$]A*>$BC\:E0M/F-.UX6 M!D=BIJ/M>;C![,C\050A&?KV%JW?"XBRN);9?5;0:Q":,>"OIS6U".O]_UD!" MX\+RWJ_-]*2FP&&_?)#UEY8?4$L#!!0````(`-J!<$&PO=V]R:W-H965T,'C(!:M;$F M[6PVNP^;3.9A]YE:6LV@N$#K[-\OJ'4,7E\4\-QS+L+ADO="?JB*,>U]-KQ5 M![_2NML'@2HKUE#U(CK6FB]7(1NJ35?>`M5)1B]#4,,#@M`N:&C=^D4^C+W) M(A=WS>N6O4E/W9N&RG\GQD5_\+'_''BO;Y6V`T&1!W/I)=#_X1 M[T\XM9`!\;MFO5JT/9O\68@/V_EY.?C(YL`X*[6EH.;U8*^,<\MDE/].I%^: M-G#9?K)_'Z9KTC]3Q5X%_U-?=&6R1;YW85=ZY_I=]#_8-(?8$I:"J^'IE7>E M1?,,\;V&?H[ONAW>_?@ECJ8P.(!,`60.2-&0^"@TI/F-:EKD4O2>'/]M1^T2 MXCTQ/Z*T@W;>)D5EOEE$D3\*G,1Y\+!$$^:TQ)`1,R,"PSY+$$CB1%;A!`X/ MP0S#17@XJD<()HA`@FA!$$U3W#E3A#`)+!*#(C%`D#HB$":#17:@R&Y-D")' M!,)L+%<"BB0``7%$($P(BZ2@2`H01(X(A(EAD0P4R0`"=^$AS,;"6W=##D(` MA;OT(&AC[?&&4_&*(EPY=8W!V899,.C6(R8`!79U(-"&JS%L:QP"%*&K`X&B M#1W8_1BP=K;Z;Q!HMZ$#'P`8<'>6N#H0*-W0@<\`#!@\RUR=-+>ZK&XS:/S]>%( MAIKY!2_RCM[8+RIO=:N\L]"F\@ZU\RJ$9B87]&+6L#(7G+G#V57;9F+:+[GF#F:]1Q7]02P,$%`````@`VH%P1]99^Y"Q`0``%@0``!D```!X;"]W M;W)K&UL;53-;N,@$'X5Y``''W;ULEP"#-_?&$@^HOXP+8`EGTIVYIBTUO8'2DW9 M@N+F#GOHW$Z-6G'KEKJAIM?`JT!2DK(TW5/%19<4>:B]Z"+'P4K1P8LF9E"* MZW\GD#@>DTUR+;R*IK6^0(N<+KQ**.B,P(YHJ(_)T^9PVGE$`+P)&,UJ3GSV M,^*'7_RNCDGJ(X"$TGH%[H8+/(.47L@9_YTUORT]<3V_JO\,W;KT9V[@&>6[ MJ&SKPJ8)J:#F@[2O./Z"N860L$1IPB\I!V-172D)4?QS&D47QG':V6J+!8M9G-A_=!:G;Z,)MROZ=G+/TKA`%A7(5@+9W.+^ MIL48YCYNLHN:["("#SG$UJJRQ-X8N'@O^%% MWO,&_G#=B,Z0,UIW?<(%J!$MN"CIGZ+"34UD_OW5Q/]W9:6.ROKW#Y M*RB^`%!+`P04````"`#:@7!'GPL8K:H!``#R`P``&0```'AL+W=O80?: MK]1H%'<^-0VUG0%>19*2E*7I-55#\AOH7D;W5( MTF`!))0N*'`_G>$>I`Q"OO'_2?.K92`NXXOZ0]RM=W_B%NY1OHK*M=YLFI`* M:MY+]XS#(TQ;B`Y+E#:.I.RM0W6A)$3Q]W$6.L[#N'*=3K1U`IL(;":PVVA\ M;!1M_N&.%[G!@9CQ:#L>;C#;,W\092B&?7N+UJ\%1)&?"Y:E.3T'H0ES7&)8 MQ&0S@GKUN05;:W%D/^ALG;Y9=;A9T+>3PU_Z;U<%M@N!S23PBX/=JL!NQ<'F MVQFM8;;?FM#%I2@P37Q[EI38:S>>_ER=G_<=BY?Z!2_RCC?PCYM&:$M.Z/S3 MB)=;(SKP5M(K[Z7U'W!.)-0NA#<^-N.;'!.'W>6'S=^\^`102P,$%`````@` MVH%P1S9)\$7``0``>P0``!D```!X;"]W;W)K&UL M=53=;J0@%'X5X@,494;;3AR33C>;W8M-FE[L7C-Z5%)^7,"Q^_8+Z%@SI3<" MA^_G'#Q03DJ_F1[`HG?!I3DFO;7#`6-3]R"HN5,#2+?3*BVH=4O=83-HH$T@ M"8Y)FA984":3J@RQ%UV5:K2<27C1R(Q"4/WO!%Q-QR1+KH%7UO76!W!5XI77 M,`'2,"61AO:8/&6'4^$1`?";P60V<^1S/ROUYA<_FV.2^A2`0VV]`G7#!9Z! MB[V3W_0F`?%=AO!/9+B<5-B3',?=PDCYKD$8&'&Y,8YC%N M4D1-BL\")+TQB6%N?Q?>=(<`W85+8%"M1FGG-EBCZSU[(J&[/N!5.=`.?E'= M,6G065G7HZ'+6J4LN%32.U=P[UZ"=<&AM7YZ[^9ZOASSPJKA>M77]Z;Z#U!+ M`P04````"`#:@7!'WHJ'QJ4!``"Q`P``&0```'AL+W=O=\?&7-5!UJX.^S!A)T&K18^ MA+9EKK<@ZD32BO$LNV=:2$/+(N5>;%G@X)4T\&*)&[06]N\9%(XGNJ.WQ*ML M.Q\3K"S8PJNE!N,D&F*A.=''W?&<1T0"_)8PNM6:1.\7Q+<8_*Q/-(L60$'E MHX((TQ6>0*DH%`J_SYJ?)2-QO;ZI/Z=N@_N+)AIVP0^$_A">,B2\:E0LOE= M>%$6%D=BIZ/M1;S!W9&'@ZAB,O8=++JP%Q%E<2TYYP6[1J$9,+L%@0+ MZDL)OE7BS/^C\VWZ?M/A?D7?3]4/]]L"^:9`OA+(YQ;W7UK&PO=V]R:W-H965T0' M*`[Y:1K%=DWL8QL5.![@N'O[`79<*^,FP.'[.P92C&C>;0?@ MR(>2VIZRSKG^2*FM.E#0>)XRC;9K?`FVLZ%`BT+NO!JH4!;@9H8:$[9\^9X MW@=$!/P2,-K5G(3L%\3WL/A1G[(\1``)E0L*W`]7>`$I@Y`W_C-K?EH&XGI^ M4_\6N_7I+]S""\K?HG:=#YMGI(:&#]*]X?@=YA9BP@JEC;^D&JQ#=:-D1/&/ M:10ZCN.T<]C.M#2!S02V$)[R&'PRBC&_QY.<'-D_D-4H1CZ M]A&MWPN(LKB6C.T+>@U",^:\QK"(V2P(ZM47"Y:R.+/_Z"Q-WR83;E?T[>1^ MV*4%=DF!W4I@-[=XN&LQA7E,F^R3)ON$P-.=20KSYO&MEW(GV MW@]'QES=@Q;N#@V8&RR()I&T8CS+'I@6TM"J3+D76Y4X>B4- MO%CB1JV%_7L&A=.)YO26>)5=[V."525;>8W48)Q$0RRT)_J4'\]%1"3`+PF3 MVZQ)]'Y!?(O!C^9$LV@!%-0^*H@P7>$9E(I"H?"?1?.C9"1NUS?U;ZG;X/XB M'#RC^BT;WP>S&24-M&)4_A6G[["TG4=]HU"BQ?L\2Y/F:=XI MLH6V3^`+@:^$QT1@(/YD8>#J&,R]ATLNK`7$55Y MK?@A*]DU"BV8\Q;#$R9?$2RHKR7X7HDS_X_.]^F'78>'#?TP5W]XW!Q\DNI5MYR;Z+T7@S[&K3'C`0!=M;QG^D&.?+`KC50],W:H MSD"/BK-Z-O4"8`@ST+-NB(M\GGM612XO1G0#?U:1OO0]4[\?N9#3,4;Q;>*E M.[?&38`B!YNO[GH^Z$X.D>+-,?Z"#F7F%+/@9\M'COTDY:L;?*^/,70( M7/#*N`1FFRLON1`NR&[\MF9^;.F,^_XM_>MO2]M-\SMM*QD9+6%#7@UX,V`DO\: MR&H@G@$L9'-=3\RP(E=RBM3R+4;F/CDZ$'MRE9MT!V5KTG;-*8K\6F!"F4LFF'6T$4# M:08]67DO0X0DE(9QDB!.$L#)/)QDMT\Z:Y(48>C1!%0(H7^<31J$20,PU(-) M[[9!A!+H_1/*@`QBFJ9AG"R(DP5P/GDXV=TW()\AQ)ZLO)=A2DF2>3A@=QE& M=N8_F#IW@XY.TMA[-=^,1DK#;21\L"6V]KG;!H(WQG6I[:OE!5@&1HZW]VQ[ M5(L_4$L#!!0````(`-J!<$<7!_[$V`$``$0%```9````>&PO=V]R:W-H965T MELT[07339[T5XS>AS- M@EA@QNW;%_!/C;)S(QSXSO<[@)`/7+S+!D!Y'XQV\N0W2O5'A&39`"/RB??0 MZ9F:"T:4#L45R5X`J6P2HP@'P0$QTG9^D=NQ5U'D_*9HV\&K\.2-,2+^GH'R MX>2'_CSPUEX;9090D:,EKVH9=++EG2>@/OE?PN,Y,PHK^-7"(%=]S]1^X?S= M!#^JDQ^8$H!"J8P#TQ74Y$;5&Q^^P[2$Q!B6G$K[]L=Z(T@R:=>L2I9XSBB*_%SAZSM'= M&$V:\UJ#1TT<+!JD_1<(=D+PRB"R!N%G!I'3(+(&G35(Q@J",-F4N1:E5A0% M.,)N3NSDQ"[.8L`Y.#D'%R?;&UL ME5C9CN(X%/V5B`_HQ-=+0HE"J@"EF8>66OTP\YP"LZBS,$DH>OZ^LQ45[.," M7DCBG+LXMFY*']5>ZUK[W>6YM7S9%_7QR??K]9[G275M^*H\^;-MBBS MI&X>RYU?'4N=;#JC+/4I")2?)8=\,I]U8S_*^:PXU>DAUS]*KSIE65+^'^NT M.#]/V.1CX.=AMZ_;`7\^\R]VFT.F\^I0Y%ZIM\^3%_;TRL,6TB'^.>AS-;KW MVN3?BN)7^_#WYGD2M#GH5*_KUD727-[U0J=IZZF)_-_@]#-F:SB^__#^VM%M MTG]+*KTHTG\/FWK?9!M,O(W>)J>T_EF<_](#!]DZ7!=IU?UZZU-5%]F'R<3+ MDM_]]9!WUW/_)@H&,VQ`@P%=#"YQL`$?#/BG@?C20`P&XMX(9T'6!A(T)AY'#3R>JVDU?@A&,F M',XG']GS83X%=B"@`S%R(/J99`:/N,?D'2;L,($Q%S<1KU\AKM*4,$UII4E" M&FG*40C987@X#8V%E58>/)`&X:7MB06*&:Y6MBM&$8\P+05I*4!+&;24E8PQ MMXNO$%=)A#")$"1A<(U#*T0H@\C(`X&DX6EI@X@4,TBO(,HEC0C2B@`M(^,X MLL),E30TNK@'M+1!%$V561%LE`AI1/Z*UA32FEJT(F,_Q%-;"(KD=&KPLF%, MRD@9L*4-BT(NI!%T9<,$YSQR%*.V_:+V$(!%,Q**!]#57,M0F*H`,-$T&W,_ M`ACCI"0S^`&<"@*2#GZ.]L=L?N9,Q@/H>BI#(

!7`44$329,A`H>),1A9% M$%B(B#E*&H/-]841X,C,G,C.G45*\L@A!H;['^,@&#ED"FA&5*0*8V6P1RQ<&*(2`& MY?@#RK$8>'`_6X[%P%%G-=DBD')\.7*L&`[$X"HQW/'-]L!'&\=BX/9G&V"+ M0`[=ZZ(Z7*6Q>GO.ZS MNXQ>CJU>J#WG,,9C]K1@8'S)GE;]H=2G^_GLF.ST]Z3<'?+*>ROJNLBZ\Y%M M4=2ZR3WXUDSS7B>;RT.JMW5[&S;W97\TU3_4Q?'CI.URW#?_`U!+`P04```` M"`#:@7!'Q^H\Q9P!``"C`P``&0```'AL+W=O;,]@$,W*90]X-ZY84^(;7J0S#[H`93?Z;21S/G4G(D= M#+`V-DE!:)9MB612;=8+-*L$F$JA(4":"+"\_V5R"=A%4^G_O"Z/%JDZQ,%I,M_%9 MIOB6#%D,8&!G^,/,F2N+3MKY6<9I=%H[\(S90XE1[U_,G`CH7`AW/C;I)TJ) MT\/]2'Y/Q1J00``/49```9````>&PO=V]R M:W-H965T-T M5]?'A]FL6N],GE;?BJ,Y-+]LBS)/Z^:V?)M5Q]*DF\XHSV:",3W+T_UANIAW MSWZ4BWGQ7F?[@_E13JKW/$_+_YY,5IP>IWSZ^>#G_FU7MP]FB_GL8K?9Y^90 M[8O#I#3;Q^EW_K!2JH5TB+_WYE1=74_:Y%^+XE=[\^?F<@-Q,8CH MI@'U!G0Q$/RF@>P-Y%@#U1NHKY1N&^C>0'\9)-W@GP>K&^IE6J>+>5F<)N5Y M?1S3=AGR!]U,YKI]V,Y=,\Q5\UN+6,P_%D+K^>RC==1CGJXQHL=$-N898"2S M,4OD)[8Q+PB3V)@5P$1?L69-O9>B!2Q:7#F@W@''#@@ZH"L'LG<@G$K.F$.' MB3H,CQ1CSJ"L`"P1US`K'0G3D5XZL3.'S](+HX7FPIG&I0_C.F&*.[5=P]09 MIGC"(@>W\G'4A*48%Z=@<0J,-6$'&CK0XV<[@@XBD(%T1B3R*A6*DPXD&L,X M,8BCG#BQ/_+4A(EPG`3&28:72^*7$S'2SOPN?9BSO%\2;T&14IRY"^66(ZNB MMDT@&6-@['3`14`)^?AUPK&N<`&RB%R%$_[8!J)@\>%(?6)7C\F/(H1RY>>% M^_KCX.R4L`!Q7X%$E+@I`=70,8&I"UK.R.;(?",B$X*#B@-"*P_;AC_R&P!H@1.Y"5`-RF2"2!]BLPMP7@=ASH M-P(S4:@["L:\$8@2KNA!D"-#+P,@.QE,+@%XDX26$>:-B.\8$LP;X?=Q,"0` ME+AZ,P"R-\28@008F`0DBS"SZ(X&3)A9-*(!KVAT`Z;`[G]$`UZ2WX"UWW]7 MY'-4A]LO88K2B/:[)+^K2G@@&<39*6'*TXCFNR2_ITJ.!FD09Z>$)81&2,@2 M@5R^K`9`=C)80@BU7B\.TIG`D8*PSA#JS^3&`:`DL`\@+$:$)$2Y@PM.`RS2 MVFUSEN"PS@[)2QQ$FP>$E>?>M`U`6_P3V(E ME$`)0XU?8IF3-%Z/9>#%!!(F=[8E>ND0!=DML>!((#A)H*U++!#RCC<%$M-: MHG<%7L&15[!@47B&,;.E3UH*NL"DE7?LO!4FF?))1N[I_DGYY!&<@@4K3![E MDX>8<$,A4$`R%::.\JE#3+IQ`+]40#(5YI<:QV=7;\&/Z9OY*R[?]H9J\%G5= MY-VK\6U1U*9QR+XU#G&PO=V]R:W-H965T'QLSYP9.YE^%.6O:IWG]>CW;KNO[L;KNGZ]G4RJU3K? M9=5-\9KOFU^>BW*7U5_\WQ;?-R-U?CSQL_-R[IN;TQFT\FIW=-FE^^K3;$?E?GS MW?A>W::N@W2(OS?Y1W5V/6K)/Q;%K_;+GT]WXZCED&_S5=V:R)J/]WR1;[>M MI:;G?X]&O_IL&YY??UI/N^$V]!^S*E\4VW\V3_6Z81N-1T_Y<_:VK7\6'W_D MQS'8UN"JV%;=_]'JK:J+W6>3\6B7_3Y\;O;=Y\?A%__9##?0QP;ZU$!=;D#' M!O35P%QL8(X-S-`>[+&!'=J#.S9PK,'D,%G=5"^S.IM-R^)C5![\XS5KW5#= MNF8Q5^W-=NV:::Z:WUK$;/H^H\A/)^^MH2-F?H[1'<93'[*4$'5"3!H")Q8: ML9AKT5SW.UA(A#>,PU4C#]>-I,`(X9$0G$\Z:T_'^8RQ`0,-F#,#IC/@+%N/ M`V3?0>R!HXVZ/S8C0X'I`&"/NH74K:3.IG=NSSJ*.TATT_3"1K@TC92\J*D5EXN:+.QIRR M1"EJ_QAG"3/JW%B/C$R'('OL$\@^D>P=8Y]@7^0B M-0R67H7U2+>Y$VE[!!R%^>/\"#IW2$,FB87"2YPB9;4/"+T*Y!L%.&G.2 M"PU@*#(%R"L#P,E1R>P8BT++2I=0B>/5U@+8TIZ/4-HBH[7UW.,OVNJ/#&=0 M)5.HBK@\*B>F,0'*#F#*QT&U5CA!*I0A!2.9U1(RHJJ\"NL3PME/R?1'RO-5 MC66DVRBV,5\Q@(MCLH$R4^&4IF1.(Q4PH7%^T>?YY4JQJW$ZT#(=>.83#L2E")?0.:[/'&N\1AJ?<$I:.D^SICSK`)BZ4*-HK/$::+P0/BWU MV%L1AP\`IK0.,\*BK:5H>UY_:*FO>'6'X5*$N[2Z6*VU5$72H2TMED7MOA$= M6,>TU#$9'5*?P.0-`*4`I)0);*8T%CJ-A"[AE$%5+BE+4*MQ%-B-:ZQR&JB< MUKRK1'1%-N3JA+600*W-@V].D>RH*>82EIJ6")<$%H*PL!(05AYZ)(50NLX0 M4`I`8=B:!9-O7AS&<[IY>\;C7[3L![/YBQJ.MBU[U+\%P4==Z0CVZ:<%GGV=/IRS9_KMM+WUR7A]8A`P``J0\``!D```!X M;"]W;W)K&ULE9==;YLP%(;_"N)^!=N0+Q&DIM.T M74RJ>K%=T\1)4`&GX#3=OY]M"*7V:RF]*5^OSV-3GM,ZNXCVI3MR+H/WNFJZ M=7B4\K2*HFY[Y'71W8D3;]23O6CK0JK+]A!UIY87.S.HKB(:Q[.H+LHFS#-S M[['-,W&65=GPQS;HSG5=M/\VO!*7=4C"ZXVG\G"4^D:49]$X;E?6O.E*T00M MWZ_#>[+:L%1'3.)/R2_=Y#S0DW\6XD5?_-JMPUC/@5=\*W6)0AW>^`.O*EU) MD5^'HA],/7!Z?JW^PRQ73?^YZ/B#J/Z6.WE4LXW#8,?WQ;F23^+RDP]K,#/< MBJHS/X/MN9.BO@X)@[IX[X]E8XZ7_LDB'H;A`7080,I"9YO="%GG6 MBDO0]N_V5.A?(5E1]2*V^J9>MYIBIY[I1)Z]Y8S1+'K3A8;,9IJA)D/&1*2J MCPB*$!OJ#&>,X0(,SI%-"C!3@)(9+I#``LFD0#+,(+$6V6<:DTE[2$K8@BTP M*(6@%(!2"^1FZ!PS9I`Q`XR9Q7`S/L8<,N:`,;<8;L;'6$#&`C`6%L/-^!A+ MR%@"QM)BN!D?0^N-%(I=2A+;#KDA+\9C*@$88F.(^QDGZCOV?<8$*GM/*&!1 M3PDL+?F"M01K2V[QEGQ17(+-)4#=A-FL=,):FE!\EWB:(<'Z$N2OW2-`R/NU M8(,)4MAN$R#DQ6")";+8[A0@Y,5@CPD2V6X6(.3#4&PR!28[_6((33^X;S.: MQK$'A6VFR&:[:8"0=T589(I$MIO&$+JY:5!L/&6`9>LZA#XK-'G'GT&X+U#0 M%Y+44P+K3M/;NQ/%(E,DLK/3%89(I$ MMML2"/DP#(O,D,AV6P(A+P9+S(#$3EL"(2\&2\R`Q$Y;`B$OQO-O-O+7;DD@ MY,5@>QFRUVY)(.3%8,,9^H-NZPE"#B::;*5JWA[,CK$+MN+ZE/Y^J\ M[7>2_844I^O&>-R=Y_\!4$L#!!0````(`-J!<$?E+\9/B@(``)4*```9```` M>&PO=V]R:W-H965TTS>V-+Y2]\X(087W55<-7 M=B'$:>DX?%>0&O,7>B*-_'.@K,9"#MG1X2=&\+XEU97CN>[,J7'9V$G646/]2R$FG"2V!EX^[(F#2]I8S%R6-EK MM,R1KR`MXD])+GS4MU3P6TK?U>#7?F6[*@92D9U0$E@VGR0E5:64Y,H?O>AM M344<]Z_J/UJ[,OPMYB2EU=]R+PH9K6M;>W+`YTJ\T".5KS]6KLS M%[2^4FRKQE]=6S9M>^G^S-V>!A.\GN`-A&$=F.#W!/]&"!X2@IX0F*X0]H10 M6\'IO+<[EV&!DYC1B\6ZXSYA=:O0,I1GLU.3ZBCDKG'Y3R&2^#/Q@UGL?"JA M'K,98[P6$_E32'8/00/"D0$,47A0%!OOCNY-%TCO$5&@Q?!4)'\H,@G3!S?+ M'_']?K,B6"``!8*10-`+S+7=AC`+;3<`3.AJVV&@DS_6F1@*04,A((`T0Q!& M/UX#3&:`R1]C)H9FH*$9(.##`A$H$)G?D3DH,`2?=953=U`T-.U"!PJT>0_ M4$L#!!0````(`-J!<$>+_/1Q-P(``%8'```9````>&PO=V]R:W-H965T^V`$]`:3&TG M;-^^MB$L@D%[@P_\,]^,8<99S\6[K"A5SD?#6GET*Z6Z@^?)HJ(-D3O>T5:_ MN7+1$*67XN;)3E!26J.&>OFF=U[%7G&[XK5+7T5CKPW#1'_SI3Q M_N@&[G/CK;Y5RFQX>>9-=F7=T%;6O'4$O1[=4W`X!]A(K.)W37LYFSLF^`OG M[V;QLSRZOHF!,EHHXX+HX4%?*&/&DR;_'9U^,HWA?/[T_MVFJ\._$$E?./M3 MEZK2T?JN4](KN3/UQOL?=,PA,@X+SJ1].L5=*MX\35RG(1_#6+=V[(. M8YQY#^-HU)SG&F0UP:3PM/<)@2#$&:W,,<:P`PS&B&<.\!AC"#L(00?AS$$X M1A`NDAPTK=5$5A.F,=Y',0R*0%"T!H7+TXQFH/UPFCN$8$H,4F(@G6A!B5?I M!)'O^S`F`3$)@(D7F`1*9N/CIB`E!2C)@K+6H`1F[$'&'F"D"\9:L\4P50Y5 MD@]0]LM26HLV,1L%&P#_F+_$K$6;&+!H3P$",,$2@X"B2=+-H@G@^@XPP%K6 MYRCZXE?S9GVOH>)FV[MT"GYOU=#@IMWI"CDAVS<_Y7G6D1O]1<2M;J5SX4IW M7]L_KYPKJH/Q=[J(*WW)30M&K\I,$ST70]L?%HIWSUMLNDKS_U!+`P04```` M"`#:@7!'8E.^NKD"```N"@``&0```'AL+W=OGT8?;N0V[RC)]D6=3LN7'$J:IH\V_!2GZ>N\B] M=+P4^X/4'5Z>>3UO6U2L%@6OG8;MYNXCFJU1J"$&\;M@9S%H.]K\*^=O^N7G M=N[ZV@,KV4;J$%0]WMF2E:6.I)3_=D&OFIHX;%^BKTVZROXK%6S)RS_%5AZ4 M6]]UMFQ'3Z5\X>(Z%?UHGT5MGN?V"XD[&DS` M'0'WA%X')@0=(?@J(>P(X940?DJ(.D+T5072$8BEX+6#989Z127-LX:?G:9= M'T>JER&:$369&]VIYTX-LU#?-"+/WO.`1)GWK@-UF,40@SL,&6.64TP3'K0B)`VO3 MKJ:H$(>!M:F>IBB$4C^QMO=Z"B,8#8*-,M/5'JI&/I#;I-3XDY6-DH3$&-D% MYSYP;.I&B42`*;OR=*"A5IC$21H1V]1]X-@46`T?$09,W:@A"*Y"Z!ME",%U M"`&%*$[MH0DG*R/`:H=']LC_JKSB/79 M:/4OT6R%@/XG?34R9^DU?)X=Z9[]HLV^J(7SRJ4ZDR\@$` M`#H%```9````>&PO=V]R:W-H965TQ#^\PXUX\LB`5FW/[[`CJN<6E?!"[GG'LNPBTF(=]4 M!Z"#=\X&=0H[K<<<(55WP*EZ$B,,9J<1DE-MEK)%:I1`KX[$&<)1E"%.^R$L M"Q=[D64A;IKU`[S(0-TXI_+/&9B83F$M>959A`/\[&%2FWE@O5^$>+.+[]=3&%D+P*#65H&:X0X5,&:%3.+?B^9' M2DOF'X5TS=82DBM8"V8"'@E7#\/X$L!+(2$E?H;,R5]85J6A923(&< M?\5([1^/TZF)&7V+*(L[B4Y1@6Z6Z$%<]YBL,/@9(>I/F/(,5XQ MR'A8C6"O$;P1((L`WAF9,?;B?1(E7E&R$4T64;(3)8NHQ1SFZC!.XH/??.+- MDWCR)+L\'DR*_4E2;Y+TW]5G7D+F<17O7/DPZUEW,=)7A%?/,FKQ!-_3O,J]>&SI4V@#SME,=(6?E#9]H,*+D*; M%^,N?2.$!E-J]&0.L#.-;%TP:+2='LQ+]54=&9.":=-LWNQ29-+W:O&>>,FH*X@&/W[1?0L<:A MV1N!PW_^[P!",7+Q+AL`Y7TPVLF#WRC5[X-`5@TP(A]X#YV>N7#!B-)#40>R M%T#.-HG1`(4A#AAI.[\L;.Q5E`4?%&T[>!6>'!@CXN\1*!\/?N3?`F]MW2@3 M",HB6/+.+8-.MKSS!%P._F.T/^9&806_6ACEJN^9VD^>X"*[&:-8<;W&"4/K%QF5.4.8`11M0=@]" M.=[E;D[NY.0.#MIP\KL#RC".MIA@]>,S$+6]W]*K^-"IZ0]?HLL3\HCLQ?F4 MET5/:OA)1-UVTCMQI:^?O4`7SA7H8L('?8R-?N26`86+,MU,]\5T[Z>!XOWM M%5N>TO(?4$L#!!0````(`-J!<$?Z"]>]V0(``)0,```9````>&PO=V]R:W-H M965TP!]O9M[8P].07EGSPD^4"NNM*FN^MD]"G%>.PW'GAN9[;525#G'=T*GRHK:S5*\]-5G*+J(L:OK4 M6/Q257GS;T-+=EW;8-\6?A7'DU`+3I8ZO=V^J&C-"U9;#3VL[:^P>B1$033B M=T&O?#"V%/EGQE[4Y,=^;;N*`RWI3B@7N7R]TBTM2^5)1O[;.7V/J0R'XYOW M;SI=2?\YYW3+RC_%7IPD6]>V]O207TKQBUV_TRZ'0#G$&I#,@O4&T;.!U!EYO`/ZB@=\9^",#ITU%'\1C+O(L M;=C5:MK;.^>J2&#ERZ/>J45ULO(0N-Q3B"Q]S;S$2YU7Y:C#;(<8HC'D'O&( M(-Z=.))`SX*@+,C`WNM8^+@##W7@:0=UFX:K/7R!>Y(;;Q#$;X/$(\QVZ"=J M$Y%?B`?CA*>XT(_<9"9I'^7L3_DDP8B//X@3M&E%80@Q'B=`XP1(G'`4)YC$ M@80DX>`2VKRGN*6\0Y1/B/")<`<1ZB`RKY88=1`;5$ML4"VQ8;7$GSJU!.6< M&%3+%$-F#E9I(:8&KD&M=*"/TT:`2WG#C$(!PFGF`P!<7N`3^@*XP(")PH") MQ""@P2UU)[>(N>>+BPN8J`OXDPM:DA?`]05,!`:"CT)UF4^=S6:.RPM@^I+, MN,`%!CZA,(!+#)AH#)B(#`*:ULLBYIXO+B]@HB\(:"X,P06&F`@,`IIDO(RY MIX+K"H'NAC"3F3:%?'Q?&P3DN^Z(FC/HSRK:''6CRZT=N]2B+;E^M6^F-[KU M':\36&T)MB.)R!W=?SOO(;+TG!_IS[PY%C6WGIF0G:7N#0^,"2KYNP_R"SS) M7X1^4M*#4,-(CINV:6XG@IUO_P#]CTCV'U!+`P04````"`#:@7!':_+IY0$" M``!Z!0``&0```'AL+W=O'3`"MC:EMPO;OZPLA+/@%V\.YS`QXBI'Q#]$` M2.^3DDX<_4;*_A`$HFJ`8O'">NC4FQOC%$MUY'4@>@[X:DB4!"@,LX#BMO/+ MPL3>>%FP09*V@S?NB8%2S/^=@+#QZ$?^(_#>UHW4@:`L@IEW;2ETHF6=Q^%V M]%^CPSG7"`/XW<(H%GM/YWYA[$,??EZ/?JA3``*5U`I8+7L;EK@L.!L] M;K]%C_4GCPZQZERE@[I1JB:AWFE$6=S+)(R*X*Z%)LQIB4$&\T0$2GVV0"Z+ M$]K0T5>#\Q:1)VZ'V%E$O.#'4Q'(+9`X!9*%0&($XMU^U06+Z0PFMR91EF:Q MVR=U^J0;GVC3[73AD]IVI5&\\+$]VTJAW)U*YDPEVY:\7Z>2;5/99?N=VR9W MVN0.FW!EDV\Z&R<(I>MR@L4_38'7YJX+KV)#)^U_,T?GY"L M?TRZ>=R6_P%02P,$%`````@`VH%P1ZH>RJN6`@``30D``!D```!X;"]W;W)K M&ULE59=DYL@%/TKCC]@%131C'$F7YWVH3,[^]`^ MDX0DSJJD0)+MOR\H,0;);OJB@.><>^_!X9)?&'\7!TJE]U%7C9CZ!RF/DR`0 MFP.MB7AA1]JH+SO&:R+5E.\#<>24;%M2704P#).@)F7C%WF[]LJ+G)UD53;T ME7OB5->$_YW3BEVF/O"O"V_E_B#U0E#D0<_;EC5M1,D:C]/=U)^!R0I$&M(B M?I7T(@9C3R>_9NQ=3WYLIWZHTJK22BOS'B-YB:N)P?%7_ MUI:KTE\301>L^EUNY4%E&_K>EN[(J9)O[/*=FAJ0%MRP2K1/;W,2DM57BN_5 MY*-[ETW[OG1?XMC0W`1H"+`G]''B_"DR0VIN-7M1;H5P3ZIM&%/FYB,,H#\Y:R&#F0PQL,=B" M+,<0T","E4"?!71E,8"`0&P%DN=UAFA:#.RM!E$9I:#DRQJ4@C5%BN3*&P33,$+)V<.4(FR*(L\1= M'W+6AQSU/1!(G`+)\PYCIP!^PF'\I,-#'#(.QPG(+(?',.4P3D)+;C7&`9Q% M&&;N^E)G?:FC/NP6R)P"V?,.ZQ/6=62$3WCL`$%L^6LPPXU0VX#MHV6,`MGH M][U#=>[&`"4/K`$/#D/@J"Q](.$\R68`_H>_[E,&1%_[NW2`;']7!G/G'$:# M_[++)ACTBIKR?=NEA;=AIT9V-?2K_4U@!G6OL=;G8+(`CO6EOCFTO>DF7^1' MLJ<_"=^7C?#63*H.U_:H'6.2JNS#%W68'-3=II]4="?U$*LQ[[I]-Y'L>+V\ M]#>HXA]02P,$%`````@`VH%P1\C[>6W!`0``200``!D```!X;"]W;W)K&UL?93+CILP&(5?Q>(!QA>O;0AE".H&W\XY_GYLR'IMWFP-X-"[DJT])K5SW0%C6]2@A'W2 M';1^I=)&">>'YH)M9T"4T:0D9H1\PDHT;9)G<>[%Y)F^.MFT\&*0O2HES)]G MD+H_)C2Y3[PVE]J%"9QG>/*5C8+6-KI%!JIC\ID>3CPHHN!G`[V=]5%@/VO] M%@;?RV-"`@)(*%Q($+ZYP0FD#$%^X]]CYK\M@W'>OZ=_C=5Z^K.P<-+R5U.Z MVL.2!)50B:MTK[K_!F,)FQ!8:&GC$Q57Z[2Z6Q*DQ/O0-FUL^V$EY:-MWR&)=7X03>69TC\QP%IT(1TX/J7]S19@,+\K79/U:4.39 M+>=DG^%;"!HUSW,-BQKV47%:4:23!'N`B8*M4K"9/QTH*%D/2%<#TED`CP$; MOJABD+11LAT8&6%DN]\LBGD4TAWAE)'=.A%?)>(/1)S2!1)_1/);[>EN0?2H MHV3+M[LE$)Z=>B!T=_]PI[]'_A=02P,$%`````@`VH%P1UBN9J?-*@``YL4``!0```!X M;"]S:&%R9613=')I;F=S+GAM;.U]VVX;29+H\_HK$@TU1@9*-.^D[!X#-$6Y M-:/;B')[&X/S4")34K7)*DY=)*LQ#_L/Y^D`N[^P'[&?LE^R$9&7RJK,*A9E MSV[W60,S;8K,:V3<(S+RAR1)618&?\OX-,K"](_?]3O=[]CG]2I,_OC=?9IN M7K]ZE2SN^=I/6M&&A_#+;12O_13^C.]>)9N8^\ODGO-TO7K5;;>'K]9^$'[W M]H/M#^O8H6F1K'J;,#Y=L%J9!^L1.0C%"$(7L@"7W?LR3'UZE;W]XA7U$ MOT-V%H7I?0)]EGQ9_G7.-RW6:WNLV^X,RC^>1P\MUNFY?]RVGK].;I(T]A?I M_RGWE(VO^%V`+6"(TUN.5?U?^]=9?)=;LTRR.J4.0+&#HG[D?(P#9D9]:;0\..MV# M7J<20-=/&ZM/IWWPE\H.ESP.HF7E?.K,7OS3/]4>C%R['.T8OK:0XR^];;UI MY\Z^$OK'P8K';`KKO(MB"_3SM;_"WZ_X)HK3(+QCTVB]\4.KH3K+:+T&Y)FG MT>*3Q^:$T>PB2Y,4T`RZ6^<4P:&'"5^R=_[*#Q>`+TA!"9##A_D1V]][:6V0 M+P!Z'4+J?M6Q^TD"@UB_^LD]H?L"/_"_9<&#OX+F5L,K#H@=+%(NFI9^1I[P M.MGX"_['[X#H$QX_\._>,@MK%POD(PF+^8+#3#TL(H%75Q/3MED/I]=SZN.=A7X-\$J2!W@ MTA#?^$\^+0/6["\6<<9SZ-AGO?+QH#<^[E+VM#%G$R"L5MQ'`!\HH-D<-^7Y M]+H9`8)%MVP)1(E+=)#!`T"98!>:8VSM>03Q\^K/%IJXOIG_^\>+T:'8U_P.;_>7#R;751K*F1+`F.&X&U)]QMM=N MM=OM/@,T%R+X#>NTVUY;_%]*9>9GZ3W0Z*]\^8;U>EY_//;Z7?TK'-!#1.QQ M8#>T#OLZ<%K1P%V*`>I8(F" MWF@]]]%J"9^1BFTDF2R7`0I^E#C`30Z"D$FL=Y!9MLX$U2SY;;`(+*P49]OD M5"PLH*-NTG/.D66R"8`\)Q[@Q[<<\'Q9H4U=YK_3"1$*5(S\;J>19:?IQU$"DB6. M;FV.(C<,)U,MR!/0=1="PUO"2E81Z2K69D'G$SK2VH\_\=0!:\$S[WC(T2XA M+6*Y#D(R=U#4NJ5>M'6)I[B_VSA:J[9P?NZY`P'T?362=:"@;''`F%3-94'[ M'G0Q#N-(*8R8\ZJ-@E:4N_J08:)$2R:@X M7D6/#2EQ.IG_R(Y/+S[.V?'5Q1F[N)Q=35"O89/I]R;$P,0T5A`:=)9VV->\1!;BP"8?$3GJ_1S/M5?%%Q M_A.S#>'53:KU4QKE!B@']0+4.DE&)=CTEOMIYI`J[WW`4OP]BN\`[4*>)&I8 MR\K\O,!?#4R.8'1D&0O.EW6XK)5C=NL'2O7S-5CMB:0M19;5S1.`/#<3'%3S MT8_1$Z*5-=@+0\,0##A;?I/F<>,C+@&"XD0$RSI1UV1Z9K4F6RV7DO(S%B+'8BBS:T:4]F$^ M.V(GYTXRVT::)^<_S>9;^EQF('+@*!',&Z>M7-T_L5'`>5)[PY=7%T8I_=G#7;+-9D7@&D(=1>$#+#.#<$L'B8(&W00@FT!;9.,TE%]%V$U0E<&WJP86BI%4,\A5RDV@!=@Z+\1"Z+X"X, M8![T^4O.C4"\C%8PM^LHFO:LL2GF'\[.)E<_LXMC-C]Y?WYR?#*=G%\#74PO M/I`_B%U>G)Y,701R<3UC'=#$F@_!)L#[]*(38]%^ONB-6C3:82+*\1__KN(< M'@8Z6FS_/__E7^5O__DO_\;@Y!'(\*5TG\.7+P$O&/F/0V1?@%`@`L#$0&K. M0->,M:<'N^I^_R]1Z`M'F&A5M,6NH95KE?D4,#`,A4(YBE*!3X`M&/*AV8V^ M0)R+8(-VDC2"5D_X.WJLU##L0XB:KM"&"1:3->#0PB<*NP<-')@))Y:)NX(5 MX!A`FT$^!%%#K!7)5.Z`=HKKJ-PH[L'Q&TTM-@8*/W!]N7=I*UP4[B=.%@; M4`R,V!\)?7MR!%X0`IUF"P%0P)ICQ!Z,AE&GJPR`!G^U.PB/*WZ';D(<<7[P MSZ@>K;/5'0EKT*AQM#E?@"!`]BO"D)^E0$/V"5P3>^+2Y[,IK1S;H$')8:G` MLB(\:T2P%#5?@(,ZX?)>2\ M]1![LY6P3',?@T=V1LSO8;ED#*'%J$7X+1FO:CXAC@VV(;9=`&EJNYT52;O` M4_`XHC-@E2T5$P#*^5L&FAN/5VAD8901E$5IXBF%C1B#L*QK!S.GGXB#%(%+ M5,,4IOY9;_4)8Z,<'6*._=R">;W,\1[Q`P8Y(P^3;#1HL8^(C8*M+42\IK@* M&JIF*0'AB5`L@)HJ0>(G2H#8([90PEP[NR7W4;9">YQA<@+IB5'X2Q82_>:; M>O7N807"*]GIC;Q>NP=GT_5&@P$33JS`V.(>ZQVVO79WC).-H'5_R+1& M3!]FN48,@#I&\OU):5HYHS@A/KJ6K4[170FZBOBW*__M$>49_@H)IK7_2T2B M"(D\BRU%7!(0!N""$'D=N1K@P`%]Y$R(,D&XR9"K?=2LE&00(*[TC))!GN0L M6M*8'J6+H^"^]3<]_&8AV6"$$/E-F/1-N4`J9GA*KF@CGB14&%W2&D3(4W@S6=YN! M-1@\%$+U%#-=T4#*"P,+A]6DTG0(@*<$,4T=@&D`*T*I9WX+VB+`/HI%UP"X M;PKJ*W1OL<$!)8*XW'O"+O%3K4"!'K[DB`'HS4*:%F29O!:4MX<4V>UU\:^A M\7ED?!ZKS]?('_U;0$76&8^]PW$7^_?;7J??E1"48)/!1L.OF$2WZ2/N9%*U MZD=^`W)/@O'#U:G`_+U#;SCHTW?RHV+XZ7W,@7PP$J+EG.#_5<%8X#*>@3DK M0.I=5].%;0^[8CGRLUH/&-I?O)Q"V.,H#WLPC+*-^6\"HW_7ZP(8+V_1`.P]@ MC[G$`.464#18"4.-ME,SI?(1@8@5RXLV0H.5ICE\CSOFZ\TJ>N+R")%3@0'X M*_Q.]A@IC"T-GN<=WG.@T^EU`8T[`CQ#E#Z#,A;,[X/-1KDW?H3_K(3)@2@P M69(3(2%U6V#L)"MB_A#P M1W+#4H^"]5'H0=IFI+0U)0V>B%/Q@!@!2J!HHH-;`K!1PE;D1!2;O,0_BO#N=.5T47:*Z0CL-8(F?RGV::^F&$SG/04%XQ4;N6L$)1;I? MR`W5+_8%4HB$$!DWO4E-]U@H9(\041B9Y625(5BE!ZOE4%(>2]&0H*".."S+ M:;0D1PNM+8TVP8+U1^V#;AO(+<;($B(@6H2HY2'DQ:SR-_Q"678)K")^$FLG M?59:P?A)^62!L479W7VN50I=OCPBK!K]AX&*M-X`GX6!W[#[Z!'X;.PQ_1,< MA;#=01QG9(:GK--M]?K?4\P2E[(6$V2AE,&8/*-C9DZEF:1'WQL?CK25BB$^ MZ)^)L$Y:6G"E^BU&&GF==@\`*K#>`1?'D#HL$W-3$WA!PPZZF"'U0BC)>_)/ M=I2[=G,66<,;'S66I]SE82<$\0$KTL)I:F3;ZWC#<<\;P-2(JO!G?]BA/Z5; M7`!>^[M0;4(^$0=W`2(R3DZ8J(Y#4)F:$6?H=KLXH"<=(_+08](58U3V8+\W M/'U$#!A_3ZTZW>_%O&754L!8>B/(V4$F[I]\P%9`[I$G]"K@?F?^$^O3GR,Q MU`+,L8#T.^(-.([@7'CLJ+:GP9H+SS0!4?K8%,0HM!8^Z?":W@A\*'JS2YXR M,3SS[^YBCNZ;''$1!*3!%P36Z'OX3IDJ:$C@(A;%*%Q2-[N&X$$`AU2@Y28#B8 M-)K%B$*I5".`*V-:?.(OI`'QC&U)BJ!\AN?01-_<9;_3_;KT,*PF!_CYN:@/ MRK'@"`#&'"J=MF?PY_]1$MB)"-+[`&U&<8(@!!8B%O^;)8OA*&>AZ$5IYPCS MVR$++AW$<(HBG"HI(2QFQFH)N==#?Y"TN'R+D!0=.:7*0.3_XMXE,145K>(9 M(7+*%?F)!9D@32KAHC=E@F=7Z(!!\&AKBSXH3)C=HQR9='8M4/PM!6PRGTJ- M"YUMH`/2MWDLT?142-O)D[0E4F]R1ZV!(#YH"POA[U1ZXJ[9FJ6*,UK@)W M<0722V8@87?0\7K#'B.OG)$KE;!L`SM0B_#,#"RQC(27>_A)SK24R4@Y4#CG M*KCE!4"V6)[6C59TR0#"F162Z5WI[239#<`#9(*P)[F(5CF3@"1)5]$2.5_(.-\E43&*>UZ(":B61T+N),(Y!FU`7FD\=]V MN;)V=AJY;,$X,!F"?6-AM9$,UWB9[FK[Q3 M*U\!A83$H3](UUN3-G4I$#].KF9;;D.0)Z&'KCVC,>@2LCDS\M.%%+M"Q23W MY'0'Y1LOCJ27/,_>OD`SR"_0M)B^FV%>;"JER+]FDXI[,(4@&BQO:4PL6(*B M7>C>\SK]G@>*?,VZEQQ3.8B/`;DV69P(.ZN&^D>,0@M97U"7>5&3L_NA+V&O M`V`R@42^<2$H!YVQ-QH(96-PV*//CE&:7`AJ>K>Q`-?:,9;S'/:!E0WH4$ M!GZ3'X8;(I[,U=C:L)A*@NBS5%SM,DW(1#'>03%\7YG^'/4`'^. MGH,_LR_$GP%`8S@<[HH]M=.:V#-[)O;,=E"*Y!9J<&?V>\:=60/V$.V;U M#3-9D>)3A@[MN-^.-IBZ"*\U^THW9"-8O&;[G9=H8$@X2)'[(I_1'/]%V2V& MGL<5!GX7A9SX;=+^#=OOFK-VO-%PY`T+O0J.7FO>^A1\&+]GCG]8!F-A9(`"]!R\+9O5>U^N-R4FK*W^43-Z:2VDPW+`\7.?0&XYZ M+KO9N'`7<\0-M:11>8PA)7(H\QTW0/'0HA?-SK[0F1<>Q5S5GZ`2PMCH[_=4 M!@'ZKOQ0%AWSL<.[>ZS;&QHU_V M->NT3&SL];Q>KU=WZ'MCQ*B.L-ZYK3C MWL`;5Z^[X;R]P\$6VNV;D]J*U\#<1I&*H0((;]C07%C/&P%%][XBYQL5]CT:-^=\ MX]87,+[#HCMQK]/!%*AG,[Y.NS1>K]_UNH/1+HROTRFO2>9H_<8X7Z=;7J?7 M`RVQ.^I\(>]KH@'TRQH`2(?!N!9C]@!C#=*0[+L@T'O#MC<:=YH@M8,-);7W MZ@K7CY7;VA/'1TD]%!8<#\8[1R_+H.AWMH*B>^B-3%`4P=#O][WVJ/L_!8;Q M&#C+6)Y/02'J=+MU?*&IFF>II[:,:E6:0 MQXK[S=4MZ_S]6/V(75Q>GUR?W[Z/6O[*+""RYF@Z^HN)N\@Y5X%(LS=8:(%- MBOVL"37$5B;+AX#BEL6?2KD>=!F2L@E!Y`I9N_8!B[(UMG0%2HJ&TH43EFJ3 M.A-27.D),\)<0S80;!^#U0JU@#M$%G274Z8`I;OB&18R:JB-C,=+^*O;+NK\ MU.UG+&"ZS%84LY4E;1``ZC`H-X`.\B;A$NX^*B9X%T1D,\C4%4/.5>7,B`4Y MD*H$`9*06$5$^:5'D/YX1BKS[C9X$)P+\PCQ;I>1E+"4.3H$*L'> MLC3"^VP+&DHL"!L=MJ'Q$T".+BTD&9R8@"F(NX4H_R?T,X2+PD"\>@&8B_FF M(E5<`52F3,"1AJ**B)^HHBD^"%R\:!(DLC*)\*%0G4W11B&$Q`&!&)25BJ%4 M'B^PZXJKM(JEO!OS1>LU%IFOG!9+1:HP?JI!)4J]**4CCZ`K.C+7A02,L*3K MC2+#91+F*T4'11BQF+*E*"?`K%@GLI6%8X;H,0\-+##6SO6%4@MD$;L/U@QS MTE>8`(3BCA*-C=O!1!>X-NW$+EX+6+=8D8WC,>FK:DQ>DZ)KX\&OI(L:5R5O M5!J+I',JAE$N4R3IIL@`T-N3@Q8S*`C=E^43J\KZ?3_7I@^MY3]*0.=2(OCKC?H],"`Q%MS M[5:_0U7F#HROW\OS$M^K_ZHIRM\?*["\F@H5&%KLBZ1$]K+0LK0JAZ;0]?J8 MGB.7UCO42U-?7Q>8=%$*F518G7K=\<;CH3?J"ILA2Z2PS%'(!W1;&X(->+6Z MZ%9A/RC\+N%",3N$G(J[)%"\KE(6*KY6TUW3=&:%N=(LJN$YKJ:F77ZU,_\T M4S<[D/%@TH9D[B_9X*#3+O_GIPCM(2KTM&_26>LE&_=:HT/V/>L#!@[@W_+? M5T'RZ>`6=U+(:66M\>![P(A."VS6[^&?05O\">K[]]:/_;[QHUXZ<5LLC4(# MXD_F_Z_O>7Y_AW6,3^PP$+& M7G1#58Z%9IPWE;FV7'$"_'43)>F!4C>*%JJ!O\"N%>]/%%4`IT[PEBV6K7[( MCS$(A15.16FR.)_>:),3D+X"&A@WZXFARML^1B^=IF4!WX:C%+NKX!,E]T9P MI*",Q;F&L?&3M`1*?>K&\DS(XF[$GI\,P.9UU51WL,JB+'7>M*&%NFT98@VK M)V6D%K>#\C8'-^R($BS,.\-"GMXH[4V[(T`1"U$:W8@B#,?\)A;9V^U.%U5< M'EJZ&_V!ZJ2X6TH'*?%*G0!E_G&\[07,'%!'3KQ_<3W]R[N7I$G&/+]F`ZK" M)@.-=&&JH[;*.(6M\K]E5'O$J]B/#0H#"C8#MG3>4EJA4#`+`AUA21<7$8V1 MVYLZORPD(F@GR?2?M[Y8G2AP@-VT]TF>-%9.0;DC2HP$J-(;A=SR*D=X0X#' MI))0DBGE)?I"6U\%P-B7\BJYJE,E]P4CF!4P067,P%X%Q0N0%'4HAD4(HS5\ M`.1<1=$G#Q/ZPCNL\DFJH]Q"BQU/YN\HPWC4&>?WM`Q?E=!07RBYMW0#5;AO M'U`?\/`*M*Z5@1>QR(\KSEI?QX0VL`0JYV',523<"%B%FK=8X0-PE`HIH.NRDQN7W]!,#@PEZK9J'N--UAUJ$@' MRDXI#+Z(T'67)0HA[O!V_U([!/PTC8.;#+22-0=J:'H[$RC9$\5+]!UIS)X"V)Q;]YLQ>N]?HS\>/]7'D?`YT+D M8X^1)Q1=3_J^`6I",Q1HJWEV8=B@4#9)IW$C;!GZXU"Q.EBAGDH0;KFNP__C M[L&#F=`;FO?@_WNNP3NONKN"%`(>!'A MD#_K"]&YVZ3D**QBQIY0RX2TS'_-"4XHZT&N%I&C8`N,\R-";N.+^^E:_ZH_ M')4N?RO5G8#\($81.H/U**>79!.D/FKQ6=I#4NTH]^2MOBPT`&OQ#PMQBF+$ M<+84*RBX`UKB.G*OB_%)C*1*AWAKFU\%Z5M&]HRZC;O=B'A=Z?4P/1K:1W]) M&4RUKHV^-Q[VO,/!$&L.M;I=[R47 MA8Y^-O-.Z-&L,(=Z&N62GD:Y-B[O-6]95RU^=CJYGAVQR\G5]<_L^FIR/L=J MIQ?G[C#'@,HD5'9/V2H`GG&%9=0P MK#<12M8>PXOB_-<@/EU5U'"_MDCU6#+Q?$Q>S\E/DZ>56J:?,>UP7SBZN?XL_DVQ#->Y@*YE]#O[H85E8.,ESF06VG?E"^ADAJ$W M&/:8JD"_Y(N8[D)O?WZ"[:OLFY=L:J0G['?'WO!P#-\6M^+8^QX;#;UA9^Q. MR3!=HT7CKK"_PO[MC6)ZK-HEBEC2\?3%7OX9[T`+/53=A]:^HO)0%`%R7($M M/[M1=$:0G9\G_^Y)\!12VNX`_(ERK>6EP8M.++TR<^^X/7D.+5603=(#.6/, M*H9H*%UA44`"MBA^>YS[R-8F&4%7$1VJ*G!(%1-1#H+L!'5IZ/4ZW<)G#.(< M&2O=EV>-+VR8G\4TJG)>6GCEH1IQ.MYA]Q``V2_-GX^,&AFN[\0H-%I9`5W! M/J__61"#K>;`&/9'7ONP9WPZ:+))%Z&[A_IJ>[+?$A*^*>,MT09-ZK)A9N^1 M7[*3\^.+JS.2OJ4F[@<9B0./B0,[AB"_3(Q7%N[\4%[D%GX$X3)"RB%'@RRE M*FMATL)?2_K1M?8\C.(+/XHJ.9SX*^'"0&^IOTJ?R)`/8I^\_<`EEMDB577F M!.-9\R4Y_]2/'E5UQGOV)'QI5%UT"_7&Q7W`;PVG+[#=`+GGP=K_A*_N")-I M2JW`_EADQ%Y`.X,A8C%$Q8^RL%M241\Z+RE.M2.S&-4*0D"5(UDHWFVXGT7J MA2@+00H'3V"-"RXV*SW9%'VPH^CRJ0_\\8Y'8'1N@`O#MW>BG`ANQZB!2'):+F.JLR<#.!E8 M^FO4\V),^BI;YWDXDGA2W=E\6?G-UR_LZ/(+'1U^43S-`T4\1'\)F$LGDF/!&>->\ZX8(R,9!C_)4AR/98&4\ZO-*.7?5M@]8ATH(Y2#$N0Z] MP:!'1RB4N/39723>&Z0M&A[>%#UGU%GX,@JU<8V' MFM!/E]P*8U/$]'+E6JXE1,:!AEX6BY*1JJAFB_UH1CZ5$4HQUB1#9R-QBH6O9`5+6E2KS-N>X>=L9S3:X_ZWF@\^L*+@1]UQ4F*/&+&*>*0G[^BBDX7 M:6B'&9Z/*D1-T?`840[T#N*U2N(+(6:\#8!>*%7.).&<_#?&%%)VDN#5-3Q? M85)AH8RG4;%2.Y9#>FXDBTE4"1\Y6AG%Y5-D1B:B^@]^L$*LI1Q1U`Z4(0$R MB9)(EUP_&G43/7"/#!/TKLJ'UR@GF&J7F]YZ@=S:%$ITA4OT?D6/H2X68[ZE MX3BU&ZF5)N)=`%S.!CDK0)$DK?1R\*49$RPGK`KBPQFS.'0,8C2F:*C:&IXR M39L:C@R%(/HA*-]TM%'(%ZPD/+$=(50.FLDV4S*C??]9#J+28+7XF$4 M7UT;P6B\<-;`7UCLM8BKRR@#+!&Z%44<\\TH8`G;M,"AI"+@XII2(9)O,DB$ MRA^^$"6UQ.TE=>H&>A!IK/`-'!UKA..I0(THUA_=_4PN*%[2V M\DFB1JR][DDCZQGY\A-'C69P/8SD>F6[XJ&D9E'(VH>6;&JM?WAIU_;_2QYJ MVL47@KOQM8 M_Q17U0G+9XUF1U/VUS,Z("N*1"\?Y'8$^^LI\M<3?-?;3DO(<>ZV[D4E.6UH MO*;4'&;R2:72"TL[%!FI1/=\]>K]%/F>=3.,_W:U_&M<+:\YE6=?"6]X?M_N M>?^WW_.N.>W2M8:&1/CUKS(<;K_*T/[*5QE*4^YPLZ`!;VMX"\#-E]_^(Y+^ MFR8@-]%3%K4)Q'88Z7]?2G`=]*12LS;27$W&&I(&JG(>*%K;C"J_Y<)^RX6M M271MP+7J$LD:X>!O)F/N_^O$M5VLSB.\L[-*D#H_S(_8_E[=^9]4VI]O2T9D M^>>2_6@)FX(!6?[5LA^_PH99Q]XHW[0TWZD`1F[^.1?Y-19VS3_C[;-F)[+= MJR!'LRU*H$I\@J_:9'Y[DOO[0:+'=_+NC_3?6ZXNTP@G9T7)3*_MH%\HNY4Q M"G>?^==V9M8Y[*AJ4!RM(WW?V$;["&$A:C8L@Y7(51?5`2P6*2R:I9=AY,U+ZN&._,7]\#>XW+P;8<5-1EBRRI&;M"=HK*)&:$,R`L+ ME,I[?!Z8KMN%-7(8T[^YYZ(53&E,S]N@=5"'+A3Q?P, M+MUOT$9Q_B:-RHMD<9#9J^I$AWT/7_;]OH[VP;^#X[GY[&>^*,;5$73V>4*"=FSXS\P/T47DRB7CC"AB>?967U!W$D#_%7'C3V>(TK7;;?623`X'IS>1@_E9Z:WMC>K7ZN:+.7`65 M(JI8Z%'CA4[M-X8JQIPU'E.&E>I,S1P+#,FQ,R9N&6@'9*@)DAM/O9+V=<5WWMY5%`%?[3L3\1 M\OL[RQ=HR7H5RJO\X3&TI>WKPP"H!7'RX(R]C^@Y+&!_,%Z#)8.W9 M:,DMKTAUBH!EX6"&@*5A4;Z`;:$X8_WE5FV7X;#-"JO,@+!\'.X,!GL18WO] ME-=@?]FW-.W$4QCL40I&4[Q2I[.`'\>*2Z9)GFY5M M-\T^4RD:^ED;+Z*]IRSWW?H(U+:]!.*M&%4_4\29->13Y)(\;CI6U5._" M0&I2[G+$[N&J8Q[5CKC*-T&JN[AJ=-8C:A7J?ZBMW%K(X+^VJDCU>V9.6YW@0TH._'&LOU_4[4V*[-^%'RM+39-^[$, M[/JL'PO`7R'WQ])4=T\!JO:I;TEKLC-;=@4]J##57#_O[*E;38@#CZ=9_9KU?C@/X' MI-]L/>KM8KXZ/:]"4CM3?K9[Y7!+4:ARQG=(`)*X('LXXCUF5HUJ57D,5]$C MWB"A9)HY)=-4MMR>5U/5M5C3J0%P2ATJ06\4`?J#*CR4-WJ5).G;_P)02P$" M%`,4````"`#:@7!'B5HD/+P!```F&```$P``````````````@`$`````6T-O M;G1E;G1?5'EP97-=+GAM;%!+`0(4`Q0````(`-J!<$=(=07NQ0```"L"```+ M``````````````"``>T!``!?&UL4$L!`A0#%`````@`VH%P1R!1 M'K4^`0``:0,``!$``````````````(`!>`<``&1O8U!R;W!S+V-O&UL M4$L!`A0#%`````@`VH%P1YE&POLIOH7D`,``,H,```/``````````````"``:P1``!X;"]W;W)K8F]O M:RYX;6Q02P$"%`,4````"`#:@7!'T=AB7D0"``".!P``&``````````````` M@`%I%0``>&PO=V]R:W-H965T&UL4$L!`A0#%`````@`VH%P M1R@!.4K5!```_A@``!@``````````````(`!XQ<``'AL+W=OX<``!X;"]W;W)K&PO=V]R:W-H M965T&UL4$L!`A0#%`````@`VH%P1X*0!O%N!0``VQL``!@` M`````````````(`!K"0``'AL+W=OZT8HP$``+$#```8``````````````"``5`J``!X;"]W M;W)K&PO=V]R:W-H965T&UL M4$L!`A0#%`````@`VH%P1^L\44*D`0``L0,``!@``````````````(`!`2X` M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`VH%P1QFR1G^B`0``L0,``!D````` M`````````(`!:#4``'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`A0#%`````@`VH%P1R=38MME`@``4@D``!D``````````````(`!]3H` M`'AL+W=O&PO=V]R:W-H965T?"QBMJ@$``/(#```9```````````` M``"``7D_``!X;"]W;W)K&UL4$L!`A0#%`````@` MVH%P1S9)\$7``0``>P0``!D``````````````(`!6D$``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`VH%P1VZ>3WVC`0`` ML0,``!D``````````````(`!%$<``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`VH%P1[(;C20#!```^A,``!D````````` M`````(`!(4T``'AL+W=O&PO=V]R:W-H M965T'Y/Q1J00``/49```9 M``````````````"``2Y3``!X;"]W;W)K&UL4$L! M`A0#%`````@`VH%P1P0M=9T!!@``)B,``!D``````````````(`!#E@``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`VH%P M1XO\]'$W`@``5@<``!D``````````````(`!7V0``'AL+W=O&PO=V]R:W-H965TR\@$``#H%```9``````````````"``;UI``!X;"]W;W)K M&UL4$L!`A0#%`````@`VH%P1S[.ZW3S`0``5@4` M`!D``````````````(`!YFL``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`VH%P1ZH>RJN6`@``30D``!D````````````` M`(`!6',``'AL+W=O&PO=V]R:W-H965T M XML 13 R33.htm IDEA: XBRL DOCUMENT v3.3.0.814
Fair Value Measurements (Details)
9 Months Ended
Sep. 30, 2015
USD ($)
Schedule of changes related to derivative  
Balance as of December 31, 2014 $ 416,563
Additions related to embedded derivative of convertible notes issued 416,563
Gain on decrease in value of derivative liabilities (342,257)
Conversions (28,698)
Balance as of September 30, 2015 $ 76,618

XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814
Notes Payable (Details) - Frisco Note payable [Member]
Sep. 30, 2015
USD ($)
Summary of future principal payments of Frisco note payable  
2015 $ 52,000
Note payable, Total $ 52,000
XML 16 R37.htm IDEA: XBRL DOCUMENT v3.3.0.814
Going Concern (Details) - USD ($)
Sep. 30, 2015
Dec. 31, 2014
Going Concern (Textual)    
Accumulated deficit $ 22,020,795 $ 18,041,208
Stockholders' deficit $ 2,180,918 $ 1,074,788
XML 17 R9.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock Options and Warrants
9 Months Ended
Sep. 30, 2015
Stock Options and Warrants [Abstract]  
STOCK OPTIONS AND WARRANTS

NOTE 4 - STOCK OPTIONS AND WARRANTS

 

Equity Incentive Plans

 

In April 2004, our Board of Directors and the stockholders at that time approved the adoption of a Voting Stock Option Plan (“the Plan”), which provides for the issuance of stock options to eligible employees, consultants, Board members and Advisory Board members of the Company to acquire up to a maximum of 5,000,000 shares of common stock.

 

Our Board of Directors, which determines the number of options that will be granted, the effective dates of the grants, the option process and the vesting schedules, administers the Plan. In the absence of an established market for the common stock of the Company, the Board of Directors determines the fair market value of our common stock. Options generally expire between five and ten years from the date of grant and automatically terminate 90 days after such optionee ceases to be an eligible individual under the Plan other than by reason of death or disability.

 

The portion of options granted that is not exercisable on the date the optionee ceases to be an eligible individual under the Plan by reason other than death, shall terminate and be forfeited to the Company on the date of such cessation. An optionee has no right as a stockholder with respect to any shares covered by the options granted to him until a certificate representing such shares is issued to them.

 

Stock Options

 

The following table summarizes information about the number and weighted average of the options that were forfeited or expired under the Plan as at September 30, 2015:

 

  Employee  Non-Employee    
     Weighted     Weighted    
  Number  Average  Number  Average  Combined 
  Of  Exercise  Of  Exercise  Total 
Outstanding at June 30, 2015  2,513,838  $0.41   -  $-   2,513,838 
Granted  -  $-   -  $-   - 
Exercised  -  $-   -  $-   - 
Forfeited/Cancelled  (62,500) $-   -  $-   - 
Outstanding at September 30, 2015  2,451,338  $0.39   -  $-   2,451,338 

 

The number of stock options exercisable at September 30, 2015 was 1,886,721.

 

We used the following assumptions to estimate the fair value of options granted under the Plan for the three and nine months ended September 30, 2015 and 2014:

 

  Equity Incentive Plans  Equity Incentive Plans 
  for the Three Months Ended September 30,  for the Nine Months Ended September 30, 
  2015  2014  2015  2014 
             
Expected terms (in years)  5-10   5-10   5-10   5-10 
Volatility (weighted ave.)  83.79%  40.45%  83.79%  40.45%
Risk-free interest rate  .85% - 1.74%  1.50% - 1.80%  .85% - 1.74%  1.44% - 1.80%
Expected dividend rate  0%  0%  0%  0%

  

The expected term of stock options represents the weighted average period the stock options are expected to remain outstanding. The expected term is based on the observed and expected time to exercise and post-vesting cancellations of options by optionees.  We use historical volatility in deriving our expected volatility assumption because it believes that future volatility over the expected term of the stock options is not likely to differ from the past.

 

The expected dividend assumption is based on our history and expectation of dividend payouts.  The fair value of the shares of common stock underlying the stock options has historically been determined by the board of directors. On or before February 2012, when our common stock commenced trading on the over the counter bulletin board (OTCQB), there has been no public market for our common stock. Consequently, the board of directors has historically determined the fair value of the common stock at the time of grant of the option by considering a number of objective and subjective factors including valuation of comparable companies, operating and financial performance, the lack of liquidity of capital stock and general and industry specific economic outlook, amongst other factors.  

 

FASB ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company only records stock-based compensation expense for awards that are expected to vest. While we generally consider historical forfeitures in its estimates, judgment is also required in estimating the amount of stock-based awards that are expected to be forfeited. The Company’s estimates for forfeitures may differ from actual forfeitures. If actual results differ significantly from these estimates, stock-based compensation expense and its results of operations could be materially impacted when the Company records a true-up for the difference in the period that the awards vest. We adjust stock-based compensation expense based on our actual forfeitures on an annual basis, if necessary.

 

Stock compensation cost, using the graded vesting attribute method in accordance with Codification topic 718, is recognized over the requisite service period, generally 5 years, during which each tranche of shares is earned (zero, one, two, three, and four years).  The value of each tranche is generally amortized on a straight-line basis.  For the three months ended September 30, 2015 and 2014, stock based compensation expense was approximately $26,736 and $42,437 respectively, which consisted primarily of stock-based compensation expense related to stock options recognized under GAAP issued to employees.  For each of the three months ended September 30, 2015 and 2014, the number of options exercised was 0.

 

Compensation expense is recognized only for the portion of stock options that are expected to vest, assuming an expected forfeiture rate in determining stock-based compensation expense, which could affect the stock-based compensation expense recorded if there is a significant difference between actual and estimated forfeiture rates. As of September 30, 2015, total unrecognized compensation cost related to stock-based awards granted to employees and non-employee directors was $323,715.

 

Warrants.

 

The following table summarizes our warrant activities for the three months ended September 30, 2015:

 

     Weighted 
  Number  Average 
  Of  Exercise 
  Warrants  Price 
Outstanding at June 30, 2015  4,863,956  $1.22 
Granted  15,000  $1.23 
Exercised  -  $- 
Forfeited/Cancelled  -  $- 
Outstanding at September 30, 2015  4,878,956  $1.23 

 

The number of warrants exercisable at September 30, 2015 was 4,878,956.

XML 18 R29.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock Options and Warrants (Details 1)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Summary of fair value of options granted were estimated at the date of grant using the Black-Scholes model        
Volatility (weighted ave.) 83.79% 40.45% 83.79% 40.45%
Expected dividend rate 0.00% 0.00% 0.00% 0.00%
Minimum [Member]        
Summary of fair value of options granted were estimated at the date of grant using the Black-Scholes model        
Expected terms (in years) 5 years 5 years 5 years 5 years
Risk-free interest rate 0.85% 1.50% 0.85% 1.44%
Maximum [Member]        
Summary of fair value of options granted were estimated at the date of grant using the Black-Scholes model        
Expected terms (in years) 10 years 10 years 10 years 10 years
Risk-free interest rate 1.74% 1.80% 1.74% 1.80%
XML 19 R28.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock Options and Warrants (Details) - Stock Options [Member]
9 Months Ended
Sep. 30, 2015
$ / shares
shares
Summary of option activity  
Outstanding Options/Warrants, beginning balance 2,513,838
Granted
Granted, Weighted Average Exercise Price | $ / shares
Exercised
Exercised, Weighted Average Exercise Price | $ / shares
Forfeited/Cancelled
Forfeited/Cancelled, Weighted Average Exercise Price | $ / shares
Outstanding Options/Warrants, ending balance 2,451,338
Employee [Member]  
Summary of option activity  
Outstanding Options/Warrants, beginning balance 2,513,838
Outstanding Options/Warrants, Weighted Average Exercise Price, beginning balance | $ / shares $ 0.41
Granted
Granted, Weighted Average Exercise Price | $ / shares
Exercised
Exercised, Weighted Average Exercise Price | $ / shares
Forfeited/Cancelled (62,500)
Forfeited/Cancelled, Weighted Average Exercise Price | $ / shares
Outstanding Options/Warrants, ending balance 2,451,338
Outstanding Options/Warrants, Weighted Average Exercise Price, ending balance | $ / shares $ 0.39
Non-Employee [Member]  
Summary of option activity  
Outstanding Options/Warrants, beginning balance
Outstanding Options/Warrants, Weighted Average Exercise Price, beginning balance | $ / shares
Granted
Granted, Weighted Average Exercise Price | $ / shares
Exercised
Exercised, Weighted Average Exercise Price | $ / shares
Forfeited/Cancelled
Forfeited/Cancelled, Weighted Average Exercise Price | $ / shares
Outstanding Options/Warrants, ending balance
Outstanding Options/Warrants, Weighted Average Exercise Price, ending balance | $ / shares
XML 20 R30.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock Options and Warrants (Details 2) - Warrant [Member]
9 Months Ended
Sep. 30, 2015
$ / shares
shares
Summary of warrants activity  
Outstanding Options/Warrants, beginning balance 4,863,956
Outstanding Options/Warrants, Weighted Average Exercise Price, beginning balance | $ / shares $ 1.22
Granted 15,000
Granted, Weighted Average Exercise Price | $ / shares $ 1.23
Exercised
Exercised, Weighted Average Exercise Price | $ / shares
Forfeited/Cancelled
Forfeited/Cancelled, Weighted Average Exercise Price | $ / shares
Outstanding Options/Warrants, ending balance 4,878,956
Outstanding Options/Warrants, Weighted Average Exercise Price, ending balance | $ / shares $ 1.23
XML 21 R31.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock Options and Warrants (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Apr. 30, 2004
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Stock option and warrants (Textual)          
Maximum number of shares acquired under voting stock option plan 5,000,000        
Expiration period of option, Maximum 10 years        
Expiration period of option, Minimum 5 years        
Termination period of option for ineligible individual 90 days        
Stock compensation expense recognition requisite service period       5 years  
Stock based compensation expense   $ 26,736 $ 42,437 $ 119,083 $ 62,137
Number of stock options exercisable   1,886,721   1,886,721  
Number of warrants exercisable   4,878,956   4,878,956  
Stock Options [Member]          
Stock option and warrants (Textual)          
Unrecognized compensation costs related to non-vested stock option   $ 323,715   $ 323,715  
XML 22 R8.htm IDEA: XBRL DOCUMENT v3.3.0.814
Shareholders' Equity
9 Months Ended
Sep. 30, 2015
Shareholders' Equity [Abstract]  
SHAREHOLDERS' EQUITY

NOTE 3 - SHAREHOLDERS’ EQUITY

 

Preferred Shares Rights

 

We have 25,000,000 shares of preferred stock authorized, par value $0.0005 per share.

 

Series A Convertible Preferred Stock: As of September 30, 2015, the Company had authorized the issuance of 3,143,237 shares of preferred stock designated as Series A Convertible Preferred Stock (“Series A Preferred”). The original issue price of the Series A Preferred is $1.00 per share. There were 518,750 and 593,750 Series A Preferred shares issued and outstanding as of September 30, 2015 and December 31, 2014, respectively.

 

During the three months ended September 30, 2015 the Company did not issue any shares of the Series A Preferred, and no shares of the Series A Preferred have been converted into common stock.

 

Series B Convertible Preferred Stock: As of September 30, 2015, we had 3,500 shares of preferred stock designated as Series B Convertible Preferred Stock (“Series B Preferred”). The original issue price of the Series B Preferred is $1,000 per share. There were 750 and 1,145 Series B Preferred shares issued and outstanding as of September 30, 2015 and December 31, 2014, respectively.

 

During the three months ended September 30, 2015 the Company did not issue any shares of the Series B Preferred and 150 shares of Series B Preferred were converted into 313,296 shares of our common stock.

 

Series C Convertible Preferred Stock: As of September 30, 2015, we had 770,000 shares of preferred stock designated as Series C Convertible Preferred Stock (“Series C Preferred”). The original issue price of the Series C Preferred is $2.00 per share. There were 770,000 and 0 Series C Preferred shares issued and outstanding as of September 30, 2015 and December 31, 2014, respectively.

 

During the three months ended September 30, 2015 the Company issued no shares of the Series C Preferred and no shares of Series C Preferred were converted into common stock.

 

Series D Convertible Preferred Stock: As of September 30, 2015, we had 1,050,000 shares of preferred stock designated as Series D Convertible Preferred Stock (“Series D Preferred”). The original issue price of the Series D Preferred is $2.00 per share. There were 1,050,000 and 0 shares of the Series D Preferred issued and outstanding as of September 30, 2015 and December 31, 2014, respectively.

 

During the three months ended September 30, 2015 the Company issued no shares of the Series D Preferred and no shares of Series D Preferred were converted into common stock.

 

Series E Convertible Preferred Stock: As of September 30, 2015, we had 531,666 shares of preferred stock designated as Series E Convertible Preferred Stock (“Series E Preferred”). The original issue price of the Series E Preferred is $1.00 per share. There were 531,666 and 0 shares of the Series E Preferred issued and outstanding as of September 30, 2015 and December 31, 2014, respectively.

 

During the three months ended September 30, 2015 the Company issued no shares of the Series E Preferred and no shares of Series E Preferred were converted into common stock.

 

Common Stock

 

The Company has authorized 100,000,000 shares of $0.0004 par value common stock.

 

During the three months ended September 30, 2015:

 

 (1)We issued 313,296 shares of common stock pursuant to the cashless conversion of 150 shares of Series B Preferred;
 (2)We issued 1,767,650 shares of common stock pursuant to the conversion of convertible notes;
 (3)We issued 90,000 shares of common stock for services;
 (4)We issued 93,474 shares of common stock for compensation;
 (5)We recorded $2,380 in expenses in connection warrants issued for services;
 (6)We recorded $219,673 in connection with derivative revaluation;
 (7)We recorded $26,740 for the computed fair value of options issued to employees, non-employee directors, and consultants, net of cancellations and forfeitures; and
 (8)We recorded $434,983 in connection with beneficial conversion features.

 

During the nine months ended September 30, 2015:

 

 1.We issued 133,333 shares of common stock for $80,001 in cash;
 2.We issued 91,500 shares of common stock pursuant to the cashless conversion of 75,000 shares of Series A Preferred;
 3.We issued 835,833 shares of common stock pursuant to the cashless conversion of 395 shares of Series B Preferred;

 

 4.We issued 770,000 shares of the Series C Preferred for which we received $700,000 in cash and recorded a stock subscription receivable for the remaining $700,000;
 5.We issued 1,050,000 shares of the Series D Preferred for $2,000,000 in cash held in escrow, to be released upon our uplisting to a national exchange;
 6.We issued 3,719,350 shares of common stock pursuant to the conversion of convertible notes;
 7.We issued 178,000 shares of common stock for services;
 8.We issued 93,474 shares of common stock for compensation;
 9.We recorded $11,025 in expenses in connection warrants issued for services;
 10.We recorded $342,257 in connection with derivative revaluation;
 11.We recorded $132,651 for the computed fair value of options issued to employees, non-employee directors, and consultants, net of cancellations and forfeitures; and
 12.We recorded $1,315,271 in connection with beneficial conversion features.

 

During the three months ended September 30, 2014:

 

 (1)We issued 26,580 shares of common stock for $19,000 in cash; and
 (2)We issued 360,781 shares of common stock pursuant to cashless conversions of convertible notes payable and accrued interest, valued at $150,858.

 

During the nine months ended September 30, 2014:

 

 (1)We issued 41,580 shares of common stock for $29,700 in cash;
 (2)We issued 444,072 shares of common stock pursuant to cashless conversions of convertible notes payable and accrued interest, valued at $188,358; and
 (3)We issued 122,000 shares of common stock pursuant to the cashless conversion of 100,000 shares of Series A Preferred.

  

As of September 30, 2015 we had approximately 33,488,420 shares of common stock issued and outstanding.

XML 23 R32.htm IDEA: XBRL DOCUMENT v3.3.0.814
Related Party Transactions (Details) - Julian Ross [Member]
Sep. 30, 2015
USD ($)
[1]
Summary of related party financings and notes  
Amount $ 222,417
Stated interest rate 0.00%
[1] (1) Our CEO, Mr. Ross provides us shareholder cash advances and other consideration from time to time to fund working capital.
XML 24 R2.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Balance Sheets - USD ($)
Sep. 30, 2015
Dec. 31, 2014
Current assets    
Cash and cash equivalents $ 6,312 $ 647,093
Restricted cash 2,000,000
Accounts receivable, net 830,596 $ 369,575
Inventories 390,028 277,346
License fee receivable 403,478 463,308
Prepaid expenses and other current assets 91,747 53,588
Total current assets 3,722,161 1,810,910
Property and equipment, net 89,544 91,537
Intangible assets, net 340,142 362,764
Other assets 276,692 246,237
TOTAL ASSETS 4,428,538 2,511,448
Current liabilities    
Accounts payable and accrued expenses 768,674 558,338
Related party payable $ 222,417 154,850
Capital leases - current 149
Notes payable - current, net of discount $ 47,103 40,897
Convertible notes payable, net of discount 1,132,808 606,932
Derivative liability 76,618 416,563
Total current liabilities $ 2,247,620 1,392,176
Long-term liabilities    
Notes payable 44,484
Total long-term liabilities 44,484
TOTAL LIABILITIES $ 2,247,620 $ 1,436,660
COMMITMENTS AND CONTINGENCY
STOCKHOLDERS' EQUITY    
Common stock, par value $0.0004 per share; 100,000,000 shares authorized; 33,488,420 shares of voting common stock issued and outstanding as of September 30, 2015 and 28,436,930 shares issued and outstanding as of December 31, 2014 $ 13,398 $ 11,377
Other stockholder equity (1,231,666)
Additional Paid-in Capital 25,418,546 $ 19,104,322
Accumulated deficit (22,020,795) (18,041,208)
TOTAL STOCKHOLDERS' EQUITY 2,180,918 1,074,788
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 4,428,538 2,511,448
Series A convertible preferred shares    
STOCKHOLDERS' EQUITY    
Preferred stock value 258 296
Series B convertible preferred shares    
STOCKHOLDERS' EQUITY    
Preferred stock value 1 $ 1
Series C convertible preferred shares    
STOCKHOLDERS' EQUITY    
Preferred stock value 385
Series D convertible preferred shares    
STOCKHOLDERS' EQUITY    
Preferred stock value 525
Series E convertible preferred shares    
STOCKHOLDERS' EQUITY    
Preferred stock value $ 266
XML 25 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2015
Summary of Significant Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

A summary of significant accounting policies of OxySure® Systems, Inc. (“OxySure” or the “Company”) is presented to assist in understanding the Company’s financial statements. The accounting policies presented in these footnotes conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the accompanying financial statements. These financial statements and notes are representations of the Company’s management who are responsible for their integrity and objectivity.

 

Basis of Presentation - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The interim financial statements include all adjustments which, in the opinion of management, are necessary in order to make the financial statements not misleading.

 

The accompanying Condensed Financial Statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (“SEC”) and therefore do not contain all of the information and footnotes required by GAAP and the SEC for annual financial statements. The Company's Condensed Financial Statements reflect all adjustments that management believes are necessary for the fair presentation of their financial position, results of operations, comprehensive loss and cash flows for the periods presented. The information at December 31, 2014 in the Company's Condensed Balance Sheet included in this quarterly report was derived from the audited Balance Sheet included in the Company's Annual Report on Form 10-K for the year ended December 31, 2014 filed with the SEC on March 31, 2015. Where applicable, the Company's 2014 Annual Report on Form 10-K is referred to in this quarterly report as the “2014 Annual Report.” This quarterly report should be read in conjunction with the 2014 Annual Report.

 

Deferred Revenue and Income - We defer revenue and income when we invoice a customer or a customer makes a payment and the requirements of revenue recognition have not been met (i.e. persuasive evidence of an arrangement exists, shipment from a company warehouse has occurred, the price is fixed or determinable and collectability is reasonably assured). Deferred Revenue was $0 for each of the periods ended September 30, 2015 and December 31, 2014, respectively.

 

Inventory – Our inventory consists of raw material and components for our portable oxygen systems as well as completed products and accessories.   Inventories are computed using the lower of cost or market, which approximates actual cost on a first-in first-out basis. Inventory components are parts, work-in-process and finished goods. Finished goods are reported as inventories until the point of title transfer to the customer.

 

Inventories as at September 30, 2015 and December 31, 2014 consisted of the following:

 

  September 30,  December 31, 
  2015  2014 
       
Parts inventory $207,605  $133,477 
Work in process  45,120   41,114 
Finished goods  137,303   102,755 
Total inventories $390,028  $277,346 

 

Cash and Cash Equivalents - We invest our cash in deposits and money market funds with major financial institutions.  We place our cash investments in instruments that meet high credit quality standards, as specified in our investment policy guidelines. These guidelines also limit the amount of credit exposure to any one issue, issuer or type of instrument.

 

Fair Value of Financial Instruments - Our financial instruments consist principally of cash and cash equivalents, accounts receivable and accounts payable.  We believe that the recorded values of all of our other financial instruments approximate their fair values because of their nature and respective maturity dates or durations. The fair value of our long-term debt is determined by using estimated market prices. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:

 

Level 1:  Inputs are based on quoted market prices for identical assets or liabilities in active markets at the measurement date.

 

Level 2:  Inputs include quoted prices for similar assets or liabilities in active markets and/or quoted prices for identical or similar assets or liabilities in markets that are not active near the measurement date.

 

Level 3: Inputs include management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument’s valuation.

 

The fair value of the majority of our cash equivalents was determined based on “Level 1” inputs. We do not have any marketable securities in the “Level 2” and “Level 3” category. We believe that the recorded values of all our other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations.

 

Property and Equipment – Property and equipment are recorded at cost with depreciation and amortization provided over the shorter of the remaining lease term or the estimated useful life of the improvement ranging from three to seven years. Renewals and betterments that materially extend the life of an asset are capitalized. Expenditures for maintenance and repairs are charged to expense when incurred. Furniture and fixtures are depreciated over five years. Machinery and equipments are depreciated over five to seven years. Software is depreciated over three years.  Leasehold improvements are computed using the shorter of the estimated useful lives of the assets or the lease terms.  Depreciation expense was $3,797 and $3,052 for the three month periods ended September 30, 2015 and 2014, respectively. Depreciation expense was $10,617 and $12,838 for the nine month periods ended September 30, 2015 and 2014, respectively.

 

Other Long-Lived Assets – We have two types of intangible assets – patents and trademarks. Intangible assets are carried at cost, net of accumulated amortization. Amortization expense for patents and trademarks was $7,508 and $7,557 for the three month periods ended September 30, 2015 and 2014, respectively. Amortization expense for patents and trademarks was $22,616 and $22,623 for the nine month periods ended September 30, 2015 and 2014, respectively.

 

Intangible assets with definite useful lives and other long-lived assets are tested for impairment if certain impairment indicators are identified.   Management evaluates the recoverability of its identifiable intangible assets in accordance with applicable accounting guidance, which requires the assessment of these assets for recoverability when events or circumstances indicate a potential impairment exists. If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. Impairment charges for patents were $0 for each of the three month periods ended September 30, 2015 and 2014.

 

5-Year amortization expense for patents and trademarks is as follows:

 

2015 $30,232 
2016  30,232 
2017  30,232 
2018  30,232 
Thereafter  188,982 
  $340,142 

  

Other Assets– We record Other Assets net of accumulated amortization. Amortization expense for Other Assets was $9,654 and $9,654 for the three month periods ended September 30, 2015 and 2014, respectively. Amortization expense for Other Assets was $28,962 and $47,216 for the nine month periods ended September 30, 2015 and 2014, respectively.

 

Capitalization of software: The Company accounts for internal-use software and website development costs, including the development of its partner marketplaces in accordance with ASC 350-50 (Intangibles – Website cost). The Company capitalizes internal costs consisting of payroll and direct payroll-related costs of employees who devote time to the development of internal-use software, as well as any external direct costs. It amortizes these costs over their estimated useful lives, which typically range between three to five years. The Company’s judgment is required in determining the point at which various projects enter the stages at which costs may be capitalized, in assessing the ongoing value of the capitalized costs, and in determining the estimated useful lives over which the costs are amortized. The estimated life is based on management’s judgment as to the product life cycle.

 

Amortization expense for websites and URLs was $9,654 and $9,654 for the three month periods ended September 30, 2015 and 2014, respectively. Amortization expense for websites and URLs was $28,962 and $28,962 for the nine month periods ended September 30, 2015 and 2014, respectively.

 

Research and Development Costs – Costs associated with the development of our products are charged to expense as incurred.  Research and development expense was $362,599 and $155,869 for the three month periods ended September 30, 2015 and 2014, respectively. Research and development expense was $873,450 and $433,384 for the nine month periods ended September 30, 2015 and 2014, respectively.

 

Equity Warrants - We issued warrants to purchase shares of our common stock in connection with convertible notes. In accordance with ASC 470-20, Debt with conversions and other options, the proceeds from the notes were allocated based on the relative fair values of the notes without the warrants issued in conjunction with the notes and of the warrants themselves at the time of issuance. We record the fair value of the warrants at the time of issuance as additional paid in capital and as a debt discount to the notes.  We amortize this debt discount as interest expense over the life of the note.  Additionally, as a result of issuing the warrants with the convertible notes, a beneficial conversion option is recorded as a debt discount reflecting the incremental conversion option intrinsic value of the conversion option provided to the holders of the notes. We also amortize this debt discount as interest expense over the life of the notes.  The intrinsic value of each conversion option was calculated as the difference between the effective conversion price and the fair value of the common stock, multiplied by the number of shares into which the note is convertible.

 

Stock-Based Compensation – We account for share-based payments, including grants of stock options to employees, consultants and non-employees; moreover, we issue warrants to the consultants and related parties.  We are required to estimate the fair value of share-based awards and warrants on the date of grant. The value of the award is principally recognized as expense ratably over the requisite service periods. We have estimated the fair value of stock options and warrants as of the date of grant or assumption using the Black-Scholes option pricing model.

 

For the three month periods ended September 30, 2015 and 2014, stock based compensation expense was approximately $25,740 and $42,437, respectively, which consisted primarily of stock-based compensation expense related to stock options issued to the employees and recognized under GAAP. For the nine month periods ended September 30, 2015 and 2014, stock based compensation expense was approximately $132,651 and $60,025, respectively.

 

Shipping and Handling Costs - Shipping and handling charges to customers are included in net revenues, and the associated costs incurred are recorded in cost of revenues.

 

Advertising Costs - Advertising costs are charged to operations when incurred.  We incurred $437,442 and $202,825 in advertising and promotion costs during the three month periods ended September 30, 2015 and 2014, respectively. Advertising and promotion costs during the nine month periods ended September 30, 2015 and 2014 were $1,231,581 and $444,818, respectively.

 

Net Income (Loss) Per Share - Basic earnings (loss) per share is computed based on the weighted average number of common shares outstanding. However, basic loss per share excludes anti-dilutive securities. Diluted earnings per share is computed based on the weighted average number of common shares outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive common shares been issued, and reduced by the number of shares the Company could have repurchased from the proceeds from issuance of the potentially dilutive shares. Potentially dilutive shares of common stock include stock options and other stock-based awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan. As of September 30, 2015 there were 21,865,386 potentially dilutive shares.

  

Recent Accounting Pronouncements

 

We have reviewed recent accounting pronouncements and concluded that they are either not applicable to our business or that no material effect is expected on the financial statements as a result of future adoption.

XML 26 R35.htm IDEA: XBRL DOCUMENT v3.3.0.814
Fair Value Measurements (Details Textual) - USD ($)
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Fair Value Measurements (Textual)    
Additions related to embedded derivative of convertible notes issued $ 416,563  
Excess derivative over proceeds 251,363
Conversions 28,698  
Gain on decrease in value of derivative liabilities $ 342,257  
XML 27 R22.htm IDEA: XBRL DOCUMENT v3.3.0.814
Summary of Significant Accounting Policies (Details) - USD ($)
Sep. 30, 2015
Dec. 31, 2014
Summary of Inventories    
Parts inventory $ 207,605 $ 133,477
Work in process 45,120 41,114
Finished goods 137,303 102,755
Total inventories $ 390,028 $ 277,346
XML 28 R36.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Components of revenue by geographic region        
Total revenues $ 1,138,380 $ 818,456 $ 2,809,553 $ 1,852,796
United States revenues [Member]        
Components of revenue by geographic region        
Total revenues $ 1,138,380 814,619 2,807,600 1,793,729
Row Product Sales [Member]        
Components of revenue by geographic region        
Total revenues $ 3,837 $ 1,953 41,567
ROW - license fees/service revenue [Member]        
Components of revenue by geographic region        
Total revenues     $ 17,500
XML 29 R24.htm IDEA: XBRL DOCUMENT v3.3.0.814
Summary of Significant Accounting Policies (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2014
Summary of Significant Accounting Policies (Textual)          
Deferred revenue $ 0   $ 0   $ 0
Depreciation expense 3,797 $ 3,052 10,617 $ 12,838  
Impairment charges for patents 0 0      
Amortization of intangible assets 7,508 7,557 22,616 22,623  
Amortization expense of other assets 9,654 9,654 28,962 47,216  
Research and development 362,599 155,869 873,450 433,384  
Stock-based compensation expense related to stock options issued to the employees 25,740 42,437 132,651 60,025  
Advertising and promotion costs 437,442 202,825 $ 1,231,581 444,818  
Potentially dilutive shares     21,865,386    
Furniture and Fixtures [Member]          
Summary of Significant Accounting Policies (Textual)          
Property and equipment, useful life     5 years    
Computer Software, Intangible Asset [Member]          
Summary of Significant Accounting Policies (Textual)          
Amortization of intangible assets $ 9,654 $ 9,654 $ 28,962 $ 28,962  
Property and equipment, useful life     3 years    
Computer Software, Intangible Asset [Member] | Minimum [Member]          
Summary of Significant Accounting Policies (Textual)          
Property and equipment, useful life     3 years    
Computer Software, Intangible Asset [Member] | Maximum [Member]          
Summary of Significant Accounting Policies (Textual)          
Property and equipment, useful life     5 years    
Machinery and Equipment [Member] | Minimum [Member]          
Summary of Significant Accounting Policies (Textual)          
Property and equipment, useful life     5 years    
Machinery and Equipment [Member] | Maximum [Member]          
Summary of Significant Accounting Policies (Textual)          
Property and equipment, useful life     7 years    
Leasehold Improvements [Member] | Minimum [Member]          
Summary of Significant Accounting Policies (Textual)          
Property and equipment, useful life     3 years    
Leasehold Improvements [Member] | Maximum [Member]          
Summary of Significant Accounting Policies (Textual)          
Property and equipment, useful life     7 years    
XML 30 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 31 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814
Notes Payable
9 Months Ended
Sep. 30, 2015
Notes Payable [Abstract]  
NOTES PAYABLE

NOTE 2 – NOTES PAYABLE

 

We have issued warrants for the purchase of shares of our restricted common stock in connection with raising equity and debt financing and for other professional services.  The fair value of warrants issued is determined in accordance with Codification topic 470-20.

 

Frisco Promissory Note. On March 22, 2011 we entered into an Amended and Restated Performance Agreement with the Frisco Economic Development Corporation (“FEDC”) pursuant to an economic incentive package. In terms of the Amended and Restated Performance Agreement, the FEDC provided us with economic assistance in the form of the renewal and extension a forgivable loan of $213,000 (the “Frisco Note”) together with performance credits over 5 years, commencing on March 22, 2011 and ending on the earlier to occur of: (i) the full payment of the economic incentives; or (ii) March 31, 2016.

 

The Frisco Note requires varying annual principal payments through December 2015. The Frisco Note is non-interest bearing; however, interest has been imputed at 12.34% per annum. The unamortized discount at September 30, 2015 was $4,897 and the net amount of the Frisco Note as at September 30, 2015 was $47,103.

 

Future principal payments of the Frisco Note payable are as follows:

 

2015     52,000  
Total   $ 52,000  

 

During the nine months ended September 30, 2015 we issued ten convertible notes with a total principal value of $1,683,500 for $1,461,500 in cash. The notes contained original issuance discounts for a total of $222,500, and interest rates ranging between 8% and 12%. The maturity dates of the notes range from January 7, 2016 to May 4, 2017. The creditors have the option at any time to convert the principal and any accrued interest into common stock of the Company at an aggregate discount rate of approximately 7% off the market price of the Company’s common stock. During the nine months ended September 30, 2014 we repaid two notes with principal values totaling $175,000 for $237,298 in cash and the two notes were extinguished in their entirety pursuant to these transactions.

 

During the nine months ended September 30, 2014 we issued eight convertible notes with a total principal value of $475,000 for $412,500 in cash. The notes contained original issuance discounts for a total of $62,500, and interest rates of 12%. The maturity dates of the notes range from January 28, 2015 to September 10, 2015. The creditors have the option at any time to convert the principal and any accrued interest into common stock of the Company at a an aggregate discount rate of approximately thirty eight percent off the market price of the Company’s common stock. During the nine months ended September 30, 2014 we repaid two notes with principal values totaling $167,500 for $207,000 in cash and the two notes were extinguished in their entirety pursuant to these transactions. During the nine months ended September 30, 2014 we exchanged a lease with an outstanding amount of $307,662 for a convertible note with a principal value of $150,000 and 75,000 shares of our common stock. The lease was extinguished in its entirety pursuant to the exchange transaction.

 

During the nine months ended September 30, 2015, we issued warrants associated with notes. In accordance with ASC 470-20, Debt with conversions and other options, the proceeds from the notes were allocated based on the relative fair values of the notes without the warrants issued in conjunction with the notes and of the warrants themselves at the time of issuance. We recorded the relative fair value of the warrants issued with the notes in the amount of $251,363 as debt discounts upon issuance, and amortized these debt discounts as interest expense over the life of the notes. Additionally, as a result of issuing the warrants with the subordinated convertible promissory notes, a beneficial conversion option for each note was recorded as a debt discount reflecting the incremental conversion option intrinsic value benefit totaling $133,637 at the time of issuance provided to the holders of the notes, which was also amortized as interest expense over the life of the notes. We recorded interest expense in the amounts of $270,361 and $0 for the three months ended September 30, 2015 and 2014, respectively in connection with the notes (issued with warrants) that contained beneficial conversion features. We recorded interest expense in the amounts of $355,101 and $0 for the nine months ended September 30, 2015 and 2014, respectively in connection with all the notes (issued with warrants) that contained beneficial conversion features.

XML 32 R3.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2015
Dec. 31, 2014
Preferred stock, par value $ 0.0005 $ 0.0005
Preferred stock, shares authorized 25,000,000 25,000,000
Common stock, par value $ 0.0004 $ 0.0004
Common stock, shares authorized 100,000,000 100,000,000
Voting common stock, shares issued 33,488,420 28,436,930
Voting common stock, shares outstanding 33,488,420 28,436,930
Series A convertible preferred shares    
Preferred Stock, shares issued 518,750 593,750
Preferred stock, shares outstanding 518,750 593,750
Series B convertible preferred shares    
Preferred Stock, shares issued 750 1,145
Preferred stock, shares outstanding 750 1,145
Series C convertible preferred shares    
Preferred Stock, shares issued 770,000 0
Preferred stock, shares outstanding 770,000 0
Series D convertible preferred shares    
Preferred Stock, shares issued 1,050,000 0
Preferred stock, shares outstanding 1,050,000 0
Series E convertible preferred shares    
Preferred Stock, shares issued 531,666 0
Preferred stock, shares outstanding 531,666 0
XML 33 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814
Notes Payable (Tables)
9 Months Ended
Sep. 30, 2015
Frisco EDC [Member]  
Debt Instrument [Line Items]  
Summary of future principal payments of Frisco note payable
2015  52,000 
Total $52,000 
XML 34 R1.htm IDEA: XBRL DOCUMENT v3.3.0.814
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2015
Nov. 13, 2015
Document and Entity Information [Abstract]    
Entity Registrant Name OxySure Systems Inc  
Entity Central Index Key 0001413797  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Type 10-Q  
Document Period End Date Sep. 30, 2015  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2015  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   36,220,761
XML 35 R18.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock Options and Warrants (Tables)
9 Months Ended
Sep. 30, 2015
Stock Options and Warrants [Abstract]  
Summary of option activity
  Employee  Non-Employee    
     Weighted     Weighted    
  Number  Average  Number  Average  Combined 
  Of  Exercise  Of  Exercise  Total 
Outstanding at June 30, 2015  2,513,838  $0.41   -  $-   2,513,838 
Granted  -  $-   -  $-   - 
Exercised  -  $-   -  $-   - 
Forfeited/Cancelled  (62,500) $-   -  $-   - 
Outstanding at September 30, 2015  2,451,338  $0.39   -  $-   2,451,338 

Summary of assumptions to estimate the fair value of options granted
  Equity Incentive Plans  Equity Incentive Plans 
  for the Three Months Ended September 30,  for the Nine Months Ended September 30, 
  2015  2014  2015  2014 
             
Expected terms (in years)  5-10   5-10   5-10   5-10 
Volatility (weighted ave.)  83.79%  40.45%  83.79%  40.45%
Risk-free interest rate  .85% - 1.74%  1.50% - 1.80%  .85% - 1.74%  1.44% - 1.80%
Expected dividend rate  0%  0%  0%  0%

Summary of warrant activity
     Weighted 
  Number  Average 
  Of  Exercise 
  Warrants  Price 
Outstanding at June 30, 2015  4,963,956  $1.22 
Granted  15,000  $1.20 
Exercised  -  $- 
Forfeited/Cancelled  -  $- 
Outstanding at September 30, 2015  4,963,956  $1.22 

XML 36 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814
Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Income Statement [Abstract]        
Revenues, net $ 1,138,380 $ 818,456 $ 2,809,553 $ 1,852,796
Cost of goods sold 580,126 321,932 1,325,165 792,378
Gross profit 558,254 496,524 1,484,388 1,060,418
Operating expenses        
Research and development 362,599 155,869 873,450 433,384
Sales and marketing 437,442 202,825 1,231,581 444,818
Other general and administrative 686,828 527,289 1,930,425 1,132,276
Total operating expenses 1,486,869 885,983 4,035,456 2,010,478
Loss from operations (928,615) (389,459) (2,551,067) (950,060)
Other income (expenses)        
Interest expense (626,127) $ (169,051) (1,519,071) $ (362,638)
Change in value of derivative liabilities 219,673 342,257
Derivative expense (47,091) (251,363)
Other income (expense) 1,407 $ 96,161 (342) $ 154,521
Total other income (expenses) (452,138) (72,890) (1,428,519) (208,117)
Net loss $ (1,380,753) $ (462,349) $ (3,979,587) $ (1,158,177)
Basic net loss per common share $ (0.04) $ (0.02) $ (0.13) $ (0.04)
Weighted average common shares outstanding:        
Basic and Diluted 32,425,195 26,120,974 30,543,678 26,042,971
XML 37 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814
Fair Value Measurements
9 Months Ended
Sep. 30, 2015
Fair Value Measurements [Abstract]  
FAIR VALUE MEASUREMENTS

NOTE 7 – FAIR VALUE MEASUREMENTS

 

Changes related to derivatives for the nine months ended September 30, 2015 are as follows:

 

Balance as of December 31, 2014 $31,010 
Additions related to embedded derivative of convertible notes issued  416,563 
Gain on decrease in value of derivative liabilities  (342,257)
Conversions  (28,698)
Balance as of September 30, 2015 $76,618 

 

During the nine month period the Company recorded derivatives related to convertible notes of $416,563 of which $251,363 exceed the proceeds of the convertible notes and was recorded as a derivative expense. The Company also converted $28,698 and recorded gains on the change in the fair values of the derivatives of $342,257.

 

Assets Measured at Fair Value on a Recurring Basis

 

     Fair value measurements at 
reporting date using:
 
  Total  Level 1  Level 2  Level 3 
             
Cash (1) $2,006,312  $2,006,312   -   - 
Derivatives  (76,618)  -   (76,618)  - 
Total assets at fair value as of September 30, 2015 $1,929,694  $2,006,312  $(76,618) $- 

 

(1) Included in Cash and cash equivalents on the Company's Balance Sheet.

 

  Total  Level 1  Level 2  Level 3 
             
Cash (1) $647,093  $647,093   -   - 
Total assets at fair value as of December 31, 2014 $647,093  $647,093   -   - 

 

(1) Included in Cash and cash equivalents on the Company's Balance Sheet.

XML 38 R11.htm IDEA: XBRL DOCUMENT v3.3.0.814
Off Balance Sheet Arrangements and Contractual Obligations
9 Months Ended
Sep. 30, 2015
Off Balance Sheet Arrangements and Contractual Obligations [Abstract]  
OFF BALANCE SHEET ARRANGEMENTS AND CONTRACTUAL OBLIGATIONS

NOTE 6 – OFF BALANCE SHEET ARRANGEMENTS AND CONTRACTUAL OBLIGATIONS

 

We have not entered into any transactions with unconsolidated entities whereby we have financial guarantees, subordinated retained interests, or other contingent arrangements that expose us to material continuing risks, contingent liabilities, or any other obligation under a variable interest in an unconsolidated entity that provides financing, liquidity, market risk or credit risk support to us.

XML 39 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814
Summary of Significant Accounting Policies (Details 1)
Sep. 30, 2015
USD ($)
Summary of Significant Accounting Policies [Abstract]  
2015 $ 30,232
2016 30,232
2017 30,232
2018 30,232
Thereafter 188,982
Total $ 340,142
XML 40 R19.htm IDEA: XBRL DOCUMENT v3.3.0.814
Related Party Transactions (Tables)
9 Months Ended
Sep. 30, 2015
Related Party Transactions [Abstract]  
Summary of the related party financings and notes payable
Related party Julian Ross (1) 
Amount $222,417 
Stated interest rate  0%
Maturity  n/a
XML 41 R15.htm IDEA: XBRL DOCUMENT v3.3.0.814
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2015
Summary of Significant Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The interim financial statements include all adjustments which, in the opinion of management, are necessary in order to make the financial statements not misleading.

 

The accompanying Condensed Financial Statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission (“SEC”) and therefore do not contain all of the information and footnotes required by GAAP and the SEC for annual financial statements. The Company's Condensed Financial Statements reflect all adjustments that management believes are necessary for the fair presentation of their financial position, results of operations, comprehensive loss and cash flows for the periods presented. The information at December 31, 2014 in the Company's Condensed Balance Sheet included in this quarterly report was derived from the audited Balance Sheet included in the Company's Annual Report on Form 10-K for the year ended December 31, 2014 filed with the SEC on March 31, 2015. Where applicable, the Company's 2014 Annual Report on Form 10-K is referred to in this quarterly report as the “2014 Annual Report.” This quarterly report should be read in conjunction with the 2014 Annual Report.

Deferred Revenue and Income

Deferred Revenue and Income - We defer revenue and income when we invoice a customer or a customer makes a payment and the requirements of revenue recognition have not been met (i.e. persuasive evidence of an arrangement exists, shipment from a company warehouse has occurred, the price is fixed or determinable and collectability is reasonably assured). Deferred Revenue was $0 for each of the periods ended September 30, 2015 and December 31, 2014, respectively.

Inventory

Inventory – Our inventory consists of raw material and components for our portable oxygen systems as well as completed products and accessories.   Inventories are computed using the lower of cost or market, which approximates actual cost on a first-in first-out basis. Inventory components are parts, work-in-process and finished goods. Finished goods are reported as inventories until the point of title transfer to the customer.

 

Inventories as at September 30, 2015 and December 31, 2014 consisted of the following:

 

  September 30,  December 31, 
  2015  2014 
       
Parts inventory $207,605  $133,477 
Work in process  45,120   41,114 
Finished goods  137,303   102,755 
Total inventories $390,028  $277,346
Cash and Cash Equivalents

Cash and Cash Equivalents - We invest our cash in deposits and money market funds with major financial institutions.  We place our cash investments in instruments that meet high credit quality standards, as specified in our investment policy guidelines. These guidelines also limit the amount of credit exposure to any one issue, issuer or type of instrument.

Fair Value of Financial Instruments

Fair Value of Financial Instruments - Our financial instruments consist principally of cash and cash equivalents, accounts receivable and accounts payable.  We believe that the recorded values of all of our other financial instruments approximate their fair values because of their nature and respective maturity dates or durations. The fair value of our long-term debt is determined by using estimated market prices. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:

 

Level 1:  Inputs are based on quoted market prices for identical assets or liabilities in active markets at the measurement date.

 

Level 2:  Inputs include quoted prices for similar assets or liabilities in active markets and/or quoted prices for identical or similar assets or liabilities in markets that are not active near the measurement date.

 

Level 3: Inputs include management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument’s valuation.

 

The fair value of the majority of our cash equivalents was determined based on “Level 1” inputs. We do not have any marketable securities in the “Level 2” and “Level 3” category. We believe that the recorded values of all our other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations.

Property and Equipment

Property and Equipment – Property and equipment are recorded at cost with depreciation and amortization provided over the shorter of the remaining lease term or the estimated useful life of the improvement ranging from three to seven years. Renewals and betterments that materially extend the life of an asset are capitalized. Expenditures for maintenance and repairs are charged to expense when incurred. Furniture and fixtures are depreciated over five years. Machinery and equipments are depreciated over five to seven years. Software is depreciated over three years.  Leasehold improvements are computed using the shorter of the estimated useful lives of the assets or the lease terms.  Depreciation expense was $3,797 and $3,052 for the three month periods ended September 30, 2015 and 2014, respectively. Depreciation expense was $10,617 and $12,838 for the nine month periods ended September 30, 2015 and 2014, respectively.

Other Long-Lived Assets

Other Long-Lived Assets – We have two types of intangible assets – patents and trademarks. Intangible assets are carried at cost, net of accumulated amortization. Amortization expense for patents and trademarks was $7,508 and $7,557 for the three month periods ended September 30, 2015 and 2014, respectively. Amortization expense for patents and trademarks was $22,616 and $22,623 for the nine month periods ended September 30, 2015 and 2014, respectively.

 

Intangible assets with definite useful lives and other long-lived assets are tested for impairment if certain impairment indicators are identified.   Management evaluates the recoverability of its identifiable intangible assets in accordance with applicable accounting guidance, which requires the assessment of these assets for recoverability when events or circumstances indicate a potential impairment exists. If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. Impairment charges for patents were $0 for each of the three month periods ended September 30, 2015 and 2014.

 

5-Year amortization expense for patents and trademarks is as follows:

 

2015 $30,232 
2016  30,232 
2017  30,232 
2018  30,232 
Thereafter  188,982 
  $340,142
Other assets

Other Assets– We record Other Assets net of accumulated amortization. Amortization expense for Other Assets was $9,654 and $9,654 for the three month periods ended September 30, 2015 and 2014, respectively. Amortization expense for Other Assets was $28,962 and $47,216 for the nine month periods ended September 30, 2015 and 2014, respectively.

 

Capitalization of software: The Company accounts for internal-use software and website development costs, including the development of its partner marketplaces in accordance with ASC 350-50 (Intangibles – Website cost). The Company capitalizes internal costs consisting of payroll and direct payroll-related costs of employees who devote time to the development of internal-use software, as well as any external direct costs. It amortizes these costs over their estimated useful lives, which typically range between three to five years. The Company’s judgment is required in determining the point at which various projects enter the stages at which costs may be capitalized, in assessing the ongoing value of the capitalized costs, and in determining the estimated useful lives over which the costs are amortized. The estimated life is based on management’s judgment as to the product life cycle.

 

Amortization expense for websites and URLs was $9,654 and $9,654 for the three month periods ended September 30, 2015 and 2014, respectively. Amortization expense for websites and URLs was $28,962 and $28,962 for the nine month periods ended September 30, 2015 and 2014, respectively.

Research and Development Costs

Research and Development Costs – Costs associated with the development of our products are charged to expense as incurred.  Research and development expense was $362,599 and $155,869 for the three month periods ended September 30, 2015 and 2014, respectively. Research and development expense was $873,450 and $433,384 for the nine month periods ended September 30, 2015 and 2014, respectively.

Equity Warrants

Equity Warrants - We issued warrants to purchase shares of our common stock in connection with convertible notes. In accordance with ASC 470-20, Debt with conversions and other options, the proceeds from the notes were allocated based on the relative fair values of the notes without the warrants issued in conjunction with the notes and of the warrants themselves at the time of issuance. We record the fair value of the warrants at the time of issuance as additional paid in capital and as a debt discount to the notes.  We amortize this debt discount as interest expense over the life of the note.  Additionally, as a result of issuing the warrants with the convertible notes, a beneficial conversion option is recorded as a debt discount reflecting the incremental conversion option intrinsic value of the conversion option provided to the holders of the notes. We also amortize this debt discount as interest expense over the life of the notes.  The intrinsic value of each conversion option was calculated as the difference between the effective conversion price and the fair value of the common stock, multiplied by the number of shares into which the note is convertible.

Stock-Based Compensation

Stock-Based Compensation – We account for share-based payments, including grants of stock options to employees, consultants and non-employees; moreover, we issue warrants to the consultants and related parties.  We are required to estimate the fair value of share-based awards and warrants on the date of grant. The value of the award is principally recognized as expense ratably over the requisite service periods. We have estimated the fair value of stock options and warrants as of the date of grant or assumption using the Black-Scholes option pricing model.

 

For the three month periods ended September 30, 2015 and 2014, stock based compensation expense was approximately $25,740 and $42,437, respectively, which consisted primarily of stock-based compensation expense related to stock options issued to the employees and recognized under GAAP. For the nine month periods ended September 30, 2015 and 2014, stock based compensation expense was approximately $132,651 and $60,025, respectively.

Shipping and Handling Costs

Shipping and Handling Costs - Shipping and handling charges to customers are included in net revenues, and the associated costs incurred are recorded in cost of revenues.

Advertising Costs

Advertising Costs - Advertising costs are charged to operations when incurred.  We incurred $437,442 and $202,825 in advertising and promotion costs during the three month periods ended September 30, 2015 and 2014, respectively. Advertising and promotion costs during the nine month periods ended September 30, 2015 and 2014 were $1,231,581 and $444,818, respectively.

Net Income (Loss) Per Share

Net Income (Loss) Per Share - Basic earnings (loss) per share is computed based on the weighted average number of common shares outstanding. However, basic loss per share excludes anti-dilutive securities. Diluted earnings per share is computed based on the weighted average number of common shares outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive common shares been issued, and reduced by the number of shares the Company could have repurchased from the proceeds from issuance of the potentially dilutive shares. Potentially dilutive shares of common stock include stock options and other stock-based awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan. As of September 30, 2015 there were 21,865,386 potentially dilutive shares.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

We have reviewed recent accounting pronouncements and concluded that they are either not applicable to our business or that no material effect is expected on the financial statements as a result of future adoption.

XML 42 R13.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment Information
9 Months Ended
Sep. 30, 2015
Segment Information [Abstract]  
SEGMENT INFORMATION

NOTE 8 – SEGMENT INFORMATION

 

We are organized as, and operate in, one reportable segment: the development, distribution and sale of specialty respiratory products and related medical products, accessories, and services. Our chief operating decision-maker is our Chief Executive Officer. Our Chief Executive Officer reviews financial information presented for purposes of evaluating financial performance and allocating resources, accompanied by information about revenue by geographic regions. Our assets are primarily located in the United States of America and not allocated to any specific region and we do not measure the performance of our geographic regions based upon asset-based metrics. Therefore, geographic information is presented only for revenue. Revenue by geographic region is based on the ship to address on our customer orders.

 

The following presents total revenue by geographic region for the three month periods ended September 30, 2015 and 2014:

 

    Three Months Ended
September 30,
 
    2015     2014  
             
United States - product sales   $ 1,138,380     $ 814,619  
ROW - product sales     -       3,837  
                 
Totals   $ 1,138,380     $ 818,456  

 

The following presents total revenue by geographic region for the nine month periods ended September 30, 2015 and 2014:

 

    Nine Months Ended September 30,
    2015   2014
         
United States - product sales   $ 2,807,600     $ 1,793,729  
ROW - product sales     1,953       41,567  
ROW - license fees/service revenue     -       17,500  
                 
Totals   $ 2,809,553     $ 1,852,796  
 
XML 43 R14.htm IDEA: XBRL DOCUMENT v3.3.0.814
Going Concern
9 Months Ended
Sep. 30, 2015
Going Concern [Abstract]  
GOING CONCERN

NOTE 9 – GOING CONCERN

 

Our financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. Historically we have been suffering from recurring loss from operations. We have an accumulated deficit of $22,020,795 and $18,041,208 at September 30, 2015 and December 31, 2014, respectively, and stockholders’ equity of $2,180,918 and $1,074,787 as of September 30, 2015 and December 31, 2014, respectively. We require substantial additional funds to manufacture and commercialize our products. Our management is actively seeking additional sources of equity and/or debt financing; however, there is no assurance that any additional funding will be available.

 

In view of the matters described above, recoverability of a major portion of the recorded asset amounts shown in the accompanying September 30, 2015 balance sheet is dependent upon continued operations of the Company, which in turn is dependent upon the Company’s ability to meet its financing requirements on a continuing basis, to maintain present financing, and to generate cash from future operations. These factors, among others, raise substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should we be unable to continue in existence.

ZIP 44 0001213900-15-008716-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-15-008716-xbrl.zip M4$L#!!0````(`,>`<$>XL7^A&)0``#=V"``1`!P`;WAYWTGGIS6RZDTVZ=V9K]U:*!L71'0P>`4D\M^K^]BOA-V$#QB"PL34U M-1,#@N<CU7B$.4>"?'8%CZ:@'?2=PD3\X._K^[;IO'O7^ M^O'GGS[\I=_O?88^Q'8$W5XN=?_KO7[\]>]0%\C&8W"-WWW]@#YW2__8(-C\\ M#=['X=G12Q2-3D].WM[>CNF%&,-P'$9P&!X[P3#YE&0ITM'//TU+>A#[AHGDAMH!^,KF9>GSE$V]*\CRP+.LDN9MZ M/$19#Y.7@Y/?OMP^.B]P:/>1'T:V[Q!<*5BH0)1%D449%`:J#(RB4I,GV$)^ MX/OQ,+N,&^&3:#R")^2A/GD*8N2DRJXON%HHT6F4J7!MHO"(?=P)8C_"X_3S M(72.!\'KR?0F98+2ET!?`:FB,<:$UWEEIW=I876UL`M1=CER(Z<(?'=>LLO0 M.PE=5PLA_Q6&47:QR;T06+096BX7(R2Y$;N05B48XIPRYDU,H M#OL#VQ[-RSW;X8^DGJ+#8#)R,<#"".$($\L+P3%Y`!3D["M%P MY,VOO6#X?'9$S5Q_9MB.WT/WJ'"'T(Q2-%[^12Z\\(XA[ MB3[2XL\8<7'S]Z./$C%O*E`,R_APLER8OO`D^PM$6RAPF2\F-BXB%RC&/OE7 MD1:E%W=G5Q;E3U(Z*5;211Q&P?!)`AW5$M$"CBY)!\WH20*+\NS].6AWJ0"K MV,7=>HJ=L$^6G[[85'\`I/2:>?TV\`<1Q,-+^"/Z1MK(^3L*GZXQ"IW@'@=# M%(8!'G\-(O@%#G]`W$X]3-4(!T/HST5VR2??1QYR4#3!TG,1N3_QJ*8F[C1+ MG*./M(F?Y@OUX23S_8SV&2@56A(UUDI?EAMK2;(D:GSK-9ZV"M,ZETI;A562 M\+4*"GBZA`[E@I*VMAG7=\K:IEJ2T@$H(L> MII3$@EB%IN=TKG3LDFJ3CQ/#>'MOD[VY0*%,DEC0%LAT46:PI M66Q_+X9YH)M:%<.\`Z]T,9UE5ABF+>%85YG MR3(S[!>>'89WSX]1X/R>$.:1`(#A^3V&SQ!CZ"9W.D*7/*$6E"F03A"&FW7Y M]A9TA#'9!B;Q;=;))OC"C2]W_M1H/]&G;_PPPC'5W,1QAB-[3'_=/2=EY@_O M(;GFLA60J_3W5W4Y\]KS-"HHO1U*[[.]W`ZEA95NL%<_="M=AES"2N\=I??9 M2F^'TL)*UY]4[@@EUT\D'R`3YME3JW7>A?7Y5*3ZBI)X1:IOKB0Q6='*9$6K MU3_/VEBJ_HSKN]Q&&LKFV%Q)8@:XG1G@G:W_\S<;NW/;^*N-,0'2C5I.05_4 M;$J&`Z[+J^'("\80)LR^&]%$[D[7:ZX\!U7'Z^SUI[VVUYG2B?IGZO]BK^L_ M4SI1_TS]7^YU_6=*)^J?J?^KO:[_3.D.JOX?()U0=:(8(W]P$80TI(Y<@_@U M[?5-Y[/WQ"5<(_5T]B,M.X\I;.&*UJ#BU\#/5=1A$;-($X*F#=/TVD;XG[87 MPT_C^9]_(Q5O8^=E?`M?X60-97[OQA_%49C<`-T@83D)%[PH$%4PHQPSY,-A MABR8L0DSE,-AAM)U9J1SZ+6<%45M-Y>4EI:SM4V3S;5V=B98KU61%GW@E2[2 MH@^ETD5:M*A^D18M&)++$)$6OO27N=*K>K83@;K:05R,^C(%\HM.?(\(O+>=^!8(+#KQUD,0#\(6UPU-%%:YNZ3>6_N\55(+2]U( M3.\^GZC:YMFF7>:+.`AR/YFP?,9AQS)Y4YNVKBBIJ8,@JRY`76,4.@'I3X^TI:3?Y0C71D':VPD7B0_NGI.Q2_8L\AGVMR\Y&/>U"O-'. MUK'(,CAL>RV2!D3]BQP`4?]B=[O#K'^1TG%H*1V=I:+(T#BD#(V=I:DXU7"7 M3C7<$V:(4PT%,\2IA@?(#)&AU4*&UL[6OH@_:2/^9&>K_P%Z=@3=>QM'XV_8 M]D/;H4YU^&G,WIEPX@7!YZMWZ,01>H5WS\_(@;@;="@O)1,_ER_N03&D.+N; M_!P&/C-UM>?+[\5YX2O:X#$4%DO_6^-JMY<>=YFK8MFSFN/5U=#UAARR\A[` M%H+4]YAZ74H%VD7J-9WTTR;U@/+T-7A=I5[6]5T.60:@#Y2J2OI+O]_[[J.H M]PB3H46OU^_/KO_\T\W_@?]<__/^;_`=7FJZ8?[K`?Z!/MZ\_`Y?KWY'^/W- MLAQ551U-TYQO__OR\>SJPXUQI>G@ZL,'`YBG_W4%SL[.3H%U\PN]HYF_7)O3 M#TR0Q/33M&K"%QM#PK3I]2&TPQC#CU,>)3=GZ&?W9K_I.S+>^/WQ`G]8(C\K->6 M55#J%2=I],62+YN:%:5F&J0-U3N*&:VF9:.WUKV-LO7*2QRX%)$_N!"=7B7- MZ0$.4!C1<-2O]A#VIDW@`3[7.9'L[GW\2/#T'L]D`Z%UQ!,&_9D% M9/Z==).\1A[$%T1-@P#S:I"/0]LC;^T]P!'QYI`_Z-%QK>V/V?:9^O"2F5B, M=I.N)[R+(]J_N_1561`K^#8]:D:3ETQ[X9X+'42`AV='-U^OCSXJNBQ+A@Y2 M-J4`&!5A/ERWPY=SWZ7_H^/Z5]M+AO31A8WQF#R;K&052**`ITOH4,1J6MT9 MUQE):._/B$%J0E<-R2*\W`@85TDV29$KE$0!<@TYDD`9Y$30W6;=O(?HU$?> MV5&$8WATTA!`7BJ7I>2?A=8WQ,B*=^XD1]:%#]"!Y''J,<%HVE>UT1`4W=(, M;2%*$1X>N'G5@:E(FJ5OCON&>*9^1/,*82OZE0U#41F<[/>KX.*E/\62)-G, MQY7X\;?(@7X(KR%"E?PL8JE%9B-9U#DP@68#I1NI#XV8= M#%D&U,5;"RUW-Y>6[*L%-"55Y_EP>,#FUGU9FJIN#GMI^YN0W+YZ=[R8^MF? M@\!]0Y[7CM<@&[K*]A[K0.DDWNM*%$#0%7-92NW&1ANSH,JFYI2#&;JXT[7=XB=(%?(@,F] M1?8/Y*&(9F*VZ#-HII("7!Y>`U+QJ@=#-W5#Y2T5$Z'5;B4!334U*5><3%P\ MY>!F1F19!49U.2[L$8IL+]FT^^Z'AP9V$CO79DVH%CM/4P2'#_`:JB^8CV%7 MF-L<"TJFQ51_!HH:(+G9<`-(2FF0.!>0DS&W#3H=3N=HPIT36>X4(2'!VY^W9\.S,UA;T?)0+%D8#"S:SQ!\NNY M5$.7I=(@`W]`XWS:-@DJ\809MR<+1AV8S71&,Q0T*"J9=L_L*[>HOF)@?$5I M2,4+MK;C)2FZKF>WE@JPVFC$Z5YR.$31,%GT(95(P"!_`'VG.>T55%U%,,WP M*!TJS7,QL6*R1F%ULTM+&>H$].P=BAJ# MWOQFJ,53?V93+:'Y70.WTL";WPRO<*+>U+H@6*GFGYY$E3LA6"GCD&YA>ODN ME`D?:RT"#`#%,-@IA32$JO"XS7DHBF46PTO"#))+]!1"B">9V=@GHXWPW''B89Q,SE_"9YH8U(:J^\"45""S)^, MI;>CUY7UZG6@>`G0V!KW)@*D?8A[&]_AQ&MQDP[Q'N(D\KR1>F"2O1B!U*./ MTK$D2;D.7!Y&OE)5KIQ]D:JES3U*Z$XFMN^8#0P_-,V5&*]F:R[I-7AJ;I*& M7L@&)@?$2H9@2Z*D+K+3XO%0H0?SX=?EI'3S=A M&'-C:E,R:Y9B:&NH,1%DM\1=9YIRQ"4>5VY/N+O"KIM@RQ&V@]6Z;L9M?R1= M-P6W74G;G,[/LTS`;,TRM3G)GR-N)V6M:)@,8[T_LHOB5K1.0-*Z*6]%&Z5- MYW#KBULN(;XK?E1.%OV."-Z81[7;8C?C6^VVS,UX6;LMI%^VVY(WZ*'E[?FSF(W;H44;)E:[!$".\C2T7,-%GJU- MF@-)6IYR+H#%`3W7^7*.Z+E.*968Z3=51;>4(N"KXZX*H+FJ6U%4TU3EFJ#Y M>Y1B#;5=7!1?`[\1]N#X0-\A7X,Z3X*8=XV&\IT3[W8R]#Y''3)>`D3 MF*K&=%I9*"JA3._\5Q,E,#79L)J`F59F_21,4S&EQK59-ZS'E"Q-4\K#I(=# MWCTG=QX#+]N*<66E(H.EW-L4@$VQ<>6B8 MBJK+*I7X"^9Z1=&#;>GY@.>^>TG/_PN2K:.F^YXUSS%`=*UL4PJF'FRL/ M5451V)S=!G%SI:JBRYJU#7W7W?/,4%1VOJPT[D?H><2A),]]L?'OD&:QMD9N M69)--D4G'TL-Q'QIK:IF*JZY"<1<":TJALKNPM:"CNM:9ED!F@DVA9QDHWR& M/L2V1S>2X,"OK,#IF:9S$!Q!<+F^+@2G#PI MJ>Q@C`-`OC,"*N$NZ_AQUV#]_9BUU`10.8`WOA,,X2UQM9LG85\Q+57+TN$" M11607)G8MS1)8O=DX022*QO[EFSJ0&M8D[43^C2-#'^-TBAO"`@,PQ8'<[HE M:8QCLP2@:6R;G>I7(@U=XB8*UR9%QG"Z8FX-VPZKF:]W)>M`-K:&C;N:94-2 M='ZMDZ\/J`%+,K8'CKNR%6JKR\GSWN>>,,AZL9D(&E&XRKOP807U76G>U395DS*F%G-N]<>JQM0FZ(I$$NUM)) M[>V!)8NQ)_E0N*FN]@X@0,G9Q+8`\=?`#V9>+>5H2!]N8T1OZ:DS2W)P5(7* M=_:*#$SEYK!R'N=+1DM:K3N\4MAIY`V13@9@K0VT^G025LI&FX)2'2_?20!9 M,@'((0(GP'PG!&@+8\=8C6NX]EY6='L48&V*&$:MSEC1DV?8HPQ2W]\,&%^" M`KHDP^[I5@,97R82&DH&&Y3$36>U#:9E6)I91F>S#:=F(<2?[!`Y#=`M=V>5 MOG0L,=8]$T\UP/5H6`A8;01P/79N`7`]TA8!!LH&@'^%:/`20??\E1C5`?P: MTSF`N^?D829R-2E'HQ*0%TI'_0I>4A/4K]S^1Z"_/V&G%_V`'Q>E`-"%%W2DF1%:NZ$.SUNVMK`VKJD6>W[F6DB\\=>.%P::S%J_C02@MV_\,,(Q#9B[A`ZF MIX1;%5^\.^;F8RKHC)NH>!PZ$ M;FN*Y`&D_M+T9+)O+9;LVBF\F=*S>]6!\1YQGXM)(8!D[`4NKORIW'Z M3,,VXJ&I^[D6""^TM4VH`6@T<2F\\R6\,(QMWX&SO&C?_=7&V/:CD%B&1XA? M$:']';[P;#1LW8KR!E<[X4MB(_HV0I>*TYT.Q:!+MVDDU93OY?!-?9%5=FO& M;!@5@7)M=[H,&@/*=QE5-Q2]%8W6IJXEL:&=^4@3Z\%DL4X2AR]C3`8C]\1& M!Y.\^`FQ>(46=B3_Q>&>>[XT_.S'Y`3J0^!YYYS7RSD6QV)C,,J@: MD*+NNKU.ND*)IQ0W/AF$1`%NQ:\#('6D:R$:GK!K&W%9-^4-<">&:/6I6V)L MB&]X#>&B=HJ.?^5K58A-L>2ID=P(6V,2U;7[-&M"JBI1?F7>8S@BWOO,D\\_ M08AO_9B&9!0V[2QGE=$.T MZ58C;03D6&SZXUI$O.%S=5>_PNC"#E_N1I/&WL%>-I+.)2N6A-290W?T1=':G%D[RW/B1[0]H]D.#/?A2+K!9 M(,4R'M[@V[!*=-P1MF^5)',I[*XDML8DJFN4TH2O)M!L4>H:!\/%%#4S'=7" M8K2ELV[46D2\X=9SL+`JJA+>WUG0N&'^;:.;C:\C&*I4`_P-&T.JBI M;UG1P)*EM&G(!=,FYLWRB>_\:4KQ4SKR*"DSAWKWG)29/URLER4"[K]>OKT% M99+@%4.VS([K92XJ1[[HAM9YOFRDEY)\D8SVVU%=0UZU[;NQ,XDAG6O]PAZA MR/9NZ3S?W0\/#9+@AS;<$E5-25`:6G,2U`V*53N"4[/D.F)-(H\R"Y$K#Y#T'<@A(PMZ+U.E+1`&=>+`_DT M(]EF9!--;2%>HA("K#B;>9#CQ8Y*I MPR%="9_,,H*V]5$;3=U0#S8IJQA,?GCN=8"GP3:-A@LO9<1)\ZFU$H`X@^?* M2#JH6:A^.MJA3MM\+)A40S/<3!LRTU0T9J:A++*&I*F_:;EJL(=/51'GW/V? M.(QFR[2NB^@`Q_:H\;KQI\.?I0'JKRAZ67SF&MI1G'-$7H.&I47<==?C5$5C M8Z9Y(6<"2LDK[/]O[UV;V\:11N'OJ*UIX';QS7`V24OP?6#(RS M0QX5SYT9SM]5A7ZC*CZ@,?E%F1G>O>6\5=KSIU\4!.?,L`&5MPK*DS59_`(@ MVZ[W5OD?UKV0/Q1XAN-/8(ZWBN,ZA']K.29!".A@-@G`;SOSYP9NH?$YA.@7 MY='US.1;^NCCU`H(_8X(SUFF^^@#.K\HB-<9V!L2C*?)`V>/9/3#`EAP:OC5 M_4'.X*5@RD;]*2+/"#]\N;Z[4C3E3+G]_?/GBYO_*M.;FWH6RK9SE-H:TQF__R M/UJ_71=]3D\<+Q0_G`&."\6=*'YB,A0CMAG*G!L-?.3Z:7$+5IE3>M#]1;E= M^`&9`<%@4]!27K-?AKK>_B7U+'P#@+J>$DR)(CR$J6V&LQ`>^EFQ?&4.^RL@ M%3&5P%4,W[?\0+$<,)`FK`Y1!TD<:NE];?"+KTS8,1FPUX_Z"OLMY0Z>SL(J MF0HF@"%]`O1T`P>/ZM$\(A*LI?!=E>(BA]\(Q:A"45 MR]0:RXGL`,KU([BIU1D#C]"8T92&@;&9&3^(@A&$,_H"ZA)8P7`V9YH:3`TP MT9,)*!<='I!P<1.D&'3O0V\.$<2.%SS45>4-[/-P>GR%1 M8Q23QG:EWYG34_"6\`QM&H\6VJ9B6H"`ITQ`7N$MUQ<09M8:;8EG MS?*8,K9#$V"P;<5(-ALH8N.IFC"<,\"=6P[G<4)IE1HRAV#5$%P#X5F068`I MXD`N=<"(*C/+MXF!*Y&T;=*VU4BRN^5U'S9J)BJ=J7R(A?,V$<[$N6#6C9DA M',$S,3"6F;"T2GOT_@,^=A?8]!N0IHP4= M[9:,P2`QDP>O7SV-IX9S3[T;4%P\84BA+S!.55!. M/3(%)C9H0SP?6QT$#SPR^P))`^4]P(G1,DI'4Q4\M8G6 MU"SRO#-L*E2W4T*":(W@JS"X!7^&!JQ+'D@Y6Z*41P,6+CP_@8?X0@2Z%II4 M-=8-)DY_P1AYPX8$J"/)_;\QJ@MB>`IQ\/55?":6#=_'>H#R`8-\QBZCT4.] MEO(-I9'M$,886$!ENC=N62Q/"7]VBK([?$3=U=YC#^E"[R M(_0&#)/[4'^$#M7O!-FLL1N^+LC%])@7TWBC$.6.*C>"-\MN-I6SK`W#-U@' M\)V4^VNQ%Q[!WBF/:+L>7`M,AJ&,@5KPBX=G'L)?Z%:"051X8)S@9M/5@MEM MP<7VR-B]=ZC%9>LZKD-T;9^!37IMM4@+[:@?&M3<$HP70IN%&P`PGYA,P8T_ M>;+\`-D\Y:F!U-X9"OK3P!Q0`E MDP`K9[`JX/:?VG?7QC6(;306S-H8OHL/+.C>!0;[N:6L4!TM\*LV-93$`(/' MU]5H;6`V\Q8]$F8TV\P>TCE73"E=E.;TR('8M1TY2*/Q;(U&5+QED64@XA,S MF.LZ1$^8/QP=\C'--AX5W.1ZZ$TQS9G-`7E4?-0"%][$=9!JEONT`,]<\=DA M*Z[-CP2=/)^^!;3!3;;G8DPG/R48HU='J\NT!!@S/HEE<0QZ13B;TUK+H1_M MX\%;0P,V@=_\`+5^1MM$JVR3C;Z(YSY%1Q1LB\^>!,L#IL+SD9?\@QN"W<*S MF9;R4:!+C#J"`'L5M%#`VA_PXMD!;/00C]8^#LZSN0G M%7Y,>D0.]S`V,RHN;$ZHA;$"("Z3/K;=QY\C(RWMQO'8C9 MT?.WHJM9?#=@QB=UL,BZCPAU@U@@Y?84B98B%5N,U2[](WIN>X9.J#'W@1C1IPQR6'^1,W9*$DV]'9F4 M,2S%'`R,T:!_SPW3Y'_'Q/,BRM%H%R!6)"PC-X`%)R%X8&;(*_^2_BRRX&QB MS"Q[\7:SL-*G'VDO`YS3-C/U(FL>4;+'>$3C\=%VF1MY`V1SL!D*3AF;PP0@ ML(L'Q_VD:!RM+0*)M4.1^$W@U:@:7`'/V`"@]JW>/*B`H@?D9F3=&$IG?&49 MV<;XQ_)OD:5E2*=_HQ"^57S7MC(D!-V0IA)5\G1KGG:;1=1Z='\+/GH(\BK% MMI_D\#"4H2ULQ<<_[CTW=,Q(]OYG/"9D,A')'@T22:!VKBW[NS:9E!4:.@'6 MS4BVZ8M<>D53]W'B\M,4X$AJABI0>[5QJJZ^/!<3A2TFT]L#M=_.M]R58U>" MHKW:>=;;(\]61']KGFF=CMH=#/:'75TF@VX_LPQ&%4!_<[T?>&W(3P&K<5:W M6?)KU)1*Q*G;4S6]?6A4)!LT55OC;C59C]HD:_24OGPM?/LOXFV.+8VA, M[`V2AX;FT;)7&&1#/P@UJ)0S2LQ1FL#?:"0OP5"VT&.I"Y:CF(0F/["`M!G@ MO>`!<?!;7/C#]<+Y7\`H0,0IH"?PU?`4#8:T)3R=V>3PB&Y=E/R^4^]`R MB6TY)$X;3KY1#-MW%=N:62QCD.7_T6A`-BMY`G)@<1%,CG86"A!$L;`:C\K^ MH:'/P6).@Y$3)&1TG=3NBK7[`R8NT6HH*&I)BM1'07,R0_HQ2C>MJM'C//0N MRGRCF7$H^I$=H1](8D?4*%T.X][C)I\\(I=]/V>U@O.,`$_.8BK.4@(P1P[4 M]P$Q8SF]+/$,E=FE#?JR@1<"YCARY*\6)Y6,F8$D^V"=X5Y`6`J1P'F`$1I`BP-CD461UF^9F0] M:78!#'J1G;$\(P;-'L#026%.&K,,P]S#CO4O'!\[)6/H\>.44-H`Q)@LP;+T MYB&/,79'H!R,.SR1BT,196*8Y-XC`ALRWV44B*?/R!\7^8$+`Y\,86=/3RWB M88H7S95@P(=SUXD#KT'X;)`'FUE/@(&!!`^+=3IXZ+)`%TXN:FHIE*F)@-8N MID7^19<%^C9B2V?RE==T"?M$I^V`H(B!X'[P,^:_4%X:/@]%]>L*1)76_#E: MW#:^XL#OF&WAH=:!$;XJ, M&@W'BI)X+$613^5@WK/4**E1A]6HCJ!1RWJ4U$=(5;P:H0,6N:KH@SVR8@IL MC<&N3[@MH-X=371'CYI&JUCCR&NB&B,JS")W?>&%#^*U+736^JD9'F#B;Z;0 MB/U-N>V6NE5=.9KTWH])YQ\NW2[RO>#R!IF7VDBV@Y'W)A2:B#P_H;@$TXF6 M\BTNPD*SX/&\B>D#RTQ*BKUP95D951='11U:>:(C/L&W=@LZ<^&M>>E]^9BU M7]]F?^YA`SJ:YXZU-KQ@[8:]Z<(M+4)#+<++%^6.XJ)^SZSH4M3L>5.V?.HM M$KT%<[.\;JYL1L#2R^DAA8G%*T'#XLI+Q@R4(#J*F?/..8K[0)@#2G6$9;,S M#9X9EH,KM4W[QM!3*UZL)SF@`C64*B^Z9%IH%YK$C,O`^+5?$[,0<+`I/[)^"]+&B/[Q8'RM7`@X0+?'1 M4CZ$GF/%-F9B/;&!\>68S!$M)VA[.'*?C?$4C+FWQ+=U;R[3Y]:=!%AYA!T6 M+KW!2,J>S#HUI1VKIBYX7P)7X5S3=VF3WB!\(E68V.7`5F7L^+"\8TP?S!X=.E5H\].RP,T MS/0"AJFQ^,K<")("IYYA$O0C:562Y;>8V?4\*UE[5&`5O0,UQN-P%M(6P*F5 MIZ5]D3,W4=J+WVD&DK?.P-JC436X&DZV!!^@PF_*QWI`61%J1Q M%F15;;E[B!6#8)^56MQI37)J:>A5I4TMC:#ML&]"A:9GH#/TH*B;9TV4,7BG M6/E3_!8<,-@ENMS+8F>F&&X1GSUM*,"4G$E]3DIT$G9@0_QXGPF.4'1ZA+8- M3Z[X5/QP:!G_C/*J2=5(L:HKQGK@,U$]I[@6=>0`^3Z%B;E$?CP!DF<),NI0 MHE_'?*:QY8%YQ'"4,=V24TIA5;RYBP:'[HL32K+*=`*U/DY2A$Y&$(X->.$Z MS_*%XOALS4C.OZCYIB5S^=XZNN0-84"?$H*(I4G5R,6/YJ;E2RWQ#MH7@V%& M"TXZ6CXJFBN)E!$\2?)$6YHOW]:F'H)%*)F:N>U^RDX_8@G0C&IY6ZT2\E"@ M08;YJ&UP[^R_>,]CE'0S++^A@02-(6R>V,EZ3'768]JN.$*GWVLQ>F+XY-F4 M!XF#G=5I\GT4?8ZQZ(Q=2\'G,=<$5L7SX9.E5$(,6%\F9;K@"SZ2!*EOJB&0 MC5Q!1$I68]AIKEJ(]JH#KU>;0)15PK=T:AFOQ@G:M;& MFH<_.<5HHBZL6;J.1AL&4AND-ISNRB`DA1;1AF'EY`<`I#X\2WTHO3HM:MV&Z&=-I1I.YPY$7E/O&.B2'=T2Q[2PD$=%?':'P)/4,#2V MXUSM][HLM(-]W$^XR2H@.JS*?9U!TAVHNM:7029'?Y=YFMI+(S4NHRC<../; MYP&L233'6[%Y:Y+^'_?&=<#=P_C^Z$TJO0"$C^$J)J8BN*Q!'P:<`8E9HE(4 MQ2H^P.-!,!O)(5%W+EI,)#,*Y.+V4NGTVF>]MO(Z"9M)1\=]XW#@W#^GVM`* M$4W+^&914!4;HR&H&$Q-P>/3T^E:RL<@,IDLR,4G$2`\2MSR M%R'&5 MB@6-[(DF<9U[-PZ0B>))A%2-FY=AS(NB1H(*H3$4'BKKG/Z\UV_R.@UZ MCRLAN$Y>7EY,/,./1(0WP&-#C!=C6V:7RN6@3I+E.CCW-.AVU,^P>@:&0-N'9V@1,-PT6+U\HWVC?<]$,Y%9YQ$*% M)O8^IR^@-L]#4`U,]_-!PUE"$C'NPNBR#G MV:9\&A83#EL2=RE`GN4/L!SQ5'XY]_'YVS"[&[*L]I@*G"H,RS]"1T`S>9." M.4F_"'_,?(PYC2LIT:T<[MM@2"1#2SC>R@Z%CP?+&8'N\4S30IA`^N>&Q2!E M6Q:6"@Q/L!)T491_M%5@G,FIP!?M3>!)FHTJOF_P/2^M"L+-9)Q;+.8'XPR9 M$US$,-L+E8$(HX5V$"$7;:EB`L0$7Y$M>!]V=@Z96+3&0"(]7&38SC)*FUZE MADV;@ M4-CI>LH7.NI,1P>"*CU5!#TQHM01(.%9_#/PQ/4(&@45ED"V9*76<6ZC4B-$ MQX^T?M.:A8!6G>`'+%KP>X<>PAE^;`<]`V\G%XD]I)#20UNL&(56B+ODK3@].CEFR\`@ MQ8$4\$9LNU/P8X8?;)G"&;.=286%=WB]?'8[!L./?D:T*K"*6#/7)+8\'I!V MK$:2?=AMF\Q4@2GS6+1^XL98*.($6OA*[ZF#;K1+UM5N9Y#>YZKQD3R](F&% M%H$-%BLH3:<\6S-E9+*P<$I*4[F3SBU=/_61Z\AA`ZGZ]/LS4FL]I'C8(W;_@/S;^L7PN&+LN9TKJ MA6GT0I1_#0HV!@*Y,Q)E^K/"D737B4$9'N:]AX3?D?%L[N@\D=U\1<>"Z7I6 M='_MT_U?-(94!ZD.%:O#A4GWBWZL!-FM$,3'DNM:X90;*[2Q:H)+Y<-RG.A8 MYE_AFMCM1C=.;5T=ZCUZ$2U,B;_!RC%SZ8K"`#!#+_(LJ[DH*S[?-BLDK\Z@ MJ7I'4WM#ONAUNUUUJ`WEJB?5O%8U_P(KT4<'_#*BO/[D^O[/RE<0TEOUIVUL2+Z*4.E5G[,US,L`#,O7AT%1UR\9/S M,*`=B6#\EO(O]Y'0S?J(SDL+JR23D2>ZIJ+W&EAGIF6']'PMJ>O:4M[CES!K M#'%-H*KL.)0.LW(V)QP\\S=I'4=6`IINM4=X2B@,!]^:/)J'E[X!OSA&,`T% M?9?Y]2KWX\UPO.:,,!##LQ(8/!)=8IC);4'Z_B`^3><;_$SHV"PMY6O^CR(I M^=4(*ZN]>JS`[C3$#0\_,*&'"O%6)7='-+<-/A*?&N>U`KXY&A$E09J-).Z+ M.#SQY0X.AAUG$/X,FXZ@$F;0=4T=]GMJ9]A?2Z2F6ZQFFOGC+ZOS\L4^K'L< M@'I#QGA3?Y%4\?KJN0Y\'K/BITD8JG#CN8:V`+YT-Z2[491DT8$R[%+/_WO+'-NV0&#^" ME$#RWI#)/W^Z9)^_GW^^^M[6OO_;<+[CVG/7;G]G_[N[_MYI?X?5*?W]3[\B ME!S(ER^DQ!9TD*_OKA0]%>R.7]TJ7R_^>_'NTU66O:R8NB=H+Z7\%;28RY%& M421=[)$F7CV/.,+H!\\:LU/$]<%'GL%.-0B-@.)Q?:,@,H;\O`.G9$XXV.@) MY@"PC0R[-

F2DG5RZ)C6>%-S`G@OEBQNU(PN7_.:8XM>.\IE&S.HZW2!J&')`TV^B M-IJ&HUS,V!$AJMH-H=Z'B8\%,GLS5UV MY*J\%KK5?+AZ?RFTJOD930ANY@/6B%DAT6"P%'F04AXMQ)G%?(8]3B&0T?[SCIB[P/#PZ4]-R@O3!8LPAL=T$#IPQ\YIXW MS+5=@V;5O=*UC@KBIKQ>:N;#"88\2]$@<.]9UU<*T%S`@'6KYBE)/9:;I5*+ M2IAI=%>82P%DIS?AT?6D&I1FLF6AWB:E!S4DJ?3\8O&2UXX083!M%'\516WCS MXH;W4[!,8W9&AGL1%L$DC@A>`(9GQ5&;(]`8&/@791J=^\8_@;?#3SKYD2WL M[32]U>G^C1[I(B@S-D'HQ.F"0FQHD'5@1U,6NNJ0-UNAIZ4D6"K%+0)L^-DC M)?+%AARH6KLC552J:-VA2^Q,(D,#,X27MY)G&;59);3EQK680&XHI+V12L^W MDC:GWZXEY_@PJ]6T!^?+>HXU&).*C&S\J*I8NJ(U*^J3-W2JL&/&,)D5@M8. MM@KE7DN\Y<&66WVZ+NAZ.OKL!2#KE>;M&L1YX:;M!5(HK;8,\&88NQ&$=VY@ MV&MPSWVQ$$\K$+%NH?)>KPH"L:TH%8-BHR258$Q1T4FJ?C7563F*);4'!!G-?V/-W52`C0Y@LL8G]&^TM3^L*/VVJQ5$/S9[6OT M3YHIZ4_9_HH-AG=2!CV\=4&I+3P2CJ-#HET7.Z^.9J0'-+J.`T:%8?C>SJ.M MJZ*^J%'2W/!O]"E-_QN;=[E3L9B0RNKJT!B5?QNP*?46RH"=D^#ARV=CH73I MGP,V%#O=P292=&0$L!1;6$.!%Y*$Q$,9HMRJHT>2SEE2-"#_52 MQ^X^0>DV.2W$J>*I..A!_\#;Z+.F6S'O(T83`]:JK2C3A[ M2RDG0AB,R)K`FK0WHB`V2^+B,Y[BV*^T08\>NE&9T3L#53\?1A(3;ZN%X0B- MW,++T-#RI^STGU=1<@(+]&21.IMD%9>HSAKCY;[4%1F/ER].T'Q(8UN?L>T* MQI9&"VYC;KNBXG0UO5I3V\^WM/#SME95'T:Q;JY`%8TO00VPKJ7L:S"UL'\X MX^"<>&-V%M]XB]L?)*NTWAY0*:K5XFZ#%GD:3U&`@)N\%3;3B'2@:W+6^JH# MF/1Y72EC1:$B?>\C5J=>JJP/`EYV>EZ5;GU9F2UF6]"OET.C"OC1N1.0\`OM`4KI_>#118EMGF>Q$04 MJS(3MZ%E5MVHL>@,@R,0E\Y.1^UW!KEE@HI4HXF2LVGFLEB4QBS-D&^IQ,ZE M%U.RXS/A&;1!>'B26#NKP%OI#+>LR+!$?E^+8AU)Q<\LM#;Q2[/Y/2'H6VZ# M9J?74[7V"IJ%3D&*8PE:4#6FRTO::E1P3HRO&`9,RZEPP6/5R?#ZKM[`X&>R M]E9UU[4:(]Q1SI3;?UW<7/WK^M/[JYM;L9_XU?_^_O'NO\52*T[COK52.C_O MA(M:1#;.#/H*ZRNA"=>W;,-T@WOAT@E!3:"^%.7G),I1A+Q.M_M+6_YY+-7L MG,@(80?AL5KVZ'*A7`H[*\$VHQ2_ M%:J"YF0@JZGC4,PA3R2?;9^$!.Z.JG4[JMX9)./F:Y!)?&!#5.:R"+BIZ//X MA?@A,0Z;GK>>8=^SA@N MJI_)-@'TX$`\I6PEFS=Q:MAVEA[;W-C0\*-2_X25*4$),ZIY=Z(_7FD*OQNYU7XT="%V$64U-R M<5T[>];B^F['Q?7=\N)*G>H-JVNTLFK@3/2R1I+K:D.$6MJ'HUI711VB"M83 M+4C&0U0=EY;3C@8._GE_W65XTX5!:M9STBPNUY=5K;R#P::CHADBU-!#K2/GR1?0J?*I]^>7:D+=+O5Q: M=E//93R3M>K*3:S4E,.3D@OK^ZJ64M@.]K9:3-="D+68OM]Q,7V_Q6*:8,>6 MTTSCD!Y8KJK25IR(K:AS17U?8$5]WX`55>Y8FTC,QJL.E^"KJI;9'JP-_7Z_ M["*[=OZL1?9JQT7V:INK6([;FB7V2BZQ#1)N:2>.8HF]*K#$7C5@B95:(K6D M;(#J)9-+NH[M,2I5BJH4U,YOG5PNJ:"X;%)S/$1.NU.IWYTYHJ+J480Z=[ MK?U,<<(G8HE-"NU+*2$II_5+: M>792>KZ\04J)*.;\1SUFI/S5+W_=YR=_';4[Z*Z3/[&1J)3!^F6P]WQD,"Z' M\DI7.T-:O8W70_&72Y4L%1B2AG&_0ME_ED*IG:O]02>K:@[L_JT'5@W+(WB. M*[H26]0Q/*I_[<8MO'T5YSN+.WJ;%HR-Q4G5 MJ,DLUC]#`ZO2WC_H!V"&O&T;21-RF'U"+%KBZ1?\0@I[[<(^?(["WNUTU?-A MIMDM4GALLT0FW0KDT?U!;Y[DE5.) M!K>`@^.%J`3*-+Q' M2S;AQJ7343N=SKK#Q%=#/._6HCK]Y3?,)V-JFLIOFHA:@WV!<4^06ALGU:51 MV?&"0ENJ&[3^#C<[`F&E'<9J.2YIBHY/2O;NZ!PMI3K2#.UFAH:=GCK,]VT* MVJ'.>:^22*CU)U@=>D"WOTCIYN__[2BA(FTP,G(GY)&`/!(XP;VM/!+8BFQ= MN6SNMFRNEA[+*3.$AP.\H1"]"R+6`]X%#7@"D=C7+VF4Q!=?/QSY8\]BW8_8 MN]2*1]>E'ID9ED,['_'QGK&S?QJ**>W95F3K27NVXQ%G1OVGG#(OK"]IG`(9 M6;`IL6G#/@(FRWU4<<,PHKWU".T'2-O?87W2<&Y;/NOXYH*E3:PM%N'EBIIMPK;+1G&7X'=4CM:3]4'FLSL;GBL;*,L M48-K[!Y%X//>F5FRE'+W[5'Q7*KP#BHLH^N??71]*@JI(C>FH5><9<&J@S1U M$Z9P8>PMH,FTV4="E^3*4N^KO>':^(=7VKD8(OKLMM-'PM(];)>/A!*%JXD_ M6Z7O]-OJ8*@5";',2!7U,P,ME;FQH/X3'K\9X[$7LK9E!&8(5';P!S\$8$]Z M;7786Q]L4O^N6>ZHY/98,G/=]KA`V;CJN:K-#0`N06X8^`%\`/2$OL__>!/Z9_>&,7]+ MNYU/71OV'/[5GZ$5++[`,O;>\L>VZX<>N0.PW]GPS*\O7_PC>BGY^7IR*:0" MW1`;0#0O73_P;Q&T=UANX:NQF`$C_'@HM#!(CALR^>=/E^SS]_//5]_;VO=_ M&\YW1/VNW?[._G=W_;W3_@[$27__TZ^(CFD]/#.YVZDTVY?KNRNEJYPIMW?7 ME_]7N?YZ]_'ZRZUR\>6]\NWBYN;BR]TM%9*,FFVGV";\<$T9GJ?XX0<+/S!+ MHWQTQ@`J!N=_M0$52E`K%CTIA%((JR/91T>YF'N6#0MKNZO2ZC_O7,,S<8:0[L MH1M/(>0\%5;.\)M1GX*A=F$^6+[K+99^XO65<"DWG`6MA30&#?6($LY99:29 M`>Y'.,,G>W&UI6SOHR555JIL)22[SM312%E,`A#.8&/NLVN>D+K.0DX&U=E' MR[:Q]M<])I@24Z7/DLD$PZ)AW3&-(*DO1I_QV2-$&V/+A7>3=#Q*(^26)_Y[6 M1P90AK%:H@#-3.'#)@DJH9?63FZ8?.6>.,0S;-A0D*1L%0#"!\Z+P-#R^`!62`,D#5`U)+L#Z9N[7K3"1X:%VQ)F8"P?#WY!AX@W1A$$*7:= M1%<26[*=W`O"GF@`%7H5UU\P;HG*H3J.2)0TQM+1Q'5=A`L="M1)M&YT[]Y2 M+IP$TJF!:"D>GG@J\-D0/2*63`)+_QP,$?4/8'#N#(S!-\+"C`!W@KI`,E>9 M6C-`,@!/S(#9@;@3L!T!YK#,80#<#Z!]1=CXD):87@>#SJ2"2P6O:V+:MOM((Y588$HX`ZRMOVB%%,2!FF;P(MTP$+UZ(A0RE,ZY((]L8_UC^+1(GAG3Z-PKA6\5W;>?/_4I M;E?\2*FIA)5\W8ZO7USG[#AYN_'M&%.]SHD*1>.4-E?5X580]1Q>OGQQ%*KR MTS)!OG%?J"R^E6';%`9*]C69??48CY,4B2]THW-P7$^*IA=LHWAP9$^*J%)0 MI:`>!5$OW=G(<@ZVR-:[]LG]8-G](!.*ZTE322HYNAU'K]A%Y)'M[B5?I:8^ M-XY*33U-OMZY@6$WBZIEG"]E!-2X]]S0,2,"_<]X3,A$R&=;R;KNZ_3":AFY M;F6H72=Y+'A1^>_0(?$=92ZM(Q[VJX&M9"8ZFU848YM,2M.CM,1V<^75=,.1 M34JCT=67\:!A00U!1%=[6D<==H;;LN-`3BJR.7PG:KJTD!/&(!+&,/ MM29+XME&^'M-$8<0P!_]&<*^`'9325Y_TO7SQS.7O9,Q@<;?P0`*YXY:, MAC9F;,Z5#9I_;)52]C`GN2U-MA?]W6UUVZ7H'EE'/]9"M4:QM2W M^M0&[[3)>OEAW!KFW`-'52C:% MM:>^"(#CO?1O[C5_MZ>IG377_(<,-7GVDM6D-;YH(&?G7,I2$V7IB*W4+NN[ ME"AIG:0@-5N0CM@T-=&!:F;7[".H/GEZ7<6W+:R:=`-(M\T0RW1G[A*51\-7 M-'4X[*L#79.5IF6UWVI(]HTHH<^[QB15?PW?#V="1Q?`=!95C:?M')(^#DN% MU)?*]T9M)(*I1U@A^`)MSWOTP:3_N91S6>6W@55^[8IZ7F;VMK2C`O!I5H]B M!P3?3;R1VLHF-1S)FBM4]?=(A#6]YR37GR&24K2?#]=W*4+72(3V5%>FX;@? M8:F@?9J%:'-P1S<'G]F>X&IU3W`B(O?RA50XJ7!-4+@ON`<_>7V3Z[4T'R=O M/O0]$C:.5I+B)'&7JK2C*G6E.$G5/ZB30U=.$MJ[F4RM&O3.M_4R9<^3@GQP_I+*41.7E M"SX0?)`*TPR>2(5IL,+(U44JBU26QC"GKGJ1_'Q]R'IG-(PT_W%M([!L#(1^ MS8ZZ8;=G/)!6P2U>JEM5PW`KJY-5=MYJ+G;5M(:K'[]AIS4X/T7&_4UJ5K,9 M=.J:U6VWNKU39%Q)S6KB>KRM[%71)JVYV%73/:V1:]9Q,$YJ5L,9=.J:M<6: M=1R,6ZM9S_CJ\<;R?YQ-,`7/PH@XX@>*9P1$GG8=.T+-M"^M8>]O"59GR4>M M->B>"-<*+N(-@UHJ3^.51VOUVGG:,SR50V2I/4>/4&.T!V_(Y>(CU>>X$&J, M^BPM/MWN\UY\ZKJX;#Q5XO!4TWJP3.*808$)(*(A5$ M*HA4$*D@4D&D@C0/CZ+;-=FP8T,A>=DZ89M^'D1,VUQMZ^&1N4=\@-NG=1?% ML%_/N"?*'`CELN8+Z1<-3QS;A8%FAN4H;M),LJ6LSF_YRLC`;@ZN0\=T1\") M!YP/-NS)H\`DVM6!]1QA;1GFKA^&1L.%LDW&"Q"EX?1@G\DQ&]E M"0]K)Z%,+4#'PT,1Y2$)>P8$3$#X`:=P0R^!2'@FZ3RAC,C8P,&L`#[:%@'H M`"LC4"9A$`)]A+?M%V.&B"X7?:-2=Z MT.5F;P&O.+Z%IA);\0@]H]S1'P`&%M!'F?##^,^)P:"SG+$=4I(A"+&X``AS MPZ/-8>A'QT*U35=MT?JF(`6>Y] M0!_9%:&0*\,K-5%F7<(P_@/9FJ8DV`HF/B^V#95/1R0#.Y)>$>GH_/@("'P`-QMK3' MX8*S$\WK,__NDJHK*)P#I@9L$!#+9RIWQM8*U&?B^$S5<94`&T;MF_%HX+/4 M85KV)M'/:RG?II:-/FFDN'9B>$0'3H07<+/`EXV!5$$NS/L9(@JKEV'[;D15 M-`'1<]&B`@H?,G,G8K`.T!&)IB=FBB!,]H>Z-OA%`(QD5=B% M1E8'##9V.(CVMD80>-8H#$#G")A<:J>,,2H6.CP`53`%A3.IXM/Q`G<.7@LL M&"K:.-1!,`M_H5)$[B@U>3Z@B$1_L,:1]JF"9>VQ`_ M2.OQE"XNW#F'>>!A="E?_T4\%UPU!UVQ1U=EC115YK&A2K(B4;G^?^R)IF:" M\1/(P"I[`4,(*`&BYAEX2G%F8Y,(JM&9HW](=78LVM"16TQEC<7!1J?&?.ZY M3]3(`H2O]+XZZ/3I(*^ZNMKM#-">SIGSB\XZHR9=O7PTG7,/WO4L>[&\V&3. MZ!';X`O.\O%-S&S6U_*WBXNO0#T_9$^3V=QV%WEG(4@A2G;NWY>E5)#J%[O4 M*1;7!R!46YY/2%-:#*A%QKY'',T&VQ_F=::7)=39:<=;,>9_)JX M$S2HB!T3LDTU/KI)?1/M1U_*`$=H'"1G&.OU'LT^NJH3?F2`3JSH]XF.U8@$ MCWB:P)T@>BH3;Q*6<`"W\H+Z>JL*#E+EXKXY=`3"KBQ@*S8I[2Q'W79%&\2Z MZ[K.6?2-<&J!IN)51^^H`ZTG/3)I1NHDF1V5U88/%G[X9G@HKCX3/"N^D8N? M:C)=FR2,]J:"Y0VF8V/D\R[5Z)QWS`YGZ"[^A?M9\*D?F<"BI;<>K,#B!PN% M?;BZNI:?I%`?C85M$M%2I))=WS/(5%O7][2\KA31SO]YI?#W]B-M$_7%Z)C1 M8V/S/#5WHF;D^,9C(PZ$[2Y-/9X9I[[0,XF#XWI2-+U@`4%2^)O.J.O)P?$\ M:GJ^?+%,T2M^H'F2LE]K=ZS#L'`O_?UN&'$(V>H<2RBJ*V=7&RE>;9;&2,H.U(:"U='U;%M0O#775 M=R@/XF_LAJ\:IW@;MV+K;*]RTVR=':?UU':[?6A4&LN&?$-1#?5;>N_6=4RU&CI36&6J@VD/.E3%86LW M5T)--QS99'_6>G_8=-7A8+CVX&JSXNU54*24%N)KC;9_?TB4W`(?0#3J+W]S M^L%U\YA?W9O&/.W[RU_;+M^Z)'KB9C$=,-2:"Y=/_!O,;'R':;0?#46F*_N MWP'@[VQW_./7ER_^$0W%7_EJ>,'B#JF,(>"NXR=3Q*]AMB$B?T,F__SIDGW^ M?O[YZGM;^_YOP_F.B-RUV]_9_^ZNOW?:WP'5]/<__8HH<8RDX*QD.GRYOKM2 M>DJ<[0^CWEQ]NKB[>J]\O;BY^Z]R=W/QY?;B\N[C]9=;*AUU)D-(`W[",G?! MLT`64;INE($W1V,0E<=Q[J,\.RPW@9G*F0;,HK^Q-!._KG20$Q7'#>D,&VDD M\QF*QC"FKDCJCP7#B6]$I=KJ?+3:>+G]1\#].[0MPU%N7-]/`'^M_5PW,>H/ M<^L,SF-C2BO]%`HWJB9F;,?@&/JZKNMJ5QML&9URF&NQ;#!N`ZIDJ^TNC:LC,IUZ"F75]>J\MEKT853F7LN%D#UE=!G-9.FL`"" M`SXV_*EBF`]XL\\<=59<,JIKQPILL%)N%JN"'/T[`2.!J/U@!9!I<3=X:-$-Y."0DN\%3DGM`SB0O'Q),$CY48N1X!(UFA.'GJ ML.]3AT15^ZGCA^L/'Y1W%Y\NOEQ>*;?_NKJZ4RYN;BZ^_';U^>K+W:UR\>6] M[FXO+N]XM/RO6[3Q]_N]C/\<1)'L9+BUF69-^P\O$#H;7-Z5:'>8*N M@B4D`\%(L5IWH8/&$?$-UC%BTE0@W!Y+%J4>1ICL5/0UI_-:J%R5\)T2![ MEO\#1A,&@5W4"(N_LU+&'L6.S>3&=I-7;3.4!P,&Q&.%V"6V:-W*+.07#*1X MB8E/?M2D`+(:59)&N'#V,5#9XG_ZX1QK8R$JH9^[A.R^%H@'UQ\,R_L/UOI+ M5IZC631.3P73Y]>#U`+RX>+CC?*?BT^_7RF?KRYN?[]A*X=<'>3JL)GCIAR2=K6^VNN7",([U`U)-B"_T8Y>6.P6=@^&3PO?QO6Z!4X( M.YVF4/YUIZNK>B__KB1[PN5+KOTF"S'_A\JTCQI0\L9M^S#<9J7FU`7-:WVH M]L^')>BRALX52TK)9(>,!6S'5(4]"D\-(=@UP3#HJWUM%X'93%D9`MV\[4E0 MY;XZ:`C)WK.V'NF]L]C?,]W$)^5KI7RQ5:<+K,\K[NK0.%I:[?Z5WM/4#GQ# MGL"TL2GFGHN?_:3SW/)0>".&P;4Q$!C!)OH:O#1^NOD4[>O$!X-W7C%#SWM@ M\8'NP9GQHT9]8WK($+4B2EKBQ9")N"-ZW)V0I>GWK://0SGC\UC\0`O07_@^ M"7SE,_C=H<>:O.$1NO(?YG]C(YP;,@X]JM3OL`D.I7*%Q>N?*^67Y'8M165E MZV94MMYQ8U2\\'4U.[`MB*UHC:.DY&`Y#N;76I0J9Z+:\X:&PJUI:@,; MR3>>_?*OBLGVI@P*K=O2.O.G3'>,RI)/"DZC!&AE MD&*P<`LC$(*!J@FL/%K5.4"EW'I!U=1S_5SMG^>G=A0+Z*QYJ99"TR2AV7RV M]#R%YN6+9HM-=`U_,,'9W:TKR]/B3ITT,4TR,;OX<95QLE0>@M9MZ?WY4Q+? M*`8UI@)&CSLVM$0$\W,A2<:E94'1PT)9'YVQ'9JT`(MR24MA.2:KB47^#"WP MNFEL'P_2Y]']?_>5*-.)UB!IK=Y<5ACA?-S6@Z M2O[),,WGQ4$9IGGL')1AFL<4U'AZ$QT^3+/2R(^LC5"SHS?WREM4MKVPOO>WJ5MIW#(0X8P5!0U>H"`A@VD MEP(G!>Y4!.YP$='["*8I7F9SFYLN3.%^-K>6![_AWN0E/,_`B&8+C109*3+E M06Z$[#0B3$)*C92:^H-KZ/'AJ4>2E`NN>18DR3A3;E!PS6IWN;5-?<3N/[?D M'LMVW43%N>IM5Q^+T+(T;")HND)G'&["I##F++4Q$5_I=[1[DQ,L?1M=BD5? MYLF8;3GD;+KTL.O-IR"U;Q4C#-RLZ)ILR=XDG!GRO$$R<^1Y8_G26*)'^.%+ MJF/=,-5PZ/;J-^PPI'S\\N'ZYC/M14?%;906P99D5HG97!-^VEPZ M/@W\1F@7)->[-QP@)!945EG?T3EV&\4:R"JL"41AA1-9H""SUF]Y)>0'8KMS M_$)53`O`L$8A[5V'H_BPJN"YCC\GV'HOP/+1_MR"D5UO@?6>S7`<^+P2,RLA M/2,F'F7%/P(XXS'Q?=>CG?+HJ,1[L."[%NVL.IY:9,+AI84=82KLCW`V,WX0 M3[%@3@9:#S&3-^>:`"T9X MF`IVG9J''O8`I,=8!,^T)JP`@?9?6Y`M%#AXKZHU5M"D/)_%#M$1B'J.+;(D$L7^"!ZP"2 MR`A.H)9RLX92^"Z;CSL\_M2:4TQ-$X:D?A#"/09E<6?8E!$W$F(WQ-.V9`VV M6W*].>+U!LORLWY[:/>X]F+75+P86&?:E*BS7S#U2+H]P;H.?V"C\!KA[7.1 MB`;S?PN]E8D)6R8FJGLPUZY+'FQPHON*6K< M9OX4"<5NYG3EZ+8I_GN9Y9$L:>=:\<*..6U0T_OFL^B8@IYT^&O$KM)ZK!4, M7J#-;-XL+"QUBVF$!IR:JG6&:F?8W@M6I8A82?'/"@;?A4/;RKG`H:'65?O: M^5YPJM,R"!%O%2QD"I?M M7?W47=^OTEG%T%/JKNXB)#5XSWD2M0.!=\&P22R3#&ORHIS;2IG&F.^^%)?L MU;PSYS>&J]7G-38#UI*;@QV"\?:P3DOA.9CP#+6AVNWUFR(Z*5.91'?*6ZCC MN8627&H0EYX);X[P9A_9L1*>O#T)LV%9850F14LQGT*_<3T;5O'J#)%>+@^%7M"ZX`8CR(LAH$DM*_BBZ.I3BMBE/G^,4I M#BG)E1G)N<9RKOL,M+TP+X\%FOT$H>@`W%`3BP2Q6BJ]5G=%!I<)<JP/5#[[?9AY;"WTVAXQ5QV MO&-F6GFY7JG6=>IRK:F#\XXZT,_+DFH72:SS,&`Z";G>#3U.2G: MV?&P1?*US.(X4'O%=U8GX70>[6E[(X$JJRS'80(D^_9/?>EF56?6A3CK1MY0 M===(9A1I>K+,*7PV5@M9GY-W@T?'YVKOF+;_4I6D*C61TIHZ[.GJX+R_S[W" MN,R:>4T<]VPADNVR#ZW2@:"K, M=ZM"R>5"^NHME#S"#U^N[ZZ4\U0UV=^N/W[Y3;F\_G)Y=9-91_;@9*3![@TA M9(DBW%O1)S/V_ZAE#^MO)C4_?8QVF-%8`\G^Q4IHP6%0UE)9M#2Q_8HRCGVS+&%FV%5CP)HK!@DZO:L*V>:T,^ MM]H>=-7!<,";&6TW.T7;PUE`8/QP!"($(H)MDV!WB82!CQ/8DF)V`BB3$R*? ML/(J+>?NSD`D4/1@>:8%3*,RNJPR+#QOW%.!Q`*H!I\25)/\H`*93,$+TM)J MM@QC&/^-ZP'U1T$DX<[]+\K4?22P@591*@`*&-9Q499"C]9_#:;`!RP?NP0^ M3O=HV38(AF(\&):-TMN29EB:X4I(]M%1L'0SBB]:JYF!,/D@O/[8LT98YWKD M/A#4O#'\ZS'S1K7:@(?_P'K.Z-@Q\\>,Y1C]=).92<68H>7V%1_$WXEL8E2[ M>8'"G:'](]Y*P<=6"J@I)ID32CI6!ADMM.6$Q!2L8#0_;\@0&7.<,?2`_TSUR8QT43`G]YAN6G;1]NAP)> M`!NMFH!,1#0TNDLK'YTF>S7F5:LMUA.#&R@4??8S+4:.(\$$$?<%,:&FU@9) MP'K8\0*:(R(@2]''[/?$U96:RQGN:-`P.@0KGQO>`N4LM&F];?@Z=**E/D8> M6$*>8-TE@/B2%4TV+_F[$;$9QSOD]O7D(G9.OKK@7"S8?X]E_W)Z%BW>U%#^ MH-Q\93I(Y6AIB:`/GE'Q9SYG+&R9VF!1VX-$0.E^M()I=;XIMRR^Z'M02_*# M*`08,Z,OT(+XX#3,YLSJ,;+&,]LA M1WN5,W24\HG/D*4SAMLFV4[:)+@!JPG#.`'=N.9S'":55NNU(S`@\2T^; M8@[D4H?6]+=\FQCHJM7EF%6FIM);.V;;=K?L/,&"8J+2FT0`FGI8U(2E35*&ZJUJ:Z=#B9 MP`14W0'_<,PMG*M\@)=`#L[^E[YT$\*:#G^U-=3A&W*/VUT<\?;L_^$V#K:_ M]W3_.UK0T6YQ]\Q-'KQ^]32>&LX]=?Y`<;$#2@J5VZO+%";<_+$6&Y$_A(LZ MNG=H<[CM7,9MXKH!/$K\R+)3@)!0L46%J2BA#,=!HYAE7YC]2[J,;6`X0&GC M4K!L"YF[E"PL(V);8+K]);,7)>G3?L-S8=GD2%KBFE&58VMN3L1?%<5 M-]DPQA3`Q5XQ].@B;J4VL5WL%\/GBRH!Q%U*(K,OD#18/1"(UM0L\J3:L45K M!%^%P2WX,S1@7?+L!5^BE$<#=P@>0&I&"Q'H6FA2U5@WF#C]!6,D.^W&[4$D MN?\W1G5!#(]7/%C%9V+9\'VL!R@?,,AGPX.=#'^HUU*^T0.$Y"Q+78*"#K4& M%(O*"?$\UK,FER0&._X2=&-UY):@*\"SK&&X2SZB!VDF]Z'^"!UV:A8CFS5V MCG]>S@,7?7;>ZN8&=B#W#I7>]YP241,. MKI=(#EM=<36@*^P,+,-KJT5::,W\T*!&CSQ8)N'MG?!TUO-PZ:$ST6THLGEJ MT:Y@S.H8"E_=P2"![71#'\]V`80Q'@$3D^DZK,)C>H0XL9[P%`1/&X&5,XMM M>-D)IXTK0;03ISIO^"X^L&#'CL3\N:6L4!WMX*LV-5?$`+/#5[="M5HVG=AN MTN>-VBFJ\D<'OL+V:'+#W1`-CCF2I:WBW2*>L%O1P\@O'U6!JIGQB&>00#<\ MR&<']7-`'K4019*>U$?]]=RGQ3U>EBQ\$$8?EZM'@GZ/3]\"VN"^4VR=)S3( M:PDP9GR*4+&XBX0#AD%\(84:`0X,6I,)_.8'J(+`YA\DB`X>87GVW*=HU\YV MO>Q)/#2<6)Z/O.0?\+B.'AZVE(\"76+4Z9T8+*L@4\#:'_#B&8R.R#!7$W:T M_A2@NW=!1UOH&@I_T[>3S;L?DQZ1PW739AKN@K].U=T*\-",2A_;`>//D<64 M5P]R,UO5U8.@8WZ9:\C(9.#2QP^NHIID;YM.?BFS1TZT%*EDX[4MZX$5"BQ/ MGLSOBY..="L53)>.Y1NYMKDF)"X_+RFJV;/SW,N-@F)SF`"4;I)V&-Q/BL;1 MVB*06#L4B7F\94VJL64_KR9S\Q`MZQI%5,G32EK?-8"H]>C^%GSD%>(+-:T[ M$AC*T'93+EL:Z*6&>2M%[[<([O^*V_SD="277J6:OFVL=[MQABI0>[5Q*M8Q M+R.78XM\(UJH*M]R5XY="8H6:@2W^PQ[XMF*Z&_-,ZW34;N#P?ZPJ\MD"$GR M^59N6Z"_N=X/A886TA/`:IS5;9;\&C6E$G'J]E1-;Q\:%FA56F_(05G<5LHT-5G,1L;%FW M84NQLS+M#XG.>5MMZ\,=5&NOTB%%\_F(ICX`OZ+;;X9HYAK_I)X$_6LE%BPO MO$L,`;LT_.F%8^(_5W^&UH-A8[2,C`<[_`TY#?E"OM``#OI!X)#"2EB.TO;C M&PW7)#[+7*11XI:#69L89\X"G6:`]X('6O'D;AH_S#)1Q3P#(&00LAS*K/@N MF&L.BD;$J7#J.,V+I2"(P?,8^3T%^5;&'C&M`..<:60EYEZ:AF=B=J:O8+2C M-;%8<+C+X]S8N,J<"J9R'UHFP9(L<7IG\HUBV+ZKV-;,8LE9+-6*1IFQ6%E(E4?<^&);W'\,.R?4D MSD3XF!"-O2EU[U"ZA^Q1*']0$))<$8%%V5'5Z;H-0H;PA#C\<$OHYBD^/OY\:"E3/(5E&>I<(4,)5<_H"8L>1&EH&#JD;3 MHG.`%\(QHT06I!`?9T3&1NB3),O%,>)2$4D$,T:F8B;1@N9,TH1E,Q0SM84Q M(YAL%]95#,UF]2!H&CJ+U&;Y0"R>-$IW-"/;1@.\8="+[-3-&3%H`#<&S0ES MTDA5&.8>]BE_X?@&9L)@DL644-H`Q!BOSM*5YB&/+'5'6/>9.)MJP4=;GD\P_7X]72XG,F88/,:PXDV\'(>Q,R[B//3\BR9SI!RQ_R:A2\^&-T,L9R M4I*J%UQ95D;5Q5%1AU:>Z(A/\*T=*[Q8>&M>>E].\YR=8)O].:M&QBHU3K'T MP+H-^Z83L4('7.*)V%+50Y*#(E"'26C#.CJ)[8TUP['9$HIU!N+Z ML>Q``U9%']/H:0D2L!\W!"3"L-GITH@R*E4LAF5A@RX!:0D_"8JFPUH&K'@? M/7*:6P&MI&JVE"NL`F9:J)[,M5+*LM M]_:P_`IL7U)K-0HCV_?0&T";6AI!VV$[@@I-CQ;CU46Q)LH8%B>L+"A^"_X4 M;+Y<[C2QHTB,,8B/=#94LTF.>CXG)0`).P>)>QPLU_?&F(MH*G[FLHQ_1OE& MH<."4#42`QSPF:@X3ESK-O)G?)_"Q#P@@6H61JYH7[*3O]B"4&,^J`;;5*R)/M!AGFH[;!O;/_XO6) M4=+-L/R&WL\WAK!Y8B<+W-19X&:[;/-.O]=B]$PW=NNV=)K-G.ZOREK/I:)Y M8ZX)K,IMB[=1)<0(X&52IBMHX",94<$Y2=G9R!5$I&1Z^TYSU4*TW':*V5CD M9F$W#S-P#_2.7@Z]7FT"45<^TM&H9FX7R2+X5*:--0]_P[;*]A3&`#>LSRW["B"(W#HA;1T89#]7RX MBZ*^?)%-%"SLT,R%Z]""WC@]ZJZ10#%/^Z#G!H=4T<,2J--MJUIW'XMIKE9N MS'VO/MX$PUEH6U,:_B`^*$-2&A*2DAV'$D>?L%A#17QVAQ"1U#`T"N-<[?>Z M+`B#?=Q/8,@J(#JLH7V=0=(=J+K6E^$@1W_K>)K:2V,J+J/PUSCEV>>1HTG< MQ5NQC6.2_QYWR73`,<,`]^A-*KT`A(^!)2;&XKLLZAA#PX#$5F3\>7YV\@"/ MW,!T'(=$38EHK8O,>(V+VTNETVN?]=K*ZV0A2<>Q?>-PX-P_IQI2"J&_?HP( M@S$J%X`P`DQS8^&Y-NOI9%H>]JCD7YW1J'T,CG!Y$R@RF]ON@A!LX>LB-2`*Z3 MEY@6$\_P(Q'A?;_8$./%V);IE7(YJ)-DN0X.M^(L)N7WFT^'=;=RH!%]+OYY M#S'Y&S8DZ<:M/L&*'1>.^3ZQ_E<,,UELZ+#[EX@YO%M;LCA?HHW/C*=?WN;@ MSY=L1?!]EV?:Q+V!EQ9\V@4R;NR8G4=$^QSR+**LF-@4S.+XZ1R9OJ[VSL]Y MLDJOIP[[Y]5J:C$XAH..V@4?C6V*.AVU,^SN0T-+J%]\PH`9-<'B&^UU*P\9 M&J.DC"U*Q)=$$W*+\6$].1/[$-,74+GF(<@`YIOYH'`L!88F-KLS$#_@`3*8 M]?=VB-#>&_ZFQ\\82NB`,T]S8#*W(MU!^TP'67V/Q;*$=WU,V16"ZMTY[S'/ M?3T6\1SW;:>3L!AF<,S=I8!N%N_.4H53:<;&1";;-CF:$)835I,@>RPD\"W:YXZ6=TLJ#<Q22D2QB>JS"K0XNT)1M)Q!39*LC">H]S[0(E M.IVW.-\[-!NX90=:4W_ZFA(&5L*/#C8]`VPQEU16O#SP^G:+\G-&N:6([!*/ MLK)2_;_%F4JL8A3R_(RM%7-C,6.5+)/SMGMF@5`:Z7+'5R+J>D;G5BH]_`)! M-J)1S&N"XHF]MZA9T6&'QLJ MS\"+KT5BL"BD]&P1*_N@F>`.;"O.MTU.@S(P2'$@!;P1&]<4_)@R!AN,<,:, M6Y*!_P[O*\]NQV"9T1&(S#:K7#1S36++\R-Y?E0CR3[LMJEDJL"4>2Q:/W$; M*13;`2U\I??403?:4^IJMS-([PK5^.0XZK8."@%LL%CA7SKEV9HI(Y.%A352 MFLJ]:&[IDN-^9N=BRQ$"VI[RV\7%UY;R8:>][C;4T3JZVN]IC#Q][/;0*[EI MWL)]2'L?UGP.H@>/_@N`L.$CGI#(#753'`[.'RHA$8=6CKQB/^-,2;TPC5Z( MLF]!&\9`('=&HCQO5HV/[N'PHM_#K.>0\'L7GLL;'96QVY3HQ"M=G(CN5GVZ MFXK&*""[181/%-<+DWK?/G]2'OPT14X%QC#IS"[\+CZ6W,T))ZM8-X?53ELJ MTI3CBL;"^`I7EFXWNEYHZ^I0[]%;1V%*_`WL[\RE=ID!8(9>Y)]5-*^I>D=3>T.^='2[776H#4NN'1NT252\*\/#JU?_*_'HBB,5KR&*]P6, M-BSR8-&5UY]G\MJF+X'\L;T:.^3@Q<-2IYFL M\0[:?:R4<2^>F42G*_S`-@QHOQ(8OZ7\RWTD=!,ZHO/2"A3)9.2)+C_HE076 MF6G9(3W82>I*MI3W^"7,&D-<$Z@J.X>CPZP<"@DGGOQ-6K^.E:"E6\@1'D\) MP\&W)@^FX#5"P-^+$4Q#0=]E_JK*_5,S'*\YG`K$Z)@$!H]$9^=F*RN_ MRZ;&>:V`._TCHB1(LY%$?Y_#$]\IX\0+AS["R""IA)E;7U&&_IW:&_;5$ MVF1C-QA.T<9^(8\7<3F;KY[KP,8-!8M$0:YREI9,V2W&AW%U507E!_FUC4 M)--^`4DI+?2^0T\9X7DE\7GM3WC-<>,ZK?SN!1=>/-08!\F2FU1>AA4PB(!( M7[--0E9DU63+PT;;6=8@I@XVQE-81&UR/8F;_%VRHL]WB&W-1E16M*FSHHV0 M-E8P+RN53+.G+J1C&B:[E,BSS=S(&R";\\^?=`I'[+-*KIQ-XR;M23T+DM(7'"J@425/-V:I]UF$;4>W=^"CRQ_ M=X5BVT]R>!CJJS<12:!VOE(Q;8O>Y'2"KX9'[UZX+YM+KU3%N?+3E*UI5P5J M^0W1X\)S>D[AN?*3Z>V!VF_G6^[*L2M!T5[M/.OMD6=YQ0++3Z9U.FIW,-@? M=GNO>E$%T-]<[P=KA>:.8?]>C;.ZS9)?HZ94(D[=GJKI[4.C(MF@J=H:=ZO) M>KQFZ5\%NPJ_D45O68[E3XFIW+NNF:_?E(4IENH"E?^=F)G1=H?$IUS#.`=[J!:>Y4.*9K/1S3U`?@4W7ZS1;-$\;JB MM[OBC?`'VD&+%K=;KF8G5K+@^>;REOC8;XEEWY,U)YNR[XGL>R+[GLB^)U4, M?W**T41=D'U/I#9(;3B=E4'V/9&Z<*"5X9#$EGU/9-^3@_4].:Y%Z]!"WC@= MDCU/&DV@_?4\*7V`+#/O$L:O2[C:Y8@\._GJLQ'P3&[66^:.>#.LNUG#\?IW M'#^(QE_,R<63Y7__@B4*OQH+G(]6@>:?_<\TOZ/LF?Q&<9&'\G4SCT`3W%CA*ONFF#8(#LE&%+M/7.QA2Q[$\KDM3"2OYNAU?O[C.V7'R=N/;Q;,5=YGH,(FBE66#GF01 M@6^\#-G!L)7LD^S;/%*]]25.2B2^T$I\!\?UI&AZP6HT'AS9DR*J%%0IJ$=! MU$MW-K*<@RVRLK92LW:#3"BN)TTEJ>3H=AR]>B+>V/*/;&\O^2HU];EQ5&KJ M:?*UW/UDXXK;;14XT-<'61?\U>6R7@L%_XU`^7?HD+B8?"ZMUP8?;%F18/=` MA7+TJ.GVMTQ40R4UX6I+N%9[6D<==O*K`6Q@QX'D0HICL8"(E!2^?-%8.6RW MNIH4P2,6P2KBO!J!R-E&^`O&@]4O#[W#B&$5Y2L/:`FE]$GIDT:P*K?P0.)8 M5R!M>1!_8]W!JKD7V#[4MO9IMJZ?FF_2GGL%V_I*=DG"2]%O-`>DZ$O1/ZZ" MV>6!C&XHI&_0-"DY`@Y(`RE%_YER0(J^%/T&^@:Y9P;5-Y+4VV%_W=;6W4P+QUAS_60K5&L;46$>]+I#+V%/9@Z4X;UZ^ M>.Y62DJ6-%12G)Z%.$DSU9!]QIHSR+T%B-Z2>4#KCFV.$MU?!,#Q7OHW]YJ_ MV]/4SIIK_D,&FCQ[R6K2"E\TC+-S+F6IB;)TQ%9JE]5=2I2T3E*0FBU(1VR: MFNA`G7)U:4JF6DI*[UX%HH M'QW$PWH@RE<;]$UR_;DB*47[^7!]EP)0C41H3S4=&H[[$9;IV*=9`%]2":9$ MN9MZA"B?X86IKUR!/VFFKRBDR$GR1L'"<@ MQ4GB+E5I1U7J2G&2N$M5DJN25"6I2HU1);DJ'>_F+XU'+N<:`\A^A?S8J%,- M("]?2$8]%T`DFXX"$,FF:M;6J)-`5T]S,@Z(J8!7.O.5UY:C+(CA M^3\7\\,:ADUA93@6]NR"T-:5-&K%J'>FM9\IL0T#+>R.EEEOYOF8E=-8[#Z\1MV6H/S4V3=HS/)5C9*D]1X]0,[5'+CU2>8X`H68JC];J=I_WTE/7 MQ67CJ1*'IIK6@V42QY0;Q)-`J)F&YEG8$JD@QX"05!"I(%)!I()(!9$*(A6D M>7@4W:[)0OD[%B849&D7"^3&JIV,W)\XR'D!\)VEQ(HSXQ37T(LJWIP7$^*IA<@:L8] MD<+?=$9=3PZ.YTG1\^J)>&/+/TW)K[62V&$8N)?:<-\,#[S.P&\J825?M^/K M5\\:YVOZ0:A:7Y1L1";MG`9*UXG=4B_L?X<.V=P&.Y6@L\]^\E5F!AVRN7RU MR5NU8=)5S_L=];S7WY8AAY"-WJ&$LHK`_]I8F=_`MMITI]H0T%JZOBT+ZI>& MNJ)ARH/X&[H_59V%;.-6;'TV7G]G7"9(/;7=;A\:E<:RH;Y.UY$:'XCV];EK MY8&,MJY237/G*=._7&KH\1.^KA6TLK7_@^M-"$QBOKDT'+P26J.]^W0_F^IQ M[L%0U`9[&1W8)Z^E7-5I_DJ#_/+%<0I4?:[0,NS=N@ZJ4CT:UY]6U0?3'K2H MBN/6;JZ$FFXXLLG^[/7^L-E\=+59\?8J*%)*"_&U1NN_/R36GF4U0BYEN.!N MX8*E@_JR8P-OB&T$&'+HP?-(&V.<$5=XD(#`C=Q>B@BL*GROEO"\U)Z__LM- MG)BS%I0;>+N5PU_M!?#^KW3_'=J6X2@WKN\G@+_6?JZ;&/7?VW8&YY')N)C! MNT&A^[-J+D%WO.VAK^NZKG:UP9;7+8E517Q0G==X8E%UE$Z_6;1^*^?W9 M>X;W@,@#[#0>R"?+&&&5?8OX%\$'P_(P18G(O4,%>X>=_<)WAHVW2(KA*^Y$ M>4_&_#!3HX>9W2-S&`'LMI;OSQR/OW@!HD`U3?'X_BQP%62-:6+%EUBUD&F@ M.10.%'7'#4"@+=\/,VX%#^1?=K6^VNMWJIIOCT5A62"383F*ZP#1QQXQ?"S( MJCR@`4/:"YRP$RO7%,J_[G1U5>_E;Z"R)US>^>[W2IP^>$EEVD<-*+D-W_ZH MN5D7T'5!\UH?JOWSX<[W@'5(2N.W@IDGX(UP.=/K>(E;24G8!FR&]K:9K/XB MZ0`LR7<2CVE;>A*L&/35OK:\F&RUU2RW712WG/$C%[Y/`O\S.&FA1\QKYX:, M0\\#BK\S?,NO8ZMYS,4J:I.+`]2MV-$E+%[6HAK?<\O(JH-D71XJW5)C@H+* MS;=;,Z;86/3&5XP@C>_(4][@\QZ9NR!,SKUBPK99"7W4A88PHI&9VL]*J)A^ MW[F!83>.CI)_1?GWB3P06]$:1TG)P7(PLI:G=LH)ZIG MHMI#J(;"75&R!Q,.1?'DAG]53+8W71!KW9;6F3]M4H[,*^!+PY^F:>6'-$PT MBF;C?]+/.??$.==U99"KO7Y&H23$G6M;"+/H:KO=5SO:YLS_W3$J2S[)F09R MIE`/V+V6]]ANLJV+<11*Y#T(2I(U#6%-K1$5F8OUDC.ZVQJ>'%A77N2M[@39 MH\RXKAGHUYE7&37DQPK,W2[%0`I.HP1G#RG5>TG.E[(CC8X4G",1G(88G>K/ M7UZ^*.[&=8L[<3!L#F[T,D@Q:.@`%G28)!>.I6.IMDJ0;JKZ'"`/OEY0-?5< M/U?[Y_E![16EO.^V7$NA:9+0;#Y?DD(CA68)U-W=NK+\+.[424EIDJ3LXL=5 MQLE215:T;DOOSY^2V$8QH#&IK+)M#&U00VIG!6'?B, M[="D11`4O*A4#,<$DL$'\F=H@<=-X_I<1PFF1,%"-8:S^+NO1(D-MU-"@M;J MS>5:SN1'@)\>=W($5H8H'T.(L@PQDF&:I\8_&:9Y&AR489K'SD$9IGE,08VG M-]'APS0KC?S(V@@U.WIS+S=[E03:U79C5GLX8FV0][L#M7V>;\/KZ7VV`^^E MM$EIVPOO=VFQM_V,+U\T0][PJGR[;H^[18X>(*BAGKYZQR1TS1`Y*7!-#ZG9 M(2JZ1#C-UL$TQ0L,RGO+)M];;O(29%"$%!DI,HT4F6;%NQY1F(24&BDU]0?7 MT./#4X\D*1=<\RQ(DG&FW)#@FJ1:7]E*>]F%X6_)/=;PNHDJ=7UTD#^T)]6[ M!?^QCF)]L70M"\HF6J>K1<:1*$Q`8Z93\Y/J[?5@>);A!$O?1O=ET9=YXF=; M#CF;+CWL>O,I"/1;Q0@#-ROP)EOH-\EMAJAO$-H<44^U5A.M+,;L6)-%OOZ_ M?$%-M(Q6VBY:B9.OT*TJ?S;_SBYZH)PQ6E3*4)K4&RIJ,C-@UW-J0PU!Y8L90'ME21+VKE6O-I+3D>8WQT+^Z_0#GZ^;.PN^HMIA%ZD6BJUAFJG6%[+UB5(F(E%8$J&'P7 M#FTKYP*'AEI7[6OG>\&I3LL@7(%5L)`E,-]=B#O+AA*AAT%PQJP)&?=SR0A M)[LOQ/D3U,/YSUBEI?`<3'B&VE#M]OI-$9V4J4PN M?-G?IWH#U>#[IJ7;GE;/$;/IIBL]5K]*T*DZ=XQ>G^&XW5V8DYQK+N>XS MT/;"O#P6:/9S&ZP#<$--3-]C64Z]5G=%!I<)<2V8>9$>^]@/[#S`\]*S\U[G>%@C>5N"MUU-[?4'-3-W M/_$LS\EJVM:8.#Y1)H3X;^#7!_A;\<@#<4)R/)KZG!3M['C8(OE:9G$]-';OVQVU\AF%/1U MLNPI?#I6"UF?DW^#1\?G:N^8#@"D*DE5:B*E-778T]7!>7^?NX7EZ%C3>LAX MG7^;%*'9LI",6(OFH_,`/[G>XL9X_&P$0`=843,KS5SXWZ\GWSO:]_=DC#5E MNNE:,QG?_Z2$CL4&^?WV_4^*2<86<,7'L+5?M4ZG.Q@DN&0"LA.D&=5O.R;^7HC:U32MFP%I"I#=0*V*JMV>IK>W`O6# MY5@^"/YOKFON1U3;^J"7)0`I2':#M2JR:IU!I]TI`RO^$)!/U@,Q/SJ!X=Q; M8(I85:N+&5J3OZ@9N7J:XV'F%X#Y[A%#<'F0X1YPZK3UCBZ4WMH)X.U1_R\Q MO+M'M_$84>"*@&Z/ZL4$%BLZ#+RP%V,T')X/ MMT8X!6Y!K+^08"^,[,+B40PQ@$B$_3V9$,\CY@V[!KH,X0]G+'C&T,R@8@U:0@IUV3Q>A2^8N!5.Z9...,&GZ ML#.L`*@TH795C\'YH')"[6J+VGVM`%`?9W/#\G"[=#U95F6FY39J>?W")OK& MQ6"J!XWJU'D+-,158?6E^ID`;K\@,^NAV3/L/AJ&TYPX9A7?X;6 M'*G[;G&WF).+)\O_CN5M0UA%;]U)\&AX9`F2SS0O:"T%SON][IXH4*E=U/6^ MWFDHX'MBG3X\[^L'D=X=;<:@UQXV%.Y3U[I=C\KTOM9O*.!-U3KW:>&_S=C^ M7$^N@RGQ]K74,9$K!,QN4%=JYKL#'05N#V!7:N$.1.Q=M9N)=F&P8QVP;7=L M!,2\G8)*O3-\8J*>P3OBZ_6+>%?O=D1WKA!8%2%2J=3WVVV]=R!$*M4#O3?H MMAO!D9V/W?5^3]L)$Y.&`/F6<[\WA=#;^C`E2"LP;`%AM?:]VQUJPXHAK%2$ MP:1TQ:/`&FBXJVSJ':TWU`J#Z`26:=EA`)OQ6VQF8@46\:^>6%>5#YX[8TX2 M=VFN#,^!@?ROX#2AK,/"$.:<%.Z`E8]#^R)B'[]\``'6AOU>9RBZG%5`+Y(C MUVO\W2>3T/YD3:IA887NZ:]?._]-*%(`@<;B^XF`Y9RZMOEQ-O?`.7OJL^58LW#V7+$WGE+8#TX$^P\AJ&80@DXZY@?K"3_Y,9*]$T'RLS&> M6@[Q%N+O&P7\F6%_H@)>R)@_`S-7F@Y+\K"#-GQRG?L[XLW>DU'PV0BXMW!# MYL:"&MOKR5?/M8X1^?@HY4N(PUQ/`&[J"7'\+DX5$%H@5X5PK1:X?4B"CSVZ\G-\0ACX:-FO\4P,X&G/P/ MKG=O/2`(GUPC^Z*9R:VN@VGQ$$B!K]E2DVA'[@SP*A&A']];?U,6VR"V;45 M;FNP[SU^1P`J>&>L@-V!KV&OYF.A5N6U!2_!W..ITM%4!2#HM\0[^SPL8SF` M?9SEFF#1B$<#H&%XH%JNP=H+(>@"M0&Z?&;^[ACLJ)68[W&.O,WULNW=AZ'* M.)G4>^UV'L[VW7G"UUMSM,A[HT$=^=[7361=\.C!:G:[`L=P>]E"LA MCK`3.OL6T8$F1H3O$XT:)$_K#SN](FP19BGLL!Y(T+2T,BU!OBM2!^)3MZ]M MPHHNBM31`4.1LB"P!R0>\8,;(U@GC'MRV>:A1T3TNC_]VFYI>B>ZP]V(0K[9 M%Y^ZFDS(&)TA\`_0+3+NFV,>ETF@,Q+DK0`;T*J7'@4$_H;8>#OWU?""Q1U6 MB3?&>"'@OUN(OS`B32TRN7HB8WJG<#V96&/B%:"/8IFPBPG([+N&M,I?+9M. MJ^V,0^Z!SU@YG?CAT.(]O/B>^&//FE<6Q+ZM!?HU`DHQ M:OH%TZ"F&AZ13)F"\%0`D-+R%H@_IMK&G!*Y0^5YKLV]S-Y,YJ-=!J_J6 MX[*T&K`=-I+JL[%0NO3/P38THJL@K+@_2/#5`_L8>?VYR_?^#]4RE0A3)];! M7@%N^_"^L@W$8#-N\2DIWC1^C,YB^$QEDGX.XSAWVH.^&&RY#HU\5?Y@C-=% M+30#5?2E\UV(!(5E--FD>'K(I\<,M>@U&O+@?_3]D)A:0_1T-=*#180O(U\< ML5B)/QB6]Q_##L&)^V9X8!`#_L@!U+C(&4M/Z_0[7(ES88^Q2PAR3>TRN`&> MY?C6F+[63!2U#F`8V:GU"*SN@NF3D]O`'?]@_(X%H2I9QBX!*$Z7MN'[?"J* M\2WQ+.)??/5XAB+]I8`HTTL-K9U6Y8W8[(YZZ32'3:B_*XTZLV%[Q;J\>-?# M\/.L@Y#CPKP\ORGFPTYOV.F41)T:`_HKLW#OP>MT[MG=B6C8/[C>I>%/P2%J M-`W8:65YI-*DN'#,M-U?'2`-GO!"LZVAKK?3!-H%U9J)U@`[RF1*Z^CG_2,A M6E/,,'+_M042O5BK0T-W] M^-%%Q>#)M]XZEOW/GP(O)#^]:2(J19EY!*A<;8\*]3G?$8=,K+%EV,G!P0>" MUU![2>SLG@^CX]VV!_J1H+^#`N:M48/^H-\KND8=&O_JO;7.0#OO5(O_\GT2 MNVWA&_H[]VHVM]T%J9[#&1O7/BW_4!2@G8&OI>1#&>B3-#5Q762\NPU'&%,Q M(N:[,/C=L>C[^7=WVP0HU;YK+8=7TD.^`QQ6LK.[C>S)W?:NZ9)`=#RBR MZDPM^0DIN%,JE2F'%QZ-7F5U`Y)'>`;HQ:/AF=SKN@X#/S`<[(''[AAOW/>$ZH458[F$=(P:*!)/]^R?_%=7*)O`,SUIW[[I-499:4':WG8'BB MUG-[&NZBOEW0W]-4WW(I@`>RGI+\)V\]O]%VD,2\>""><4^NGH@WMGQ"A?\04K]UBK&-6N]75)+,:ZYTML:[99J9Z MUVV#F>D\=\EME&.RWLQTSB6S&NO&[,_,_,:BO!UV2ES=N?5N>T$MG0A:`Y)' M2,.&^+^U8;NWG=HI$J>!^RB_%*U*6_&:+%*%+DYU!#@ANN]Y^6L:,?;M]3TG MVAW."5M[YYY,X4=$J:@413D?J_$(5+4P'0B91O@O#<7]"-V3B$)-]U!.F@8- M6_$.0(]3V/%3\[#.V6@S;4?+ MM(T3!"]@#SZ+O-XY&0,=L:!FD;J-!8JT%>L961\61TJKI8Z"6OO4B56Z^M\S M%JQ=:/7L!*MT%NXS%JQ=:/7L!*N\#_%\!6L76C5$L+;Q7]?-\A_7AF%L*UCD M]FW8(44ULT%4M]WM57!V41RK)A!QA_Q82<0*LM\SB3CL#*H(ZCPN(NZ04'_B M1+RQ_!\?/$(V-MFK;/NY@;3M5&>`VG$];L(6;*;&"3M\7H2M;%^[D;#=KB2L ME-BJ3<$.^YI-A&T/ZW*D3H^PY21V\)Q-@9381A#V.4ILY#:_MQXLDSCF/G;V M^G(OW]HQ.CSY*MS3/T?R5;B;?X[DJW`??Z3D8X4WKB?T5_\B#*:N9_V5$Z$= MY[!>S#T@3'M%75>^WQR'U5NNWU8Y*G%IWR3<@,4:1/5T^0*7B?)EZ`?N#(6D M.,[\9+O(G)MA8UY-A;#U-H+&IHQ!PT-TR\EX\(/K?72(;=UC'>B/CHFR&1IV MA;">M]]S8,L"D>ZA)4H2JI+CDQLR=N]!-N&;&_)G:/E60'CIT0I#Z$1Z;PU) MJBIC%'+"'LA6EB]8GMO'*!K4"__.#;!8?_([1KU\<8/_DH#/O5'AZRPEE=%[ M6>\,-,$_KPWI*D.;>*@2=J>MM)I1@<3UX;`_T"NLX+*"2J)-VX[,JD`G!4A9 MJY"[J>&LSKDWPL75W_:'FRAQ8D/C&V+#D@[#>EA*GU9'M286@%*B47JAX+=X MFL4=(.8;8PKANX7X"^N\/+7(!"`?A]CP_'HR`6K/A43^NY/O_:[@_:YV)BX**"'Q.Y[//2[ M1?SQ7Q;Q#&\\77PB#\2F5B'^[:,S#P.?_J"5L0K]9T@@/9M`Z5C@A$2#=%SP M,6':*8?IL`9,M_,0UDCL.2TRWN]H>A-$MLQJOR^=UMK/D40EM5K3#BOL>U1K M34^CFK@3%[Y/N4"LT^(:UZG3@_I0BO/7H7N"%2HJH5%.]?/^^?=?8A39G$Z>J3+Z]H-O.;D=1NOM//64!MVQ58>,9]: M8X/1[O?;#:!V^]IY,T"]<1^_>JX9CH-;V$+X1:Y7AIW!#K!7W*:LIP_.=^%Z MZ>C1K;FN#?Y]\7P]\D=:?@U2%EAV5;-=EG_:EVBI3$7J9#'`.NCOI!T5PEK>%FGG3:%SKBE: M%4F`[O\[.U,^N&[@N`%1;@F]/%7.SA!PVW)^O)WPWS[!'\H3_2I8S,D_?P*H MB6,2\R?^K>?:\.TT".9OW[QY?'QL/8T\N^5Z]V_`T^Z\P9_?X(,_Q4/;[C@U M(OQM!*X7#3CU$/+_8>=OT9>V,2*``?SSG?_P9@74"R\]+GB1T>OP<0.<_(DW M$V,6FCR:Q_WG3Q$1O^L_*:YG$N^?/VFMM@!>"70[>>AV#HEN MIRYTNWGH=@^);C<3W=[NZ/;ST.T?$MU^7>@.\M`='!+=05WH#O/0'1X2W6%= MZ)[GH7M^2'3/ZT)7:^>N1.V#+D7MVC#.7WL/N_AFK[Y58*SG8JP?%&.]%,;1 M:"G@/.*[H3 M2[G!'BYSS\5H?U\)?85&,$Y=V\2X4L.?*H;Y8#AC^-%P3,7%@$/TE'UXGL5T M*T@.);!F1`G<^-])"$\_NMX/R[F'<>968-BM?[Q)46`WDO0J(LE'9VR'X#`K MEJ-<4H0!&C611;J>$!%F8I;]!/YU^B\!9 M;_&_\.?_#U!+`P04````"`#'@'!'DL=U:%$+``"XJ@``%0`<`&]X>7,M,C`Q M-3`Y,S!?8V%L+GAM;%54"0`#1D5*5D9%2E9U>`L``00E#@``!#D!``#M76US MXR@2_GY5]Q]2WL^.X\GMW69JO$RE*HE3>=G=^S1%I+9-C0Q>D.QX?_V! M+,62)0&R'0F2^30S'AKUP]/0#33PZV\OT^!@#HQC2DX[_<.CS@$0C_J8C$\[ M3X^7W5\Z![_]]Y__^#7`Y/LSXG`@!`@_[4S"]^']% M48X_\UC^FGHHC"%H]3JH+"'_U4V+=>5/W?ZG[G'_\(7['=D&C`9P#Z.#^/.? MP^4,3CL<3V>!5#O^;<)@=-JA+TLNY/L_'YT<'TGIG\XH\8%P\+^@0,)\F`"$ MO',@:WRZO\JI+:4C!GS)0YCR0X].>[)8KZ*.GM3,0X$7!7$37`L]83X<]S2$>^.$9KU9//T(`AY^DO< M8-VC?M+@/R4_?QMP+KYZ%C$&)$P_$*!G".+/?JLHUVM8S7O@(<->"/X9XI,! MB?^X^"O"S)=^F.D"CS@8GQ2`Q'$1?JTIE4!06=@P7@\204 M_]5IFN&!Y]%(*'L/'@C%GP.XA=#`+I5B]G.GUC\AZI--1%V1N="-LJ505$%, MOIC]1.3U31K^>#\-7_18\I=OU]B3#N`28,U^M<7K1>QM9+WN28/_RR9+OV,P M0]B_>)E)O<6X.@PGP$P]II&TO935@I&P][.6O=Y&*/4AHBMM6-5\/+5+V->N MN58ZTE*+M"K$N6-T!BQ*5;2CSMP%91WF)N M*C0V#IP^F.N]QN@9!SC$8.#FR@JW-0&^0TL9&8OQ4OS"(O!K(:E52ZO67@VK M:HYLA,E&Q[\!X!Y$JM+0C[)3J;N.JB@@/YF)6((/,K,ZJ_E,EX0@U ME?H;+YLT2,\Y,#P7^.=0*^Y0BSE"E!I$PM:_?T3:&Y$V)>-'8--S>`[CS:=2 M-Z&*O@TK:+HKI'H9#E/EQ=LU_5K4;':']E3FS! M.%YIL8Y,")L=,FTFS!"'\7SP@PTZ#R'UOD]H(%J'R^7U<*DPFK+"+>RICD#T M3#]61I>L4UJZ59NN;O"2C=.B[C8.1F=T.J7$B(]B44?(*"J^WQ6FB@R/C((K M_>)%_*KDCJK2EK>Q4G<;%X4&OH]76MPA[%^1Q.NH5F"K)"RG1JN_C0M$]Q`B M3,"_0(Q@,N8#SXNF4;Q,?`XC[&%5U&HB[`AI)E!^)-YH9SHBK*P5)>E%6YRV MU9I96A#W*QM?,7NS-U+"X33.J1:3%4I"T2^!>&IBE%).$J5$9./6W7ZF2:[1 M5%;2.!XK(',K_2DFF(%`&8A&-@A2"R5;-6MMLY><',NKKQ]HNLV/-$^$`0KPW^!_19C(SCHD MZZ1/U;BCE72++BT<&P/53'KNAL(*XE1";G&F0J(/25OH;5F$TLRXU%O9RRHE MW&*J$H9]AS5M<_<0<9-LJU%K'N.,%IS:++FKDR7LT6M7'^\!8QHM7,*)3? M*5%V#S?P9<<3>0W994`7V^[SF5;:P!U]&@V:'R6E$F)./\<"UI?EDU#QBKQV MV($GH@)=ODB=2AKOT3NX@19[;DU2"MTZC\;&H?8<9@P\'+>'^'L`<3,3?S"E M+,1_Q[\K@W$3<<=I-`-IXP0KJ^%P),]DG&,>']>_8S#%T51!K8&LX[P:(+0Q MVUDJ>D5XR"+IO\[!8_)TS:6H2\P<"2C'5P-9QTDU0+C?'.F*DP(7+Y[XV'I* M/YP#$[`\`+^,(`,91XDQ0*9/>FYAL6.M;-F*FCKKR4#6439K(-0?KZ_%:F4_ M6^V]R',07Y;YVV>J^YE*QE%F#)`EC/S')F]VQ7DDCQ4,1W%VJPBK_D",(3$Q M$V/V`[`Y%B/'D)T%"$]5GJUF/8Z2O"7:A/A?;"+^88(8?!&^V3^C4VFUNKE& ME8#C5%;!2C@[>=,H)7.,4IH4^.<1$UK?B9&<^O'!RM7/&:NJ&E2WJLI1[K8' M_+H&8%6LD]G3&)*+%PD^PGPB(^C5Q$B50J.7=93E&@A36JU:V[DBJ\E/.@FZ M(L7'"90)#";BCG-K!C*EUR"OIU5^TSH68FCQ&T#-651L89C18?,/[;`JVZ+J%N!HTS7A9FR;-?"4%'[6-W$-K4O M1)B)OSN&RT"F_.YKB>BMPR;5?=5;!5+J"M^=#9C!3JW"KF6J`ICSY#:HY)AH M+?X+LN^.Z@+"E%7]&E3S-YLXD0PBHUB^:S)(:26-7QF'EG%C/]*!]U>$&52^ M*Z,`6*<2&WN7@L["Q7,UH%J9I5\`L/DL31V>B[+OC=XB0@N/%;DU>%YB@HBW MX^!96DD+;X[%N^:7PA+7NT"9M6A57]++VMB7%.25O%"F0VAC%M[F)E[%?D+^ M!M),>=6NV`^>C;H,DD@;4T=&W2@X&,XR0KD.WY)%7%>N_:B9NE MH%27=Y0)#2I]SET;<6G&6V3>=-%L>"JE'&7/")N-K]OGF32E42CE. MH1+;GG/R]L6A'WFK).R'"66A?#^@_@L*M6IQGN,:6/59?S\FCZMFE1K$CU;P MB5Q2F:-`:K8*$C>7.!666*^:%HYBM7#6K*V^M@VE)<>XC,':.+ML9T'Y'3)> M"M;&J^@VO8ZZE1^-;P*LTLJ7Z[$^^6//[U,G7[]'B1L16#*-`G9M06K[5 M_ES6T,4=YU*];72_KZK^0=EWF>I$/?4AS2H!=TC94-Q&%_FJZZ6\$70"?GS1 MM`DK&P+NL+*AN`MNK/^&?JQOBR/K-^W)I"&$<(WG,L3)[S6K?9M.L.E.K-`G M>[@_22L=C(2?^!\@=JF^86ZG6EL=#LR(W1P@=L)KH\>M!RC&0B-57O:V%;Y[ M8UA#M=''U\?R*#Z_OZ$A4^.'L(0$JXV7IFP!9D'W:PBROH]A!A*IC0]1UH-R M*Z*_QP4$<[BA))RHY@:[5OSNS:((>:>'+K>??=S2$-+S!ULME955\';SB+*O M-=QILB^Z*[I`OECC+VIFOGZ#PHC%2[79K?`[AHF'9RBX(C4Z]H[UMOO*8`EQ MA1487,M,C`Q-3`Y,S!?9&5F+GAM;%54"0`#1D5*5D9%2E9U>`L``00E#@``!#D! M``#M75MSVSBR?C]5YS^DO,^)(RFS.YG:G"W9LN>XRHY3P:?/ M)Q](Y,5^$#U]._GQ52C\8AN2.S#^4_?]Q=[=8+HO34 M#Q:G99E3-PS9I[@0OZ6K)?EVD@2+94C6/YM3,I-B7`O`1?^%"_T7WMII!VG8 MOTG$N\9'G\S<+$Q[E&VW[9XDC1=N$-D1M&BZDYQY$Q\79/%(:)]"UMKM(N&< M"4.][)%\?`/>HYRBUKM(&\7IN-7AM3-*DE62DD7RR8L7ISDT21M6)+MU*8G2 M.4D#SPW[$+/>8$>9O\0//`_&FI24+^C1/?98N'2U71V'SQ%P8R! MC-*QY\59E+*5\S8.`R\@R82D;A`F#^0US9JJM=47>M1SV7)[1:\;Z%^F5OI4 MM-.U+\Q97Y_'H<^LJ(M_94&Z:J4[>3-=Y4MC[V>\Y.91XD;^BTLIZTN)WTI( M=5M]2#HM6A]'_C_+UDL]#%J(JFC,JJS#/F4=VI6UW?1DU&1'N>](Z*;$7[HT M7:6L_<3U\@^VZKJZQCK*>ND&]`\WS,@-JF^K:%\@3;^\JFL5T MD>^9VLU6TF9R^9A)'T0!__$U$Z8F)NL:A%D,_EI0WEP7>RC?G,9>[1LAWP[& M5&@"YN;?S$T>[RE.OHE(1ILOY)KK6/GP?E_N\OY8^=^Y3U(@Z= M`2-77,+U5T+WD83YMQUY88=ML$^A1,YM'Q-Q\X+.H!1U0^:8UH5F5OBZN=(@ M;[3#G=%X8:*P\I.Q3MJ8LL7SVPFKD25,DF*=XC/;A\+*_\V+HY3UOXLPK\>& M3-&+3]Y^'\:L?WT[26E&`'DZ#]TD898?GV/'KX%1#]NNXPRML*?8'2K8?&-( MPZ0(A)S4??-3E6Y2\S((B-DM[(RL,"+S?"CH$*E9S(P8Q3NBQ)FL'5MVJ:F[ MSZQQLX$CY6COLQJA;*,ZOF5-$DJ)G\M[4_-_B>8U>2WGBQVR1)ZY7:+$(T(R MKZE!X!E&A:!GK3@2UG)^.2R.I"!*C@9H2#IO19*PEO/7PR))"J(D:8B&I$DK MDH2UG+\=%DE2$"5)(S0D7;0B25C+^?6P2)*"*$GZ@H"D<9*P[?WX,4FIZZ4* M7NH%G:^05#39O^[*C6BQ*80[SR@_QC$F8:N\,_@,2<:N@E5$B&3'8Z&=N\E\ M'/G\+WXX\.R&W"DX3L]=2E=!])3["U5['Y/ZSL".RZ<17R(>)!L@8TQX>+PC M#%;@I<3ORFC#EIR!'8>0)6[;H,,T?18GM$IJO;D`=G13ZW M3Y9\]Z=>1U35G`&H*\%TRZ2%@,@6NXI2-WH*V%125G".H(:,2"ED@1-CS>NK43HXP;9WC93VA&_%T$!EX=@U:<(:A; M04.,VM-C"@\MO66$\*U+6_$JK.X,0;T7?1`JQX7(R#]WET'JAM?$3 M\IAD`Q+5%9TAJ!.C%7T&B!`MCM5[.7JV!*6=(:A#HQ5%,AB(S/SS.'IF.WR^ M6:Q*JQI)XAK.$-2CT6X(*:`@VB9,"`V>V>A^)HWL$54U9PCJR6C%EA8/(I]M M(Z($<$:@CHQ6]$A0(/+C7L?1TP.ABPEY3/.C9N$":K)I:]20,P)UD?2QD6N. M%Y'-N);><'T3%7=&H-Z3%OI7$[F##<]FS0QKY\'IC&"]*WTS:H`6TY#+(,VO'_,N%.>I)TCDJ=E1U')&6+PA;=G2@4.T M@VMU;*!0R@B+*Z0M=QILB#9V]?!\722HH+0S`G6*:#0MID<&`X\)P@=_'!EQ MLEW4&8%Z05H1(L30B[$@"1RL2%D(F1^(RV(&Q:6=$?`%D`:*UL%`9`J,?3\H M/G[K!OY55-J3JM,1<0WG"Z@'H]5`4$%!M.#?\0PL$?$O7!HQJR09>UZVR/+# MFPG3M1>H%GY]9><+J+NB%7.&J!`M_;LP&UEKSA?@<(X6)$E0X/3:"HW/#G$X MSI=W%,TA1Z@C\[2>,6J_.:3JR2J/":6.":6.":6.":4.('O1,:$4.DJ.":6. M":6.":6.":6.":7PDW1,*'4`)!T32AT`28>04*HN(MOS3VEN)/GYX<8MH7D& M?N-S-ED#AY.`RAP/HD6K+G0N83+.TGE,@W]O'$):]K8K`J>J:D^;$`BB]4LD M[5629(VY*BH!IZCJRE,%!*+E2R3I-$OYBVS\:GA#HBHU@9-.=65K&PFBQ:QR M-M]B)3.H#9QNJ@EUIF@0'2A51&ZPA"EJ`>>C:DF7$`6BBP$[HFI7+DD-X"16 MG>BI("BI^1M&:LP6+%4UX(Q5G4C:AE$R]2OP>:O@Y;V]WY%[3*^B)*69Z1FK MI`;$06M=%-UIJZ`TQ)&K0G_BSBR1^\`/7_D%C+2\@/'`/J8Y=Q45QW#D*B%' MS*0,!)Z#B6T)M6=\X@K@1Z\R39OQ@O'DM3=FL)S`]D,1P@/8ZJ*>!RN7_TZT M'F]-3=B#6/D@$3-F``;/Z+KWYL3/F*"S&S?-:!ZM-YU5+PGF4SM_N/.,B?%3 M=6S1L"G8H]O&UD@;>#K_^)ZL[59O1F/)F6IBFNLK@X1#OO48J7S:0$G#)B#L M>3.EZP:3'M>!V_M2@&%9..5`3(]6@-OA>PI"2 MAGQBW6?L@4\L.Q#[Q"+2K33E6O*,ZL/N0CKQ:(P/49C.C>O-F7E(5U6P6B85 MM6!C2SOQIT&%*%@G3P_$+^]=+98T?L[M;/WDJ:@%&VS:B34-*D3A.W=L-M#M M+][*6(HLW?,NH@8'T;27RZ4=,)52MJ)%C8W_FB85RMZ(B\=P:*%M+*9Y4[4C M-+1OF.86V4*_J%?+`+G_COIHIO5H..&C63.D[`EO--&3D M*2]=Y(JT:>T;`PZ-;>/4[0@6T3(]*6-][\@SB3*#O//B"D`QLAUY$(\_!4(\ ML]^$+"GQ@CQWJ9*M33&@P%A+'&WA0C2DV"[)#2B?0::S[7?F+KG>21@\*T-G M#5L`"J6U0F@3R(CCVV5XK,@2*Z[W-'$L*4-6>FVH2MT&&<&VNEY*K-KZH>T&.S M5@:<'BBBZS_C,&^<^'GP_IF;$)\[^9FHU0ZIFDB-&@!ZEM;.A&J.&-$%HK&? MOR.4,,@&I.X4!GJWU@Z!8G2(KA2-&3(_"#/^DM`]\9\/*#)8CZ^-]MN-] M-C2C2W8WR^")*UW5`[NO9@('T3E15<2-Z'=DZ:[R"#L>$Q9$7K!TPZOH.S.' M'EY(^$QNF&TT-WW=L7&[L,&E)@S*)]E.H/$,Z"H40YIA@TO[8:T22@I]>U2P MN06Z(WK]SC'O>X?_H]KB3"XY(&B1??,@1!DL1TQ5=OZ7Y5 M4^,P]JD&(/",C/MY3-,'\Z5$6-[23M3>6B)%@6@#NB.C=M*2U+"U:31_?DFF M;4-R-C`0CYOV[&!94_JB":'G]#R.\J`.-BE4=X\&-[85]6"W]8I1(N9+BZ6/ MP24Q`B3?GD8:4T!7#_;Y$6,*C+'8O$HD^?[#2]R*@[=ZP.^(],%!#0NB^/5F M%Z8MW5BT9X751<>F]T;W=6U=7&QQ/7H@]85M"XS'FFJC<"QF4W/-(S206MZ1 M!KT:NMV=)<>..Q+CZ?8M+TF#/GABJ/4=B1'MK.N+E&9]W2ULZZ:FO856@@%1 M:IBZA-_=A7X_+:MB[=ZE\5HL4;<)-ULP\$Q5_1*$9>WNBZE].-+?HB6FLWSO MHMT\2RL`OQ^C[/&"39L:AT6OQ?:'M5ME:06@ZZA]:;R.PZ:3HK8K-\MJHJ@" M=&^T<;""$0ZK:L\XDNELVS\BU;FD/.1%3IW^1"I7P;`XL107PJ:S.Q*1%R9F MY%_P8"B^9ETR^,$SQW`=NZ+5M5D#D!#\B MM\AK0?P)CY-0WT?6UG6&#"$`ON3*D^SQF;;"A5QN35U%**$G2.S<5=7BSBLX0 M+E-4B^7$#`^B3!AR22]F,^+Q?`UL:?38[]PG\^AV33O.$"ZW5!^KC0D\1'DJ MZL*7MUE6$R;\A"0>#9;:)(L&]9TA7(:I/CA5P=+EI.@R==ZX]"=);VG@D;7E MHIHP)<6=X4&Y#50HWO:D"$9.]7Z=N?F@J.6,#L6;8`IF31<6'T(A(_=WE-(2 M?S/(_^E2ZG(H=)I+6;YX/]!,?JW:=$:'Z(%H#W7=$3"$'^4O>EQ%?#WF*W.A M"'WN9U4U9W0H?@UC-&O&\'DW+EU/GV1-5L49';8O8PO)FB4,/@SM#)%G:^MC M5JTUY(P.S0_2`M^:YVZN$MD=,C>@?[AA1J:S]21>?%MF9THK.*-#<888X%CK MW(I39,-_L5JR72,-HB3PK9'^P/-5W*=NF@M6#`B>+3>.^*Y<=]M8 M50]#!@L-;1*N=:CPA'UN2:B-^126!T]HH56XF"M:!+6`GX-O#E-XRR= MQY1?UE`,&'5%T,>^C3@0#R`#5'B,N[JPMRZ=TGRWX>?'M^O'^8PYE#4`^LYW M;UPJT2$?D-)8$'TET*>\>QZ(%42(S,)*$,6L(NQ;4)$JSDI;%_29[P[TF0&S M^?!Z_M6BQTPRRM_$S*^25GO294S/W60^C:31/HT:`7W$NP57+1%:M2%SYUCD MUV/!=@6KSPZ5"DHBNS0,^H)W)W([HT9T1U326_,%_3MYR7^C/F(QJ`_ZUG>' M.=<<'*)WV97S3P=*MQH`?:R[?TY%Z!#=6JVT^\\CW*MJ-, MVS!DV@UK(]`,=3_W6/7WL&I7:!_BB\4RC%=$GC'0H"ID7HW6H]44%Z;;JCMF ME]:!*JD!F36C5[NS`@?3A=4=.:=9FJ1NY+.IH0E;E6J0J39ZI6P;4S\74.T= M4MQGCSPMRR/QS[+T1Q3D/4YVE[)=0Y#I.?H^S-"@[.?JJSVVS0:JIB9D#HZ^ M^=R&A>GBK,HS^.;COR?T.?!:NT]WVH',R&'+C2H&J;V8NT>J?T24N"%W,/W. MM'0=)\DTFC``SR[/,J(B5U,3,FU'%SI-8*T)1.^[Z6&P2AJ"S.%A;4H`.[[HO8/`U;2>Q]"C/ M$#7V/)KQU#1%0@@%\4;U(3.4=&'9'-R:4@RQ01?,Q(]?)F09)X&*NEHYR&PE M72C:!;&F0NH3VE?&$CY%%-].F(G^4D8W^#!I2\1STIC+])3?%#M;;8J4#PV, MF` M,5"]F#,EI'?+%I;[X39HV\=KC>O3/_6#@?52L'E>E/U<[FU6IRUJI6KJ@.;S:6IJG5($-W/*59!]A6-/5`KARR#BZW5?P[R5"19V,MW8?,"676/V5;;(1E) M&JR5()CBZ6F+W7'G6\!9CZSW$SO=4ZS&]S-;5O#]DP1/\Y3XXV="W2=R\X[FFA_+^YS1T6L@S8DI/^O`2?%.M#>*E,D MHG0F[4UV(49;,5FC4%T<:MX84&HTZ/[6 M3D^]))M!,C&ND8'/C8T$`]0_>B5DR)A6P#!O(F=)(+*)W@>^_[6I7KI"GM=E_BS!S56\>$Y(@M8TET*:IVA'&QMPPS2VRA5;_M7*P8<=;/5FL]QUY\73X&_?5 M3.756NV:S[*/JN-:7B6=)Z M5?(:YQ]QR)H)@W1UYZ96/(#F7T<>]6N]#]O7+K;YMR_$=T'R\Y(2LDZIL<^^ M+/KV@<85H^O),MT>4N11FY$["9X#GT0^Q)Q<_?:A!B>CZ\A2Y>HBC%"OL/PU-B/G:E7A6(Y MX`+M50A/RTKC4WMT4RL'>UIF:\2+>\(.<(L9?C:+YGI/H#B*T=2`/5ZS81\: M`'X/+C<4]Z0!,P`K">[9>Z#"?T`&P+NYWPR8U1BVV^FT\HXF-OA[R8`/=@'T M,HD&#LFK_^[N$P.^/V:C!_:KF>,]X,W]5L#'S-ITE'8(CS=XX6_P`KZR!C$C M-=?.\>[M?KX-E#4&S#PS4\CQUBSV6[.`3]]A[+6FV5YPWWD8D8$S(J/?W/Y_HD@-I1)L1FULOE?906P] MBBH-X#"I_%YC.4RQOX?3SR*PH#2^DG&6SF/*GYRWL5.3?0LRK,.4ZY[]%2I5 M6)P3-AZ1PATRG9434I%10#8;:*I!QD>TX\\452\CO"D714*-QEP4U2"C"&QP ML4'52V2`A`M^TSN(!-^_C.E51,+@*6`[S*O(YU>WN.=-0D[3=B!/W#NPU09F M+\?G*E.G.@/SJW910NZ(%S\5:KTC_\J")$C)/:'/@4>D)TK=&@0]&N_`:#?` MB$[*WZSM0DCQ`OT]CIY)PH\!^%JHX+M$52ZD)W3-O) MFF@K\05;(-/55<3?CL[=2--T3NC#W(UVL4@MCWU\'.@AC^Y6RMZ44_:O7X'# M`.Y(Z++E<>G2=,44PP![N;A^$0>P[P"`4IQ;+L[#1AR3XWU=5=C#>XETR=FJ M]AOC@_H&[4$*>TPP\GD/5JG3: M(]'=PN"GX\WTKN<.X\%W9XZP'#K;(@OA>?+Y/"`S9G9Y61H\LTEF%GB$:D^4 M%;6`.Q5R;D,=TX(ZJ)32]F,^+Q5>&6&>KL=^Z3:L/9J!W8 MS,K],M\8.*(A7Y?]QDTS&K"5C,D^(8E'@Z7F_,"H/FSR89MD*P#K(@3VY+1[ MR_UZ0UQ>('&Q:.]5QT=N-?Q31=GJ[=__F]` M*.-KOKHFSR34>!S-&L#@;>R5=DW/TBH#CZ4H7$MVI=:#UBRIJP?I%&P]%#:]B?`C';T7082OZ MAAB=N,F>V(?^+!_T\NV$-\21( MN$G/-*$Z9#)M`]:9NJ<-62-M(!K)$T*9L-P56.A'Z5*K%X5UE>Z)5Q%H1`.Y M$*K9P)76@76'[HE0)7HL;TP5_I6K:!;311Z].8$*97PF4482[I"^8&@HT\5Y MEJ3Q@M"*!V%T'!^ZW MO$_=-!?L=Q(_47S.J*2GJ$#CV=26LW952'UV&%D=<.^B M4ND2GE1@WBU/6)R"_1)FS>>7$._34_Q\ZL59E-(5IVVT_@]G;%1AK/RQ\^-> M0,WFE\!YUBL7@W6JA3)1.JPV`,67;0;6-H8\!;=,<=%Q@WS9X6QT@'ES+3(P,34P.3,P7VQA8BYX;6Q55`D``T9%2E9&14I6=7@+ M``$$)0X```0Y`0``[7U[<^0VDN?_%W'?`>&]B&E'5+N[W1[O>'9G+DJOMG;4 M*JVD'I_#<>&@2)3$=1590[+TF$]_>/!9)$``?&3*MQ&[8[6$3.`'(A]()!+_ M_K^?MQOR2),TC*._?/7AF_=?$1KY<1!&]W_YZLOMV=L_?47^]U__Y__X]TT8 M_7;GI90P@BC]RU<1%E"_ZOMT6SM_Q7;S]\^_;CAV^>T^`K/@=)O*'7=$U$]W_.7G;T M+U^EX7:WX<,6OWM(Z+I[#)LD>'=U\ M17C++]?G2C@_-'A)HG=_)7.,\(HF81R<1FY#/:">=:4*3OJ-J<5Y8ACS=KCM)[(:@:YIN8_7[#^&R.C MSQF-`AH48^.4&FTI&`LM*Y1_[#>8;;BZC9,FSOCY)658/OSQ_0\?WPLD_#>_ MGL3^?DNC;!DQL<_"[.4\6L?)5JCKY5V:)9Z?%8S$T`7[7]__Q]_./O['G[[_ MX6^??OC5@M&[OQ93T!AQ0M-XG_C4"K[\"LVA>7>_?GOQ^<<_7KS_TX?/YQ]L MAL8L&V/##2N-WGZY^>JO!1GQHH!(0E*C)+\4M/_WW^5@QL/&3/Y=7,H!1HC+ MI+GFO,0O!LI^[,&8MWCGQ\RGV&5O&Y]RG<3;88LL'U<\:++>&4M6#E-`3*G_ MS7W\^"Z@(8/ZX3O^`Y>Z[]Z^_Y#[*O_"?O6K[/>:WH>\NRB[]+:T0\R^X_C/ MOO_7LX\?__3#AV_/OOONNP^_JNEGD*[O^5S^^*)MS9@N?_T9?^BR/ MAG!N2Z/#H%@^>4,B6A+6%-2.3`%@=BO1NY(ZK8*::MHUOV16*."6Z&SCW=NH M_P-"2+U_B.%PJ91_)[P!&D4_;-B@FKUSU?2J]";5M.OZ>)\DO*KX`P3*723_.QH-/V30H/J]:[WTJO<&T3SKN0P6FZIV M!2&$7E=A4*X2V1"/0A\;`(@FUZXDI1KOIIIGS4O;(7L^8[]+711Z!Q,,VKT+ MFW(YY=Y!OJI$)\\?;;1S=9+'_V\V#Q[[Z:I_Q%".>V601 M]-=R`3P!T*-31=,%%1%D"R()28T2W';,"0[RY,!@;?8=(^A8N,G7VDOO!,)] M^O;>\W9>1N>[,A6*:59"ICG,06XDHS$:U(2DH(2..5CA$5G8/FL M&(*)ZZUWM^F-JZFHYC9^RM&KU]\OH@E\9I%^XCLUO8($;*D<;[PT7:V%P5D^ MA\91*0-&:'1X!\;6T15OPO6::,14&6N&5&F/A0:/4E:M03M-W.(RMTS5!W`2 M;[TP,E7!7910:K@31=\"DPUALUFG``!F4=1K26M5.LAFMRPT"6FZO&(L:9+0 M0(SE,]W>T<3:MNA8@5L7+CY!(VIB(L$F8 M_1(RV1AIZ&$DZG@\6Z9@A<.6J7`JUN,Q$@F;`ADV27-?6M:VK)L/C.2=#+=E M"A:PMDR%2[$>3Y!(VIB(L$F8_1(RMF7=]#`2=3J>+5.PPF'+5#@5Z_$4B81- M@0R;I+DO+6M;ULT'+-9^$4;TG/W8F\"FHP0_GJFCT!S1\&9$M,,355-_";.S MFHIL[C6T3%.:I:YG[H?4T#JZA:9UATXTP'I^WC_\FYO3VQMTRK5[$1GITP-2 MF.6?W\(R+2[20PRE2%58NF5@08I;=4B*AMC"*(;OB?9H3(%V16FM03?E[(>- M7OJPC`+^G]-_[,-';\-&DRZS8R])7L+H_N_>9F]\9]"2*;3Y,,7>6HJ,0-2K M$3_42!?$RTA!300Y(K_?%:XH%49\CI56=*@LZ>`O.3FZ7:O"'#!"L5;OZ'T8 M17RQQFLBAS@1\JH>(`;LAVO*C>.: M^I2-Z6Y#+VF6+S;KT(*6%[2GV(.TM>7*FY.J_8(PBNE$<5`8PA%<4@,7T18F M<#-JLCS-@A8Z1G,+W7GTR+J-DQFK#F-9.+RM@.0+5FJ"I;.SJ:("]'((H/@WVD;]"X M#Z82IG4=>IG,[39<)73GA<'I\XX/B>TE5MD#31HQ:%-OPH@5E)-AAO-P;>94 M)"<3^VA!2`Y.3U#8^&$8J21+!>''UH!F=9SGGSX\!MUG41;P)_?IL8[FF0O5VS*Q5,._]B'.^Y* M66S-]3S@K*@66=NTR.8+(@CD6QX%R33;>3>[Z81*P*$5G(Y8%\#>V1*,5`2[ M&2$9G'C.L_86Y*@\YLP+J\Q_R#D7U%-1X4>%$]"5ZU>5/3Z> M"2T-$!O#Z;._V?.I_Q3'P5.X::V!/B-HQA/:U3-$W@X[%F3EAHI1DCD.ZK%N"1'YGJVB.',+GD7H7<7;L*,EUV)Y+V^AW@3T"3E6XOL MQ?9VB#D_*"-K@;AU=G>^/#J_.+\]/[TAR\L3LKZ[IQLMH<.4E>D5EE"^NYPGM)1@B[U-5"Y)3DIP4:7J& M&]H"V\[CAYVY]*)S(VP6L=5%!2W#^6^8[T*NO*F7TM7=)KP7B::VWD0?%[`R MUWWHVA=3!0$1%*1&@NF>GC.J#:=(R=U$Q^Q.=;P'8GE;I$^A,?1F$J4O\*UG M,;>.N(PS6F@M1^O=R0+:6'?C.EQPHE5EF$'4P`@P;A[B)'O+>MF22"!2V%U0 MA\+FBQ1>?ZD!Q'$W+QP0A*FPM./G$8FW?QZGQ":W-NE<'^N?-(GG^E(+E:H& M/,UJ5M:P/Q]@O59&#.:1* M/*TU5ROHV3!!.-PV)QQMH=&I:S@/3K_H]*Z;@G9NP3FA2?CH"6-E$B/6*A(] M+V@OK@=IZ]GJLGD9`W[!Z-6YPRK.9L9_27EHF2Q+3,4[FYYXP^F$^J*R+_GX M84'XP\'(:F$-`G?#=%2.[KU`]T=T[H2)1C'R*[2,X`^O'5)*P.-<1BL.[9&7 MQ9E/<5=.<_X,<)HU+@`,Z2HVT2H,4AQ'][=LMWQ"[S)1B:LS?N:SBM/+-$F#L6$/)O$MFPF72(\.MHHUZ0:,*E8N\LF4&HU*]5 MU'4PH("NPRCD'7[:AP'?HHT,3/J!FQ*>-L`/YPMJM*O>&^PBQ.D/3N,'OA;_ M;Z#?]PJ=/0-A!-M7@L-[)9[L!!XL9,S)(=B$(LJD#R_AHCN,H"Z-[&OG=LJA_"$+'"MH'T.-L']*6 MK:75K[='9>DM<:T^?SZ__7QZ>2MO"QZO+F_/+S^=7AZ#7!)T7TX61D_'9_Y' M,8=>W,5X5=?JPFJ],9&MR3++DO!NGXG\M=N8)_G#7A`<`2;F>[@#;]XBNFO; M?.K6Z?FW3A;0YJH;5T>1W/KSS0OYB-N"G*?IGH[_-M80.V4+*!7O43]V/4H' M;IDTB\[((G710_A]<:25&D4NV"$=7.I@"T&7&Q='*(1C((140MAYB90)\K_> M?_/^_?OO^*-P\E7S?R,?WK]?O)?_GS]T3KQ]]A`GX3]I\&_DX\?%=W_ZT^*[ M;\N_QFOR&'-OB/BU7D@H)D@6W-YG:>;)(HVJQ!S1\%O&^./WBQ\^ELRU7'IS MEP!S';OEHB?)\8!H\)L9-1,K+:PH`&5JVK0L0%_*4.+2N(F%ERB:HC!J=E!D M*;*T!HB*]HC>QC#&(@.H3(*]S28OQU\#EOXAAT;>\&,C/\R^)B%_.;[,;:Y> M!DD)ET3V.]:.42Y($+(_,OE@/\9/D?B5N,#.&FQ"+Y/ZBO5(&$+>Q=-#Z#\0 MIFN(5]\^9+%HM/,0OM.AE^K^)SH4]+-?9P\"<2#H;:Z\,#B/\CBRJ0NA)`/:@E?/NG29S["7E1:.)$FVC9>8L(1.GQBA+I= MAD,2D8**O*G1D9P05\EO)Z!U5+F?ANAP'RVDH;=]Q@)&WI*[TASD/G'WV_#3 M&X6Y`%,>1I@&Z@\2:D3O>9^HEBQXI-/<>A@%/@W8P9_(N9_$83J!ZSEY^T/G MT5M6'+TAR*!V@#25XA_GL-#PBR#8?QF-7:;?F!QS@FV]C'!@W5D9#5Z_<1K+ M)EY-!Z!W]A&=D3N>C:.K%6^[X>OG![W=,T"LRI&TI"*"%&A)VMTN8I9 MME5,*PL*E7\WX#.:X@/W=LP$TR%KLL4*@\J1J85NWDV3`PZ/Y@"5J5J9*,-R MJ-=BBZ:1R(C02>G!4ZI%OU9Q>./#NDSU*M*$V MBS5J>J,(39"M-J:A$38M*VAO3X]3+W?3!]:&%HNP1O9J8DT&Z].X8(2*#[C, MV868E.0(;%O/WKY+KB:[O.OPYIPMD+2A(!`%E\U>1N:7M-'&NWIIS@.TDMJ?=.WFP>T@#(3C%PE]C.\&$#AG`Z M%WM/Z*9),[>`?DKB-+U*XK5]F9`&*;3/T,1QN&C$7XG\,RI+:S+LW33#=K>O M[H,&MZH=R]W(F-;IYA;1U8XF'@]$G3[O:)12W:N.G7I)PP#*KNHPM:HK%FU) MT1C;YM@-#'912<,/]W$^_X1CT?EJV5ZV$& M;??ZL+8W/;*]N!)=HRAD"]$^>A"TH*)`9?#'`E5H#W06UDCX#&L)Z3C-'FZC M&\;SG@WFLY?\1FN*SM0,ZSB`E172H6JGA(O&8BF6S2=3'$XU>:S@\`")`+,M M&J,QQ?VK35^C1$T^N_?*"QA_HA%S#C9L/,M@&T8A=PRR\)$ZVF0SGM"FV1!Y M=S'QG$XLSR8EE,!-A_6^AM5K4**S;C:KV\(:X M"CJ;(>&_SM_/`);Q*DP1U8HBI;B`S.GQ@M3:U[[NU"KZ(0FX:.(AAA'(7K90+DN_?@.EUM%03A)OI\A M<41J=`@N2]HC.WY@_Z+\D2CYW&F\)D%)0#95V5LT/HSAZM1Z,'T\YI:XJN_# ML=BZ,CI.T%Z-%N7APJS^N"!BX]H0-E0FUQ$76MO5OQJ-S)B&#>2&G$M\RD=D M;LF4Y!@VWTT\VBVW:"J-5\>N%'R7K4?2N;<>'X1]H'UL""BB`QU28AP3J-.B M";W9&E(-(V@[JL-H%7)#%32P096?6YE%VP!C"9-A`O<1>N7,R$50U37K3";1&#>P,'86SJ`9LV#.+R/T9E`V;`_X?!=H`;KX*-`#94_%1B)!YH_ M[<.`UW`8>\@+XJ4DH;LXR6!JI9FH!A,/JD$QM_XK7@HMBAX>>6GH=^A!K5%0 M,('VEU386H_\%<]1EP4\%T2T1>4GF:(1O^=WJH64\-=\RPHZ7;5)P3T*[0HT M\B:Z.:"0))X\'V[V3$.)/>!)F/KLJ^P3^UMDSNRAO!/W^3"63WF+1O);$+G+ MKK'$EEDPWHS\1,/[!UYXV&/C\.YI0\(;Q;'^C,8R#I0/K0UUY3VWCBB^VU)^ MMLO]]HXFJ[48EWJ`XD./4`;**=9Z8I?B*5KV\/;_\1);'M^=_%V]/@_BPHR]>F_"X/?NY%<0R M^*]]FG%UE=[&UY1/9KBAC5C6;3QQGS>4_\#O%&_C)`O_*7YOG]5GPA/:+3)$WLZ(J\@6I"24=^YKI(A1]E50K?A?FOLE?0S`G,Q M##"VK%M]B;+=-Z,5_C(OHS]M7H# MAO!VM!]SV[3<](.)V5)(M2(T0E0FU!RGNWG#IJUH50HO0:AHN7$.3V7-:7G=](6LO MS%^\)EX9E$)ZZ7`.J`C<*4/!M;R:J.(V@CLEKVY<>6%P]')--_Q+7WD)CTT: MNE,Z!D#NE!93V[CE=>)Y>W+T0G(*DI-@\*?<`.TXH+L7DN2`=A,!F>7X-8K<5CC\LH^,E+$B_*4K:;NZ')8\CM*C`YO4CHXQQ$Q*[@P<,$I.!"V,^2#RJ'9>@,E%CE ML^`"?9T_CR5&0:',=;KHI49X#="64*:K#4/16:5M(> M;_CVCK]$A5.>?4&WNTW\0OD[`^FT0-WO.PY>D^"NFIF^TR>_=I,.WHW5GM<^%Y;R M9)^$T?V5>.W\[WSS*W]=,Q>FOI<[?RCW:\",Z%YP)Y*`2$9$D8X'RPP[\]8[+2.8#^7^6N,RZ2+(OFBEG5\[.U"MK]QO0)EPQD\9&"9?OZO5VL5WTI`F/&"\B$,D1H*"`N0TV\J;U'(P8P6N3\^B1^3)QTIT.8*F,&\SPN0A-K(:*I$:$W`GH M@S"AD-!T+WI$.\'#V2.J?!<>@V^XO0YP=)9Y16ZNEXG_!ZG$9I0I8< M0?*&;%$K-43!@"D'DK,@C$?-UR`Y%T"?8Q3(!;HU/[2:POMPSC":"!F"W.V9 MOAE,"I63YE'G5-FQ@W>WKA+*4]R*5#!1"6ZXW]7-%9\#ID!OZ(GEU.7KS'F) M1427R9P1%]"*0NLB$B-KL/MR[>8A&N2NV]1P$7IX.HEV=/4Z6<+K+C&.7)4N MQ>=Q#SQU\<(3>.I$:AI%%LLX)R;+D:5VP!&6(TR)!T;[S(4#4;1)+626T:8. M1O`JI`B!77DOW"_CQ39\/]FS%5"=.@QWA\QZP><>&^#W)29;S((_#J`MX]7%"UY0IM.":/M)H/^#=%7,Q/84W.UAPC\)>P$>N"HQ%I?$CM'18 MK5\7SH#O\=G/@J5J*YFAK;X[RBP9S8GY= M,26,[+`AWX6+)5;R6RFP(=+QL M'L-+_FBKU#WTH6,[^[8H+V5\QB:H*D-6JX]@'?'H9PCMO)A@;J<>2AKY`%:] M:%.]A@PJ-\4%9J-&2+J_2_TDO.,/=$=!O60(?PH,G=DV7LIFH8Q>;O,_I]NL M#:BH7'*5Y`?#A^U-3?;P?N">Y1T\0]W5RAIU.;OJ1"UDH:@%*7EW5/1$$7&8 M8(XJS*W:0N+-0#X'3XHY`'SH>!QIZGD,>6`G<^N8/)F$*[W>FM]:9:QA!&W^ M=1@/EW;>5EK]R>I_CW"`80-*;$_D!2\NIAQ:3R5P<-O>NRZ-;+J:R^";L56@ MTJ%6OIH8Y+ZK!HOR].`VGKP\ON455A<46R^@\A%<;(7Q7="T@2"XI3KA9X&Y MF=HG^>I+J$I*R"#`L7@E,N,G+(HB@\:;L!8K:,NOQZG?\M?:3U->T#T1TPY6 MA_7W:]BB.*/E[0=T?H#!2K7>W1_RF=_GWN6*@,<7^J2OO&=\\ MQ$EV2Y-M7EGP@M\"6=UMPGOA1#ILT"U80QMNNWEH2V).+1[:X?1OF;'=EN4Z M!0M2XX'(M@]#7HHOE]P<[8:380M>S`,2W'UQD&?#P(8Y7[RY!>/G%+R&7()Q M<@@09&@.@WR8*622+S`G7PY9D"/?OZ])$:,G!`QNYKBXUI& M`?\/3U)_]#;0(J?J`5/T0YGC"`P;TQ%Y$WL&`]_'*RS-_:;:YIF M2>@SKYS_S>@DRI@7R,&4.=).I;3L4$KBEQ6Y^/OHDKD37_XF\Y+,_*!D(-@N M"5P0+R-W]#Z,(NX]\NMJ8F03`3Z-+,Z%IH)+>8G`R8#:'^2YXUQN8QE,5&I8 M\P+944NI#,U-&LV?G[7>[#15K8<,'<+:)G\ZC=9QLQ=IP?5S' MF"VTUVB.OY5B5Z.4^IG3DAHQ6&6`.1`'8>IOXG2?T%*VUQQ_6+'"]Z".Y6HW M\II,>8[B,%UY82,/S_1>BP$#,-=(@ZG39O+V!\^=HBC!X0Q(%`<.)*#L@>9& MGR>B@DB0[<(Q,7U*ZOFK[+$/RDPN'Q#;`-K:M18YM/UJXVG7SY,MA-PL"&N$ MR!B9#Q^=+5&L),.2E$U:@%J3\9;>>L\T50N"JBQ@BQ*PFF0;14?Y2-:(B%90 M(C!X]!EO!6X+^E=/7RW(0[+9#_486F:-JKO+45`&\<\SNM7=$];?O39G#&TQ M;.:@%3*5M+5:!WSK7AWL"7JGUC`:*VJV-+46M8?%\(A#=6U8\CR+D_RUEAN: M/(:^^04[+ZN;PZF]^S983E$TX%*8KCXN$X6]=E=SG.="J<5 M4$!!3BD&RI>!73=F-K@#XD_UMU['6"S!F-K>T+H/_VJ=940@Q"$*N MO;T-W_R?1WF>[\%5A9_"[*'"L10W5DKD\ M7PFCXI[!HG6KB3RQ/FJ:A>2](-KM3SAQ1S2BZ]`/V4SYU12LNZ<`?,,_M@P: MQ0-&ZW2$E[]9W]Y&E"M9K4]H$CXR'_*Q]RVE'F*@][R56-IA8]%45O!0HF&'GAZ/!=$A<7N4>"PR2?*<^>=$]3:V@G-WKD(^[\:/F>,/T MM+;XIUYW:CB!>P8ZE.WX]7;K)2\BYA?>1R$S7QY_K;7D00HF@#4]QX-KAPO> M1/U)AMR.B,WYY\NS\_.CY>7MV1Y?+SZ#HCS%53?`;+',KEZO;TAEPM?UX>79RB,4(]2ZLW+-Q%.[=X M\.LNV8NK>3FDAC8K+30M5^?!2^A#O&%;^_0/1#;':E5ZP?0.']R,=*\N(_-Q M0`I2%SU?*'(HW'8/,"06#$$KG1MB[BQIGM,6_H+C1MQF=^[*,8A7%'8T2D5X."]]>ARG62I4_IV7 M\DJHLJ:3\V9J8&_0UG'P;'6_8[#:B1I0S?<,D-K4T:?@I''1LLZR+%TMF"Z( M8/M6\"5E=3'$MGL5,/5%QT=E%Z><'[808(&Z76JW>@'@A=2*L;L9<(,&=!-/U:UAPM(<9 M%ND<$`:P8@E79-T&M\5*QAP,&`CZ]&)Y>WI"KI;7MS^36V9Y;WCE36:,T=A? MA]7<4]/GWD;?A[B3H% M1(\8&_DQ>@!)7AXZ*V,*!Q:_8)J).3LC1\N+Y>7Q*;GY\?3TEHA=^J?3SZ=L MJR[V[<>K2^8^'-]^65Z0U='%^:=EIQLQ>"[L\ZG'GHQZ[)1?#5N3NWS-I&+- M>(=KQJ^MF;BV9J@HV,.OQ60QKVK/D[?9[_@95*MP%Y)4[E'TD#K?>QC[N?=9 M9UZ8B-3T:D4X1T#TO*"C'SU(#R6$-\^OB7RF'F^-_MC`Y%L:10.TC#"L4.N] M?P\3J-U^'S;-HJQ13&NX[>\K6Z-:GE^3OR\OOIR2SZ?+FR_7TB2#6PNK%:C= MK^LYS)Y@0^^Y+KNFNS@158E<:QDK^4#K>@W"UNF-;#I7>>(AH>W)4(%;KKX5 M:59O6,4$6KZ&I*Z9L`)+6C/"J5J:)1GJT+0CQM-/W(21\\NSU?5GL8M$8\TL M5J<^-8<3[F*!/KDOL:!J"Q8@6FPS4DFI&\'3:3A!*(>S$L%R3( M2ESI)*4_,MQ)/:KTVD5R%90@$5H5BIYUCL62V6%8\3NGQZO+X]-K>)/5OXC4 M8;ANLKE=P2,O#=/5^N!VZXO\7YU(:-UE4Z[0VS!C]*U20IR0YQM6I`MY_?N% M_)+_%U"^I@0=KWEUS+0P8VB,C-N*-MJX&;*DW]^#X2E9I.\@*Z M^5_,$X]Z&<&E&_5C;"<9B;^0&M&"%&2D^"L",1T-<0L1(S& M\-HN8JWM-68V^T9SNV,JA(]DE9R$Z2Y.OP+\B+=\@^CQ'4G&0*T:9]F7EN;Q[(7$B>DZ(<;1-[36]$5D2P7I.R- M5-V5?\2C9A!,ZRI[H$E["M'Y$Q,*K]GF?H+^AU^XX1^OWH/E;1H-. M[I4K6V,0YE'@>)W2-WGBQ,"Q-POU>%5!YYW\*OP!L83Z<2)4,FL2U\"2B&8Y MV7Z[E]>;O2U/.?JG&"Z62R6]LJ:Y,:*FG?_,*Z5L#GATY(0^TDTL7+/39U[- M@[I%((Q80CLI9KC;)V&22OCM-3J2$[X:9V)D^*+6"SH?P6)M&];,Z.R7#LK26O7B6[)`)--0;._!K^4^4AYW<3Q+<.H"VK*[ MS4MG\>J\MEV=SR(OP5EDA$A>(GXYJY8:=*UHG!GB!4D[9@B=&S!`4,RN(3GP MGU]9A+L=OR(5!3^RE;L1J;*IZZ&$*3>P>TJF:-M2+PF%=!>DPKO%Y-G/A1E/ M)H#=\M7?8C)C-?\+P>(-T#0?CH'CW_/8:0\[:"O=C[?]3&])412@Q2.24V-% M9U0-UZOA([EZ7K._T^(E$1M+>D438=L=K60O&RCSV(^OM6G-*0@CD66?,0G? M2"`O:9;G>),W%W&:?EVA16,(#9>FU@+V\9A;W"[I4^TF2!)'[$>?UI)X!MI" M>_[0QM%A1MJ+^:GQDF:#"2;AG7HBKBG??JGG`IUE=14'(U-KS7SVC:K_0(/] MAJ[69?K\\3Y)V$^W_!U'^ZVJ,3^PS:HYXM;6+2?E$=?:39&[L1B5FM3#929UF<2"-0`G/.4%U!K.NS%5:SE:>9U'-*")7\T3D# M8XB:63;]D(X@WAFN4OW%8$S]@4Y2R/>%VSAT:UHD9F8TV1+QXG#MOD,NZ#A, M_!S`X-Y64J^^WF>(#^GFEAP^S7R6^5AN66?+YS"U-T8VJI,!M`2=Q%LO;"7:J'2'BAK*`BG1F"TTV1R' MS9D&"IB5T:\SK:%1D,X>UXTSFEYY+]S0B8SG_.?T,]W>T<36[/2R@[9`_7A; M05I.0?)F"R)3_@LJ\HNDFSG#<62(9TF8^C$Y/3F>#L^@"+,K(O'@^DXV5D(# MM[F&,F@6.^[A!;L+O`@C>I[1;9<[:^#&U\AQ[`;K>-KEJ1I;)/(+;TQ$:QRV M>!HH2'9\K95FL>NK:.$.5CY[V3X)LY"F\L+B;>$J#`K4VO.'MM<.,Z*+8%1, M.N(9R*.P8TS%?KOU$I'\O]YG_'+`+@DC/]QY&VXF92B'ERN1YC.JF4]T5M-5 M5LS2A6V9PVF*[LQFD?@MTYO3I9^%CV'V,O1PUKTG^&/;`;.DU">K-5'?0!"L M\WL(Z8(4W!$HF1EGJE(W<7XA(R=%XS6,)T>&Q\3.W6#0,%?21BR?O"2H#YF7 M>!(XEFFZW\K?C>6IC-,['C]FI-DTU4IY)T3TTE)+95>DUA<"'04\EY7>\FK3 MDL6$IEFX]9A7Q-_/7/,2;X]%B;]=N_YP^N*: MBM(X5U["!L4^7,J_VXB^D2E_/-Z/\8SHU$/.A`@NI,X&@4*8?"(J;<"=D"2? MBYV8B[4LLLIO`?&;HI$XN\(?P;&3$TN?PY`YG)8XH4GXZ/';YQ>A=Q=N1+1I MF96UZ%+;\X?T)ZQG1Q7PK9J3&C7@9J=5HGD%OV#_9/-&$^`_L+VP&"M7! M]C5!R1]CGKZ;@!CZ$Y;,P>K/RSS?_-7[8!5=4W^?)$S5BX>:W'/WK?E#.Q,. M,Z(NSKXH\O(+-B2.2,F(R->_H)7#U--15PYYXOVVF`ZF)NMQCHAXO"ID/CUW MG#,ZO\)59.PJVILR!XS;'KP%7'MV_.@E_^.0XR`[]O!>A>U\Z,2D_5YVC=N" MW+V4+>!W)%-/2[4A2?*7V!C\>QK?)][N(?39;^^!2DZ-NX+MSGFL>(.]WW9) M,]L7O/4\H+T#!3+-FVV\I,2$[U^[6W9+*,QM_3.J8(?A^&OZXQSVNK##W^DM#;&&=C*HBA++L*BT;664M2-EV03TF0-\-J9S;9D9F28I[J(LEVQ[>/M$-X_T,2,Y$LD9E!$>?);YVT5G(<21G@BHKK:YP MZY2?J9?;U+8JOS75^X9M&1B`I>@Z@._ M?CAC"W$Z9T!R?SW>0#X;(RH#SO&5^@.*R6!+[T^OV"&H+_B1/0+!&K?(+]?, MCHBQ,H)IW8*#KEZ7:W`X3^-H!(]SS?4"HWRU/D+?[-P^T(0*L*_<6^@4EPD\ MAF8_B%3()>U*"[%5Q8(+0B]`HK.5;4:%(#?<%9:BTO(TL$9V5*R^U_C?*,Z\ MS;10;GD7K\&YJND%5R>*LX#+C;U*XAU-LA?^WF.VC`+^;.Q.5ZC:\"93'U]H M-\AB!G0W\`KBA7A4-1.7S4H&4%6N)P<>.P(']WILU[WE#;L>IG-+N7(X1R^: M4C>U!>]>>?O^I)I];BGBAFGU&DYMXG3UY"3W8 M#[O5VS=D"FT'3;$?KM*"CA2$BU9`#F?%>E?`17N\Q>JMEK&1R3/C.+>X?O;\ MAS"BR4O="-M9/2T+*+.GQW6X'LO6AX$.3(9O6DA@IL]@!6IMGXY^]@>9J)?2 MAW@3G&]W2?PH'S-V,WE:5M"&3H^S]Z:5WFR"7;6"*"L4WW,K4?B^=\PA29=!PMF45HK0FL_JM8@*]?-.C1(H:U! M$X=BB6`,Y`T9.+@N[U@]1KJ[3C?[;B.,PNU^:[F_:!*![2@.QMYRN.7?D>T9 M!@X:;E?0M5+T^X`&Q?S[Z&?MRM:*\@$QM#X_Q-+>6CZ#KO1)!P^NUSM7DI%F M;U*B.?R\L'T-T803NF2$"\W#@CW9-!?(7DR<&2.^5(36BG7+1+AP>&`Q?GY) MA82]_^'C>R%?_#>_YL7#5NN;\#X*UZ'/N_+]>!_QHGM7\2;T0RJJ<>Z]C6VE MNR$]0-FJ0;.B*LW&WQ2J.)&*%2EXD3(&`?0TI+5I\*IIV.6\OD'C1@Q7%UI?8P#[^=]D7M,DH<&UK-9ZO&?_B(SO M>:BHX5YD5J!IOV(L&Y*\Y8+D;5'X%O8P\F*[".XYC#9VP,>C=2+1\W9T)^G\ M0KU+J!]VVH2^G563%GJ7?8"DO8:J/R.Z06DQ:D+EK3\4[A&*6==IG*E[/ MZ))8HW!&@W#V`H_;G14R M#7G-K7SJ5^?;([-U>_JX03M"O6@/5VJCZD27SD'D+PT#AT'-O'9X[E[78'`= MQA#LZOL@%6'AM?6P&AP)[R@KDC^6J]2.#3MBR&1N/\P4FW;)Y335T](3J4,; MQV048/E.4KP_+X!-I"OZ0LZS(0.))[O(B<;+,N,PNV^U$_IZ_6DVWNTW\0MO//,$Z;6BG!=X1LM(.9@Z1&R8$F=FA$?I$4U*[9>4KO>;BW!M;+2- M6*%+JFW@M"RH(VD))T9PZC0,HL!&*VQ[B6W3@0U?-FU[L;JET];XS'^[(\M5 MQFI]$4?WMS39GM`[YS>E^_E!&W8#Q.V;%04)-\:BM-`N"2,_W'D;LO->Y`UP]L>S)$S]F$3,+O/?>QVU>L$-L>FZ-KQ^TL-L M]FH,M4%4@[NFQ5?B%3WS+W<>&;Q"V*GV!G8"97*'SDVK$D)#W!>DXKD@%5=9 M6K:0EC":X]%!>UL]]MRPY?D11@2(Q`-0WLIKVJ0"X9V\,GWUP]ZQ+A,WJ\]0)!Z=<2$^6 M[5'G2VAH9W]%Y"%.LD*+'-9F-_4D%$R@70H5MM9FG[=K6#G8DOHNG\SHV`DAQJKZW&8[C<`$M0VI(G#PS]X_KV/1* MNH*N]:FUS*"U71_6=CWJLKVPJRG)*:;S%]QW6=.#`U?L1FO5L`BUCM/@G8*" M_2JRV2_T,P'9-1A@,U]JC`I(ED8!=DLCT@:':#/A@.FG),PRAFLG?&_*^B+W`P_WF[C2*9'?KT@7B8R(F6>)*?B_Q+9D@EAO/F_>)U=FB#9VYA* MN'J'T\MA*BUT^Q3;67=#9J`ED`RPFFLE1H7)PKL"/`WO'S),^FE4=/^MIPR] M)RM=T%_TJ)?3_*50[K+S*,T2L?9L*J!W4<+5->I`T2YP<9>1JA6V@N/J+]%3 M4J=%!KN&+KVMXS.%:C[0>U\-PIY5MB"\-=X"X'W?SK#(BH+)8"^L/!=?K86^ MM-L$:JA!=G\Z-*W"\45;?A%7NAZ3[O>LCXQLP(AC(MWP8?8AO:M+O0%1DXZ^ MYMVV'!HNH'L-'3H#&<"XN["!U(\"UM7M77S]/JZ:Q6#1:/C,O76*VP*OI0.*ZU([7*I#;VTB`R_.#D,3>#$1(;?5T MQ,.%>\^5Q&I]N$>V,GMJ)J!63X.MM9)$4V[Q6L$G+`;/'@T3!K^&)IH$C7L$ M;1Q`R*)6??+4;\F5',8HP+3G#L(UC>@34R)1SU MYFO8(_6$NNMJR3(2O8B.:5W,[P?"/KU$4=)UQ1S0.4O7'-O#T1 M!*CN'-CC"FNXBI!#UH4+6;RV:V4Z1&P;;`;;]BN:A'&P6K/_,A6V]1A8)LZ* M&T1M!:,C!['>6CRMW'C1F)OK6G/"VD]SK\C:/+N`819J5P/#CX&#*<#8F]\1 MT2`QK_W"H[:G&EI8`_HE\F0%1QJ<\)L)#J6.#!CB,J?=F'NM:HV,%'0(MOU# M,(IK<22MLM*YF[LI+_XU@F2+Z4"/YU&8P:Y_R2!OMB#,TYTH^C'D89#7LG`# MNN85]9EY^+0/`Z[@YL!Z?!CH690?%+N#J-&\#GYB%[>Y+4L]!&V:JM2D@4I2 M.ABY]B0$00&+GN'::'44=2L,IK^R0A'-R)M25X]_'&7_;MR$GP,LY:U+EK7) M;@T"P,M>+N4P6N30_FH;C\[P06Q?1QQ^;K=]+WT@C]X&YCE%N_5A8:8/:4?( M06+*CUGYAOD_CY@NH6EV[66]IM>4"U`>7C^Z=BZ2H"&'6<0%&>%T\/$=%VB7 MS,X%S3`H?U)'PDJF@&4?Z1GRR;38D,1]C`5.EY+8QP(V"E0?RNEZ37V>+G-% MV=)A"^'>^K4,2^;0UM9V+GHWW`W%LR`E%U*Q01LXLH=_DXDW(:952^.%B.P! M5M]O6HNRB].0=P,"\ESW^<`],"=UY1!&Z>,,JZ;SHH0O)VQT)S3UDW"G>"?; MX!J3DAF.FV)JK+WJMR`E)T+]UJ@1Q&Y<418M401L!GVJ^HG^MOA4`:-EWN!T M7\HH/CW)%Y/8BISCA0XEDAN./7K&XM*CBM/@7?!G+_F-9E=)Z-,BWJW8^ZJS M,)4\0/.1U;`SC6OBF(ULC64GL!1'.#`[W#'@Y"Y#A<3;[3:A M?"%M6XW MQ2--AX*.RO(/DHQ>;\"-^^SEU*F7TO.(:VV^Y9,'6;YZK<6#38M=7H<(8P&HMZH!6\-\ISA4"2'9[FU]Y+`CG,MUXOUOK9&C,Z5 M%2\::OS7WD"K#7=H8V8]&XZ>JV0#XJQ.B[\EO;SHFTB_KWFL.)\9=9,$XU,! M"];#G^#PPN3O7%FNUH5'+'D;)7-HJ&$>X-"@:;WTP-H2T9C?S"DWB."[0C<@ MPN!QR7DJ@(33`'%X?\,"2W7_521H)'0CCGC7.HA(LC5Z)4GS-H>2=*22M5R7 MR&WN>90Q)RD-?=&?5=2ZCQ6"#[K="_U0Q"NUY1M)9GS<$>S)TJC`Y6QCP*:;%[X3EOZ%(1- M"S\>$R]'TF>:^+SDK;QLG_\CCY,7LYB6?PG(FSC)HVO[*&2*R"_L]-=\KN.\ M#V0Q=3-58%JO5LEG]D==_`<:[#=,=][P^.;1R_'&2]-;F[L@6A9@C[MH<;5R MH?+6W)<1[^ M!S=:I&9ODVDYS2U\!X.P>Z%,00QEPE18^H1*61H;Q&:-C@+,2&G7EM8\=5/. M+1OYYMCM*;4#8FC#=;SQO._1*K-;]:5/-KFEX."`/#ER$$3UG6Q;KO;B"";0KI,+6 M6EDB\E,&N'[A;8EHC&O[;8"FF;$@D!Y)7:VZDQ(HZVIP-?TL0 M.FUO,.A"0'>E@'K[["%.>'E-#+[-0'S50SEY%H[,X&-:AVQ"NA>9O_Q3\@+< M*4T>0Y^*Y)HL">_VF;S%RE^$IN*-Z6](FU_D;_8!O^S.VC/N/+.8L=Z&DGAQ MT*^RG[L7\DBC(&;N&,\)6LP_/RZ-U"&! MJ79FSS;=*V?'#$K M[>6&+(-T-,W=GV0ZO*OYL^8ZK:A(BKVD3^(O7::K.YW0C!E8;JHA5G.G?B&3 M[A>$%QZ5]`C.%UUQ=EF.0O&!NY!."U:?O&K$"8E`2KVAD\B>O$,SKM#Q/F/T M-C(JJ>&$=!K$.FE=8+V#:K>Z#1-AC5BBDN-5]F">=6/""9E);:)TD55!B]>6 MF@"LRV0<1;PXJKC5QO[OD::9*.!]YT6_B4(J]PD5V=PHQ>=4> M"IM+T2&J+OY$G@Z]$-O4QT!G%%>-=+N5JR6#VCD2(_P<-%5K6M% M*4C>'H&5'P:I%K%9R_:8`@]VL&X?*!%O!9'[)$[3ZI)KPX$)I#7@T?*=C.:) MT!7_MSI\E5*?5TT-T=U=-9#6_IB"C@DJIZ9^*%DKDW)3?IU1'!Z#7E`Z0R:S MX^(H-;,=ZN5I*M;XG0J7V7$(=.Z^27\78Q;L:12NO(U/M[M- M_$+-0QKF_$#]&#/$^O(^S9JOY#8F)2V>LYD!0$L?H*A5D4LQVS#0R8"Z.SP3 M(T7FO%B(;+\38\)L;F>F>0@C5>'-_HY7W;^CP=$^^Q+)KZ0J.M2IS&VY0CDK MUNC5^_T\Q3(_"LF9R*^,(((S(E#I:J0U@"2A/@T?4;U%ZK:NM>Z#)4LDVQ(Q MF#(3Z";/F!KIZ$3%'.D)BG(N'`X[SZO`9L$(0:AEK`GXJ2/U(U7`Q'J>HE_Y M0XY5%)R12/Q!\I]&Y.TW8C"R;K^;&RKD16`!7,JG@:XZ-H44\5$6X]`H`'*A M%O][Y*4TX/5<:)2*_=LG'DL>-1E"VP]2XVXR0RXJ0/SW[1UG2>H\%T1PQ6_T M729&F5=1HWTM?H"QZ`S/M-!U`OU:LY_P=SR6OI_L>5%R^6:IJ5-@R`S'&QIJ MK`:O,$O2!*39 MUD`?$$-;W4,LK1)ZXN\D;X`B,F\Z='$%\8%NQ&4V*AJCLVV=2\G(8#4I`4L\ M=]K&)8\SW(NLK_3HI6ISY;WPWRV?O"1P+0@]M$,$Y:,'SYFV+K/"LR7U#OA] MRGK#O!,B>L%:H/J53AN&$MCC2*EIP>R!OPWU9\DRY=Q5+`4L3N9>F-6\]>``4B%GAY,K=HM MS#DM5XN,>>$>;_= M>LE+=0>7L';A8YB]('+(?L>3,NAE:+33`NX6SJ*RS++#)QW):S,%JWV69EX4 MA-&]+/<_N;>J[OC5.:^:.1S=1UL4>UKV0]7?(G^D`4'J^QRS6+U(D5?^_L(? MCMB\\-21R6KFS^KG_XZ7E"R4=I-Y289N+FMMBDEY5RRH!;FC]V$4\;_=>1O^ MHNM$>$LA(QW^O2!-W&.DGT+N$/?.(PIO^?4[L MQ,ZXH2N*=&[+R=IU2?.KCX]:NEBS1$I-Q_3:W-E/\LVT2)85497VF60'TMGU M:XV;=L_CH>"*5G,_A`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`3F&;AUA-&,2/9`R4!^P=O M+5J1?_]O;&_^!S49*MG%`-Z_?`[?7']/XX!;C`-'-=_V8[DPP M,4-$?;;8;FFR_>#D8D\T$A3^\U2S/)M"YD?7LFO"^\;G4,\UP^4T9*Q!2MZ$ M$7FA7I)^C=,EGE2\S?W=:8;QJIW9`LK?XPUCLPFSEVMFGT&<6=50?A?.K'*> M(71G-0C"1_'[\V6-9[LV$V_JT9MO0!0IG(S-[7LJQO&J5>EUF/YVEE!:O*JJ M4*33!)#,!X3"$YUXSF=4JGP$A`^A?!`91*>BFW+>[.V:STOQNC)).N8%AW\Z MAPJ8-BQK/)I7K6(+LW$2/H8!C0)P7[4YD-^5IWHPQQ!^:C&$W[F7VC/3Y70$ MQ71`*5(HN8+R3ANC&/S>7O6Z;W')V+;X4^>XB3\)^=-U>GV7BJ!_!J0SN:.9T@8;Y5/;7J$(7?,>=T?O:>P^U^ M2Z)R3E(Y)Y[_CWV8L,G;\]*RY#'.>*)&_>%:LF._#GZPO M<_-D8MYJG;_L);^\D0_5RP/$>^I'UK&5SBGRVS!\^Y&[43D5O+,T")8LPEAE M8RTFPV7O)XT*C&PE%1)?R5#*U%Y2'X/I]$`8*?2`>O?8RPLT$-&/U$HO2"H4 MGL%P>!WZ82)\??H!&B!L_,50&ON#,'V,!NL-GN041AT]G,7)>40WX7UXMZ'G MD8A.LQV=D4-ASQ3$PW#`?K@T:RS:NH6Q(14?4C&"]T)&AMXRWVL&/:R@A]-! MMW=4P+`C<69<15[MW5AS'">`7-^$\4.=**77U(_OY>LVUY1M<=,PHS0Q] MJBR$H`FCN_<">U8S8':ZPYB-6$S.C=38D9(?R1F"%"28DZAE%#L^<\_HE2LH_-^V!SQBDS`)LQ-W(+"91 M'+W-)[8>90?W"&<3<6U^SW2]OYJ#QV:=,H_YR\JW@RW!FB5YS3,2F"2QF6:Y4^$1PPQOTI'A3>0`2&T$1`R!\#$4 MVK"N#`&+$X).=:4-RP0WC2*$2'$#FIB?.J8#29!T5N6GR:Z;91BS.\EE:O&U MW"%=>4GV2VX M3]O\\R^"(XXR3`N^T#I$D,\?4J8>Y-8K9V);/H?&KDC8>L@GUM6CA]"NF;NN+_/PD=F9]>A3Y//5!'\[50L6A90UDF/ MZW"YB=:D;$[R]N0723&^`-F_;&`'Z#_VF]"+R.TWUW&:3@?#Q<(Z`='"`#.I M!L*CM:$Z^L$15+'GKFL8I52K$Q&4/$`SC-3(6H^OBI#@@3$!$H;Q\$R&P#V7 MQQ9"<3B]XVV19=_T"$Y_;HV*`9)]Z448T?.,;H?N1FM\D.U!ZPCUGF6-B/S" MR8B@PV$I9T.';4_:6J$N.]&*"1*Y.]G3,S8=MW%C@VQ9IV58'YCVL!8SHZF% MPLN[-XP)68>1%_EA="]K[$=Q-O\[7#-/@OT$H-HYV\J(]=[:N(.Y-<4E_S97 MW@L/6]<&%-+T>..E:;@.:7"\3Q+FDYD::RN64';;#G?K2)M3DYQ\T7#O&8<% MR2D1;-J'X5QNX_T$,%Q<$91`=HRHV*U\VH8^W\0E-PD>/ATF&EK8SXHRDVIW9+.@*X.4<2B5Y M&Y,:DRDK>;G>E1H+//.+_!Q\+14^*)F@<8G<5[Y-'3T3MH/E=QD$XNI05S=L M"#R'GJD.GB;*M8I1^J4M2Y`\2FO<+8-2,.@65"')%1=R. ML":CF]"[XZ^.A&,J:+,7SU&!!8\P]E%IU\],"^\3&JRB:^KODR2,[EF#RYC?`9?_//+2,'6ZJS!BQ]">RIASV'I% MOGI2)../(4W8MWAXN:"/ M[)-:9/>;G+V^EN(\Y@*_X\VNVS5(C>![LL=BT+<$W/NB7HMF1J6#'H-JG:7KX(-!_CX.MVL?,=JUCP[R]A&[7>L!I90S-3!4=NWC M0+OV$5JN!D0B+C37*"8/OES,>O=B\JC.A>9*0UWZ91M`I$Z!D08+T5[0:O28F]W!_-R+K-(F-:.#^QB=IV3>9G0 M?I]H?)]XNX?0]U3)5?KBM&I&T%M('<96)GZM"5"=U#FQ@.\P>]>?6=UB)9?9 MY8G>'XY#F??5K:+4#,`LKP93RVC(M@O27'Q`A5%GA@-GU_I6G=YD*:G=I">E M_C?W\2-#LH^RY(4+S\?B'UQN/M;D)O_UKVRR#0U.G0+*LC1&W7XH+N1W2H5. MPE$)R7RX)"D:#`RC7\=-5$@=[/[OQ-OQTSB0A1$<)#2'E+<&O3+POJFU[=9&-(ID.9 MW1H5:)"R/OJN-8RO=*YVQ&S!OB6;T!?/0*\I3=\5;V'G5@6?4>E>1/WQPXID M_F*75E&%"_OBLZ[\X8K2.L](NYRK6QCP`ETEV_&GQ#+RIYD2P/*WPV2GIRRN M(_.Y-4BUSUOR8A/Z<3N6RW7K`SI0Z#@SZK@;$7P6_>%S9.>*(T\(?\XPCL3I MHJB>*YV!NQ=R7\U40N^!GDB?8"%;A"Z=.H!R.FR="'BG0&/1$.18:D8I$UZ2 MJ<8ZQ*NP'BVXP;2M2=Z\2C#! M9O7&0X;&C)DNQ_X=KXZ)6(H2,G-K?_LK^YG]Y\Y+*?O#_P-02P,$%`````@` MQX!P1^@YSW95+P``-WL#`!4`'`!O>'ES+3(P,34P.3,P7W!R92YX;6Q55`D` M`T9%2E9&14I6=7@+``$$)0X```0Y`0``[7U;<^,XDN[[B=C_4%'[7%UMJ6:V M:V)[-^1;K>.X+(?MFMYY8M`D).$T16IX\65^_0%(2J(DW`DJ291>9KK=3`A? M?@D@D4@D_O._WY;1AQ>49CB)?_]X]LNO'S^@.$A"',]___CCZ?K3;Q\__/=_ M_=O_^<\(QW\^^QGZ0`3B[/>/BSQ?_>WSY]?7UU_>GM/HER2=?Q[]^NOX\_K# MC]67?WO+\,[7K^/UMV>?__?[[6.P0$O_$XZSW(^#K11MAB5W]O7KU\_E?R6? M9OAO62E_FP1^7D*0]NL#]POZ;Y_6GWVB?_IT-OHT/OOE+0L_4AVD280>T.Q# M^?-_R]]7Z/>/&5ZN(MKM\F^+%,U^_YB\O6=$_NPOOWX=_TJE__TR"8HEBO-) M'%[%.<[?;^)9DB[+/G_\0-O]\7"STWG:1I&B[#W+T3+[)4B6G^EGGX4M?6[7 MRXLD#E&WR<1#C#2M&+%-EOV_"[)$;&Y=_^9?JO3OQW) MMOI;$*M?)%%(5H&K?Q9D2M'4U:%\ZY&3!'].5Z6)DWGN#S]-B?YU*>0TTK)O M#R@BQAR2F2)_?R(M9GY0_H1>Y[BMM.S==#9K3F@3BGE>#3VB`S(@\Y3\4N%' MT^<(SWV#GAO]0DM4USY._^Y'!?J.?-JI\M?TNLUNHJV=HCEMQW@M9\BW[-&W MA$Q/A(0`I9I]V9$\RHS(Z8])7AGPW,[R1(H5- M=33;FW14TE87@0S_H7+,[&1M;$:L!^GXST*6C'^B[%;"1RF[&QHB75,N3'X6N]#(5& MG12WUB-*U:C]&< MCD]ZNO&5GFZ<_;7L=?WG6_\9<2AO'I5\W6FK$OK\7Q^.T<-[E.(DO(K-NKHG M?=0^/^9D3FS1ZX;\D?K]E.1^9-3CAN21^GJ'S'2[D3N63HG?BJ/')P2=XD MW>VLGP;K)LD_'C"W>Y1>?_%Y51ZH?@H6.-J0/DN3I8$&Z[XD^ M#)(&$9R:D?&Q&5FC>2+-9K[S<'"-E! M4]/Q'S!NZC6.4'I!ANL\2<5.ZLZ7WM=!TL!!4E/P&]!.(5DND[@,\9>G4MFT MR&D2-,V]%F\;!(+>V:\#9DB*K&;L*X>QS_O1AWU%V(M(QFYF?/I;Z+ M[-/<]U?4>/[R&45YMOY+&;5H6%']9V^363N=7>.8]`.3:3_)L"1TH2-N'KVP M`.NI2HV5`R@_A(ICZ*ISU_SY6+B!#()OALBNHXIC"_I?=CZJXGE@)%Y$?I9- M9^6PGKQAULHOE8&*C?#)D9#(`C!L/IN(+I.ECV,!D8"BMJ(2>*,3C$,2\SFC3,>&'K/C>AE2D&% MALSIY<+@QZ.'QN^%$;],*:C0DSF_7!C\\/?0^+TTXI7"X,?3!\: MOU=&_#*EH`)CYOQR8?##]P/B=^UEWN(8W="0@)NSTW-;"RR0 M:SS),I1G"F&3W0_!0FYB,MC$,;INR>M]0>ES`C;N*ESU4:PRA7O?>V?``20& M.R(:6=UW@DU:)(#>)B;_1R]IO/@1322>Y!=^FK[C>%[F&(NB#RKRWAEP3(E/ M(B<T`!(EB)QW*' M\EIMHKE?(.:=`8>S=+F7@K&U*X:=#&[B%P(H2=\).@&US<^\,^#0E2Z5!YVW MM>$UI8Z3+WV+`WKR>8W0UNCXHTXFXIT!1Z!4:5("8FL/"SO:R`Y]Y>/PZFU% MP9(%99HO4+JC*,$@5)#VSH##4KIC4Q43/_-M2/RK,KV''S@4I;UT'O2>GR*G MZ10U;DX=?^PF*Y3F[_>17R7B$#]P1:,#XI53).:=`8>EE/?%4A2VW%YH;RCW MXSDF:T^E&8+NZBV("IHG]2U)PE<<14(O22[NC8"C6LJ<*Z-QPQ-N+#QW21Q( MYVCF]]YH*)$N?O>AO6.;2ZUTC?5&O0A6*8H4?98;@%B06\$'"0SXEX!DQL;L6:M0SG5C*^] M$7#`S(A?'A`WMF,724PZD--HPFYU?OX89DMX(^"8F=G@%8!QXVCC$J7XA7#Q M@K0<.)&8-P8.E1E1+45DZRBC7YLVK9GGPO0U5#;F6@UY8^#HFXW-NCYB-[SS-7#%]9SUN3<&CLP9D">V@@-T3FS( MU=34>EKPQM"Q.]OFH(#76@RW'\%\-3_`&_VM0EO+/ M^-H;`X?;)#2QN>4!<<)?:]1[DE[IV?O4&X-?E31@DXD">IO%2?-N`*SPE:DX MO`QO]M?>%_"[D1HLR8"X<6XQ"4-<]?O>Q^%-7#O]HH-*MH3W!;S>EL$0%(%Q MPT-ZH*^&Q"B\\M.8>(#9)`B*95$>P5ZB&0ZPR%.2"WM?P&MQ&="NB,L-7^E0 M0UJ^L?<%/!'-@&$.#FO'&/V(6S#W""V2#[TOT+$LJQ$./L;.[`"\Z.A]J><% MRG%`X)PJD%J%=:I`.N!:AZ<*I*<*I*<*I#UC\52!]%2!E$/OJ0+I4/@]52`] M52`]5,RI`NE0^#U5(#U5(.7>^.R%D_PS5B#=MO@4%5+-6`Y,29^"[>ZAFD29$ODA3_:QLRE'*_+PA>V]2<"-'AY M4AW>5?&X<>9^\':ATJ(MD`*O7VK(-1.'&W41#U!*UVJ.!'C1TU;<-C#8NE38 M,U[5%FGQB>%[7%E>I7L"5@4Z%T"94B,2-H,`#88)HD;[+(69 M^`(YZ*0((6]LJJ5XG$A^B4B;@()WE&CIEPH1=%@9K M^3!]\+\JW^66.)@J5&Z_ALZ8,/>Y=C&X4*W]+HF3773K%WOD3K54%CQM0IMI M-4ANQ.9O8N+XH4S!L=[[$CPS0HTE-L,L+&W]Z*\5G3&:T_,Z(#I_Q"GR(WI^ M],W',9VCIO&V9*5HBI9(@N=(M*%;!9L+2>:-XJ1[&`7$\X7`TR7:<"Z!U=J= M[L5P;RJ(FG9&L0J'.4<"/$.B#=4B3&X$P[C:,7',P#,D;'%]B,H)9QSE2GNJ MG>_`,R/TG>R#[KM0:7E=)V6=J77N9S@0D,C\'CP)0IM,/HP.4R"@::41>1P5 M9/4O8WB7.`NBI,R@4-@V&[8(_EJL'=-0!%H;SV_#-IX_$)XO"-0)Z88_1W<% MO3<&$G?/W'T33-_$F"CP)R%ZR*IZD$"35 M;@PZRTM&!]>I,\#IP`FVF=,.'5(S8DO%G;=7,P>ZZ.?_*[*J-OA3\H"")`YP MA':P/B7VIHDN?@XZ6B0:*.@JKV$@4I??[FFK2%7U",A%Z05!8Z@^_8,XV".F`O=G.*W5^] M!:1[VZ.U*7'7B$H"A$(6_U(9Z/R]X_"NI(;6!U>].*#!3AX\ZCPA5H,C:6A95M#2 MW.ORKG'XAY^F/M$O608?4?J"R6PY32\B'PLK-P)1%\W;EQ37Q\V MH/`B6=+!)-L+LP7`$QZ/:RT")=@ZTPW1#,=ED?5O!0ZI:5I8:AJ7\JN""Y=% M2J#?DY4RJ:JH5']NV#QO!3)H"CQ-\H@KDZEZ6I_J]L*S;22:3>.K-ZJY`F>+ MZLB$[N@$$XQ4%CSS\KASC9H^:KOY.NS5B"BPW-ZOM_D-E=5O:JE5M%!L!#ZQ MTV+\7Q.V&U?F#D%/@C*@F)%QB$:H)K&JUL%!ZL1-CT.T-_$+ M4762BE]S%LKU(8VT"T/8A]@Z`-]-F.2PX[?$:R*[_VN$MC9\4:14E3RO5:N1 M/J2:FA-NB->-NQ^'N.]3M/)QN(X8\1Z>U6N@#QFG74P)7*QN!-X96J,(ZV$P M(:YVKK=*'(J#)Y1V9!D13SRU.*3/5I?5\02&HMZ(-^IGY%1&-=MN-'$[$2([P'Q#2(SGF#IF ML@V05-8;0=^B[]0\F'"APV;'7GBL+#C>"#BF:M50-'&[4&J8`[E^*=Z.HR)H MS!OUY4D$&XZ*#*@;9W;K1-YKHLQMVE4C84*T\LADO1%P1-:06L[*HP37B=N$ M^VEWG*R9W8>_&M^+4M9:-NV-@&.Y5FW*BC;<<';J(!,=7=*T:ZF,-P:.VEJU M$C%,Z$-"SA'QUE%7RZ+G?>^-H-K>AV`!=>&!\@>TJNV<>D>J)B"0\L;]K`Q@.IF+@;8^;^O%//"`PB*H MKA8_+I(T?T+ILCZ*NJ6'2]/G",]+'L7KNW(KWKB?05!3(]$#WOI4KA=&HZY" M*W$+;]S/P*B9R6CBMG4U!C+>1?&2S1#]/WHH\.)'=%JM]DW[I]D"B]%IQAOW MY6%7K1B7-D38C2DF"O*7!T04@`,R<]'_QKTEI2;NC0<5QM2&9LO'7)76 M0SJ;YD,C&#@LV27!O]G+V*H(OHJAW(''8K6*2CWYT5I/-_$L29<580JE&M5: M\,;`,46S25T''6S:EF"XTVH!S7BG@%6IC/<%..JGPPAGD`NQ.5#!:_V@#<4I MKJJR]Z7W!2@.J$8->XBR,#A!(KU;^^2_5=4^9#SN?^Q]`8KIM:.2"<.%?+6[ M)`Z(4K:I$7&XV3;>T%+.:J^KJ;7A?1EF.J,6/FN[:T"KJ(*3616$*L\=E_3& M0'5$>28P!;&@]P4Z4*?%)&<_+8<(.LVKEARY3M+Z>IEVB9%#4>\+=#RM!;-: M(-UXYI@>.6P-N3Z+H#'#=8''RJA%0UVU">\+=&JAA4&O!1:V"F8'1<4G88@K M"-3]N8GKXXB](ZP_<+[8ZN@:^7F1BF*OMG["^P(^0&<6MEUJA,@Z2P,XXJ,OC\5RZ:?OQ#_"\QC/<$!O M;U273NFV*XEP0`_RCCVE'?1`Y;4#KA#$>R]"?3X1OLXC<=ZN6@/0[[J(ERDJ@BR0B4#)Z2I:_'WM45+^J\JKBSH<@RPC=Y>XHBTXG>N-"N0WH MD7*H;LX"H@/(C3%#$4_+KF?-&QS'GI,W*BZOU&S*^-:)TA=)EF?E\'ZFA7[7 MB=0JRTZKAD&6)]4>GS=[K+2,M6L9>A"WIY*S++97BQ-30>-2POL3F04R/Z@2 M=(^>.\SNA\)HEXE"C&=>G_266HU6H,>I"@GLD:@)THE1-YW-SOV(7B9]7""4 M3^CZ.Z\>R:4)7TE'$B+WV<5K&;;\CGWY0XC_V(KGI!.,AKXEM*1G0A;@5&/DN)UWPC+5CGM/Q[[&$,[]#&?3V5ZGWJO_59G\U1J`GO]-CGW5D3E1 MG:DN!T,?NYI7K]*IU[*6RGK0S\(9\*\$RHVQ`&9BM)$KP`IWLZM?J4X)J$QYPCKZ)->A@<^0ED^6*C(#R_EIZB;-5DOG1 M=':;Q/-;_(+"J@CV31Q$14ASD?>J8^MN&CKX-0\X4]_([^A&#=#/EO,.TNB[ M4LVNRT_)N!(><**^#ML*4&Q=[(3>06:(J)'Z4Y=DAQ0EY919OS`G=2T4I#W@ M@AIFNT@E6*T?!>]FS%;9BNOT/<5A*Q3RSH"K:6@/73D<6R]S0][*VZ:B-9/5 MJA1.8KMD%2*Z):L2=8GD^P2#UKRS`<8(37%NPD;#GO$?%WBUJNZI_8\?AU%Y M%)%I;"+4&O#.!A@^U("VMH:!1Q$G87F'-*N1:H27))+>V0"#BBJ8UL0//+IX MY:Q!H^5`'22$X\<-2JW&(9-9G-5*L_7ZG_. MOJ/E,TH%K$HDH1.9^(1QMI5R.`Z4A]Z=OHAS@\J2:,IKZ48".C]):QX68+#E M6P(-W^V6[#NM+U@^(E1E/SRM;5]_YZK6%'1.DH!4V?95':`;%T#8A62`-B&G MT3+;:.7O8MI@AM5N%WKMV;X!&*NGP MGD\/BFW!^$N.E=S:6IA0S7KC5ZTI:'_&O/B6"5(G=B[,>CXPX]"1JCY;4]H6 MMK_%_C..JM>,\TV'#<:A7I/0X]&L%E`;M`X$$#?HJO/;>ER&4^)Z!$5*GVTK MK_QK%8I2;`K:ZV]9.TH#9656J[)=SK54.SY^_U?]3C(?B89RHI4[?T>(?'I%T0OZGL3Y0C0EMFMXB(YK>\1.>$1Z M:O@'\M.GU\2:(=7M0;O(W=M/`Z@;3I>*]>' M?YT4HN1SLP:A'?[C6,X:J2/5-K7P3V;$S$LEL)\NM]`J]*:C>R,Z@-O9H^?] ML"/QAE,L")T%;]D::D2VZG$.9FM*3W\*@N^T034_H.06?)5=UU5M8HB;3AUL MP[Y)R,5W_JYPUU=!&GK/J$,EVQ@403IJ!TIWA16DH?=_BBQJFH!+EXJOBY1X M&+3.01Q>XS?Z3_+[Q'PAZ&V;(F<<9TL(:]@\TUL!!7'J'Y-9_DI4N>=-2BE7 MDH?>;[5B7QGAP.\A?_>)%F.4OC<5).5?(`6]KVK%N@27K8@>5/T/Y&=HD43A MS7*5)B]54KZ4:X$4]+,#K;B6X+(5A`/B^H&^(BUQW3??0#\HT-Y!WX$R\"FY MQ"(=EHVOH%\&V%&^@)]M;X?M/7W',5X62_DJV?P.O/3_'@66\HZ)8_+B*Y,M> MS39J#+R&OB)SN[2WQ.M$TM/>J[-UV6+!1,`6`*NEWY)#]CP@P.@(Z:2W`2XY M$E*]_0RL(GY'!.\AZ^QBZ3'SQ+@M&DP7$&&6E+==$B+KU*$3N]!N<#BZ3VH`9-Y>@]*'8XCAV2G%Z%N'7H1BO>VD8)[)Q.%SLG6?O%) M!9`3@[@);@OZ`:WJEQ]HKA".`[SRHYM8HTA0JW:AT[I5V.^ZG2,,ITM"K/>HITN`"BZ=(`PB9G)2)'&9PD&LN>GP*Q1?$,A![]T%;+'IE:(!?7N+LV)R M.CV-)>NF3`YZ&Z[,GC(:V(L+>O0]O29&]&WDH"]B6Z%O!XT+-6SU2B%`7]/6 M\G5VNSWP\B3Z=0]Z<4][HWX!18>7M`?*D6'I`^`(S#X'G$.G@SX/G"NSV@?` M,19%K@[Z//#=W>ZT+UFM#C\&N]]LX1!_T_^!EUS:177G+^4[=)X(V&UF"4,J M=.ZAZ%FL) MZ6P_OL,EC/,][%U9F>Y9=(F`]#&,7%V:F\X>4(Q>";XXO*(I0QGIV37Y6?Q" MP=\F/LN%U&L`]NZK`9=ZR-QXJ&UW=KJO5G\:SE5?$IM"L/=3]3A71`-=WX8S MCN]1BI-P.B/_/TO2I1\'B!@I)_U2(@%[,=1@I$J@N/&8V:Y=_HC]JD0+"FF" MGN2RN536&T$6I[,Q4'F@W"A2T]20@.?F9]X(LAR=&:4'_;=55P:6O88W*$F( MW_O2&T&6D3/CD`7!5ND7ZZ$=XMF1^6)G(KF)B8.-LOS!SUE#34W0&T$6>C-8 M0M40N5':A0_R:C9#`2T_0CR)@+(V5T_8E[3CC2"+P]E8854`VBJ\LDHR3)OO MA874-X/>+PGP2Y0%*5Y)R\(JR'LCR!IQ-BQ"!,Q6G940S6B%42+[K<`A=>TM M3/S?_?1/E-^G.$!K9U$TW7,^]\8#BTZ)<&SB%T,.YS>O6:H[70(I;SRG/_PT]:D6TFD),+O)L@*%9Y)YVZA-;SS,0) MB#<>>KAL#\N:X-9A,FB"A1-:62;2QC*PTY`W'EZ@S0#AVD2`:CSS+H[Z./V[ M'Q5H.ELO5U6G>;X\5\`;#R?6IH!D31=0N67AM1=J)R) MI;SQP&)M"G#6[+6.M(&^ME('C.25LO>^],;#BY6Q(*Q9;!T.8^RTCE@+IEP+ MZ#.UQ)9H6=W\':CH;/7C"B5@=C^$*/VR?6GO,4^"/\_?+R(_RV0E8`12T*5@ M#E7*'@<2",.^S_)(U%Z^TEQI@Y8C3V(::9&5-!#)01>'D3#&H5F&:-A$[Z&2 MWJ)@?@]=*T;*$9M:+I9A4UK[R-*[:#O?0=>2X7+!INZ@[TX4D"'PETE<3DX* ME2GVOH4N'*/)(+/_MG)+VYVE65Y"RU6F7G-4E\]]&?`Z,JV63A::@=\A;4*2 M+IJ''X.7CA%1PQFP3!##7BH?48I1-KE?]U5MZA5(01>589/$&9YB&"XP>V[$ M+%,*NMZ,/K-<&`.?>BMT%T;4,J7`Z]#H<\O',?#"-!6\2R-RF5+@A6OTR>7C M&'C5A@K>E1&Y3"GP:C?ZY/)Q@-U'MN\1WRK<+V=^#UX2QVBCPX?2TTMTAP<= MBA?.I8+@Q7'X7#`.*-7@.!%;VIUVJJR'29$ODI3>)!.,4[$@6/4<#?[8@U8! MEX/$W_OI-"UW_V%Y"+]^4U;9`'@-@)7HL6P(0GQNW'UG63XWET@N!%;MIY,I MH(')A8*LC12<60/E)A%.E!THE06K!=2:>35HMK9;5C/+RNY65GI9I/0)Z;(H M0--ZKY/TPL\6TYB;:*;5"%@I(6.:#3':VH'9YWL2A[NICX>(=B>SAH#0!MHT M#%NTJ)U=M,9MZ\(^Y.+`&2&EWW.'7LO_(CZN5)"'+8?49I%0AV?KVG\/C:$: M"RVL8:\!V$I)'9@#"Y^M\@&PGN,F04,C6B"0@JVVU,Y;%(.R50R@-]E'!E$" M!6G8VDN6#$`(SE8M`.!WS$037?G,N^DJ4`K#UFOJ;`788K-68^G+-V$>C;,(C"NIGH4U'M[1A MV&)1G8U\-=S6Z@A8GA4:MRMWJA\\)5?+592\(WXU8P51V&I0QK.$*C)K]0)Z MX_HI'@=P)&!+/5GU\1N`G"@:<`!P6N19[L,2ROG74HW:PBVEI3M`T$)3N#R`]T9BMKT()&$+1=E MVQ3V@5DK7M#+_7YIXYMSLD>4ON#`^#C@H!W8\E%='0NP85HKCP`Y1_R(4^1' M-.;YS$49R5='Y+R;@Q-1E!D[!EKCHS'AGBM1D- M.GZY7X\[2&GAQDD0I`6MW585(!+8C)(\;#FM-@:B#F]M#8/.8;PB^Z_D]1*5 MM=(%K.]\!UM:JPV[AS#6+'8193QF>2TZKU5=S\@NZK5.IPIA:FS1PN!10CM* MH_;;J?0!1?1P]R+)\FJR?::3;?T\5J90DZM=P\`UO)BKRX02-2_K!63G[]MO MZKY/").A1L6O=K\!71^L/;V<5=^F@H9]>?\!T;4MR$OGARIT$H?D;\1;1I(" M*A+)'E4@:\\QVXP4-#!LXW@B/T#?JFS`E!9@X(D7G>U=,>JTVTQ,R(9Z*ICNCS)L+AQPZ]: M*,BO2);+G>]Z5&.LJ\7Q`._02^$8*VJKB3B\C_SXSE\BZ3+:Q<]!5T([,`F. M=]X1]&'[8CI+B50&NG9:5Q1SHCPB-5BR"M"3`)DV>_"UZPSHYI639;9\UMJY]&$M-= M(2N]9ONWP*OQ=6]=W5@U6Y.6+'E5G2_G?IH/S5LX5,\?",\7.0HG9`ONS]'5 M&TH#G*'R,=CCF+JH!^`5"QT8`%+]VMK5#W]#%M_6E;ZL+D*=G6Y"G6Y"G6Y"G6Y"T?LA%*CLSM/ZFY_A=E,3JP/4 M2K-E&U^!WU5JZEY`S[:WPR;H.X[QLEA**=KY#OK>TAX#;)H.>NS$0V??_3XHX],'0(%+$?X)+5#PE;(H$3[*L6&ZV<]]1ODC" M)$KF[UTFBJO_.O05*SM69MF"]=3GQ`*YW8N)=?6LHJNKMQ4*R"[O":5+T2." MW?UH[^^+V3$]@=UWIE9WS-T6/VL5_3V)2#,1SM\?_+R3N+/ZKX/?80,?`-WK M]R?WM%G*>L#9G]2O@,N(0/Z"/C$%.AOGY.M7=P_VOO@#Z)#N"2JJGD M5#1'25?#+)H#^O9['TU>M<+EJ=H-9+4;T(?I>Q&;;=2]/)6I&4QL%JK:91\, M5[4^I>/U9>J7R$]IGJ4KS/*5YGM(\A_9:Z$^5_BE4P^FU MT%,BZ"D1E)T(NATOC8U0O0.2YH2J"+N;'JJ*_N?.%*VB8?7`S"9%ODA2_"_Q M*;SMWX+-%%6U$\OSCD@9P";)F8RVP?XJTC^=U2MY5=Z--PU)Q+V@'V86DN\W6O$+']F?NDO@%9?3LB;HNV5.2^U'SO],H M]EV2_P/EM>+$'F1GOPF<2M?.E>Q6*RXGT&EO5H!3U;K8"$,*"]K%`;MO*]S&R2YSN90KTBSD#^?A,3719EO'*:+U#ZM/#C M0R5P_:QC_#APCE<;G^QHZK&5_W5@FD=,EJGS"`@G^3O1*M%64&(-JVR98Z?) MU-VYI]UY:G1'(1%&)@J;ZL+KW?G[SG]13FO1:`\ZA46%&%F2BB;<89\4JX&5 MO8NDW$A_4EDT668;C1YP=RQ%FI%R^#%T/HD>57*Z74D5N5A@-"/>1E#D^(6, MBQG9SZ?29!&!%'2Z")LD-J$2&/T\W"I=Q29*+ENBSZ$3+51HDO4?^M"JTR58 M)=]&)@J>,G&4Y?;6H2>2.!`O"W1-M/N4["Q6QAL587/0CQBIL*QE'U*T3N35 MW"4YRN[]=SJ$&D`QRBXB/\OP#*/PHD@I`P*#T6@%^E4@4[;9MJ,)W(%,T$OT MG&\C4,V'**YF,Q10C^@>I0%E=BX*%&BU`_V2CEVCT89N:W7JC]U\]_,BQ<2' M(Z`O41:D>"4YYU*2!W]JIDM#$6&VE;\#&>C=O/3Q'?GT@S+"?0D3Y=WT97N[ M327"*Q+3B^Y*"^=>+.AI058;U%-RB5+\XM.Y0Z.6KD(CT+%9F4I9YRNZ^)Q8 MEM?(;K'_3)](HSZ(U'$3B4%%7F3,"RSLUC`Z47;F.P; MQMM_5QKY^T)0H=ANQCT+74^S MG2O[S*C]\L9SXQ.H4*RUP;J'!3H)N;_K<#]*PG2W#O_57J(Q=&47T1[F[*?; MQ%B&,RM!5KOS&L[5(G M\(=]LKU1Q?G[YA__!Z.4T+!XOT4O*)*DM:@U`)W28I5QB5%)%>&(Q33G_$/$ MTNP7K7:@$V/4R948ARI81VSD)EX5>58JZ$R:+R.0@LZ7T>9/8@9LA`X$YE@( M1T;,C_J1@M,A\R/[23I]HWYL1'TM!9V8TR'U#82=G64-;,]RJY#*9?5WH%-X MCNF3VM+7P!/'+OQL03#2_Z.7BU[\:&=(;S>1HJQ>U3:@4W^LD\^V,2U]..#A M;&-[E5Z5PIS5I]!Y/4>R"!9L%QR<"HW>;,&5`<_=.9(QB!5@S?FA=1-Z&`0' M*FX.'@KG'/DQ5:58_E!%=ECA:"U8_;QF`Y*V`9FHHTI7^VP->X%BJY46KMX" ME&6-GI->WZ=)@%#(Y5X),J#'C5@U4Z\P:/MO'?#0'S:OK$K,D799M`^6&UQUY0*N$+$]D M'R#W(WDBT!4_7E!3;@BM*3$)BZ*+$^69*J@VY\DGM\2&PJK+8M.Z0_] MAJ$]51%%[$'7'N^PSS0?"4?E//4-)?/47RUPX,N2([@RT/D0[#'0^@Y`G#K4B+'V@-D/!+_/DY7.0%'&>OE-FQ^M_H:2.&Z36 M?_9^/#+8V_Y'Z+0#H-VT2^B2]*V^FC3X&?E*^'5F3 ME&S1Q9J0[PA-FH,^/V_#/MN>3+7@1.F5-5J%^0?ZG-R4)_$LTC@&[X#)(X:F MOB4XGE\D<4`TH1V4XK@>S39E)X&L;ZT<3S8;5CR5%(A`A7B$.F+X1A((CDP^ MQ$QC%%[Y:4S09I,@*)9%>0QWB68XP.+Z8#)AT"-)"7^\24D%4UON>W%N4M8N M7R01@9)5)<6%$;O]CT$/*(VX96/H;,?)7'D^TY[1)]#)O_Q_4$L#!!0````( M`,>`<$<.)U@/_`L``(1Z```1`!P`;WAY_V;4%+M$U4$KTDE=CWZ6](2C8ED;)LIZA\RDLCBS/#F=]0PQE* M9#_]OHA"[PDS3FA\T>D?'7<\'/LT(/'THO-]=-?]K>/]_OGMFT_0*Q M*1;?4(3Y'/GXHC,38G[>ZST_/Q_1Q9(G#/,E%SCB1SZ->B?'_0_'9Z=2:H@C M'(L[RJ(;/$%)*"XZ?RT)YO'B&.315($8L5D,GSHZ<8<>5@A M_\\OT$%1.*E@(#$7*/;S"I6,2,WNGYV=]53K&I[S&$^1P(&SC[,>HR'NI61F M/PGO3A&:KS@GB(\55]J@G-$][G=/^Q:V+A+"S0J-C(P3@;G)ZM,D%FR9QYIC M_VA*GWIIH^SUM-RKGS`&H]?%F[9*YO=EY@`3.Q\T.%CPPI_9>62+`QH2/V$N M[&RZS6%=C(C/[7RJ2;+URVR<^'8F:'"P@(/$_@=PY1&L=)9!<4"-:3 MIO:`J`M4F!$_Q[N9T6"2$13%,15(0*#]_`G-YR2>4'E;/JKG4MT1,'GRXOO# M_:80J,R[H7XB8^IE'-S&@HCE/8ADD>JBXQ%`J))BU7F`)R0F2C&(F5[7R]C, M2Q0'GI;A&4(^]8H2,J$)Q\$@_JRNP64<9"@.&?Q2KI3$QK$66(_>1Z&?A.X. M>CF4]X/]FL8!CD'T%0IE6'Z<82RX!MS19H?Z!/!]!%1PBO6*V4NY/DRA";#F8/))I#"6-CV#2]56V"I74D(;$)SB=(VK2VEWS4<[) MA/LAE7I(/VEITAV&/&\MT,LDMM$OWRA4%T.T1.,0:_1S=^P8_ZN(L>+Q4J8V MPO@X@QEP1L,`,W[[=P))8#J4R_?MD/Y6&K8&YS\\S=M*9`7U?PSF:H:#+/T_ MB#%X?+-(X6BT8WQ6PEBR>RF_2N`S"6U$^@&'LFR$7$XL1X`"AV)0`J.A=K9: ML>X?%[%.^3TEP#,EM!'KP61BIN.7FBC#^\08?]&88*_8B0)%$C:2?8FNQ=.BEZ0 MS)[B]DSV-D+\B*?2]M*RC>6^'=S34LC7G&U?HOF#0N(+S[*/60II[HX=S/=% M,!6/ES*U$<9ZEK'6#-T4WTJPBLT)^4BEY'*M]JW,NY>R[DN%KMB)=*6$M^WVZT:R4O M-U@@$FZ5[V0L=K^4BMIM$IY4]*N_-H'?W\%A?8?'RI7R]A[S^J\^VX3_""_D MXMD.GLLX[?XK%>>[^"_MHI5>-&N*7#RT-=A]4*K*"]5&FP.;!<7[ M5%/;P6[UF"Z_?LS/],YF.^2E:MKVDK+=PUQ5NU07NU#K/J>E;I"#O9K&COU6 M=77K/5!>M"BD3!N([#[8X@5RZW.B2H!/ZGCAQ.Z%TU*57<<+)Z]>*`&<3T5K MD=H]4J[":WBDS?-RNB0WERMRPEB0RTT3FXCLOBA5WE7+?VV>)ZS+>[GTJ)+" MCGZIBG:N`+Y";P>VOQE[Q_1\6BJ!-X'?TKFY"MO__+;9MBC>Y@!D?NR2@]K68`>Y5`OG/H;YOX%7_B/W^C[@B:P!X`?%M[\CYJE#4A&F]K#;#@L'&&P+C>UI#" MH_"RYO2RG:MPM=[/"@U@"67"BZTG`[CVL^M#!;Y07XFI8)&_NAE?5][J]D^Z MI_VC!0^T8EOTO[)HR_XSONWZMY\54+/GC$%V^:%&9Y7;\QU]JOZLC#T<"I[= MZ:Y%U;6Z8EM[E2X6MO2ZNQ:QK0ZVDP/J*&'R93_V4<-V"$$M/4S&U:_N6LRV MFI2.**BCQ8I)7>TQ),HG%M3I?LVE+[MK`=LJ4#S]H$[W&8^\V*?KXED(M?K. MF-35=KUO.NZC3C`*&JT^'J*N-*>5V+60[ MY2K/&:DS*C(>>;%=+-AP9D4=&(I<>SC&?MK&=DK0^-LN>E2?;;+[G*ED62-D M>A22TJ7ZC([+,5?;D73U)C/#O^J1Z_12'2QT#O>@=+N'$E&6/AT/I507'<$2 MF7PJ*DCW"`U&BB](6+H;)29A*-\W9[0\`68B$MGZ!Z/)/.N$@/B.U_OLE>S[ M0GRY=_P.0Q;J8_(DQ5VKZ"'C;A<^YOP&.GV"KVD$ MJJE!><]Y@H.;1$:)H=)"+63JVW>4/6+V!$^G:?].W`O%K2[Z#P&*(EOJC<.I\$-PD!V&A/,!$;BN&/S(H/Z$PW6C\@.6LZ8-!LLT< M^74Y#F#.DHK*"&8^O):,HYJL09E&*2I!^!DR/`?=Z\0P&_5!C.)[N0B+0A5W M!Y/U_)L+3RZ20YBL=CD4P#*0]Q/3H(&^BR'R!>15"(-]3T`,.1H1?8CBN]/A5$#7-(%VO M99]XN6W:0-IQWY&_3`7484LM7_*H%I23>8&"/3,'8SZ2%, MI'>,<)]"31X1SBE;RCT%7W$TSJU45!'EQG!`(T3B7YCNQ4_R'25(,7=7#.*R M29M)#\"PT3.M:YA!VB3#'B"[5O7B8**TM;FJ@J;)IMB<4T'3)%-R`\<9[2NI M&A33OR42X<&D^&28ICA)3#M(+/`4LU\W/\.4D\BQ\X!C_`QHQ\'M0L#$`Q*@ M5)WJ%:4O%,7Y::HNSR$L/.O%AL$$_JJ7'"`?S+C!8W-D5A&91F;.^74>55[! M@53M'L!CB?[N46"&N7A``N>"QT;:-(A`!`&-?=F\D_M>P+"OB/W`8LB(C^5' M@W(,%LQQ4NQGQ(NZ9_4]\&"2)?%Z9O0(#"J(U)[ZR MJ918N`D/P=CR_L^*8F8S;8,F.<>;%V4$7ZUFRH5;2)^*+R'K\^4LUC2_KEJ5 MJAL[MUQ6#!F>8,;DR>=YAB(,^\EJ$C17,%5`^4U0N'YJ[S`2"3-]7TEU$.O< M1NQ-]]YIQXWH;30/Z1+GLKQ:U"]H]TLL-*6*E2J)8D.SRH?8,LO%W,B1:7U0'IR$(+$B51 M_J.-:LIF%0M.=4E(X M,*TQ7D)>+=*+1Q1B7GX=8F]O M4J0!%6UJ-U'5XL<@]D%42?5+QTY/[ZSX_/;-_P!02P$"'@,4````"`#'@'!' MN+%_H1B4```W=@@`$0`8```````!````I($`````;WAY`L``00E#@``!#D!``!02P$"'@,4````"`#'@'!'DL=U M:%$+``"XJ@``%0`8```````!````I(%CE```;WAY&UL550%``-&14I6=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`QX!P1Z7/ M6JB/'```F@0"`!4`&````````0```*2!`Z```&]X>7,M,C`Q-3`Y,S!?9&5F M+GAM;%54!0`#1D5*5G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`,>`<$<: MW8F.*U4``"@^!0`5`!@```````$```"D@>&\``!O>'ES+3(P,34P.3,P7VQA M8BYX;6Q55`4``T9%2E9U>`L``00E#@``!#D!``!02P$"'@,4````"`#'@'!' MZ#G/=E4O```W>P,`%0`8```````!````I(%;$@$`;WAY&UL550%``-&14I6=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`QX!P M1PXG6`_\"P``A'H``!$`&````````0```*2!_T$!`&]X>7,M,C`Q-3`Y,S`N M>'-D550%``-&14I6=7@+``$$)0X```0Y`0``4$L%!@`````&``8`&@(``$9. $`0`````` ` end XML 45 R16.htm IDEA: XBRL DOCUMENT v3.3.0.814
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2015
Summary of Significant Accounting Policies [Abstract]  
Schedule of inventories
  September 30,  December 31, 
  2015  2014 
       
Parts inventory $207,605  $133,477 
Work in process  45,120   41,114 
Finished goods  137,303   102,755 
Total inventories $390,028  $277,346 
Schedule of finite-lived intangible assets amortization expense
2015 $30,232 
2016  30,232 
2017  30,232 
2018  30,232 
Thereafter  188,982 
  $340,142 

XML 46 R34.htm IDEA: XBRL DOCUMENT v3.3.0.814
Fair Value Measurements (Details 1) - USD ($)
Sep. 30, 2015
Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash (1) [1] $ 2,006,312 $ 647,093
Derivatives (76,618)  
Total assets at fair value 1,929,694 647,093
Fair value measurements Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash (1) [1] $ 2,006,312 647,093
Derivatives  
Total assets at fair value $ 2,006,312 $ 647,093
Fair value measurements Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash (1) [1]
Derivatives $ (76,618)  
Total assets at fair value $ (76,618)
Fair value measurements Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash (1) [1]
Derivatives  
Total assets at fair value
[1] Included in Cash and cash equivalents on the Company's Balance Sheet.
XML 47 R21.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment Information (Tables)
9 Months Ended
Sep. 30, 2015
Segment Information [Abstract]  
Summary of revenue by geographic region

 

    Three Months Ended
September 30,
 
    2015     2014  
             
United States - product sales   $ 1,138,380     $ 814,619  
ROW - product sales     -       3,837  
                 
Totals   $ 1,138,380     $ 818,456  

 

 

    Nine Months Ended September 30,
    2015   2014
         
United States - product sales   $ 2,807,600     $ 1,793,729  
ROW - product sales     1,953       41,567  
ROW - license fees/service revenue     -       17,500  
                 
Totals   $ 2,809,553     $ 1,852,796  
 
XML 48 R26.htm IDEA: XBRL DOCUMENT v3.3.0.814
Notes Payable (Details Textual)
3 Months Ended 9 Months Ended
Mar. 22, 2011
USD ($)
Sep. 30, 2015
USD ($)
Sep. 30, 2014
USD ($)
Sep. 30, 2015
USD ($)
ConvertibleNotes
Sep. 30, 2014
USD ($)
ConvertibleNotes
shares
Notes Payable (Textual)          
Repayment of notes       $ 175,000 $ 192,000
Interest expense   $ 626,127 $ 169,051 1,519,071 362,638
Convertible Notes Payable [Member]          
Notes Payable (Textual)          
Fair value of warrants issued       251,363  
Conversion option intrinsic value       133,637  
Interest expense   270,361 0 $ 355,101 0
Ten Convertible Notes [Member]          
Notes Payable (Textual)          
Number of convertible notes | ConvertibleNotes       2  
Unamortized discount, new notes   222,500   $ 222,500  
Note payable, net (new notes)   1,683,500   1,683,500  
Convertible notes, cash value   $ 1,461,500   $ 1,461,500  
Maturity date of notes, description       Maturity dates of the notes range from January 7, 2016 to May 4, 2017.  
Market price discount rate       7.00%  
Ten Convertible Notes [Member] | Note One [Member]          
Notes Payable (Textual)          
Repayment of notes         175,000
Ten Convertible Notes [Member] | Notes Two [Member]          
Notes Payable (Textual)          
Repayment of notes         $ 237,298
Ten Convertible Notes [Member] | Minimum [Member]          
Notes Payable (Textual)          
Interest rate   8.00%   8.00%  
Ten Convertible Notes [Member] | Maximum [Member]          
Notes Payable (Textual)          
Interest rate   12.00%   12.00%  
Eight Convertible Notes [Member]          
Notes Payable (Textual)          
Number of convertible notes | ConvertibleNotes         2
Unamortized discount, new notes     62,500   $ 62,500
Note payable, net (new notes)     475,000   475,000
Convertible notes, cash value     $ 412,500   $ 412,500
Interest rate     12.00%   12.00%
Maturity date of notes, description         Maturity dates of the notes range from January 28, 2015 to September 10, 2015.
Market price discount rate         38.00%
Lease outstanding amount     $ 307,662   $ 307,662
Convertible note principal value     $ 150,000   $ 150,000
Convertible note issuance of common shares | shares         75,000
Eight Convertible Notes [Member] | Note One [Member]          
Notes Payable (Textual)          
Repayment of notes         $ 167,500
Eight Convertible Notes [Member] | Notes Two [Member]          
Notes Payable (Textual)          
Repayment of notes         $ 207,000
Promissory Note [Member]          
Notes Payable (Textual)          
Amount of renewal and extension forgivable loan $ 213,000        
Debt instrument, payment terms (i) the full payment of the economic incentives; or (ii) March 31, 2016.        
Period of performance for debt 5 years        
Unamortized discount, new notes   $ 4,897   $ 4,897  
Note payable, net (new notes)   $ 47,103   $ 47,103  
New debt instrument interest rate 12.34%        
XML 49 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (3,979,587) $ (1,158,177)
Adjustments to reconcile net loss to net cash from operating activities:    
Depreciation and amortization expense 33,239 35,462
Amortization of debt discount and beneficial conversion features 1,315,271 $ 254,944
Gain on forgiveness of debt (44,954)
Excess derivative over proceeds 251,363
Derivative liability fair value adjustment (342,257)
Expenses paid by related parties 137,150 $ 4,374
Warrants issued for services 11,025
Stock based compensation 119,083 $ 62,137
Common stock issued for services $ 147,363
Gain on extinguishment of debt $ (123,667)
Changes in operating assets and liabilities:    
Accounts receivable $ (461,020) (444,915)
Inventories (112,682) (11,618)
License fees receivable 59,830 36,692
Prepaid expenses and other current assets (38,159) $ 87,070
Other assets (30,455)
Accounts payable and accrued liabilities $ 266,363 $ 476,772
Deferred revenue (2,976)
NET CASH USED IN OPERATING ACTIVITIES $ (2,668,427) (783,900)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of property and equipment $ (8,624) (70,651)
Purchase of intangible assets (198)
NET CASH USED IN INVESTING ACTIVITIES $ (8,624) (70,849)
CASH FLOWS FROM FINANCING ACTIVITIES    
Common stock subscribed and issued for cash 80,001 $ 29,672
Preferred stock issued for cash and warrants 2,650,001
Cash received from related parties 43,917 $ 9,800
Payments made to related parties (113,500) (115,300)
Cash received from convertible notes payable 1,551,000 475,000
Payments made on convertible notes payable (175,000) (192,000)
Payments on capital leases (149) (1,440)
NET CASH PRODUCED BY FINANCING ACTIVITIES 4,036,270 205,732
Net change in cash and cash equivalents 1,359,219 (649,019)
Cash and cash equivalents, at beginning of period 647,093 657,673
Cash and cash equivalents, at end of period $ 2,006,312 8,654
Cash paid during the period for:    
Interest $ 12,996
Income taxes
Supplemental non-cash investing and financing activities:    
Conversion of preferred stock to common stock $ 371
Common stock issued for prepaid services $ 25,000
Conversion of convertible notes payable $ 1,234,730 $ 188,358
Beneficial conversion feature 843,515
Initial value of the derivative $ 165,200
XML 50 R10.htm IDEA: XBRL DOCUMENT v3.3.0.814
Related Party Transactions
9 Months Ended
Sep. 30, 2015
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 5 – RELATED PARTY TRANSACTIONS

 

A summary of the related party financings and notes as at September 30, 2015 is as follows:

 

Related party Julian Ross (1) 
Amount $222,417 
Stated interest rate  0%
Maturity  n/a 

 

(1) Our CEO, Mr. Ross provides us shareholder cash advances and other consideration from time to time to fund working capital.

XML 51 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814
Shareholders' Equity (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2014
Shareholders' Equity (Textual)          
Preferred stock, shares authorized 25,000,000   25,000,000   25,000,000
Preferred stock, par value $ 0.0005   $ 0.0005   $ 0.0005
Common stock issued for cash   $ 19,000 $ 80,001 $ 29,700  
Common stock issued for cash, shares   26,580 133,333 41,580  
Common stock, shares authorized 100,000,000   100,000,000   100,000,000
Common stock, par value $ 0.0004   $ 0.0004   $ 0.0004
Beneficial conversion features $ 434,983   $ 1,315,271    
Common stock issued upon conversion of convertible notes, Shares 1,767,650 360,781 3,719,350 444,072  
Fair value of options issued to employees $ 26,740   $ 132,651    
Common stock, Shares issued 33,488,420   33,488,420   28,436,930
Common stock, Shares outstanding 33,488,420   33,488,420   28,436,930
Change in value of derivative liabilities $ 219,673 $ 342,257  
Common stock issued for services 90,000   178,000    
Common stock issued for compensation 93,474   93,474    
Accrued interest   $ 150,858   $ 188,358  
Series A Preferred Stock [Member]          
Shareholders' Equity (Textual)          
Preferred Stock, shares issued 518,750   518,750   593,750
Preferred stock converted into common stock     91,500 100,000  
Common stock issued upon conversion of convertible preferred stock, Shares     75,000 122,000  
Preferred stock, shares outstanding 518,750   518,750   593,750
Series B Preferred Stock [Member]          
Shareholders' Equity (Textual)          
Preferred Stock, shares issued 750   750   1,145
Preferred stock converted into common stock 150   835,833    
Series B preferred authorized     3,500    
Common stock issued upon conversion of convertible preferred stock, Shares 313,296   395    
Preferred stock, shares outstanding 750   750   1,145
Series C Preferred Stock [Member]          
Shareholders' Equity (Textual)          
Preferred Stock, shares issued 770,000   770,000   0
Common stock issued for cash     $ 700,000    
Common stock issued for cash, shares     770,000    
Preferred stock converted to common stock, Shares        
Preferred stock subscription receivable $ 700,000   $ 700,000    
Preferred stock, shares outstanding 770,000   770,000   0
Series D Preferred Stock [Member]          
Shareholders' Equity (Textual)          
Preferred Stock, shares issued 1,050,000   1,050,000   0
Common stock issued for cash, shares     1,050,000    
Preferred stock converted to common stock, Shares        
Preferred stock, shares outstanding 1,050,000   1,050,000   0
Cash held in escrow $ 2,000,000   $ 2,000,000    
Series E Preferred Stock [Member]          
Shareholders' Equity (Textual)          
Preferred Stock, shares issued 531,666   531,666   0
Preferred stock converted to common stock, Shares        
Preferred stock, shares outstanding 531,666   531,666   0
Warrant [Member]          
Shareholders' Equity (Textual)          
Warrants issued for services $ 2,380   $ 11,025    
Common stock [Member] | Series A Preferred Stock [Member]          
Shareholders' Equity (Textual)          
Preferred stock, shares authorized 3,143,237   3,143,237    
Preferred stock, par value $ 1.00   $ 1.00    
Common stock [Member] | Series B Preferred Stock [Member]          
Shareholders' Equity (Textual)          
Preferred stock, par value $ 1,000   $ 1,000    
XML 52 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.0.814 html 101 214 1 true 31 0 false 5 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.oxysuresystems.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 002 - Statement - Condensed Balance Sheets Sheet http://www.oxysuresystems.com/role/CondensedBalanceSheets Condensed Balance Sheets Statements 2 false false R3.htm 003 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://www.oxysuresystems.com/role/CondensedBalanceSheetsParenthetical Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 004 - Statement - Statements of Operations (Unaudited) Sheet http://www.oxysuresystems.com/role/StatementsOfOperationsUnaudited Statements of Operations (Unaudited) Statements 4 false false R5.htm 005 - Statement - Condensed Statements of Cash Flows (Unaudited) Sheet http://www.oxysuresystems.com/role/CondensedStatementsOfCashFlowsUnaudited Condensed Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 006 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 6 false false R7.htm 007 - Disclosure - Notes Payable Notes http://www.oxysuresystems.com/role/NotesPayable Notes Payable Notes 7 false false R8.htm 008 - Disclosure - Shareholders' Equity Sheet http://www.oxysuresystems.com/role/ShareholdersEquity Shareholders' Equity Notes 8 false false R9.htm 009 - Disclosure - Stock Options and Warrants Sheet http://www.oxysuresystems.com/role/StockOptionsAndWarrants Stock Options and Warrants Notes 9 false false R10.htm 010 - Disclosure - Related Party Transactions Sheet http://www.oxysuresystems.com/role/RelatedPartyTransactions Related Party Transactions Notes 10 false false R11.htm 011 - Disclosure - Off Balance Sheet Arrangements and Contractual Obligations Sheet http://www.oxysuresystems.com/role/OffBalanceSheetArrangementsAndContractualObligations Off Balance Sheet Arrangements and Contractual Obligations Notes 11 false false R12.htm 012 - Disclosure - Fair Value Measurements Sheet http://www.oxysuresystems.com/role/FairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 013 - Disclosure - Segment Information Sheet http://www.oxysuresystems.com/role/SegmentInformation Segment Information Notes 13 false false R14.htm 014 - Disclosure - Going Concern Sheet http://www.oxysuresystems.com/role/GoingConcern Going Concern Notes 14 false false R15.htm 015 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPolicies 15 false false R16.htm 016 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPolicies 16 false false R17.htm 017 - Disclosure - Notes Payable (Tables) Notes http://www.oxysuresystems.com/role/NotesPayableTables Notes Payable (Tables) Tables http://www.oxysuresystems.com/role/NotesPayable 17 false false R18.htm 018 - Disclosure - Stock Options and Warrants (Tables) Sheet http://www.oxysuresystems.com/role/StockOptionsAndWarrantsTables Stock Options and Warrants (Tables) Tables http://www.oxysuresystems.com/role/StockOptionsAndWarrants 18 false false R19.htm 019 - Disclosure - Related Party Transactions (Tables) Sheet http://www.oxysuresystems.com/role/RelatedPartyTransactionsTables Related Party Transactions (Tables) Tables http://www.oxysuresystems.com/role/RelatedPartyTransactions 19 false false R20.htm 020 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.oxysuresystems.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.oxysuresystems.com/role/FairValueMeasurements 20 false false R21.htm 021 - Disclosure - Segment Information (Tables) Sheet http://www.oxysuresystems.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.oxysuresystems.com/role/SegmentInformation 21 false false R22.htm 022 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPoliciesTables 22 false false R23.htm 023 - Disclosure - Summary of Significant Accounting Policies (Details 1) Sheet http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPoliciesDetails1 Summary of Significant Accounting Policies (Details 1) Details http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPoliciesTables 23 false false R24.htm 024 - Disclosure - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual Summary of Significant Accounting Policies (Details Textual) Details http://www.oxysuresystems.com/role/SummaryOfSignificantAccountingPoliciesTables 24 false false R25.htm 025 - Disclosure - Notes Payable (Details) Notes http://www.oxysuresystems.com/role/NotesPayableDetails Notes Payable (Details) Details http://www.oxysuresystems.com/role/NotesPayableTables 25 false false R26.htm 026 - Disclosure - Notes Payable (Details Textual) Notes http://www.oxysuresystems.com/role/NotesPayableDetailsTextual Notes Payable (Details Textual) Details http://www.oxysuresystems.com/role/NotesPayableTables 26 false false R27.htm 027 - Disclosure - Shareholders' Equity (Details) Sheet http://www.oxysuresystems.com/role/ShareholdersEquityDetails Shareholders' Equity (Details) Details http://www.oxysuresystems.com/role/ShareholdersEquity 27 false false R28.htm 028 - Disclosure - Stock Options and Warrants (Details) Sheet http://www.oxysuresystems.com/role/Stockoptionsandwarrantsdetails Stock Options and Warrants (Details) Details http://www.oxysuresystems.com/role/StockOptionsAndWarrantsTables 28 false false R29.htm 029 - Disclosure - Stock Options and Warrants (Details 1) Sheet http://www.oxysuresystems.com/role/StockOptionsAndWarrantsDetails1 Stock Options and Warrants (Details 1) Details http://www.oxysuresystems.com/role/StockOptionsAndWarrantsTables 29 false false R30.htm 030 - Disclosure - Stock Options and Warrants (Details 2) Sheet http://www.oxysuresystems.com/role/StockOptionsAndWarrantsDetails2 Stock Options and Warrants (Details 2) Details http://www.oxysuresystems.com/role/StockOptionsAndWarrantsTables 30 false false R31.htm 031 - Disclosure - Stock Options and Warrants (Details Textual) Sheet http://www.oxysuresystems.com/role/StockOptionsAndWarrantsDetailsTextual Stock Options and Warrants (Details Textual) Details http://www.oxysuresystems.com/role/StockOptionsAndWarrantsTables 31 false false R32.htm 032 - Disclosure - Related Party Transactions (Details) Sheet http://www.oxysuresystems.com/role/Relatedpartytransactionsdetails Related Party Transactions (Details) Details http://www.oxysuresystems.com/role/RelatedPartyTransactionsTables 32 false false R33.htm 033 - Disclosure - Fair Value Measurements (Details) Sheet http://www.oxysuresystems.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.oxysuresystems.com/role/FairValueMeasurementsTables 33 false false R34.htm 034 - Disclosure - Fair Value Measurements (Details 1) Sheet http://www.oxysuresystems.com/role/FairValueMeasurementsDetails1 Fair Value Measurements (Details 1) Details http://www.oxysuresystems.com/role/FairValueMeasurementsTables 34 false false R35.htm 035 - Disclosure - Fair Value Measurements (Details Textual) Sheet http://www.oxysuresystems.com/role/FairValueMeasurementsDetailsTextual Fair Value Measurements (Details Textual) Details http://www.oxysuresystems.com/role/FairValueMeasurementsTables 35 false false R36.htm 036 - Disclosure - Segment Information (Details) Sheet http://www.oxysuresystems.com/role/SegmentInformationDetails Segment Information (Details) Details http://www.oxysuresystems.com/role/SegmentInformationTables 36 false false R37.htm 037 - Disclosure - Going Concern (Details) Sheet http://www.oxysuresystems.com/role/GoingConcernDetails Going Concern (Details) Details http://www.oxysuresystems.com/role/GoingConcern 37 false false All Reports Book All Reports Columns in cash flow ''Condensed Statements of Cash Flows (Unaudited)'' have maximum duration 9 months and at least 40 values. Shorter duration columns must have at least one fourth (10) as many values. Column '[2015-07-01 3m 2015-09-30]' is shorter (3 months) and has only 3 values, so it is being removed. Columns in cash flow ''Condensed Statements of Cash Flows (Unaudited)'' have maximum duration 9 months and at least 40 values. Shorter duration columns must have at least one fourth (10) as many values. Column '[2014-07-01 3m 2014-09-30]' is shorter (3 months) and has only 3 values, so it is being removed. oxys-20150930.xml oxys-20150930_cal.xml oxys-20150930_def.xml oxys-20150930_lab.xml oxys-20150930_pre.xml oxys-20150930.xsd true true XML 53 R20.htm IDEA: XBRL DOCUMENT v3.3.0.814
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2015
Fair Value Measurements [Abstract]  
Schedule of changes related to derivatives
Balance as of December 31, 2014 $31,010 
Additions related to embedded derivative of convertible notes issued  416,563 
Gain on decrease in value of derivative liabilities  (342,257)
Conversions  (28,698)
Balance as of September 30, 2015 $76,618
Schedule of assets measured at fair value on a recurring basis
     Fair value measurements at 
reporting date using:
 
  Total  Level 1  Level 2  Level 3 
             
Cash (1) $2,006,312  $2,006,312   -   - 
Derivatives  (76,618)  -   (76,618)  - 
Total assets at fair value as of September 30, 2015 $1,929,694  $2,006,312  $(76,618) $- 

 

(1) Included in Cash and cash equivalents on the Company's Balance Sheet.

 

  Total  Level 1  Level 2  Level 3 
             
Cash (1) $647,093  $647,093   -   - 
Total assets at fair value as of December 31, 2014 $647,093  $647,093   -   - 

 

(1) Included in Cash and cash equivalents on the Company's Balance Sheet.